0001410578-23-001629.txt : 20230809 0001410578-23-001629.hdr.sgml : 20230809 20230809161249 ACCESSION NUMBER: 0001410578-23-001629 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 70 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230809 DATE AS OF CHANGE: 20230809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Target Group Inc. CENTRAL INDEX KEY: 0001586554 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 463610035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55066 FILM NUMBER: 231155289 BUSINESS ADDRESS: STREET 1: 55 ADMINISTRATION ROAD, UNIT 13 CITY: VAUGHAN STATE: A6 ZIP: L4K-4G9 BUSINESS PHONE: 905-541-3833 MAIL ADDRESS: STREET 1: 55 ADMINISTRATION ROAD, UNIT 13 CITY: VAUGHAN STATE: A6 ZIP: L4K-4G9 FORMER COMPANY: FORMER CONFORMED NAME: Chess Supersite Corp DATE OF NAME CHANGE: 20140513 FORMER COMPANY: FORMER CONFORMED NAME: River Run Acquisition Corp DATE OF NAME CHANGE: 20130911 10-Q 1 tmb-20230630x10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

or

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-55066

TARGET GROUP INC.

(Exact name of registrant as specified in its charter)


Delaware	46-3621499
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

20 Hempstead Drive Hamilton, Ontario, Canada	L8W 2E7
(Address of principal executive officers)	(Zip Code)

+1 905-541-3833

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered under Section 12(b) of the Act:

None

Securities registered under Section 12(g) of the Act:

Common Stock, Par Value $0.0001

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “small reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each class		Trading symbol		Name of each exchange on which registered
N/A		N/A		N/A

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter was $4,627,695 as of June 30, 2023.

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of August 9, 2023, the registrant had 617,025,999 shares of Common Stock issued and outstanding.

Table of Contents

TABLE OF CONTENTS


PART I – FINANCIAL INFORMATION

Item 1.	Condensed Consolidated Interim Financial Statements (Unaudited)	3

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	14

Item 4.	Controls and Procedures	14

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	15

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	15

Item 3.	Defaults Upon Senior Securities	15

Item 4.	Mine Safety Disclosures	15

Item 5.	Other Information	15

Item 6.	Exhibits	16

Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS.

TARGET GROUP INC.

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

INDEX

Condensed Consolidated Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022	F-1

Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2023 and 2022 (Unaudited)	F-2

Condensed Consolidated Statements of Stockholders’ Deficit for the three and six months ended June 30, 2023 and 2022 (Unaudited)	F-3

Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (Unaudited)	F-7

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)	F-8 - F-28

Table of Contents

TARGET GROUP INC.

CONDENSED CONSOLIDATED BALANCE SHEETS


		June 30,		December 31,
		2023		2022
		$		$
		(unaudited)
ASSETS
Current assets
Cash			1,047,833		223,843
Restricted cash			8,686		8,490
Accounts receivable, no allowance			2,068		2,068
Inventory	Note 3		1,814,902		—
Prepaid asset			42,674		41,714
Sales tax recoverable, net of allowance	Note 4		1,034		—
Receivable from joint venture	Note 6		—		630,180
Other receivable	Note 8		3,777		3,692
Total current assets			2,920,974		909,987
Long term assets
Fixed assets	Note 5		5,773,235		5,554,225
Investment in joint venture	Note 6		—		775,577
Goodwill	Note 7		269,175		263,117
Operating lease right-of-use assets	Note 9		55,237		62,728
Total long term assets			6,097,647		6,655,647
Total assets			9,018,621		7,565,634

LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current liabilities
Bank overdraft			506		506
Accounts payable and accrued liabilities			2,823,400		2,296,935
Settlement payable	Note 1		—		—
Sales tax payable	Note 4		—		35,254
Payable to related parties, net	Note 8		5,061,467		4,468,535
Operating lease liability - Current portion	Note 9		118,047		110,586
Convertible promissory notes, net	Note 10		480		480
Derivative liability	Note 10		16,318		15,125
Total current liabilities			8,020,218		6,927,421

Long term liabilities
Payable to related parties, net - Non-current portion	Note 8		6,275,163		5,877,930
Operating lease liability - Non-current portion	Note 9		1,288,897		1,319,619
Warrant liability	Note 11		931		489
Total long term liabilities			7,564,991		7,198,038
Total liabilities			15,585,209		14,125,459

Stockholders’ deficiency
Preferred stock	Note 11		100		100
Common stock	Note 11		61,703		61,703
Shares to be issued	Note 11		175,293		175,182
Additional paid-in capital			24,985,697		24,985,697
Accumulated deficit			(30,565,571)		(30,783,678)
Accumulated comprehensive loss			(1,223,810)		(998,829)
Total stockholders’ deficiency			(6,566,588)		(6,559,825)
Total liabilities and stockholders’ deficiency			9,018,621		7,565,634
Contingencies and commitments	Note 13		—		—

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

F-1

Table of Contents

TARGET GROUP INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)


		For the	For the	For the	For the
		three months ended	three months ended	six months ended	six months ended
		June 30, 2023	June 30, 2022	June 30, 2023	June 30, 2022
		$	$	$	$

REVENUE		758,984	—	758,984	—
COST OF GOOD SOLD		(369,261)	—	(369,261)	—
Gross profit		389,723	—	389,723	—
OPERATING EXPENSES
Advisory and consultancy fee		15,883	7,454	16,106	18,693
Management services fee		77,191	55,631	155,515	83,516
Salaries and wages		(53,083)	(8,056)	(53,083)	9,775
Legal and professional fees		145,987	105,647	203,927	172,591
Depreciation expense		229,568	225,335	442,254	452,959
Operating lease expense	Note 9	28,400	(10,378)	17,310	(33,905)
Office and general		56,502	(89,143)	59,131	(68,946)
Total operating expenses		500,448	286,490	841,160	634,683

OTHER EXPENSES (INCOME)
Change in fair value of derivative and warrant liability		4,301	834	1,326	(16,812)
Gain on settlement		(1,428,185)	—	(1,428,185)	—
Interest and bank charges		369,092	272,373	722,698	561,061
Exchange loss (income)		48,519	(76,027)	50,794	(41,993)
Other income	Note 6	(12,507)	(637,591)	(16,782)	(697,776)
Recovery of sales tax recoverable		—	(1,750)	—	(2,259)
Share of (income) loss from joint venture	Note 6	(68,115)	(104,923)	(24,152)	(151,048)
Debt issuance cost	Note 8	12,354	12,994	24,757	26,243
Total other expense (income)		(1,074,541)	(534,090)	(669,544)	(322,584)

Net income (loss) before income taxes		963,816	247,600	218,107	(312,099)
Income taxes		—	—	—	—
Net income (loss)		963,816	247,600	218,107	(312,099)

Foreign currency translation adjustment		(222,962)	(27,220)	(224,981)	(17,345)
Comprehensive income (loss)		740,854	220,380	(6,874)	(329,444)

Earnings (loss) per share - basic		0.0016	0.0004	0.0004	(0.0005)
Weighted average shares - basic		617,025,999	617,025,999	617,025,999	617,025,999
Earnings (loss) per share - diluted		0.0010	0.0003	(0.0000)	(0.0004)
Weighted average shares - diluted		727,426,007	773,218,857	727,426,007	773,218,857

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

F-2

Table of Contents

TARGET GROUP INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED) FOR THE THREE MONTHS ENDED June 30, 2023


							Stock	Additional		Accumulated
	Preferred stock		Common stock		Shares to be issued		subscription	paid-in	Accumulated	comprehensive
	Shares	Amount	Shares	Amount	Shares	Amount	receivable	capital	deficit	loss	Total
	#	$	#	$	#	$	$	$	$	$	$
As at March 31, 2023	1,000,000	100	617,025,999	61,703	1,594,648	175,245	—	24,985,697	(31,529,387)	(1,000,848)	(7,307,490)

Shares issued as consideration for consideration of the intellectual property rights [Note 11]	—	—	—	—	15,624	48	—	—	—	—	48

Net loss	—	—	—	—	—	—	—	—	963,816	—	963,816

Foreign currency translation	—	—	—	—	—	—	—	—	—	(222,962)	(222,962)

As at June 30, 2023	1,000,000	100	617,025,999	61,703	1,610,272	175,293	—	24,985,697	(30,565,571)	(1,223,810)	(6,566,588)

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

F-3

Table of Contents

TARGET GROUP INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED) FOR THE THREE MONTHS ENDED June 30, 2022


							Stock	Additional		Accumulated
	Preferred stock		Common stock		Shares to be issued		subscription	paid-in	Accumulated	comprehensive
	Shares	Amount	Shares	Amount	Shares	Amount	receivable	capital	deficit	loss	Total
	#	$	#	$	#	$		$	$	$	$
As at March 31, 2022	1,000,000	100	617,025,999	61,703	1,532,152	174,875	—	24,985,697	(26,823,313)	(1,100,845)	(2,701,783)

Cancellation of shares [Note 11]	—	—	—	—	—	—	—	—	—	—	—

Shares issued as consideration for consideration of the intellectual property rights [Note 11]	—	—	—	—	15,624	114	—	—	—	—	114

Net income	—	—	—	—	—	—	—	—	247,600	—	247,600

Foreign currency translation	—	—	—	—	—	—	—	—	—	(27,220)	(27,220)

As at June 30, 2022	1,000,000	100	617,025,999	61,703	1,547,776	174,989	—	24,985,697	(26,575,713)	(1,128,065)	(2,481,289)

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

F-4

Table of Contents

TARGET GROUP INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED) FOR THE SIX MONTHS ENDED JUNE 30, 2023


							Stock	Additional		Accumulated
	Preferred stock		Common stock		Shares to be issued		subscription	paid-in	Accumulated	comprehensive
	Shares	Amount	Shares	Amount	Shares	Amount	receivable	capital	deficit	loss	Total
		$		$		$		$	$		$
As at December 31, 2022	1,000,000	100	617,025,999	61,703	1,579,024	175,182	—	24,985,697	(30,783,678)	(998,829)	(6,559,825)

Shares issued as consideration for consideration of the intellectual property rights [Note 11]	—	—	—	—	31,248	111	—	—	—	—	111

Net loss	—	—	—	—	—	—	—	—	218,107	—	218,107

Foreign currency translation	—	—	—	—	—	—	—	—	—	(224,981)	(224,981)

As at June 30, 2023	1,000,000	100	617,025,999	61,703	1,610,272	175,293	—	24,985,697	(30,565,571)	(1,223,810)	(6,566,588)

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

F-5

Table of Contents

TARGET GROUP INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED) FOR THE SIX MONTHS ENDED JUNE 30, 2022


							Stock	Additional		Accumulated
	Preferred stock		Common stock		Shares to be issued		subscription	paid-in	Accumulated	comprehensive
	Shares	Amount	Shares	Amount	Shares	Amount	receivable	capital	deficit	loss	Total
		$		$		$		$	$		$
As at December 31, 2021	1,000,000	100	617,025,999	61,703	1,516,528	174,722	—	24,985,697	(26,263,614)	(1,110,720)	(2,152,112)

Shares issued as consideration for consideration of the intellectual property rights	—	—	—	—	31,248	267	—	—	—	—	267

Net income	—	—	—	—	—	—	—	—	(312,099)	—	(312,099)

Foreign currency translation	—	—	—	—	—	—	—	—	—	(17,345)	(17,345)

As at June 30, 2022	1,000,000	100	617,025,999	61,703	1,547,776	174,989	—	24,985,697	(26,575,713)	(1,128,065)	(2,481,289)

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

F-6

Table of Contents

TARGET GROUP INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)


	For the	For the
	six months ended	six months ended
	June 30, 2023	June 30, 2022
	$	$
OPERATING ACTIVITIES

Net (loss) for the period	218,107	(312,099)

Adjustment for non-cash items
Change in fair value of derivative and warrant liability	1,326	(16,812)
Gain on settlement	(1,428,185)	—
Shares and warrants issued/to be issued for services	409	420
Allowance of sales tax recoverable	—	(2,259)
Depreciation expense	442,254	452,959
Operating lease expense	119,562	134,199
Investment (income) loss from joint venture	(24,152)	(151,048)
Debt issuance cost	24,757	26,243

Changes in operating assets and liabilities:
Change in sales tax recoverable	(36,448)	(12,058)
Change in accounts payable and accrued liabilities	534,095	(1,150,218)
Change in operating lease liability, net	(160,553)	(168,507)
Net cash (used in) operating activities	(308,828)	(1,199,180)

INVESTING ACTIVITIES
Amounts invested on fixed assets	5,821	(321)
Net proceeds from joint venture	439,640	1,190,277
Net cash provided by investing activities	445,461	1,189,956

FINANCING ACTIVITIES
Utilization of bank overdraft facility	—	83,163
Proceeds from loans from related parties	667,846	78,660
Settlement of related party loan	—	(139,599)
Payment for settlement payable	—	(10,000)
Net cash provided by financing activities	667,846	12,224

Net increase (decrease) in cash and restricted cash during the year	804,479	3,000
Effect of foreign currency translation	19,707	(2,019)
Cash and restricted cash, beginning of year	232,333	122,151
Cash and restricted cash, end of year	1,056,519	123,132

NON-CASH INVESTING AND FINANCING ACTIVITIES
Shares issued as consideration for services	114	114

SUPPLEMENTARY CASH FLOW INFORMATION
Cash paid for interest	—	2,084,621
Cash paid for taxes	—	—

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

F-7

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

1. Organization, Nature of Business, Going Concern and Management Plans

Organization and Nature of Business

Target Group Inc. (“Target Group” or “the Company”) was incorporated on July 2, 2013, under the laws of the state of Delaware to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions.

Target Group Inc. is a diversified and vertically integrated, progressive company with a focus on both national and international presence. The Company owns and operates Canary Rx Inc, a Canadian licensed producer, regulated under The Cannabis Act (Bill C-45). Canary Rx Inc, operates a 44,000 square foot facility located in Norfolk County, Ontario, and has partnered with Dutch breeder, Serious Seeds B.V. (“Serious Seeds”), to cultivate exclusive & world-class proprietary genetics. The Company has begun structuring multiple international production and distribution platforms and intends to continue rapidly expanding its global footprint as it focuses on building an iconic brand portfolio whose focus aims at developing cutting-edge intellectual property among the medical and recreational cannabis markets. Target Group is committed to building industry-leading companies that transform the perception of cannabis and responsibly elevate the overall consumer experience.

The Company’s current business is to produce, manufacture, distribute, and conduct sales of cannabis products. As of the current period end, the company has produced and sold cannabis products of $791,285 (Period ended June 30, 2022: $2,109,626) through its investment in a joint venture.

On July 3, 2018, the Company filed an amendment in its articles of incorporation to change its name to Target Group Inc. The Company was able to secure an OTC Bulletin Board symbol CBDY from the Financial Industry Regulatory Authority (FINRA).

Visava Inc./Canary Rx Inc.

The Exchange Agreement provides that, subject to its terms and conditions, the Company issued to the Visava shareholders an aggregate of 25,500,000 shares of the Company’s Common Stock in exchange for all of the issued and outstanding common stock held by the Visava shareholders. In addition, to its common stock the Company issued to the Visava shareholders, prorata Common Stock Purchase Warrants (“Visava Warrants”) purchasing an aggregate of 25,000,000 shares of the Company’s Common Stock at a price per share of $0.10 for a period of two years following the issuance date of the Warrants. Upon the closing of the Exchange Agreement, the Visava shareholders held approximately 46.27% of the issued and outstanding Common Stock of the Company and Visava continues its business operations as a wholly-owned subsidiary of the Company. The transaction was closed effective August 2, 2018. During the year ended December 31, 2020, all of the Visava Warrants expired, none were exercised.

CannaKorp Inc.

Effective January 25, 2019, the Company entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with CannaKorp Inc., a Delaware corporation (“CannaKorp”). The Company had previously entered into a Letter of Intent with CannaKorp dated November 30, 2018, which was disclosed in the Company’s report on Form 8-K filed December 4, 2018.

The Exchange Agreement provided that, subject to its terms and conditions, the Company issued to the CannaKorp shareholders an aggregate of 30,407,412 shares of the Company’s common stock, based on a price per share of $0.10, in exchange for 100% of the issued and outstanding common stock of CannaKorp held by the CannaKorp shareholders. In addition, the Company issued Common Stock Purchase Warrants (“CannaKorp Warrants”) in exchange for all outstanding and promised CannaKorp stock options. The CannaKorp Warrants granted the holders thereof the right to purchase up to approximately 7,211,213 shares of the Company’s common stock. The Company also assumed all outstanding liabilities of CannaKorp. Upon the closing of the Exchange Agreement, CannaKorp continued its business operations as a subsidiary of the Company. The transaction was closed effective March 1, 2019. During the year ended December 31, 2021, all of the CannaKorp Warrants expired, none were exercised.

F-8

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

cGreen, Inc. Exclusive License Agreement

Effective August 8, 2019, the Company entered into an Exclusive License Agreement (“License Agreement”) with cGreen, Inc., a Delaware corporation (“cGreen”). The License Agreement grants to the Company an exclusive license to manufacture and distribute the patent-pending THC antidote True Focus^TM in the United States, Europe and the Caribbean. The term of the license was ten (10) years and four (4) months from the effective date of August 8, 2019. In consideration of the license, the Company would issue 10,000,000 shares of its common stock as follows: (i) 3,500,000 within ten (10) days of the effective date; (ii) 3,500,000 shares on January 10, 2020; and (iii) 3,000,000 shares not later than June 10, 2020. In addition, the Company would pay cGreen royalties of 7% of the net sales of the licensed products and 7% of all sublicensing revenues collected by the Company. The Company would pay cGreen an advance royalty of $300,000 within ten (10) days of the effective date; $300,000 on January 10, 2020; and $400,000 on or before June 10, 2020, and $500,000 on or before November 10, 2020. All advance royalty payments would be credited against the royalties owed by the Company through December 31, 2020. During the quarter ended December 31, 2019, the intangible asset was written off based on management’s review and evaluation of its recoverability.

During the quarter ended June 30, 2020, the Company was in arbitration with cGreen for the breaches of the terms of the License Agreement, however, through an early mediation, both companies reached a settlement agreement to settle the breaches of the contract on July 27, 2020 (“Effective Date”). As per the settlement agreement, the License Agreement was terminated and the Company did not have to issue the 10 million shares nor pay the outstanding royalty payable in the amount of $1,191,860. As consideration, the Company paid $130,000 within 30 days of the Effective Date and started paying $100,000 in monthly installments of $10,000 commencing in April 2021 to cGreen resulting in a gain on settlement in the amount of $1,704,860. As at June 30, 2023, there was no outstanding balance, the balance has been paid in full and the claim was closed during the quarter ended March 31, 2022 (December 31, 2021: $10,000).

Joint Venture Agreement Termination

Effective May 14, 2020, Canary entered into a Joint Venture Agreement (“Joint Venture”) with 9258159 Canada Inc., a corporation organized under the laws of the Province of Ontario, Canada (referred to as “Thrive”) and 2755757 Ontario Inc., a corporation organized under the laws of the Province of Ontario, Canada (referred to as “JVCo”). Canary and Thrive each hold 50% of the voting equity interest in JVCo. The term of the Joint Venture is five (5) years from its effective date of May 14, 2020.

On April 27, 2023, Canary and Thrive Cannabis entered into a Release and Settlement Agreement (“Settlement Agreement”) in which Thrive Cannabis has transferred its shares in the capital of JVCo and rights of assets held by JVCo.

Pursuant to the above Settlement Agreement, Thrive Cannabis paid Canary $1,051,000 to release Thrive Cannabis from any mortgages, charges, pledges, security interests, liens, encumbrances, writs of execution, actions, claims, demands and equities of any nature related to JVCo from their share of ownership of JVCo.

The Company was accounting for the JV transactions using the equity method under ASC 323 Investments — Equity Method and Joint Ventures. As a consequence of the above agreement, as the joint venture (a separate legal entity) has become a subsidiary of the company as of April 27, 2023, therefore, the company will use the acquisition method of accounting (using a step acquisition method) under ASC 805 Business Combination.

Following the completion of the Settlement Agreement, Canary’s equity interest in JVCo increased from 50% to 100%. Effective April 28, 2023, the Company started consolidating result’s of operations of the JVCo and eliminated any intercompany transactions and balances between the Company (Target and Canary) and JVCo.

CL Investors Debt Purchase and Assignment Agreement

On June 15, 2020, the Company, its first–tier subsidiaries Visava Inc. (“Visava”) CannaKorp Inc. (“CannaKorp”), and the Company’s second-tier subsidiary, Canary Rx Inc. (“Canary”), entered into a Debt Purchase and Assignment Agreement (“Agreement”) with CL Investors Inc. (“CLI”), a corporation organized under the laws of the Province of Ontario, Canada. While June 15, 2023 was the preliminary date of the agreement and the agreement was not finalized until the later date as indicated below. The CEO and director of the Company is a shareholder and the Secretary of CLI, and the brother of the CEO is the President and sole director of CLI therefore the below loan from CLI is classified under related party transactions.

F-9

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Pursuant to the Agreement, CLI purchased from the Company for the sum of $2,190,370 (CAD $2,900,000) a debt obligation owing from Canary to the Company in the principal balance of $8,006,180 (CAD $10,600,000 (“Canary Debt”)). Upon receipt of the consideration, the Company loaned the full sum to Canary under terms of an unsecured, non-interest-bearing promissory note, subject to a covenant by the Company not to take any collection action so long as the Canary Debt remains unpaid to CLI. As of June 30, 2023, $3,777 (CAD $5,000) is still outstanding from CLI which is presented as other receivable on the unaudited condensed consolidated interim balance sheet.

As a condition of the closing of the Agreement, the terms of the Canary Debt were amended to provide for interest at 5% per annum with a maturity date of 60 months from the date of the Agreement (“Term”). The Canary Debt will be repaid according to the following schedule:

In the first year of the Term, Canary will pay CLI the greater of $853,489 (CAD 1,130,000) and fifty percent (50%) of the Net Revenue (hereinafter defined), provided that where the latter amount exceeds the former amount, Canary will, by the end of such first year, pay CLI no less than the former amount and Canary will, within thirty (30) days following the end of such first year, pay CLI the balance of such amount owing for such first year;

In the second year of the Term, Canary will pay CLI the greater of $1,586,130 (CAD 2,100,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2021, provided that where the latter amount exceeds the former amount, Canary will, within thirty (30) days following the end of such second year, pay CLI the balance of such amount owing for such second year;

In the third year of the Term, Canary will pay CLI the greater of $2,432,066 (CAD 3,220,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2022, provided that where the latter amount exceeds the former amount, Canary will, by the end of such third year, pay CLI no less than the former amount and Canary will, within thirty (30) days following the end of such third year, pay CLI the balance of such payments owing for such third year;

In the fourth year of the Term, Canary will pay CLI the greater of $2,326,324 (CAD 3,080,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2023, provided that where the latter amount exceeds the former amount, Canary will, within thirty (30) days following the end of such fourth year, pay CLI the balance of such amount owing for such fourth year; and

In the fifth year of the Term, Canary will pay CLI the balance owing under this Note, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2024, for an amount calculated by dividing twelve (12) into the sum of all amounts owing under this Note at the beginning of the fifth year of the Term on account of Principal and Interest, provided that where further amounts are owing under this Note at the end of such fifth year, Canary will pay CLI all such further amounts within five (5) days following the end of such fifth year.

For the purpose of this Note, “Net Revenue” will mean any and all revenue generated from Canary’s Licensed Facility (hereinafter defined) to which it is entitled to net of applicable taxes and third-party expenses.

The repayment of the Canary Debt, as amended, is guaranteed by Visava and the Company’s wholly-owned subsidiary CannaKorp. and secured by (i) a general security interest in the assets of the Company, Canary, Visava and CannaKorp., respectively; and (ii) a pledge by the Company of all of the issued and outstanding common stock of Canary, Visava and CannaKorp. held by the Company. In addition to the foregoing guarantees, security interest and stock pledge, CLI has been granted an option, in lieu of repayment of the amended Canary Debt, to demand, in its sole and absolute discretion the transfer, assignment and conveyance of 75% of the issued and outstanding capital stock of Visava and Canary. Furthermore, the President and sole director of CLI has been granted an option to acquire the remaining 25% of the issued and outstanding capital stock of Visava and Canary.

F-10

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

issued Common Stock Purchase Warrant for 10,000,000 shares of Target common stock to CLI as consideration for the Agreement (“CLI Warrants”). Refer to Note 11 for additional details on the CLI Warrants. The combined impact of both transactions resulted in debt issuance cost of $251,518. This debt issuance cost will be amortized over the term of the debt on a straight-line basis.

The transactions contemplated by the Agreement and the Amendment closed on August 14, 2020.

Going Concern

The Company has earned minimal revenue since inception to date and has sustained operating losses during the six months ended June 30, 2023. The Company had a working capital deficit of $5,099,244 and an accumulated deficit of $30,565,571 as of June 30, 2023. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations and/or obtaining additional financing from its members or other sources, as may be required.

The unaudited accompanying condensed consolidated interim financial statements have been prepared assuming that the Company will continue as a going concern up to at least 12 months from the balance sheet date; however, the above condition raises substantial doubt about the Company’s ability to do so. The unaudited condensed consolidated interim financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

In order to maintain its current level of operations, the Company will require additional working capital from either cash flow from operations, sale of its equity or issuance of debt. If the Company is unable to acquire additional working capital, it will be required to significantly reduce its current level of operations.

2. Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

The unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and the rules and regulations of the SEC and are expressed in US dollars. Accordingly, the unaudited condensed consolidated interim financial statements do not include all information and footnotes required by US GAAP for complete annual financial statements. The unaudited condensed consolidated interim financial statements reflect all adjustments, consisting of only normal recurring adjustments, considered necessary for a fair presentation. Interim operating results are not necessarily indicative of results that may be expected for the year ending December 31, 2023, or for any other interim period. The unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements of the Company and the notes thereto as of and for the year ended December 31, 2022.

The unaudited condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Visava Inc./Canary Rx Inc/ CannaKorp, Inc and JVCo. Significant intercompany accounts and transactions have been eliminated.

Use of Estimates

The preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.

Cash

The Company places its cash with high-quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation (FDIC) limit as of June 30, 2023 and June 30, 2022.

F-11

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Cash and cash equivalents include cash on hand and deposits at banking institutions as well as all highly liquid short-term investments with original maturities of 90 days or less. The Company did not have cash equivalents as of June 30, 2023 and 2022.

Restricted cash represents deposits made to the Company’s bank as a requirement to use the bank’s credit card which is not available for immediate or general business use.

Fixed Assets

Fixed assets are reported at cost, less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of assets, commencing when the assets become available for productive use, based on the following estimated useful lives:

Depreciation is calculated using the following terms and methods:


Furniture & office equipment	Straight-line	7 years
Machinery & equipment	Straight-line	3-5 years
Software	Straight-line	3 years
Leasehold improvements	Straight-line	Lease period

An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising from the derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the profit or loss in the period the asset is derecognized. The assets’ residual values, useful lives and methods of depreciation are reviewed at each reporting date, and adjusted prospectively, if appropriate.

Fair Value of Financial Instruments

The Company follows guidance for accounting for fair value measurements of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the unaudited condensed consolidated interim financial statements on a recurring basis. Additionally, the Company adopted guidance for fair value measurement related to nonfinancial items that are recognized and disclosed at fair value in the unaudited condensed consolidated interim financial statements on a nonrecurring basis. The guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements).

The three levels of the fair value hierarchy are as follows:

●

Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

●

Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

●

Level 3 inputs are unobservable inputs for the asset or liability. The carrying amounts of financial assets such as cash approximate their fair values because of the short maturity of these instruments.

The estimated fair value of cash and accounts payable and accrued liabilities approximate their carrying values due to the short-term maturity of these instruments. The derivative liabilities of the promissory convertible notes and warrant liabilities are valued Level 3, refer to Note 10 and 11 for further details.

F-12

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Revenue recognition

The Company adopted ASC 606 effective January 1, 2019, using the modified retrospective method after electing to delay the adoption of the accounting standard as the Company qualified as an “emerging growth company”. Since the Company did not have any contracts as of the effective day, therefore, there was no material impact on the consolidated financial statements upon adoption of the new standard. Revenue is recognized when performance obligations under the terms of the contracts with our customers are satisfied. Our performance obligation generally consists of the promise to sell our finished products to our customers, wholesalers, distributors or retailers. Control of the finished products is transferred upon shipment to, or receipt at, our customers’ locations, as determined by the specific terms of the contract. Once control is transferred to the customer, we have completed our performance obligation, and revenue is recognized.

The Company generated revenue of $758,984 during the six month ended June 30, 2023 whereas $nil in June 30, 2022.

In addition, Canary generated revenue of $791,285 (though its investment in JVCo) during the six months ended June, 30 2023 (six months ended June 30, 2022: $2,109,626) and is represented as a share of income (losses) from joint venture on the unaudited condensed consolidated interim statement of operations. The revenue was concentrated to eight customers (2022: three). The revenue represents the sale of cannabis products. Since the customers have received the product and there are no further obligations as per the agreement, revenue was recognized. Refer to Note 6 for additional details.

Equity Method Investments

The Company uses the equity method of accounting for investments when the Company has the ability to significantly influence, but not control, the operations or financial activities of the investee. As part of this evaluation, the Company considers the participating and protective rights in the venture as well as its legal form. The Company records the equity method investments at cost and subsequently adjust their carrying amount each period for the Company’s share of the earnings or losses of the investee and other adjustments required by the equity method of accounting. Distributions received from the equity method investments are recorded as reductions in the carrying value of such investments and are classified on the unaudited condensed consolidated interim statements of cash flows pursuant to the cumulative earnings approach. Under this approach, distributions received are considered returns on investment and are classified as cash inflows from operating activities unless the cumulative distributions received, less distributions received in prior periods that were determined to be returns of investment, exceed the cumulative equity in earnings recognized from the investment. When such an excess occurs, the current period distributions up to this excess are considered returns of investment and are classified as cash inflows from investing activities.

The Company monitors equity method investments for impairment and records reductions in their carrying values if the carrying amount of an investment exceeds its fair value. An impairment charge is recorded when such impairment is deemed to be other than temporary. To determine whether an impairment is other than temporary, we consider our ability and intent to hold the investment until the carrying amount is fully recovered. Circumstances that indicate an impairment may have occurred include factors such as decreases in quoted market prices or declines in the operations of the investee. The evaluation of the investment for potential impairment requires us to exercise significant judgment and to make certain assumptions. The use of different judgments and assumptions could result in different conclusions. The Company has recorded no impairment losses related to our equity method investments during the six months ended June 30, 2023, and 2022.

Recently Issued Accounting Standards

The FASB recently issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, which requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to

F-13

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. The amendments in ASU 2020-06 are effective for public entities for fiscal years beginning after December 15, 2021, with early adoption permitted (for “emerging growth company” beginning after December 15, 2023). The Company will be evaluating the impact this standard will have on the Company’s unaudited condensed consolidated interim financial statements.

3. Inventory

As of June 30, 2023, the inventory in the amount of $1,814,902 (2022: $nil) consists of work-in-progress and finished cannabis goods which is transferred from JVCo to Canary as a result of the JV Settlement Agreement, refer to Note 6 for additional detail.

4. Sales Tax Recoverable and Payable

As of June 30, 2023, the Company had $1,034 of gross sales tax recoverable compared to December 31, 2022 there was $nil, while the Company had $nil of gross sales tax payable as of June 30, 2023.

Recoverable is due to the sales tax paid by the Company on expenses incurred during the year which are recoverable from the government while payable is due to the sales tax received (after deducting sales tax paid on expenses incurred by the Company) during the year which are payable from the government due to sales conducted through the Joint Venture.

The Company has recorded $nil (December 31, 2022: $nil) of allowance as of June 30, 2023.

5. Fixed Assets

The Company’s subsidiary, Canary, initiated construction on its leased 44,000 square foot cannabis cultivation facility in September of 2017. Since then, extensive demolition and structural upgrades have been carried out at the site. On May 1, 2019, the Company completed the construction of its 44,000 square foot cannabis cultivation facility and on May 14, 2019, the Company submitted a Site Evidence Package to Health Canada as part of the steps to obtain the license to cultivate cannabis at the Company’s facility. On October 8, 2019, the Company was granted licenses to cultivate, process and sell cannabis pursuant to the Cannabis Act (Bill C-45). Canary currently operates as a licensed producer/wholesaler of craft cannabis in Ontario and has since been granted its sales amendment from Health Canada to sell directly to provincial retail boards for consumer products.

Canary has recorded a depreciation expense of $426,631 during the six months ended June 30, 2023 (June 30, 2022: $452,245) while CannaKorp has recorded a depreciation expense of $252 during the six months ended June 30, 2023 (June 30, 2022: $714). JVCo assets are consolidated with cost $723,231 and depreciation $15,371.

Below is a breakdown of the consolidated fixed asset, category wise:


	Furniture &	Machinery &		Leasehold
	fixture	Equipment	Software	improvements	Total
	$	$	$	$	$
Cost	1,452,252	770,161	43,553	6,851,094	9,117,060
Accumulated depreciation	(481,941)	(747,730)	(43,490)	(2,070,664)	(3,343,825)
	970,311	22,431	63	4,780,430	5,773,235

6. Joint Venture

Historical information

F-14

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

organized under the laws of the Province of Ontario, Canada (referred to as “JVCo”). Canary and Thrive Cannabis each hold 50% of the voting equity interest in JVCo. The term of the Joint Venture is five (5) years from its effective date of May 14, 2020.

Under the Joint Venture, JVCo is permitted to use the rooms, of Canary’s licensed cannabis cultivation facilities located in Simcoe, Ontario, Canada (“Licensed Site Portion”) to operate and manage the Licensed Site Portion for the cultivation and process of cannabis pursuant to Canary’s license issued by Health Canada. During the term of the Joint Venture, JVCo will be responsible for the administration, operation and management of the Licensed Site Portion and all proceeds from the sale of the cannabis and related cannabis products cultivated therein will be payable to the JVCo.

In addition, Canary, Thrive Cannabis, and JVCo entered into a Unanimous Shareholder Agreement dated May 14, 2020, governing the management and administration of the business of JVCo.

During the period ended June 30, 2023, the Joint Venture partners, Canary and Thrive Cannabis entered into an agreement. Pursuant to this agreement the Company received a total of $1,577,214 (CAD 2,125,482) of which $1,018,996 (CAD 1,373,218) were reduced from investment in joint venture as these represented recovery of investment and $558,218 (CAD 752,264) were classified as other income representing recovery of interest expense charged on shareholder loan, which was primarily provided to support Joint Venture operations. Also refer to shareholder loan in Note 8.

As per the Joint Venture, Canary provided the JVCo with a Hard Cost Loan with the maximum amount of $906,360 (CAD 1,200,000). This loan bore an interest rate of 7% per annum, matured in 12 months from the effective date, and was secured against the personal property of the JVCo and Thrive had guaranteed one-half (1/2) of the outstanding balance of the loan. As of April 27, 2023, the loan advanced amounts to $253,026 (CAD 335,000) and interest income charged for the six months ended in the amount of $8,628 (CAD 11,629) is included in other income on the unaudited condensed consolidated interim statement of operations and comprehensive loss and interest receivable in the amount of $51,971 (CAD 68,809) was included in receivable from joint venture on the unaudited condensed consolidated interim balance sheet. After April 27, 2023, as mentioned below, JVCo become a subsidiary of the company as result the above loan and interest receiveable were eliminated upon consolidation.

The Company recorded JVCo’s results through April 27, 2023 using the equity table and below is the table which summarizes the activity of the period (through April 27, 2023):


Period ended	January 1 to April 27, 2023		Six months ended June 30, 2022
	CAD	USD	CAD	USD
Sales	1,068,799	791,285	2,681,955	2,109,626
Cost of goods sold	620,344	459,271	1,332,020	1,047,767
Gross profit	448,455	332,014	1,349,935	1,061,859
Operation expenses	383,358	283,819	965,882	759,763
Net income (loss)	65,097	48,195	384,053	302,096

Eligible recoverable expenses	1,437,054	1,060,833	2,475,041	1,920,632
Recoverable amount	1,437,054	1,060,833	2,475,041	1,920,632
Income (loss) on equity	32,549	24,098	192,026	151,048

Termination of joint venture agreement during quarter ended June 30, 2023

F-15

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

the company as of April 27, 2023, therefore, the company will use the acquisition method of accounting (using a step acquisition method) under ASC 805 Business Combination.

As a consequence of the above Settlement Agreement and after obtaining 100% shares of the JVCo, the Company acquired the following assets:


		Fair value
		$
Assets acquired:
Inventory		1,690,368
Fixed assets		534,816
		2,225,184

As of April 27, 2023, the Company had a carrying value of the investment in Joint Venture and receivable from Joint Venture on the consolidated balance sheets amounting to $1,023,608 and $706,598, respectively. Pursuant to the above Settlement Agreement, the Company received $776,382 against these balances. Accordingly, the remaining balance of $953,824 was compared to the fair value of the net assets acquired and this resulted in net recognition of $1,428,185 as a non-operating gain reported in the Consolidated Statement of Operations as net gain from termination of the Joint Venture.

7. Goodwill

Business Acquisition

ASC Topic 805, “Business Combinations” requires that all business combinations be accounted for using the acquisition method and that certain identifiable intangible assets acquired in a business combination be recognized as assets apart from goodwill. ASC Topic 350, “Intangibles-Goodwill and Other” (“ASC 350”) requires goodwill and other identifiable intangible assets with indefinite useful lives not be amortized, such as trade names, but instead tested at least annually for impairment (which the Company tests each year end, absent any impairment indicators) and be written down if impaired. ASC 350 requires that goodwill be allocated to its respective reporting unit and that identifiable intangible assets with finite lives be amortized over their useful lives.

CannaKorp Inc.

Effective January 25, 2019, the Company entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with CannaKorp Inc., a Delaware corporation (“CannaKorp”). Company had previously entered into a Letter of Intent with CannaKorp dated November 30, 2018, which was disclosed in the Company’s report on Form 8-K filed December 4, 2018.

The Exchange Agreement provides that, subject to its terms and conditions, the Company issued to the CannaKorp shareholders an aggregate of 30,407,412 shares of the Company’s common stock, based on a price per share of $0.10, in exchange for 100% of the issued and outstanding common stock of CannaKorp held by the CannaKorp shareholders. In addition, the Company issued Common Stock Purchase Warrants (“CannaKorp Warrants”) in exchange for all outstanding and promised CannaKorp stock options. The CannaKorp Warrants granted the holders thereof the right to purchase up to approximately 7,211,213 shares of the Company’s common stock. The Company also assumed all outstanding liabilities of CannaKorp. Upon the closing of the Exchange Agreement, CannaKorp continued its business operations as a subsidiary of the Company. The transaction was closed effective March 1, 2019.

Due to the publicly traded nature of the Company’s shares of the common stock, the equity issuance of the shares was considered to be a more reliable measurement of the fair market value of the transaction compared to having a separate valuation of the net assets. This acquisition was accounted for using the acquisition method of accounting. As of March 1, 2019, the fair value of the net liabilities was $2,534,121 and the purchase consideration was fair valued as $4,062,844, shown below, leading to a goodwill allocation of $6,071,627.

F-16

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

The purchase consideration of 30,407,412 shares and 7,211,213 warrants of the Company’s common stock are valued as detailed below:


		$
Number of Common Stock		30,407,712
Market price on the date of issuance		0.108
Fair value of Common Stock		3,284,033


		$
Number of warrants		7,211,213
Fair value price per warrant		0.108
Fair value of warrant		778,811

Fair value of Common Stock		3,284,033
Fair value of warrant		778,811
Purchase consideration		4,062,844

The fair value of these warrants was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:

●

Forfeiture rate of 0%;

●

Stock price of $0.108 per share;

●

Exercise price between the range of $0.13 to $0.15 per share

●

Volatility at 635.49%

●

Risk free interest rate of 2.55%;

●

Expected life of 2 years; and

●

Expected dividend rate of 0%

During the year ended December 31, 2019, the goodwill was revaluated after the completion of CannaKorp’s audit of the year ended December 31, 2018. This resulted in changing the balance on the acquisition date, March 1, 2019, thereby increasing the goodwill by $369,315 to $6,071,627.

However, during the same year the Company identified circumstances that would call for an evaluation of goodwill impairment and therefore impaired $1,485,925 reducing the goodwill related to the CannaKorp to $4,585,702.

Further, during the year ended December 31, 2020, the Company identified circumstances that would call for an evaluation of goodwill impairment and therefore impaired the remaining balance of goodwill related to the CannaKorp to $nil.

During the year ended December 31, 2021, all of the CannaKorp Warrants expired, none were exercised.

Visava Inc./Canary Rx Inc.

Pursuant to the Agreement, the Company acquired 100% of the issued and outstanding shares of Visava Inc. in exchange for the issuance of 25,500,000 shares of the Company’s Common Stock and issued to the Visava shareholders, prorata Common Stock Purchase Warrants (“Visava Warrants”) purchasing an aggregate of 25,000,000 shares of the Company’s Common Stock at a price per share of $0.10 for a period of two years following the issuance date of the Visava Warrants. As a result of this transaction, Visava Inc. became a wholly-owned subsidiary of the Company and the former shareholders of Visava Inc. owned approximately 46.27% of the Company’s shares of Common Stock. The transaction was closed effective August 2, 2018. During the year ended, December 31, 2020, all of the Visava Warrants expired, none were exercised.

F-17

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

This acquisition was accounted for using the acquisition method of accounting. As of August 2, 2018, the fair value of the net liabilities was $275,353 and the purchase consideration was fair valued as $3,318,842, shown below, leading to a goodwill allocation of $3,594,195.


		$
Number of Common Stock		25,500,000
Market price on the date of issuance		0.067
Fair value of Common Stock		1,695,750


		$
Number of warrants		25,000,000
Fair value price per warrant		0.065
Fair value of warrant		1,623,092

Fair value of Common Stock		1,695,750
Fair value of warrant		1,623,092
Purchase consideration		3,318,842

The fair value of these warrants was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:

●

Forfeiture rate of 0%;

●

Stock price of $0.067 per share;

●

Exercise price of $0.10 per share

●

Volatility at 329%

●

Risk free interest rate of 2.66%;

●

Expected life of 2 years; and

●

Expected dividend rate of 0%

During the year ended December 31, 2022, the Company identified circumstances that would call for an evaluation of goodwill impairment and therefore impaired $3,315,749 reducing the goodwill related to the Canary to $263,117 (December 31, 2021: the Company has identified no circumstances which would call for further evaluation of goodwill impairment related to Canary).

During the year ended, December 31, 2022, all of the Visava Warrants expired, none were exercised.

Goodwill

The Company tests for impairment of goodwill at the reporting unit level. In assessing whether goodwill is impaired, the Companyutilizes the two-step process as prescribed by ASC 350. The first step of this test compares the fair value of the reporting unit, determined based upon discounted estimated future cash flows, to the carrying amount, including goodwill. If the fair value exceeds the carrying amount, no further work is required and no impairment loss is recognized. If the carrying amount of the reporting unit exceeds the fair value, the goodwill of the reporting unit is potentially impaired and step two of the goodwill impairment test would need to be performed to measure the amount of an impairment loss, if any. In the second step, the impairment is computed by comparing the implied fair value of the reporting unit’s goodwill with the carrying amount of the goodwill. If the carrying amount of the reporting unit’s goodwill is greater than the implied fair value of its goodwill, an impairment loss in the amount of the excess is recognized and charged to the statement of operations.

8. Related Party Transactions and Balances

During the six months ended June 30, 2023, the Company expensed $155,515 (June 30, 2022: $83,516) in management service fee for services provided by the current key officers of the company.

F-18

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

The breakdown of the related party balance as of June 30, 2023 of $11,336,630 (December 31, 2022: $10,346,465) is below:

Debt purchase by CL Investors Inc.

On June 15, 2020, the Company and its subsidiaries, entered into a Debt Purchase and Assignment Agreement (“Agreement”) with CL Investors Inc. (“CLI). June 15th was the preliminary date of the agreement and the agreement was not finalized until the later date as indicated below.

The CEO and director of the Company is a shareholder and , the Secretary of CLI, and the brother of the CEO is the President and sole director of CLI, therefore, the loan from CLI is classified under related party transactions.

Pursuant to the agreement, CLI purchased from the Company for the sum of $2,190,370 (CAD $2,900,000) a debt obligation owing from Canary, the Company’s second- tier subsidiary, to the Company in the principal balance of $8,006,180 (CAD $10,600,000 (“Canary Debt”)). Upon receipt of the monetary consideration, the Company loaned the full sum to Canary under terms of an unsecured, non-interest-bearing promissory note, subject to a covenant by the Company not to take any collection action so long as the Canary Debt remains unpaid to CLI. As of June 30, 2023, $3,777 (CAD $5,000) is still outstanding from CLI.

The Canary debt owed to CLI from Canary bears an interest rate of 5% per annum and matures on August 14, 2025. The repayment of the debt is guaranteed by the Company and its subsidiaries plus secured by a general security interest in the assets of the Company and its subsidiaries and a pledge by the Company of all of the issued and outstanding common stock of Canary, Visava and CannaKorp Inc. held by the Company. In addition to the above, CLI has been granted an option, in lieu of repayment of the amended Canary Debt, to demand, in its sole and absolute discretion the transfer, assignment and conveyance of 75% of the issued and outstanding capital stock of Visava and Canary. Furthermore, the President and sole director of CLI has been granted an option to acquire the remaining 25% of the issued and outstanding capital stock of Visava and Canary.

Interest expense charged for the six months ended in the amount of $194,412 (CAD $262,011) is included in interest and bank charges on the unaudited condensed consolidated interim statement of operations and comprehensive loss and accrued interest in the amount of $438,434 (CAD 580,477) is included in accounts payable and accrued liabilities on the unaudited condensed consolidated interim balance sheet.

The repayment schedule of the minimum principal payments is shown below:


2023	$	552,583
2024		3,613,227
2025		3,706,326
Total		7,872,136
Current portion		(1,540,099)
Non-current portion	$	6,332,037

Effective August 14, 2020, the Agreement was amended (“Amendment”) to provide that CLI will purchase from Rubin Schindermann, a director of the Company, 500,000 shares of the Company’s Series A Preferred Stock in consideration of the payment by CLI to Rubin Schindermann of $75,530 (CAD $100,000) and the issuance to Mr. Schindermann of 10,000,000 shares of the Company’s common stock. In consideration of the foregoing, Mr., Schindermann resigned as a director of the Company and from all administrative and executive positions with the Company’s subsidiaries. In addition, the Company issued Common Stock Purchase Warrant for 10,000,000 shares of Target common stock to CLI as consideration for the Agreement. Refer to Note 11 for additional details on warrants. The combined impact of both transactions resulted in a debt issuance cost of $251,518. This debt issuance cost will be amortized over the term of the debt on a straight-line basis. As at June 30, 2023, the balance is $107,552 of which $50,679 is current while $56,873 is non-current.

F-19

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Shareholder loan

One of the Company’s shareholders provided a loan to the Company. The loan is secured by all assets owned by the Company and its subsidiaries including leasehold improvements and matures on September 28, 2023 and therefore is presented as current. The loan was provided in five tranches and the latest amendment increased the maximum loan amount by $679,770 (CAD 900,000) while the rest of terms remained unchanged. The specific details of each tranche of the loan are shown below:


	Interest rate		Maximum loan		Outstanding loan
			CAD	USD	CAD	USD
Tranche 1	16.00	%	1,043,593	788,226	1,043,593	788,226
Tranche 2	43.26	%	1,592,787	1,203,032	1,592,787	1,203,032
Tranche 3	43.26	%	250,000	188,825	250,000	188,825
Tranche 4	43.26	%	500,000	377,650	500,000	377,650
Tranche 5	43.26	%	500,000	377,650	400,000	302,120
Total			3,886,380	2,935,383	3,786,380	2,859,853

Interest expense charged for the six months ended June 30, 2023 in the amount of $494,865 (CAD $655,190) is included in interest and bank charges on the unaudited condensed consolidated interim statement of operations and comprehensive loss and accrued interest in the amount of $941,134 (CAD 1,246,042) is included in accounts payable and accrued liabilities on the unaudited condensed consolidated interim balance sheet.

The Seventh Amending Agreement, dated February 16, 2023 (“Seventh Amendment”), filed herewith as Exhibit 10.34, memorializes Tranche 4 of the subject shareholder loan, and is the subject of Form 8-K Report and subsequent Form 8-K/A Reports, dated February 22, March 13, and August 4, 2023, respectively. The amount of the Advance in the Seventh Amendment was incorrectly reported on February 22 and March 13, 2023, and Exhibit 10.32 was also inaccurate with respect ot the amount of the Advance. The amount of the Advance is CDN$500,000.00 as reported on Form 8-K/A, dated August 4, 2023, and as reflected at Exhibit 10.34, filed herewith, and further, the amount of the Lender’s Fee was CDN$50,000.

Outstanding management service fee

The balance owing to key officers of the Company is $647,194 (December 31, 2022: $585,261). The outstanding balance is primarily the outstanding management service fee.

Balances outstanding related to subsidiaries

During the year ended December 31, 2019, the Company settled with the loan holders provided to the Company’s subsidiary, CannaKorp. The total amount subject to settlement was $817,876 which includes accrued interest and accrued payroll. The company settled by paying $954,374 as consideration of cash, 920,240 shares (recorded in shares to be issued) and warrants of 920,240 shares with an exercise price of $0.15 per share. This resulted in a settlement loss of $136,498. These warrants expired during the year ended December 31, 2021. Of the total settlement amount, as of June 30, 2023 and December 31, 2022, $65,000 was outstanding to be paid. This amount includes late payment penalties of $25,000. During the year ended December 31, 2021, all of the warrants expired, none were exercised.

Balances outstanding related to directors

During the six months ended June 30, 2023, the Company has purchased $nil of consulting services from GTA Angel Group which is owned by the Company’s CEO’s brother. The balance outstanding as of June 30, 2023 is $25,605 and is included in accounts payable and accrued liabilities.

The Company subleases its principal executive office premise from Norlandam Marketing Inc., a company owned by one of the directors. During the quarter ended March 31, 2021, the premises were subleased to a third party that makes rent payments directly to Norlandam Marketing Inc. The balance outstanding as of June 30, 2023 is $nil.

F-20

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

9. Operating Lease Right-Of-Use Assets and Lease Liability

The Company adopted ASC 842 as of January 1, 2019, using a modified retrospective approach and applying the standard’s transition provisions at January 1, 2020, the effective date. The Company made an accounting policy election to exclude from balance sheet reporting those leases with initial terms of 12 months or less. The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and non-lease components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components is recognized when the obligation is probable.

Right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company’s leases, the incremental borrowing rate is used based on the information available at the adoption date in determining the present value of lease payments. The lease term for all of the Company’s leases includes the non-cancellable period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company’s leases as the reasonably certain threshold is not met.

The Company does not own any real property. It currently leases two office/facility spaces. For accounting purposes, this lease is treated as an operating leases. Upon adoption of ASC 842, the Company recognized $1,705,628 (CAD $2,258,212) of right-to-use assets as operating leases and operating lease obligations. The right-to-use asset was reduced by $1,578,517 (CAD $2,089,921) due to recognition of the prior deferred rent liability which was eliminated upon adoption of ASC 842. Details of these leases are detailed below:

During the quarter ended March 31, 2021, the Company subleased its executive premises to a third party that makes rent payments directly to the landlord. However, if the sub-lessee cancels its sub-lease agreement with the landlord during the Company’s lease term with the landlord (ending on August 30, 2023), the Company will be responsible for making rent payments for the period from the date of cancellation by the sub-lessee to August 30, 2023.

The Company’s subsidiary, Canary, is a party to a 10-year lease agreement (initiated in July 2014) with respect to its facility to produce craft cannabis at scale. The lease agreement was amended effective January 1, 2020, where the amended 10-year term starts on May 1, 2020 and provides the Company with an option to extend for three (3) additional terms of ten (10) years. Additionally, effective January 1, 2020, the amended agreement increased the minimum rent to $26,436 (CAD $35,000) plus applicable taxes per month and on each anniversary date, commencing from January 1, 2021, the minimum rent will increase by 1.00%. Furthermore, only the current 10-year term has been factored into the calculation of the lease liability. Effective May 1, 2020, due to the implementation of the new lease, $746,458 (CAD $988,293) was forgiven by the landlord and one vendor.

These leases will expire between 2023 and 2030. The weighted average discount rate used for these leases was 16% (average borrowing rate of the Company). Maturities of lease liabilities were:


2023	$	165,264
2024		330,107
2025		333,408
2026		336,742
Thereafter		1,147,370
Total lease payments		2,312,891
Less imputed interest		(905,947)
Present value of lease liabilities		1,406,944
Current portion		(118,047)
Non-current portion	$	1,288,897

F-21

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Below is the reconciliation of the net operating lease presented on the unaudited condensed consolidated interim statement of operations:


	For the	For the	For the	For the
	three months ended	three months ended	six months ended	six months ended
	June 30, 2023	June 30, 2022	June 30, 2023	June 30, 2022
	$	$	$	$
Gross operating lease expense	—	66,672	119,562	134,199
Gross rent and utilities expenses	28,400	132,169	(35,207)	254,382
Recoverable expenses from JVCo related to rent and utilities	—	(209,219)	(67,045)	(422,486)
	28,400	(10,378)	17,310	(33,905)

As explained in Note 6, the JVCo reimburses a certain percentage of gross expenses incurred by Canary which includes rent and utilities. Due to this unique circumstance and since operating lease expense are related to rent expenses, the Company has decided to group the operating lease expenses, all lease-related expenses and the recoverable amount from JVCo to show a net operating lease expense.

10. Convertible Promissory Notes

Interest amounting to $9 was accrued for the six months ended June 30, 2023 (June 30, 2022: $18).

Principal amount outstanding as of June 30, 2023 and December 31, 2022 was $480. At both reporting dates, the entire balance was current.

All notes maturing prior to the date of this report are outstanding.

Derivative liability

During the six months ended June 30, 2023, there were no conversion of principal balance of convertible promissory notes (June 30, 2022: $nil). The Company recorded and fair valued the derivative liability as follows:


	Derivative				Derivative
	liability as at	Conversions / Redemption			liability as at
	December 31,	during the	Change due to	Fair value	June 30,
	2022	period	Issuances	adjustment	2023
	$	$	$	$	$
Note D	1,446	—	—	134	1,580
Note F	10,034	—	—	777	10,811
Note G	3,645	—	—	282	3,927
	15,125	—	—	1,193	16,318

Key assumptions used for the valuation of convertible notes

Derivative element of the convertible notes was fair valued using a multinomial lattice model. Following assumptions were used to fair value these notes as of June 30, 2023:

●

Projected annual volatility of 329% to 329%;

●

Risk free interest rate of 5.06% to 5.06%;

●

Stock price of $0.006 to 0.006;

●

Liquidity term of 0.25 to 0.25 years;

●

Dividend yield of 0%; and

●

Exercise price of $0.0012 to $0.0151.

F-22

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

11. Stockholders’ Equity

Capitalization

Preferred Stock

●

Par value: $0.0001

●

Authorized: 20,000,000

●

Issued: 1,000,000 shares were outstanding as of June 30, 2023 and December 31, 2022

Common Stock

●

Par value: $0.0001

●

Authorized: 850,000,000

●

Issued: 617,025,999 shares are outstanding as at June 30, 2023 and December 31, 2022

As of June 30, 2023, convertible notes, warrants and preferred stock outstanding could be converted into 28,129,370 (December 31, 2022: 17,258,122), 10,400,008 (December 31, 2022: 53,950,001) and 100,000,000 (December 31, 2022: 100,000,000) shares of common stock, respectively.

Preferred Stock

Shares of preferred stock may be issued from time to time in one or more series as may be determined by the board of directors. The board of directors may fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof without any further vote or action by the stockholders of the Company, except that no holder of preferred stock shall have pre-emptive rights. Any shares of preferred stock so issued would typically have priority over the common stock concerning dividend or liquidation rights. The board of directors does not at present intend to seek stockholder approval prior to any issuance of currently authorized stock unless otherwise required by law.

Series A Preferred Stock (“Series A Stock”)

Dividends shall be declared and set aside for any shares of Series A Stock in the same manner and amount as for the Common Stock. Series A Stock, as a class, shall have voting rights equal to a multiple of 2X the number of shares of Common Stock issued and outstanding that are entitled to vote on any matter requiring shareholder approval. The Series A Stockholders shall not vote as a separate class but shall vote together with the common stock on all matters, including any amendment to increase or decrease the authorized capital stock. Upon the voluntary or involuntary dissolution, liquidation or winding up of the corporation, the assets of the Company available for distribution to its shareholders shall be distributed to the holders of common stock and the holders of the Series A Stock ratable without any preference to the holders of the Series A Stock. Shares of Series A Stock can be converted at any time into fully paid and nonassessable shares of Common Stock at the rate of one hundred (100) shares of Common Stock for each one (1) share of Series A Stock.

Common Stock

Holders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the stockholders. Holders of common stock do not have cumulative voting rights.

Subject to preferences that may be applicable to any outstanding shares of preferred stock, the holders of common stock are entitled to share ratable in dividends, if any, as may be declared from time to time by the board of directors in its discretion from funds legally available therefore.

Holders of common stock have no pre-emptive rights to purchase the Company’s common stock. There are no conversion or redemption rights or sinking fund provisions with respect to the common stock. The Company may issue additional shares of common stock which could dilute its current shareholder’s share value.

F-23

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

2023

During the quarter ended June 30, 2023, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by the President of Serious Seeds B.V., Simon Smit (“Smit”), to the Company’s subsidiary, Canary. These were recorded at a fair value of $48, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.

During the quarter ended March 31, 2023, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $63, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.

2022

During the quarter ended March 31, 2022, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $153, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.

During the quarter ended June 30, 2022, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $114, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.

During the quarter ended September 30, 2022, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $120, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued

During the quarter ended December 31, 2022, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $73, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.

Shares to be issued include the following:


	Shares	Amount		Description
				80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.

Services	115,000	$	73,000	35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.
Private placements	346,296	$	18,787	Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.
Settlement of loans of CannaKorp	930,240	$	80,838	Refer to Note 14 for details.
Agreement with Serious Seeds	218,736		2,668	As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.
	1,610,272	$	175,293

F-24

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Warrants

The warrants (with an exercise price in United States Dollar) were re-classified as a liability as of December 31, 2019, and therefore have been revalued on each quarter end. The fair value of the warrants was measured on reporting dates using the Black-Scholes option pricing model using the following assumptions:

2023


	As at	As at
	June 30, 2023	March 31, 2023
Forfeiture rate	0%	0%
Stock price	$0.006	$0.003
Exercise price	$0.250 to $0.300	$0.250 to $0.300
Volatility	273% to 342%	244% to 305%
Risk free interest rate	5.40%	4.64%
Expected life (years)	0.02 to 1.68	0.02 to 1.93
Expected dividend rate	0%	0%

2022


	As at	As at	As at	As at
	December 31,	September 30,	June 30,	March 31,
	2022	2022	2022	2022
Forfeiture rate	0%	0%	0%	0%
Stock price	$0.004	$0.005	$0.008	$0.009
Exercise price	$0.200 to $0.300	$0.200 to $0.300	$0.050 to $0.300	$0.023 to $0.250
Volatility	253% to 312%	214% to 279%	192% to 306%	192% to 306%
Risk free interest rate	4.73%	4.05%	2.92%	2.28%
Expected life (years)	0.02 to 1.93	0 to 1.94	0 to 1.94	0 to 1.93
Expected dividend rate	0%	0%	0%	0%

The fair value of the warrants issued during the year issued was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:

2023


	During quarter	During quarter
	ended	ended
	June 30, 2023	March 31, 2023
Forfeiture rate	0%	0%
Stock price	$0.003 to $0.003	$0.003 to $0.005
Exercise price	$0.350	$0.300
Volatility	342%	305%
Risk free interest rate	3.82% to 4.51%	4.24% to 4.89%
Expected life (years)	2	2
Expected dividend rate	0%	0%
Fair value of warrants	$138	$160

F-25

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

2022


	During quarter	During quarter	During quarter	During quarter
	ended	ended	ended	ended
	December 31, 2022	September 30, 2022	June 30, 2022	March 31, 2022
Forfeiture rate	0%	0%	0%	0%
Stock price	$0.004 to $0.006	$0.007 to $0.008	$0.005 to $0.010	$0.008 to $0.013
Exercise price	$0.300	$0.300	$0.300	$0.250
Volatility	279%	279%	299%	306%
Risk free interest rate	4.23% to 4.66%	2.97% to 3.50%	2.50% to 2.73%	0.88% to 1.50%
Expected life (years)	2	2	2	2
Expected dividend rate	0%	0%	0%	0%
Fair value of warrants	$176	$288	$306	$430

Breakdown of warrants outstanding as of June 30, 2023 and December 31, 2022 are detailed below:


			Remaining	Remaining
			contractual life	contractual life
	Warrants	Warrants	term as at	term as at
	outstanding as at	outstanding as at	June 30,	December 31,
	June 30,	December 31,	2023	2022
	2023	2022	(years)	(years)
Private placements	—	43,549,993	N/A	0.11 to 0.47
Serious Seeds	400,008	400,008	0.02 to 1.93	0.02 to 1.93
CLI	10,000,000	10,000,000	2.12	2.62
Total	10,400,008	53,950,001

During the six months ended June 30, 2023, 5,416,668 warrants expired (related to private placements and Serious Seeds).

Movement of the warrant liability is detailed below:


Warrant liability as at December 31, 2022		489
Warrant liability for new issuance		298
Change in fair value		144
Warrant liability as at June 30, 2023		931

12. Earnings (Loss) Per Share

FASB ASC 260, Earnings Per Share provides for calculations of “basic” and “diluted” earnings per share. Basic earnings per share include no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity similar to fully diluted earnings per share. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

13. Contingencies and commitments

Contingencies

During the year ended December 31, 2019, a terminated employee of Canary has filed a lawsuit against the Company amounting to approximately $1,586,130 (CAD 2,100,000) in Ontario, Canada. Currently, the Company is defending its position and believes that the ultimate decision will be in favor of the Company. Due to the uncertainty of timing and the amount of estimated future cash flows, if any, relating to this claim, no provision has been recognized.

A complaint for damages of $150,000 was lodged against CannaKorp by the former Chief Financial Officer of CannaKorp for outstanding professional fees. No claim has been registered. The management is of the view that no material losses will arise in respect of the legal claim at the date of these unaudited condensed consolidated interim financial statements. As of June 30, 2023, $188,865 has

F-26

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

been recorded in CannaKorp’s payable based on past accruals and outstanding invoices. Due to the uncertainty of timing and the amount of estimated future cash flows, if any, relating to this claim, no further amount has been recognized.

A claim for damages of $1,406,977 (CAD $1,862,805) was lodged against Company and its directors by the former Chief Financial Officer of the Company for wrongful dismissal. The management is of the view that no material losses will arise in respect of the legal claim at the date of these unaudited condensed consolidated interim financial statements. As of June 30, 2023, $11,098 has been recorded in Target’s payable based on past accruals. Due to the uncertainty of timing and the amount of estimated future cash flows, if any, relating to this claim, no further amount has been recognized.

During the year ended December 31, 2020, a claim for damages of $98,777 (CAD $130,778) was lodged against Canary by a vendor for breach of contract. The management is of the view that no material losses will arise in respect of the legal claim at the date of these unaudited condensed consolidated interim financial statements. As of June 30, 2023, $104,345 (CAD $138,150) has been recorded in the Canary’s payable based on past accruals. Due to the uncertainty of timing and the amount of estimated future cash flows, if any, relating to this claim, no further amount has been recognized.

As explained in Note 1, on July 27, 2020 (“Effective Date”), the Company entered into a settlement agreement with cGreen, Inc., a Delaware corporation (“cGreen”). As consideration, the Company paid $130,000 within 30 days of the Effective Date and paid $100,000 in monthly installments of $10,000 commenced in April 2021 to cGreen. During the quarter ended March 31, 2022, the outstanding balance was paid in full and the claim is closed.

Covid-19 Pandemic

On March 11, 2020, the World Health Organization declared the ongoing COVID-19 outbreak as a global health emergency. This resulted in governments worldwide enacting emergency measures to combat the spread of the virus, including the closure of certain non-essential businesses.

During the period and year ended June 30, 2023 and December 31, 2022, respectively, the pandemic and its lasting impacts did not have a material impact on the Company’s operations. As of June 30, 2023 and December 31, 2022, the Company did not observe any material impairment of its assets or a significant change in the fair value of assets due to the COVID-19 pandemic or its lasting impacts. Despite the WHO’s declaration, on or about May 5, 2023, of the end of the COVID-19 global pandemic, the lasting impacts of COVID-19 on the United States, Canada, and the broader global economy, including supply chain disruption, may have a significant continuing negative effect on the Company and may materially impact the Company in the future. The Company had taken, and will again, as necessary, continue to take, steps to minimize the potential impact of the pandemic including safety measures with respect to personal protective equipment, the reduction in travel and the implementation of a virtual office including regular video conference meetings and participation in virtual customer meetings and other virtual events.

It is not possible to predict the lasting impacts that COVID-19 will have on the Company’s business, balance sheet and operating results in the future. In addition, it is possible that estimates in the Company’s Financial statements will change in the near term as a result of the lasting impacts of COVID-19, and the effect of any such changes could be material, which could result in, among other things, impairment of long-lived assets including goodwill. The Company is closely monitoring the lasting impacts of the pandemic on all aspects of its business.

Commitments

As per the Distribution, Collaboration and Licensing Agreement (“Agreement”) entered with Serious Seeds B.V. (“Serious Seeds”), effective December 6, 2018, the Company will issue to Serious Seeds B.V. each month 5,208 shares of common stock, beginning on the thirteen (13th) months following the effective date of the Agreement and continuing through the sixtieth (60th) month of the initial term. Furthermore, Serious Seeds will be issued warrants in each of the foregoing months to purchase 16,667 shares of Target common stock at varying exercise prices ranging from $0.20 to $0.35 per share. All of the warrants must be exercised on or before the two (2) year anniversary date of each of the warrant issuance dates. As of June 30, 2023, none of the above shares have been issued.

F-27

Table of Contents

TARGET GROUP INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

In consideration of the Company’s appointment as Serious’ exclusive distributor in Canada, the Company will pay Serious certain royalties as follows:


1^st year:		2.00% of gross sales
2^nd year:		2.25% of gross sales
3^rd year:		2.50% of gross sales
4^th year:		2.75% of gross sales
5^th and following years:		3.00% of gross sales

14. Subsequent Events

The Company’s management has evaluated subsequent events up to August 9, 2023, the date the unaudited condensed consolidated interim financial statements were issued, pursuant to the requirements of ASC 855 and there is no subsequent events to report.

F-28

Table of Contents

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The information and financial data discussed below is derived from the unaudited condensed consolidated interim financial statements of the Target Group Inc. (“we,” “us” or the “Company”) for the three and six months ended June 30, 2023 and were prepared and presented in accordance with generally accepted accounting principles in the United States.

Forward Looking Statements

Some of the statements contained in this Quarterly Report on Form 10-Q that are not historical facts are “forward-looking statements” which can be identified by the use of terminology such as “estimates,” “projects,” “plans,” “believes,” “expects,” “anticipates,” “intends,” or the negative or other variations, or by discussions of strategy that involve risks and uncertainties. We urge you to be cautious of the forward-looking statements, that such statements, which are contained in this Quarterly Report, reflect our current beliefs with respect to future events and involve known and unknown risks, uncertainties and other factors affecting our operations, market growth, services, products and licenses. No assurances can be given regarding the achievement of future results, as actual results may differ materially as a result of the risks we face, and actual events may differ from the assumptions underlying the statements that have been made regarding anticipated events. Factors that may cause actual results, our performance or achievements to differ materially from those contemplated by such forward-looking statements include without limitation:

●

Our ability to raise capital when needed and on acceptable terms and conditions;

●

Our ability to attract and retain management;

●

Our ability to enter into long-term supply agreements for the mineralized material;

●

General economic conditions; and

●

Other factors are discussed in Risk Factors.

All forward-looking statements made in connection with this Quarterly Report are attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Given the uncertainties that surround such statements, you are cautioned not to place undue reliance on such forward-looking statements.

Overview

Target Group Inc. (“Target Group” or “the Company”) was incorporated in the State of Delaware on July 2, 2013, under our original name of River Run Acquisition Corporation. Effective May 13, 2014, the Company changed its name to Chess Supersite Corporation. On July 3, 2018, we filed an amendment in our Certificate of Incorporation to change our name to Target Group Inc.

Effective October 18, 2018, our common stock became eligible for quotation on the OTCQB platform operated by OTC Markets Group Inc, under the symbol “CBDY”.

During the second quarter of 2023, the lasting impacts of Coronavirus (COVID-19) continued to have an impact on the Canadian and global economy and customer purchasing behavior. However, these factors have not impacted the Company’s operations, or financial results for the quarter.

Business and Plan of Operations

Cannabis Business-Canada

We are now engaged in the cultivation, processing and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada and, where legalized by state legislation, in the United States. We believe that there is a shift in the public’s perception of cannabis from a state of prohibition to a state of legalization. In October 2018, Canada became the first major industrialized nation to legalize adult-use cannabis at the national federal level. Cannabis is still heavily regulated. However, the medical use of cannabis is now permitted in up to 29 countries and many more countries have reformed, or are considering reforming, their cannabis uses laws to include the recreational use of cannabis.

Table of Contents

In the 2016 publication by Deloitte, Insights and Opportunities Recreational Marijuana, the project size of the Canadian adult-use market ranged from CDN$4.9 billion to CDN$8.7 billion annually. In the 2018 publication by Deloitte, A Society in Transition, an Industry Ready to Boom, the projected size of the Canadian adult-use market in 2019 ranged from CDN$1.8 billion to CDN$4.3 billion. The Canadian medical cannabis industry experienced substantial growth since 2014. Health Canada projects the Canadian cannabis market will reach CDN$1.3 billion in annual value by 2024.

We intend to position ourselves with a core emphasis on wholesale & co-packaging services to accommodate all consumer-packaged goods required for the sophisticated cannabis market in Canada and internationally. This will integrate cannabinoid research, analytical testing, product development and manufacturing.

Our product manufacturing will include, but will not be limited to the following:

●

Cannabis flower pods for vaporizer use

●

Cannabis extract pods for vaporizer use

●

Cannabis pre-rolls

●

K-Cup infused coffee and tea pods

●

Infused cannabis beverages

●

Infused cannabis edibles

●

Infused topical products and CBD wellness products.

As of the date of this report, the Company (i.e., Target Group Inc. and its subsidiaries) does not have any operations, employees or corporate offices based in United States.

Acquisitions

To take advantage of the opportunity resulting from the legalization of adult-use cannabis in Canada, we completed several strategic acquisitions and entered into several significant agreements as follows:

Visava Inc./Canary Rx Inc.

On June 27, 2018, the Company entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with Visava Inc., a private Ontario, Canada corporation (“Visava”). Visava owns 100% of Canary Rx Inc, (“Canary”), a Canadian corporation that operates a 44,000 square foot facility located in Ontario’s Garden Norfolk County for the production of cannabis. Canary is a Canadian Licensed Producer under Health Canada’s Cannabis Act (“Bill C-45”). Canary expects to grow up to 4 million grams of cannabis annually out of its Simcoe facility once it is at full capacity. The Company is now growing premium cannabis in indoor grow rooms and each 2,200 square feet room gets up to 5.4 turns annually.

Pursuant to the Exchange Agreement, the Company issued to the Visava shareholders an aggregate of 25,500,000 shares of the Company’s Common Stock in exchange for all of the issued and outstanding common stock held by the Visava shareholders. In addition to its Common Stock, the Company issued to the Visava shareholders, pro rata Common Stock Purchase Warrants (“Visava Warrants”) to purchase an aggregate of 25,000,000 shares of the Company’s Common Stock at a price per share of $0.10 for a period of two years following the issuance date of the Visava Warrants. The transactions contemplated by the Exchange Agreement closed effective August 2, 2018. Visava continues its business operations as a first-tier wholly-owned subsidiary of the Company with Canary operating as our second-tier subsidiary. During the year ended, December 31, 2020, all of the Visava Warrants expired, none were exercised.

CannaKorp Inc.

Pursuant to the terms of an Agreement and Plan of Share Exchange dated January 25, 2019 (“Exchange Agreement”), on March 1, 2019, we completed the acquisition of Massachusetts –based CannaKorp Inc., a Delaware corporation (“CannaKorp”). CannaKorp has developed a single-use pre-measured pod and vaporizer system for consumers interested in vaporizing natural herbs, including cannabis. The patent-pending system is known as The Wisp^TM and Wisp Pods^TM. The Wisp^TM vaporizer system extracts the medically beneficial compounds more efficiently while simultaneously offering a much safer and more enjoyable experience than other alternatives.

Table of Contents

Under the terms of the Exchange Agreement, the Company issued 30,407,712 shares of common stock to the exchanging CannaKorp shareholders in exchange for 99.8% of the outstanding common stock held by the CannaKorp shareholders. CannaKorp continues to operate as our subsidiary. During the year ended, December 31, 2021, all of the CannKorp Warrants expired, none were exercised.

Agreements

Serious Seeds B.V.

Effective December 6, 2018, the Company and Canary entered into a Distribution, Collaboration and Licensing Agreement (“Agreement”) with Serious Seeds B.V. (“Serious Seeds”), incorporated in the Netherlands, and Simon Smit (“Smit”), President of Serious Seeds. Under the Agreement, Canary was appointed the exclusive distributor in Canada and all other legal markets globally of Serious’ proprietary cannabis seed strains and Serious’ cannabis cuttings, dried flowers, extracts and seeds. In addition, under the Agreement Canary Rx and Serious will develop certain “Collaborative Products” defined as cannabis seed strains created collaboratively using Serious’ intellectual property. During the term of the Agreement, Canary will own all of the intellectual property related to the Collaborative Products.

Under the Agreement, Smit has granted Canary an exclusive license in Canada and all legal markets globally to Serious’ intellectual property including the right to use the service mark of Serious Seeds and all of the names of Serious’ proprietary cannabis seed strains including but not limited to Chronic, AK-47, White Russian, Bubble Gum, Kali Mist, Warlock, Double Dutch, Biddy, Early, Motavation and Strawberry-AKeil.

The initial term of the Agreement will be five (5) years and will be automatically renewed for consecutive five (5) terms subject to rights of termination upon one hundred and eighty (180) days prior notice. In consideration of the intellectual property rights granted by Smit to Canary, the Company will issue to Smit 250,000 shares of the Company’s common stock on the effective date of the Agreement. In addition, on the thirteenth (13) month following the effective date of the Agreement of the initial term, the Company will issue to Smit 5,208 shares of common stock and warrants to purchase 200,000 shares of Target common stock at an exercise price of $0.15 per share. Thereafter, from the fourteenth (14) month following the effective date of the Agreement and continuing through the sixtieth (60) month of the initial term, the Company will issue Smit 5,208 shares of common stock and warrants to purchase 16,667 shares of Target common stock, each month, at varying exercise prices ranging from $0.20 to $0.35 per share. All of the above warrants must be exercised on or before the two (2) year anniversary date of each of the warrant issuance dates. As of June 30, 2023, none of the above shares have been issued.

In consideration of Canary Rx’s appointment as Serious’ exclusive distributor in Canada, Canary Rx will pay Serious Seeds certain royalties as follows:


1^st year:		2.00% of gross sales
2^nd year:		2.25% of gross sales
3^rd year:		2.50% of gross sales
4^th year:		2.75% of gross sales
5^th and following years:		3.00% of gross sales

On October 8, 2019, Canary was granted licenses to cultivate, process and sell cannabis pursuant to the Cannabis Act (Bill C-45). These Standard Licenses enable Canary to produce approximately 3,600kg of dried cannabis flower per year. Canary has curated a bank of 3,500 seeds, comprised of more than 125 strains, including the entire Serious Seeds collection. The Company has the capacity to grow 8 different strains at a time, within the facility’s 8 indoor separate flower rooms.

Cannavolve Inc. Sales Agency Agreement

Effective December 13, 2018, the Company appointed Cannavolve Inc., an Ontario, Canada corporation based in Toronto (“Cannavolve”), under the terms of a Licensed Producer/Licensed Processor Sales Agency Agreement (“Agency Agreement”), as the Company’s exclusive agent in Canada to market and sell the CannaKorp Wisp^TM vaporizer, the Serious Seeds^TM products and Canary branded cannabis in the recreational cannabis markets (collectively the “Products”). Cannavolve is an independent recreational cannabis sales and marketing Company established to represent licensed producers and licensed processors in Canada of cannabis and cannabis accessories. Cannavolve operates in Canada with offices in Halifax, Montreal, Calgary and Vancouver.

Table of Contents

Under the Agency Agreement, Cannavolve will be paid a commission of 6% of net sales based on the wholesale prices of the Products. The initial term of the Agency Agreement is two (2) years from December 13, 2018, subject to a renewal term of two (2) additional years. In addition to customary termination provisions based upon the material default of either the Company or Cannavolve, we can terminate the Agency Agreement without cause upon ninety (90) days prior written notice. The Agency Agreement was renewed on December 13, 2020 for an additional two (2) years, but was not renewed on December 13, 2022 and expired on that date.

cGreen, Inc. Exclusive License Agreement

Effective August 8, 2019, the Company entered into an Exclusive License Agreement (“License Agreement”) with cGreen, Inc., a Delaware corporation (“cGreen”). The License Agreement grants to the Company an exclusive license to manufacture and distribute the patent-pending THC antidote True Focus^TM in the United States, Europe and the Caribbean. The term of the license is ten (10) years and four (4) months from the effective date of August 8, 2019. In consideration of the license, the Company will issue 10,000,000 shares of its common stock as follows: (i) 3.500,000 within ten (10) days of the effective date; (ii) 3,500,000 shares on January 10, 2020; and (iii) 3,000,000 shares not later than June 10, 2020. In addition, the Company will pay cGreen royalties of 7% of the net sales of the licensed products and 7% of all sublicensing revenues collected by the Company. The Company will pay cGreen an advance royalty of $300,000 within ten (10) days of the effective date; $300,000 on January 10, 2020; and $400,000 on or before June 10, 2020 and $500,000 on or before November 10, 2020. All advance royalty payments will be credited against the royalties owed by the Company through December 31, 2020.

During the quarter ended December 31, 2019, the intangible asset was written off based on management’s review and evaluation of its recoverability.

Additionally, during the quarter ended June 30, 2020, the Company was in arbitration with cGreen for the breaches of the terms of the License Agreement, however, through an early mediation, both companies reached a settlement agreement to settle the breaches of the contract on July 27, 2020 (“Effective Date”). As per the settlement agreement, the License Agreement has been terminated and the Company does not have to issue the 10 million shares nor pay the outstanding royalty payable in the amount of $1,191,860. As consideration, the Company paid $130,000 within 30 days of the Effective Date and paid $100,000 in monthly installments of $10,000 commenced in April 2021 to cGreen resulting in a gain on settlement of $1,704,860. As at June 30, 2023, there was no outstanding balance, the balance has been paid in full and the claim was closed during the quarter ended March 31, 2022 (December 31, 2021: $10,000).

Joint Venture Agreement

Historical information

Effective May 14, 2020, Canary entered into a Joint Venture Agreement (“Joint Venture”) with 9258159 Canada Inc., a corporation organized under the laws of the Province of Ontario, Canada (referred to as “Thrive Cannabis”) and 2755757 Ontario Inc., a corporation organized under the laws of the Province of Ontario, Canada (referred to as “JVCo”). Canary and Thrive Cannabis each hold 50% of the voting equity interest in JVC. The term of the Joint Venture is five (5) years from its effective date of May 14, 2020.

Under the Joint Venture, JVCo is permitted to use all eight (8) rooms, of Canary’s licensed cannabis cultivation facilities located in Simcoe, Ontario, Canada (“Licensed Site Portion”) to operate and manage the Licensed Site Portion for the cultivation and process of cannabis pursuant to Canary’s license issued by Health Canada. During the term of the Joint Venture, JVCo will be responsible for the administration, operation and management of the Licensed Site Portion and all proceeds from the sale of the cannabis and related cannabis products cultivated therein will be payable to the JVCo.

In addition, Canary, Thrive Cannabis, and JVCo entered into a Unanimous Shareholder Agreement dated May 14, 2020 governing the management and administration of the business of JVCo.

As per the Joint Venture, Canary will provide the JVCo with a Hard Cost Loan with the maximum amount of $906,360 (CAD $1,200,000). This loan bears an interest rate of 7% per annum, matures in 12 months from the effective date, and is secured against the personal property of the JVCo and Thrive will guarantee one-half (1/2) of the outstanding balance of the loan. As of June 30, 2023, the loan advanced amounts to $253,025 (CAD $335,000) and interest income charged for the six months ended in the amount of $8,628 (CAD $11,629) is included in other income on the unaudited condensed consolidated interim statement of operations and comprehensive loss and interest receivable in the amount of $51,971 (CAD $68,809) is included in receivable from joint venture on the unaudited

Table of Contents

condensed consolidated interim balance sheet. After April 27, 2023, as mentioned below, JVCo become a subsidiary of the company as result the above loan and interest receiveable were eliminated upon consolidation.

The JVCo will reimburse Canary for certain expenses incurred by Canary for the cultivation and processing of cannabis products. Below is the table which summarizes the activity of the period:


Period ended	January 1 to April 27, 2023		Six months ended June 30, 2022
	CAD	USD	CAD	USD
Sales	1,068,799	791,285	2,681,955	2,109,626
Cost of goods sold	620,344	459,271	1,332,020	1,047,767
Gross profit	448,455	332,014	1,349,935	1,061,859
Operation expenses	383,358	283,819	965,882	759,763
Net income (loss)	65,097	48,195	384,053	302,096

Eligible recoverable expenses	1,437,054	1,060,833	2,475,041	1,920,632
Recoverable amount	1,437,054	1,060,833	2,475,041	1,920,632
Income (loss) on equity	32,549	24,098	192,026	151,048

During the six months ended June 30, 2023, revenue was sold to eight customers (2022: three).

Termination of joint venture agreement during quarter ended June 30, 2023

The Company was accounting for the Joint Venture transactions using the equity method under ASC 323 Investments — Equity Method and Joint Ventures. As a consequence of the above agreement, as the JVCo (a separate legal entity) has become a subsidiary of the company as of April 27, 2023, therefore, the company will use the acquisition method of accounting (using a step acquisition method) under ASC 805 Business Combination.

As a consequence of the above Settlement Agreement and after obtaining 100% shares of the JVCo, the Company acquired the following assets:


		Fair value
		$
Assets acquired:
Inventory		1,690,368
Fixed assets		534,816
		2,225,184

Table of Contents

CL Investors Debt Purchase and Assignment Agreement

On June 15, 2020, the Company, its first-tier subsidiaries Visava Inc. (“Visava”) CannaKorp Inc. (“CannaKorp”), and the Company’s second-tier subsidiary, Canary Rx Inc. (“Canary”), entered into a Debt Purchase and Assignment Agreement (“Agreement”) with CL Investors Inc. (“CLI”), a corporation organized under the laws of the Province of Ontario, Canada. June 15th was the preliminary date of the agreement and the agreement was not finalized until the later date as indicated below.

The CEO (and also a director) of the Company is the secretary and a shareholder of CLI plus the CEO’s brother is the President and sole director of CLI therefore the loan from CLI is classified under related party transactions.

CLI purchased from the Company for the sum of $2,190,370 (CAD $2,900,000) a debt obligation owing from Canary, the Company’s second-tier subsidiary, to the Company in the principal balance of $8,006,180 (CAD $10,600,000 (“Canary Debt”)). Upon receipt of the monetary consideration, the Company loaned the full sum to Canary under terms of an unsecured, non-interest-bearing promissory note, subject to a covenant by the Company not to take any collection action so long as the Canary Debt remains unpaid to CLI. As of June 30, 2023, $3,777 (CAD $5,000) is still outstanding from CLI which is presented as other receivable on the consolidated balance sheet.

In the first year of the Term, Canary will pay CLI the greater of $853,489 (CAD $1,130,000) and fifty percent (50%) of the Net Revenue (hereinafter defined), provided that where the latter amount exceeds the former amount, Canary will, by the end of such first year, pay CLI no less than the former amount and Canary will, within thirty (30) days following the end of such first year, pay CLI the balance of such amount owing for such first year;

In the second year of the Term, Canary will pay CLI the greater of $1,586,130 (CAD $2,100,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2021, provided that where the latter amount exceeds the former amount, Canary will, within thirty (30) days following the end of such second year, pay CLI the balance of such amount owing for such second year;

In the third year of the Term, Canary will pay CLI the greater of $2,432,066 (CAD $3,220,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2022, provided that where the latter amount exceeds the former amount, Canary will, by the end of such third year, pay CLI no less than the former amount and Canary will, within thirty (30) days following the end of such third year, pay CLI the balance of such payments owing for such third year;

In the fourth year of the Term, Canary will pay CLI the greater of $2,326,324 (CAD $3,080,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2023, provided that where the latter amount exceeds the former amount, Canary will, within thirty (30) days following the end of such fourth year, pay CLI the balance of such amount owing for such fourth year; and

In the fifth year of the Term, Canary will pay CLI the balance owing under this Note, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2024 for an amount calculated by dividing twelve (12) into the sum of all amounts owing under this Note at the beginning of the fifth year of the Term on account of Principal and Interest, provided that where further amounts are owing under this Note at the end of such fifth year, Canary will pay CLI all such further amounts within five (5) days following the end of such fifth year.

For this Note, “Net Revenue” will mean any revenue generated from Canary’s Licensed Facility (hereinafter defined) to which it is entitled to the net of applicable taxes and third-party expenses.

Table of Contents

Canary Debt, to demand, in its sole and absolute discretion the transfer, assignment and conveyance of 75% of the issued and outstanding capital stock of Visava and Canary.

Furthermore, the President and sole director of CLI has been granted an option to acquire the remaining 25% of the issued and outstanding capital stock of Visava and Canary.

Effective August 14, 2020, the Agreement was amended (“Amendment”) to provide that CLI will purchase from Rubin Schindermann, a director of the Company, 500,000 shares of the Company’s Series A Preferred Stock in consideration of the payment by CLI to Rubin Schindermann of $75,530 (CAD $100,000) and the issuance to Schindermann of 10,000,000 shares of the Company’s common stock. In consideration of the foregoing, Mr., Schindermann resigned as a director of the Company and from all administrative and executive positions with the Company’s subsidiaries Visava Inc., Canary Rx Inc. and CannaKorp Inc., respectively. In addition, the Company issued Common Stock Purchase Warrant for 10,000,000 shares of Target common stock to CLI as consideration for the Agreement. Refer to Note 11 for additional details on warrants. The combined impact of both transactions resulted in a debt issuance cost of $251,518. This debt issuance cost will be amortized over the term of the debt on a straight-line basis.

The transactions contemplated by the Agreement and the Amendment closed on August 14, 2020.

Forward Looking Relating to Future Operations of the Company.

Currently, the company and its senior management are is exploring several new, additional opportunities at its Simcoe, Ontario cultivation facility to expand the Company’s product offerings in other cannabis-related consumer packaged goods (“CPG”) product categories.

Employees

As of June 30, 2023, we had 49 employees which include Anthony Zarcone, Chief Executive Officer.

We have contracted several independent contractors and consultants to provide a range of information technology and marketing services who do not receive cash compensation but receive shares of our common stock as compensation. This mitigates any need for full or part-time employees for these services.

Intellectual Property Protection

Our subsidiary CannaKorp Inc. holds the following patents:

International Patent Application No. PCT/US20115/013778

Title: METHODS AND APPARATUS FOR PRODUCING HERBAL VAPO

Filing Date: January 30, 2015

Ref. No.: B1411.70000WO00

U.S. Provisional Application No.: 61/934.255

Title: CONTAINER POD AND DELIVERY SYSTEM

Filing Date: January 31, 2014

Ref. No.: B1411.70000US00

In addition, CannaKorp has proprietary rights to certain trade names, trademarks and service marks which include WISP POD^TM; cPOD^TM; CANNACUP^TM; and WISP^TM. CannaKorp also has certain proprietary formulas and processes involving herbal formulas and flavors, proprietary herbal production processes and an herbal base developed to suspend active ingredients for optimal vaporization.

At present, CannaKorp has failed to meet its annuities payments as well as maintenance fees on the 2 referenced patents. Although there has been a lapse and these patents remain unmaintained, there remains the possibility of CannaKorp reinstating these patents if done so in a reasonable amount of time. At this time, management is determining the value maintaining these patents will provide the Company. Once management has completed their assessment, the Company will proceed accordingly and advance in that determined direction moving forward. Additionally, CannaKorp is actively seeking a joint venture partner and/ or a licensor to assist in both marketing and launching the Wisp Vaporizer and Wisp Pods in both the US and Canadian legal cannabis or hemp markets.

Table of Contents

Results of Operations

We have not generated significant revenue to date and consequently, our operations are subject to all of the risks inherent in the establishment of a new business enterprise. Our analysis on the performance of the Company is as follows:

Balance sheet – As of June 30, 2023 and December 31, 2022

Cash and Restricted Cash

On June 30, 2023, we had cash of $1,047,833 (excluding restricted cash of $8,686) compared to $223,843 (excluding restricted cash of $8,490) as of December 31, 2022. The increase is because target received $1 million due to the termination of the joint venture agreement.

The change in restricted cash is due to foreign exchange conversion of balances in Canadian Dollars into United States Dollar.

Prepaid asset

On June 30, 2023, we had prepaid expenses of $42,674 compared to $41,714 as of December 31, 2022. The balance represents the security deposit for the leased land for the facility to produce medical marijuana.

Sales tax recoverable and payable

On June 30, 2023 the gross sales tax recoverable is $1,034 compared to December 31, 2022 $nil while the gross sales tax payable as of June 30, 2023 is $nil.

Sales tax recoverable allowance on June 30, 2023 is $nil (December 31, 2022: $nil).

Goodwill

Goodwill represents the excess of the cost of an acquisition over the fair value of the Company’s share of the net identifiable assets of our subsidiaries at the date of acquisition.

Fixed assets

The Company initiated construction on its 44,000 square foot cannabis cultivation facility in September of 2017. On May 1, 2019, the Company completed the construction of its 44,000 square foot cannabis cultivation facility and on May 14, 2019, the Company submitted a Site Evidence Package to Health Canada as part of the steps to obtain the license to cultivate cannabis at the Company’s facility. On October 8, 2019, the Company was granted licenses to cultivate, process and sell cannabis pursuant to the Cannabis Act (Bill C-45). On June 4, 2021, Canary received its Sales License amendment from Health Canada.

Accounts payable and accrued liabilities

Accounts payable amounting to $2,823,400 as of June 30, 2023, primarily represents consulting and construction services related to capital work in progress amounting to $148,301, interest on promissory notes and loans amounting to $1,419,320, and outstanding, accrued professional fees amounting to $897,060.

Accounts payable amounting to $2,296,935 as of December 31, 2022, primarily represents consulting and construction services related to fixed asset additions amounting to $154,811, interest on promissory notes and loans amounting to $739,130, outstanding and accrued professional fees amounting to $906,596.

Table of Contents

Payable to related parties

As of June 30, 2023, the Company had $11,336,630 payable to related parties as compared to $10,346,465 as of December 31, 2022. The balance primarily represents loans provided by the Company’s shareholder and a related party, CLI, management services fee outstanding to the managers of the company, and outstanding amount of $65,000 to be paid to a former shareholder of CannaKorp as part of the settlement agreement.

For additional details, refer to Note 8 in the unaudited condensed consolidated interim financial statements.

Convertible promissory notes payable

Interest amounting to $9 was accrued for the six months ended June 30, 2023 (June 30, 2022: $18).

The principal amount outstanding as of June 30, 2023 and December 31, 2022 was $480. At both reporting dates, the entire balance was current.

Statement of Operations – For the three months ended June 30, 2023 and 2022:

Revenue

The Company generated revenue of $758,984 during the quarter ended in 2023 while $nil in the comparable period of 2022. However, Canary generated revenues of $590,387 (though its investment in JVCo) during the quarter ended June 30, 2023 (quarter ended June 30, 2022: $1,032,073) and is represented as a share of income from joint venture on the unaudited condensed consolidated interim statement of operations. The revenue represents the sale of cannabis product and the revenue was concentrated to eight customers (2022: two).

Expenses

Our expenses are classified primarily into advisory and consultancy fees, management fees, salaries and wages, legal and professional fees, and depreciation expense. The decrease in operating expenses during the current quarter ended compared to comparable prior quarter ended is due to significant decrease in consulting fee and professional fees in the current period. Other than that, the expense level has remained similar on an overall level due to the management’s continuous efforts to control and reduce expenses.

Expenses primarily represented consulting fees of $15,883 (2022: $7,454), management fees of $77,191 (2022: $55,631), legal and professional charges of $145,987 (2022: $105,647) comprising legal, review, accounting and Edgar agent fee, depreciation expense amounting to $229,568 (2022: $225,335).

Changes in other income and expenses were due to: (1) the revaluation of the warrant and convertible debt liabilities on each quarter-end which reduced significantly in magnitude since a significant number of warrants expired during the current period ended; (2) increase in the principal balance of higher interest rate bearing loans led to increased interest expense; and (3) and significant increase in exchange income during the quarter due to favorable exchange rate.

Other income and expenses comprised, change in fair value of derivative and warranty liability amounting to positive $4,301 (2022: positive $834), interest and bank charges amounting to $369,092 (2022: $272,373), exchange loss $48,519 (2022: gain of $76,027) other income of $12,507 (2022: 637,591), and debt issuance cost of $12,354 (2022: $12,994).

Statement of Operations – For the six months ended June 30, 2023 and 2022:

Revenue

The Company generated revenue of $758,984 during the quarter ended in 2023 while $nil in the comparable period of 2022. However, Canary generated revenues of $791,285 (though its investment in JVCo) during the six months ended June 30, 2023 (six months ended June 30, 2022: $2,109,626) and is represented as a share of income from joint venture on the unaudited condensed consolidated interim statement of operations. The revenue represents the sale of cannabis product and the revenue was concentrated to eight customers (2022: three).

Table of Contents

Expenses

Expenses primarily represented consulting fees of $16,106 (2022: $18,693), management fees of $155,515 (2022: $83,516), legal and professional charges of $203,927 (2022: $172,591) comprising legal, review, accounting and Edgar agent fee, depreciation expense amounting to $442,254 (2022: $452,959).

Changes in other income and expenses were due to: (1) the revaluation of the warrant and convertible debt liabilities on each quarter-end which reduced significantly in magnitude since a significant number of warrants expired during the current period ended; (2) increase in the principal balance of higher interest rate bearing loans led to increased interest expense; and (3) and significant decrease in exchange income during the quarter due to unfavorable exchange rate.

Other income and expenses comprised, change in fair value of derivative and warranty liability amounting to positive $1,326 (2022: positive $16,812), interest and bank charges amounting to $722,698 (2022: $561,061), exchange loss $50,794 (2022: gain of $41,993) other income of $16,782 (2022: 697,776), and debt issuance cost of $24,757 (2022: $26,243).

Liquidity and Capital Resources

As of June 30, 2023, we had a working capital deficit of $5,099,244 (December 31, 2022: $6,017,434). We are actively seeking various financing opportunities to meet the deficit capital requirements.

We have relied on equity financing and related party debt financing for our operations. The proceeds may not be sufficient to effectively develop our business to the fullest extent to allow us to maximize our revenue potential, in which case, we will need additional capital.

We will need capital to allow us to invest in development. The Company anticipates that its future operations will generate positive cash flows provided that it is successful in obtaining additional financing in the foreseeable future.

Statement of Cash Flow – For the six months ended June 30, 2023 and 2022:

Operating activities

Operating activities used cash of $308,828 compared to cash used of $1,199,180 for the corresponding period of the prior year. This is primarily due to the gain on debt settlement.

Investing activities

Investing activities provided cash of $445,461 in the year 2023 compared to $1,189,956 cash provided in the corresponding period of the prior year. The current period cash utilization represents improvements to Canary’s facility to increase its efficiency and increase cannabis production.

Financing activities

Financing activities provided cash of $667,846 in 2023 compared to cash provided of $12,224 in the year 2022. Cash was provided by a loan advance from a related party in the current and prior period.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Table of Contents

Critical Accounting Policies

All critical accounting policies are described in the Company’s Form 10-K for the year ended December 31, 2022.

Subsequent Events

Description of Property

We do not own any properties at this time and do not have presently any agreements to acquire any properties.

Our principal executive office is located at 20 Hempstead Drive, Hamilton, Ontario, Canada.

Our subsidiary, Canary, leases a 44,000 square foot facility located in Norfolk County, Ontario to produce medical and recreational cannabis.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Smaller reporting companies are not required to provide the information required by this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), we have carried out an evaluation, with the participation of our management, including the Company’s principal executive officer and principal financial officer of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of June 30, 2023 to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported, within the periods specified in the SEC’s rules and forms and (ii) is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in internal controls

No change in our system of internal control over financial reporting occurred during the six months ended June 30, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

During the year ended December 31, 2019, a terminated employee of Canary has filed a lawsuit against the Company amounting to approximately $1,586,130 (CAD $2,100,000) in Ontario, Canada. Currently, the Company is defending its position and believes that the ultimate decision will be in favor of the Company.

A complaint for damages of $150,000 was filed against CannaKorp by the former Chief Financial Officer of CannaKorp for outstanding professional fees. No claim has been registered. The management is of the view that no material losses will arise in respect of the legal claim at the date of this report.

A claim for damages of $1,406,977 (CAD $1,862,805) was filed against Company and its directors by the former Chief Financial Officer of the Company for wrongful dismissal. The management is of the view that no material losses will arise in respect of the legal claim at the date of this report.

During the year ended December 31, 2020, a claim for damages of $98,777 (CAD $130,778) was filed against Canary by a vendor for breach of contract. The management is of the view that no material losses will arise in respect of the legal claim at the date of this report.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

Table of Contents

ITEM 6. EXHIBITS

Exhibits:


		Incorporated by Reference
Exhibit No.	Description	Form	Exhibit	Filing Date
2.1	Asset Acquisition Agreement	8-K	2.1	12/11/14

2.1.1	Agreement and Plan of Share Exchange dated June 27, 2018 with Visava Inc.	8-K	2.1	07/03/18

2.1.2	Agreement and Plan of Share Exchange dated January 25, 2019 with CannaKorp Inc. and David Manly, as Stockholder Representative	8-K	2.1	01/29/19

3(i)(a)	Articles of Incorporation	10-12G	3.1	09/30/13

3(i)(a)	Amended Articles of Incorporation	10-K	3(i)(a)	09/18/22

3(i)(a)	Certificate of Amendment	8-K	3(i)	10/20/16

3(i)(a)	Certificate of Amendment	8-K	3(i)	04/12/17

3(i)(a)	Certificate of Amendment	8-K	3(i)	07/03/17

3(i)(a)	Certificate of Amendment	8-K	3(i)	11/01/17

3(i)(a)	Certificate of Amendment	8-K	3(i)	09/25/18

3.2	Bylaws	10-12G	3.2	09/30/13

4.1	Description of Capital Stock	10-K	4.1	04/14/20

10.1	Form of Securities Purchase Agreement-Blackbridge Capital Growth Fund, LLC	10-K	10.1	03/31/17

10.2	Form of Convertible Promissory Note	10-K	10.2	03/31/17

10.3	Form of Convertible Promissory Note	10-K	10.3	03/31/17

10.4	Form of Convertible Promissory Note	10-K	10.4	03/31/17

10.5	Form of Securities Purchase Agreement-Crown Bridge Partners, LLC	10-K	10.5	03/31/17

10.6	Form of Convertible Promissory Note	10-K	10.6	03/31/17

10.10	Securities Purchase Agreement-Power Up Lending Group Ltd.	10-K	10.10	03/28/18

10.11	Convertible Promissory Note-Power-Up Lending Group Ltd.	10-K	10.11	03/28/18

10.12	Securities Purchase Agreement-Power Up Lending Group Ltd.	10-K	10.12	03/28/18

10.13	Convertible Promissory Note-Power-Up Lending Group Ltd.	10-K	10.13	03/28/18

10.14	Securities Purchase Agreement-Power Up Lending Group Ltd. dated December 24, 2018	10-K	10.14	04/01/19

10.15	Convertible Promissory Note-Power-Up Lending Group Ltd. dated December 24, 2018	10-K	10.15	04/01/19

10.16	Distribution, Collaboration and Licensing Agreement dated December 6, 2018 between Target Group Inc, Canary Rx Inc., Serious Seeds B.V. and Simon Smit	10-K	10.16	04/01/19

10.17	Licensed Producer/Licensed Processor Sales Agency Agreement dated December 13, 2018 with Cannavolve Inc.	10-K	10.17	04/01/19

10.18	Exclusive License Agreement dated August 8, 2019 with cGreen Inc.	8-K	2.1	08/13/19

Table of Contents


10.19	Purchase, Licensing and Purchase Agreement dated September 17, 2019 between CannaKorp, Inc. and Nabis Arizona LLC	8-K	10.1	09/19/19

10.20	Loan Agreement dated December 20, 2019 with Jerry Zarcone	10-K	10.20	04/14/20

10.21	First Amending Agreement dated March 11, 2020 with Jerry Zarcone	10-Q	10.21	06/05/20

10.22	Second Amending Agreement dated April 30, 2020 with Jerry Zarcone	10-Q	10.22	08/10/20

10.23	Third Amending Agreement dated May 15, 2020 with Jerry Zarcone	10-Q	10.23	08/10/20

10.24	Promissory Note Between Target Group Inc. and Frank Zarcone	10-Q	10.24	08/10/20

10.25	Joint Venture Agreement between Canary Rx Inc. and 9258159 Canada, Inc. dated May 14, 2020	10-Q	10.25	08/10/20

10.26	Debt Purchase and Assignment Agreement dated June 15, 2020	8-K	10.1(i)	08/18/20

10.27	Amendment dated August 14, 2020 to Debt Purchase and Assignment Agreement	8-K	10.1(ii)	08/18/20

10.28	Amendment dated May 12, 2021 to Debt Purchase and Assignment Agreement	10-Q	10.28	05/7/21

10.29	Fourth Amending Agreement dated June 12, 2021	10-Q	10.29	11/7/22

10.30	Fifth Amending Agreement dated February 16, 2022	10-Q	10.30	11/7/22

10.31	Sixth Amending Agreement dated October 18, 2022	10-Q	10.31	11/7/22

10.32	Seventh Amending Agreement dated February 16, 2023	10-Q	10.32	5/8/23

10.33	Eighth Amending Agreement dated March 28, 2023	10-Q	10.33	5/8/23

10.34*	Seventh Amending Agreement dated February 16, 2023 (corrected)

31.1*	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*	Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

Exhibit 104		Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

*	Filed herewith.

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TARGET GROUP INC.

Dated: August 9, 2023	By:	/s/ Anthony Zarcone
		Chief Executive Officer, and Director

Dated: August 9, 2023	By:	/s/ Barry Alan Katzman
		Director

Dated: August 9, 2023	By:	/s/ Saul Niddam
		Director

EX-10.34 2 tmb-20230630xex10d34.htm EX-10.34

Exhibit 10.34

SEVENTH AMENDING AGREEMENT

THIS AGREEMENT made as of the 16^th day of February, 2023

BETWEEN:

JERRY ZARCONE

(hereinafter referred to as “Jerry”)

- and –

TARGET GROUP INC.

(hereinafter referred to as “TGI”)

- and –

CANARY RX INC.

(hereinafter referred to as “Canary”)

- and –

VISAVA INC.

(hereinafter referred to as “Visava”)

- and –

CANNAKORP INC.

(hereinafter referred to as “Cannakorp”, which together with
Visava and Canary shall be collectively referred to as the
“Subsidiaries”)

WHEREAS:

Jerry and TGI entered into a Loan Agreement made as of the 20^th day of December, 2019 (the “Loan Agreement”), which Loan Agreement has been amended and extended by various amending and extending agreements from time to time the most recent of is the Sixth Amending Agreement made as of the 18^th day of October, 2022 (collectively, the “FAEA”).

B.	All capitalized terms shall have the meanings ascribed to them in the FAEA unless otherwise defined herein.

- 1 -

C.	The parties are desirous of further amending the Loan Agreement upon the terms and provisions of this Agreement.

NOW THEREFORE THIS AGREEMENT WITNESSETH that in consideration of the respective covenants and agreements hereinafter contained and the sum of One Dollar ($1.00) now paid by the parties hereto each to the other (the receipt and sufficiency of which is hereby acknowledged by each of the parties hereto), the parties hereto agree as follows:

1.	The parties hereby declare and confirm that the Recitals are true and accurate and form integral terms and provisions of this Agreement.

2.	The Loan be and same is hereby increased by the principal amount of a further Five Hundred Thousand ($500,000.00) Dollars (CDN) (the “Fourth Tranche”) upon the following terms and provisions:

(a)

The Fourth Tranche shall be subject to a Lender’s Fee in the amount of Fifty Thousand ($50,000.00) Dollars (CDN), which shall be deducted and paid from the advance thereunder;

(b)

The Fourth Tranche shall be subject to a rate of interest equal to 3.0416% per month (being 43.26% per annum), calculated monthly, not in advance;

(c)

All principal and interest owing and accrued under the Fourth Tranche shall be repayable six (6) months from the date hereof provided that when in not in default, the Fourth Tranche may be repaid in full upon no less than three (3) months’ written notice thereof;

(d)

For further clarity, all monies owing and the performance of all other covenants and obligations by Fourth Tranche be and same shall be guaranteed by the Subsidiaries and secured under the Security; and

(e)

Contemporaneous with the execution and delivery of this Agreement, TGI and the Subsidiaries shall reimburse Jerry for all legal costs and expenses in respect of the Loan including, without limitation, any demands thereof and the negotiation, drafting and execution of this Agreement.

TGI and the Subsidiaries shall execute, deliver, and, if applicable, register within a reasonable time following presentation thereof by Jerry or his counsel (but in no event more than five (5) business days following such presentation) and shall also promptly do or cause to be done all other acts and things, execute and deliver or cause to be executed and delivered all agreements and documents and provide any further assurances, undertakings and information in order to give full effect to this Agreement. .

4.	Except as modified by this Agreement, the Loan Agreement shall be unamended and shall be and shall remain in full force and effect. Also, to the extent that any term or provision of this Agreement conflicts with any term or provision of the Loan Agreement, the terms

- 2 -

and provision of this Agreement shall prevail.

5.	This Agreement may be executed by the parties in separate counterparts each of which when so executed and delivered to each other shall be deemed to be and shall be read as a single agreement among the parties.

6.	This Agreement is governed by and is to be construed and interpreted in accordance with, the laws of the Province of Ontario and the laws of Canada applicable in that Province.

This Agreement constitutes the entire agreement between the parties pertaining to the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, of the parties, and there are no representations, warranties or other agreements between the parties in connection with the subject matter of this Agreement except as specifically set out in this Agreement.

[signatures intentionally on next page]

- 3 -

Each of the parties has executed and delivered this Agreement as of the date first above written.

SIGNED IN THE PRESENCE OF	)
	)
	)
	)
Witness	)	JERRY ZARCONE

		TARGET GROUP INC.
		Per:


		Name: Saul Niddam
		Position: Director


		Name: Frank Monte
		Position: Director


		Name: Anthony Zarcone
		Position: Director


		Name: Barry Katzman
		Position: Director
		We have authority to bind the Corporation

		CANARY RX INC.
		Per:


		Name: Anthony Zarcone
		Position: President & CEO
		I have authority to bind the Corporation

		VISAVA INC.
		Per:


		Name: Anthony Zarcone
		Position: President & CEO
		I have authority to bind the Corporation

- 4 -

	CANNAKORP INC.
	Per:


	Name: Saul Niddam
	Position: CEO
	I have authority to bind the Corporation

- 5 -

EX-31.1 3 tmb-20230630xex31d1.htm EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302

I, Anthony Zarcone, certify that:

1.	I have reviewed this Form 10-Q of Target Group Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the unaudited condensed consolidated interim financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of unaudited condensed consolidated interim financial statements for external purposes in accordance with generally accepted accounting principles;

c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and

Disclosed in this report is any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: August 9, 2023	/s/ Anthony Zarcone
	Chief Executive Officer

EX-31.2 4 tmb-20230630xex31d2.htm EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302

I, Anthony Zarcone, certify that:

1.	I have reviewed this Form 10-Q of Target Group Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: August 9, 2023	/s/ Anthony Zarcone
	Principal Financial Officer

EX-32.1 5 tmb-20230630xex32d1.htm EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANTTO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, the undersigned officer of Target Group Inc. (the “Company”), hereby certify that:

The Report on Form 10-Q for the six months ended June 30, 2023 of the Company fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly represents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 9, 2023	By:	/s/ Anthony Zarcone
		Chief Executive Officer
		(Principal Executive Officer)
		(Principal Financial Officer)

EX-101.SCH 6 tmb-20230630.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Fixed Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Related Party Transactions and Balances - Repayment schedule of the minimum principal payments (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability - Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability - Reconciliation of net operating lease (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Repayment schedule of the minimum principal payments (Details) - calc2 link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Organization, Nature of Business, Going Concern and Management Plans (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Sales Tax Recoverable and Payable (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Fixed Assets - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Joint Venture - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Joint Venture - Summarizes the activity of the period of JVCo (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Goodwill - Purchase consideration (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Goodwill - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Related Party Transactions and Balances (Details) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - Related Party Transactions and Balances - Shareholder loan (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Convertible Promissory Notes - Recorded and fair valued derivative liability (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Convertible Promissory Notes - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Stockholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 41103 - Disclosure - Stockholders' Equity - Warrants outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Contingencies and commitments (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - DOCUMENT AND ENTITY INFORMATION link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Organization, Nature of Business, Going Concern and Management Plans link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Sales Tax Recoverable and Payable link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Fixed Assets link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Joint Venture link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Related Party Transactions and Balances link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Convertible Promissory Notes link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Contingencies and commitments link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Fixed Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Joint Venture (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Related Party Transactions and Balances (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Convertible Promissory Notes (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - Contingencies and commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - Joint Venture -Agreement and obtaining 100 percentage shares of the JVCo (Details) link:presentationLink link:calculationLink link:definitionLink 41104 - Disclosure - Stockholders' Equity - Movement of the warrant liability (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 tmb-20230630_cal.xml EX-101.CAL EX-101.DEF 8 tmb-20230630_def.xml EX-101.DEF EX-101.LAB 9 tmb-20230630_lab.xml EX-101.LAB Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(g) Security Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Trading Symbol Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Entity Central Index Key Current Fiscal Year End Date Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line item] Statement Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets Cash Cash Restricted Cash Restricted cash Accounts Receivable, Net, Current Accounts receivable, no allowance Inventory, Net Inventory Prepaid Expense, Current Prepaid asset Value Added Tax Receivable, Current Sales tax recoverable, net of allowance Sales tax recoverable, gross The amount of current portion of receivables from joint venture as at the end of the reporting period. Receivables from Joint Venture, Current Receivable from joint venture Other Receivable, after Allowance for Credit Loss, Current, Related Party, Type [Extensible Enumeration] Other Receivables Other receivable Debt outstanding amount Other Receivable, after Allowance for Credit Loss, Related Party, Type [Extensible Enumeration] Assets, Current Total current assets Assets, Noncurrent [Abstract] Long term assets Property, Plant and Equipment, Net Fixed assets Fixed assets, net Equity Method Investments Investment in joint venture Goodwill. Goodwill Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Assets, Noncurrent Total long term assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' DEFICIENCY Liabilities [Abstract] Current liabilities Bank Overdrafts Bank overdraft Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued liabilities Sales and Excise Tax Payable, Current Sales tax payable Gross sales tax payable The amount of current portion of net related party payable as at the end of the reporting period. Related Party Payables Net, Current Payable to related parties, net Accounts Payable, Current, Related Party, Type [Extensible Enumeration] Operating Lease, Liability, Current Current portion Operating lease liability - Current portion Convertible Notes Payable, Current Convertible promissory notes, net Derivative Liability, Current Derivative liability, end of the period Derivative liability, beginning of the period Derivative liability Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Long term liabilities Accounts Payable, Related Parties, Noncurrent Payable to related parties, net - Non-current portion Accounts Payable, Noncurrent, Related Party, Type [Extensible Enumeration] Operating Lease, Liability, Noncurrent Non-current portion Operating lease liability - Non-current portion Derivative Liability, Noncurrent Warrant liability Liabilities, Noncurrent Total long term liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' deficiency Preferred Stock, Value, Issued Preferred stock Common Stock, Value, Issued Common stock Represents the information pertaining to shares to be issued total value. Shares to be Issued, Total Shares to be issued Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated comprehensive loss Stockholders' Equity Attributable to Parent Ending balance Beginning balance Total stockholders' deficiency Value of shares, outstanding Liabilities and Equity Total liabilities and stockholders' deficiency Commitments and Contingencies Contingencies and commitments CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Revenue from Contract with Customer, Excluding Assessed Tax Sales REVENUE Cost of Goods and Services Sold COST OF GOOD SOLD Cost of goods sold Gross Profit Gross profit Operating Expenses [Abstract] OPERATING EXPENSES Professional Fees Advisory and consultancy fee Management Fee Expense Management services fee Amount of expense for salary and wage arising from service rendered by nonofficer employee. excludes allocated cost, labor-related non-salary expense, and direct and overhead labor cost included in cost of good and service sold. Salary and Wage, Nonofficer Salaries and wages Legal Fees Legal and professional fees Depreciation Depreciation expense Amount of operating lease income (expense). Operating Lease Income (Expense) Operating lease expense Amount of general and administrative income (expense). General And Administrative Income (Expense) Office and general Operating Expenses Operation expenses Total operating expenses Other Nonoperating Income (Expense) [Abstract] OTHER EXPENSES (INCOME) Derivative, Gain (Loss) on Derivative, Net Change in fair value of derivative and warrant liability Amount of gain (loss) on settlement of liability during the period. Gain Loss On Settlement Of Liability Gain on settlement Interest Expense Interest expense Interest and bank charges Interest Expense, Related Party, Type [Extensible Enumeration] Foreign Currency Transaction Gain (Loss), before Tax Exchange loss (income) Other Nonoperating Income Other income Amount of allowance recovery for sales tax recoverable. Allowance Recovery for Sales Tax Recoverable Recovery of sales tax recoverable Income (Loss) from Equity Method Investments Investment (income) loss from joint venture Share of (income) loss from joint venture Represents the information pertaining to debt issuance costs. Debt Issuance Costs Debt issuance cost Debt issuance cost Nonoperating Income (Expense) Total other expense (income) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net income (loss) before income taxes Net Income (Loss) Attributable to Parent Net income (loss) Net income (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Foreign currency translation adjustment Foreign currency translation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income (loss) Earnings Per Share, Basic Earnings (loss) per share - basic Weighted Average Number of Shares Outstanding, Basic Weighted average shares - basic Earnings Per Share, Diluted Earnings (loss) per share - diluted Weighted Average Number of Shares Outstanding, Diluted Weighted average shares - diluted CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Equity Components [Axis] Equity Component [Domain] Parent [Member] Parent Preferred Stock [Member] Preferred stock Common Stock [Member] Common stock Represents information pertaining to shares to be issued. Shares to be Issued [Member] Shares to be issued Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated deficit AOCI Attributable to Parent [Member] Accumulated Comprehensive Income Shares, Outstanding Ending balance (in shares) Beginning balance (in shares) Shares, outstanding The amount of shares to be issued as compensation to intellectual property rights. Shares to be Issued as Compensation to Intellectual Property Rights Value Shares issued as consideration for consideration of the intellectual property rights Shares issued as consideration for consideration of the intellectual property rights Number of shares issued for compensation to intellectual property rights. Stock to be Issued as Compensation to Intellectual Property Rights Shares Shares issued as consideration for consideration of the intellectual property rights (in shares) Shares issued as consideration for consideration of the intellectual property rights (in shares) CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] OPERATING ACTIVITIES Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net (loss) for the period Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustment for non-cash items Issuance of Stock and Warrants for Services or Claims Shares and warrants issued/to be issued for services Amount of allowance for sales tax recoverable. Allowance for Sales Tax Recoverable Allowance of sales tax recoverable Depreciation, Depletion and Amortization, Nonproduction Depreciation expense Operating Lease, Expense Operating lease expense Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: The increase (decrease) during the reporting period in the amount of sales tax recoverable. Increase (Decrease) in Sales Tax Recoverable Change in sales tax recoverable Increase (Decrease) in Accounts Payable and Accrued Liabilities Change in accounts payable and accrued liabilities Represents the amount of change in operating lease liability, net. Change in Operating Lease Liability, Net Change in operating lease liability, net Net Cash Provided by (Used in) Operating Activities Net cash (used in) operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] INVESTING ACTIVITIES The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Payments for (Proceeds from) Property, Plant, and Equipment Amounts invested on fixed assets Proceeds from Divestiture of Interest in Joint Venture Recovery of investment Net proceeds from joint venture Net Cash Provided by (Used in) Investing Activities Net cash provided by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] FINANCING ACTIVITIES Proceeds from (Repayments of) Bank Overdrafts Utilization of bank overdraft facility Proceeds from Related Party Debt Proceeds from loans from related parties Repayments of Related Party Debt Settlement of related party loan Represents the information pertaining to payment for settlement payable. Payment for Settlement Payable Payment for settlement payable Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net increase (decrease) in cash and restricted cash during the year Effect of Exchange Rate on Cash and Cash Equivalents Effect of foreign currency translation Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and restricted cash, end of year Cash and restricted cash, beginning of year Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] NON-CASH INVESTING AND FINANCING ACTIVITIES Noncash or Part Noncash Acquisition, Intangible Assets Acquired Shares issued as consideration for services Supplemental Cash Flow Information [Abstract] SUPPLEMENTARY CASH FLOW INFORMATION Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest Organization, Nature of Business, Going Concern and Management Plans Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization, Nature of Business, Going Concern and Management Plans Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Inventory Inventory Disclosure [Text Block] Inventory The amount of sales tax recoverable Sales Tax Recoverable and Payable The amount of sales tax recoverable. Sales Tax Recoverable [Text Block] Sales Tax Recoverable and Payable Fixed Assets Property, Plant and Equipment Disclosure [Text Block] Fixed Assets Joint Venture Equity Method Investments and Joint Ventures Disclosure [Text Block] Joint Venture Goodwill Goodwill Disclosure [Text Block] Goodwill Related Party Transactions and Balances Related Party Transactions Disclosure [Text Block] Related Party Transactions and Balances Operating Lease Right-Of-Use Assets and Lease Liability Lessee, Operating Leases [Text Block] Operating Lease Right-Of-Use Assets and Lease Liability Convertible Promissory Notes Debt Disclosure [Text Block] Convertible Promissory Notes Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Earnings (Loss) Per Share Earnings Per Share [Text Block] Earnings (Loss) Per Share Contingencies and commitments Commitments and Contingencies Disclosure [Text Block] Contingencies and commitments Subsequent Events Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of Presentation and Consolidation Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash Property, Plant and Equipment, Policy [Policy Text Block] Fixed Assets Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Revenue Recognition, Policy [Policy Text Block] Revenue recognition Equity Method Investments [Policy Text Block] Equity Method Investments New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Standards In addition to the PPE table that provides the details of each class of PPE if a separate table is also presented for the useful lives (outside of the PPE note, often included in the Summary of Significant Accounting Policies footnote), we would need to extend for the useful life table text block. Schedule of Property, Plant and Equipment, Useful Life [Table Text Block] Schedule of property, plant and equipment useful life EX-101.PRE 10 tmb-20230630_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT

DOCUMENT AND ENTITY INFORMATION - shares	6 Months Ended
DOCUMENT AND ENTITY INFORMATION - shares	Jun. 30, 2023	Aug. 09, 2023
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	000-55066
Entity Registrant Name	TARGET GROUP INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-3621499
Entity Address, Address Line One	20 Hempstead Drive
Entity Address, Address Line Two	Hamilton
Entity Address, City or Town	Ontario
Entity Address, Country	CA
Entity Address, Postal Zip Code	L8W 2E7
City Area Code	1 905
Local Phone Number	541-3833
Title of 12(g) Security	Common Stock, Par Value $0.0001
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Trading Symbol	CBDY
Entity Common Stock, Shares Outstanding		617,025,999
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Central Index Key	0001586554
Current Fiscal Year End Date	--12-31
Amendment Flag	false

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 1,047,833	$ 223,843
Restricted cash	8,686	8,490
Accounts receivable, no allowance	2,068	2,068
Inventory	1,814,902
Prepaid asset	42,674	41,714
Sales tax recoverable, net of allowance	$ 1,034	0
Receivable from joint venture		$ 630,180
Other Receivable, after Allowance for Credit Loss, Current, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Other receivable	$ 3,777	$ 3,692
Other Receivable, after Allowance for Credit Loss, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Total current assets	$ 2,920,974	$ 909,987
Long term assets
Fixed assets	5,773,235	5,554,225
Investment in joint venture		775,577
Goodwill	269,175	263,117
Operating lease right-of-use assets	55,237	62,728
Total long term assets	6,097,647	6,655,647
Total assets	9,018,621	7,565,634
Current liabilities
Bank overdraft	506	506
Accounts payable and accrued liabilities	2,823,400	2,296,935
Sales tax payable		35,254
Payable to related parties, net	$ 5,061,467	$ 4,468,535
Accounts Payable, Current, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Operating lease liability - Current portion	$ 118,047	$ 110,586
Convertible promissory notes, net	480	480
Derivative liability	16,318	15,125
Total current liabilities	8,020,218	6,927,421
Long term liabilities
Payable to related parties, net - Non-current portion	$ 6,275,163	$ 5,877,930
Accounts Payable, Noncurrent, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Operating lease liability - Non-current portion	$ 1,288,897	$ 1,319,619
Warrant liability	931	489
Total long term liabilities	7,564,991	7,198,038
Total liabilities	15,585,209	14,125,459
Stockholders' deficiency
Preferred stock	100	100
Common stock	61,703	61,703
Shares to be issued	175,293	175,182
Additional paid-in capital	24,985,697	24,985,697
Accumulated deficit	(30,565,571)	(30,783,678)
Accumulated comprehensive loss	(1,223,810)	(998,829)
Total stockholders' deficiency	(6,566,588)	(6,559,825)
Total liabilities and stockholders' deficiency	9,018,621	7,565,634
Contingencies and commitments

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
REVENUE	$ 758,984		$ 758,984	$ 0
COST OF GOOD SOLD	(369,261)		(369,261)
Gross profit	389,723		389,723
OPERATING EXPENSES
Advisory and consultancy fee	15,883	$ 7,454	16,106	18,693
Management services fee	77,191	55,631	155,515	83,516
Salaries and wages	(53,083)	(8,056)	(53,083)	9,775
Legal and professional fees	145,987	105,647	203,927	172,591
Depreciation expense	229,568	225,335	442,254	452,959
Operating lease expense	28,400	(10,378)	17,310	(33,905)
Office and general	56,502	(89,143)	59,131	(68,946)
Total operating expenses	500,448	286,490	841,160	634,683
OTHER EXPENSES (INCOME)
Change in fair value of derivative and warrant liability	4,301	834	1,326	(16,812)
Gain on settlement	(1,428,185)		(1,428,185)
Interest and bank charges	$ 369,092	$ 272,373	$ 722,698	$ 561,061
Interest Expense, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]	Related Party [Member]	Related Party [Member]
Exchange loss (income)	$ 48,519	$ (76,027)	$ 50,794	$ (41,993)
Other income	(12,507)	(637,591)	(16,782)	(697,776)
Recovery of sales tax recoverable		(1,750)		(2,259)
Share of (income) loss from joint venture	(68,115)	(104,923)	(24,152)	(151,048)
Debt issuance cost	12,354	12,994	24,757	26,243
Total other expense (income)	(1,074,541)	(534,090)	(669,544)	(322,584)
Net income (loss) before income taxes	963,816	247,600	218,107	(312,099)
Net income (loss)	963,816	247,600	218,107	(312,099)
Foreign currency translation adjustment	(222,962)	(27,220)	(224,981)	(17,345)
Comprehensive income (loss)	$ 740,854	$ 220,380	$ (6,874)	$ (329,444)
Earnings (loss) per share - basic	$ 0.0016	$ 0.0004	$ 0.0004	$ (0.0005)
Weighted average shares - basic	617,025,999	617,025,999	617,025,999	617,025,999
Earnings (loss) per share - diluted	$ 0.0010	$ 0.0003	$ 0.0000	$ (0.0004)
Weighted average shares - diluted	727,426,007	773,218,857	727,426,007	773,218,857

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Preferred stock	Common stock	Shares to be issued	Additional Paid-in Capital	Accumulated deficit	Accumulated Comprehensive Income	Total
Beginning balance at Dec. 31, 2021	$ 100	$ 61,703	$ 174,722	$ 24,985,697	$ (26,263,614)	$ (1,110,720)	$ (2,152,112)
Beginning balance (in shares) at Dec. 31, 2021	1,000,000	617,025,999	1,516,528
Shares issued as consideration for consideration of the intellectual property rights			$ 153
Shares issued as consideration for consideration of the intellectual property rights (in shares)			15,624
Ending balance at Mar. 31, 2022	$ 100	$ 61,703	$ 174,875	24,985,697	(26,823,313)	(1,100,845)	(2,701,783)
Ending balance (in shares) at Mar. 31, 2022	1,000,000	617,025,999	1,532,152
Beginning balance at Dec. 31, 2021	$ 100	$ 61,703	$ 174,722	24,985,697	(26,263,614)	(1,110,720)	(2,152,112)
Beginning balance (in shares) at Dec. 31, 2021	1,000,000	617,025,999	1,516,528
Shares issued as consideration for consideration of the intellectual property rights			$ 267				267
Shares issued as consideration for consideration of the intellectual property rights (in shares)			31,248
Net income (loss)					(312,099)		(312,099)
Foreign currency translation						(17,345)	(17,345)
Ending balance at Jun. 30, 2022	$ 100	$ 61,703	$ 174,989	24,985,697	(26,575,713)	(1,128,065)	(2,481,289)
Ending balance (in shares) at Jun. 30, 2022	1,000,000	617,025,999	1,547,776
Beginning balance at Mar. 31, 2022	$ 100	$ 61,703	$ 174,875	24,985,697	(26,823,313)	(1,100,845)	(2,701,783)
Beginning balance (in shares) at Mar. 31, 2022	1,000,000	617,025,999	1,532,152
Shares issued as consideration for consideration of the intellectual property rights			$ 114				114
Shares issued as consideration for consideration of the intellectual property rights (in shares)			15,624
Net income (loss)					247,600		247,600
Foreign currency translation						(27,220)	(27,220)
Ending balance at Jun. 30, 2022	$ 100	$ 61,703	$ 174,989	24,985,697	(26,575,713)	(1,128,065)	(2,481,289)
Ending balance (in shares) at Jun. 30, 2022	1,000,000	617,025,999	1,547,776
Beginning balance at Dec. 31, 2022	$ 100	$ 61,703	$ 175,182	24,985,697	(30,783,678)	(998,829)	(6,559,825)
Beginning balance (in shares) at Dec. 31, 2022	1,000,000	617,025,999	1,579,024
Shares issued as consideration for consideration of the intellectual property rights			$ 63
Shares issued as consideration for consideration of the intellectual property rights (in shares)			15,624
Ending balance at Mar. 31, 2023	$ 100	$ 61,703	$ 175,245	24,985,697	(31,529,387)	(1,000,848)	(7,307,490)
Ending balance (in shares) at Mar. 31, 2023	1,000,000	617,025,999	1,594,648
Beginning balance at Dec. 31, 2022	$ 100	$ 61,703	$ 175,182	24,985,697	(30,783,678)	(998,829)	(6,559,825)
Beginning balance (in shares) at Dec. 31, 2022	1,000,000	617,025,999	1,579,024
Shares issued as consideration for consideration of the intellectual property rights			$ 111				111
Shares issued as consideration for consideration of the intellectual property rights (in shares)			31,248
Net income (loss)					218,107		218,107
Foreign currency translation						(224,981)	(224,981)
Ending balance at Jun. 30, 2023	$ 100	$ 61,703	$ 175,293	24,985,697	(30,565,571)	(1,223,810)	(6,566,588)
Ending balance (in shares) at Jun. 30, 2023	1,000,000	617,025,999	1,610,272
Beginning balance at Mar. 31, 2023	$ 100	$ 61,703	$ 175,245	24,985,697	(31,529,387)	(1,000,848)	(7,307,490)
Beginning balance (in shares) at Mar. 31, 2023	1,000,000	617,025,999	1,594,648
Shares issued as consideration for consideration of the intellectual property rights			$ 48				48
Shares issued as consideration for consideration of the intellectual property rights (in shares)			15,624
Net income (loss)					963,816		963,816
Foreign currency translation						(222,962)	(222,962)
Ending balance at Jun. 30, 2023	$ 100	$ 61,703	$ 175,293	$ 24,985,697	$ (30,565,571)	$ (1,223,810)	$ (6,566,588)
Ending balance (in shares) at Jun. 30, 2023	1,000,000	617,025,999	1,610,272

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482765/220-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-8

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-9

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-10

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483581/946-220-45-7

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483499/205-20-50-7

Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B

Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

+ Details

- Definition

Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481372/852-10-55-10

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-12

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(19))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(6))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2

+ Details

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022
OPERATING ACTIVITIES
Net (loss) for the period		$ 218,107	$ (312,099)
Adjustment for non-cash items
Change in fair value of derivative and warrant liability	$ 4,301	1,326	(16,812)
Gain on settlement	(1,428,185)	(1,428,185)
Shares and warrants issued/to be issued for services		409	420
Allowance of sales tax recoverable			(2,259)
Depreciation expense		442,254	452,959
Operating lease expense		119,562	134,199
Investment (income) loss from joint venture	(68,115)	(24,152)	(151,048)
Debt issuance cost	12,354	24,757	26,243
Changes in operating assets and liabilities:
Change in sales tax recoverable		(36,448)	(12,058)
Change in accounts payable and accrued liabilities		534,095	(1,150,218)
Change in operating lease liability, net		(160,553)	(168,507)
Net cash (used in) operating activities		(308,828)	(1,199,180)
INVESTING ACTIVITIES
Amounts invested on fixed assets		5,821	(321)
Net proceeds from joint venture		439,640	1,190,277
Net cash provided by investing activities		445,461	1,189,956
FINANCING ACTIVITIES
Utilization of bank overdraft facility			83,163
Proceeds from loans from related parties		667,846	78,660
Settlement of related party loan			(139,599)
Payment for settlement payable			(10,000)
Net cash provided by financing activities		667,846	12,224
Net increase (decrease) in cash and restricted cash during the year		804,479	3,000
Effect of foreign currency translation		19,707	(2,019)
Cash and restricted cash, beginning of year		232,333	122,151
Cash and restricted cash, end of year	$ 1,056,519	1,056,519	123,132
NON-CASH INVESTING AND FINANCING ACTIVITIES
Shares issued as consideration for services		$ 114	114
SUPPLEMENTARY CASH FLOW INFORMATION
Cash paid for interest			$ 2,084,621

XML 16 R6.htm IDEA: XBRL DOCUMENT

Organization, Nature of Business, Going Concern and Management Plans

6 Months Ended

Jun. 30, 2023

Organization, Nature of Business, Going Concern and Management Plans

Organization, Nature of Business, Going Concern and Management Plans

1. Organization, Nature of Business, Going Concern and Management Plans

Organization and Nature of Business

Visava Inc./Canary Rx Inc.

CannaKorp Inc.

cGreen, Inc. Exclusive License Agreement

Joint Venture Agreement Termination

CL Investors Debt Purchase and Assignment Agreement

The transactions contemplated by the Agreement and the Amendment closed on August 14, 2020.

Going Concern

XML 17 R7.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

Use of Estimates

Cash

Restricted cash represents deposits made to the Company’s bank as a requirement to use the bank’s credit card which is not available for immediate or general business use.

Fixed Assets

Depreciation is calculated using the following terms and methods:


Furniture & office equipment	Straight-line	7 years
Machinery & equipment	Straight-line	3-5 years
Software	Straight-line	3 years
Leasehold improvements	Straight-line	Lease period

Fair Value of Financial Instruments

The three levels of the fair value hierarchy are as follows:

●

Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

●

Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

●

Revenue recognition

The Company generated revenue of $758,984 during the six month ended June 30, 2023 whereas $nil in June 30, 2022.

Equity Method Investments

Recently Issued Accounting Standards

XML 18 R8.htm IDEA: XBRL DOCUMENT

Inventory

6 Months Ended

Jun. 30, 2023

Inventory

Inventory

3. Inventory

XML 19 R9.htm IDEA: XBRL DOCUMENT

Sales Tax Recoverable and Payable

6 Months Ended

Jun. 30, 2023

Sales Tax Recoverable and Payable

Sales Tax Recoverable and Payable

4. Sales Tax Recoverable and Payable

As of June 30, 2023, the Company had $1,034 of gross sales tax recoverable compared to December 31, 2022 there was $nil, while the Company had $nil of gross sales tax payable as of June 30, 2023.

The Company has recorded $nil (December 31, 2022: $nil) of allowance as of June 30, 2023.

XML 20 R10.htm IDEA: XBRL DOCUMENT

Fixed Assets

6 Months Ended

Jun. 30, 2023

Fixed Assets

Fixed Assets

5. Fixed Assets

Below is a breakdown of the consolidated fixed asset, category wise:


	Furniture &	Machinery &		Leasehold
	fixture	Equipment	Software	improvements	Total
	$	$	$	$	$
Cost	1,452,252	770,161	43,553	6,851,094	9,117,060
Accumulated depreciation	(481,941)	(747,730)	(43,490)	(2,070,664)	(3,343,825)
	970,311	22,431	63	4,780,430	5,773,235

XML 21 R11.htm IDEA: XBRL DOCUMENT

Joint Venture

6 Months Ended

Jun. 30, 2023

Joint Venture

Joint Venture

6. Joint Venture

Historical information

In addition, Canary, Thrive Cannabis, and JVCo entered into a Unanimous Shareholder Agreement dated May 14, 2020, governing the management and administration of the business of JVCo.

The Company recorded JVCo’s results through April 27, 2023 using the equity table and below is the table which summarizes the activity of the period (through April 27, 2023):


Period ended	January 1 to April 27, 2023		Six months ended June 30, 2022
	CAD	USD	CAD	USD
Sales	1,068,799	791,285	2,681,955	2,109,626
Cost of goods sold	620,344	459,271	1,332,020	1,047,767
Gross profit	448,455	332,014	1,349,935	1,061,859
Operation expenses	383,358	283,819	965,882	759,763
Net income (loss)	65,097	48,195	384,053	302,096

Eligible recoverable expenses	1,437,054	1,060,833	2,475,041	1,920,632
Recoverable amount	1,437,054	1,060,833	2,475,041	1,920,632
Income (loss) on equity	32,549	24,098	192,026	151,048

Termination of joint venture agreement during quarter ended June 30, 2023

the company as of April 27, 2023, therefore, the company will use the acquisition method of accounting (using a step acquisition method) under ASC 805 Business Combination.

As a consequence of the above Settlement Agreement and after obtaining 100% shares of the JVCo, the Company acquired the following assets:


		Fair value
		$
Assets acquired:
Inventory		1,690,368
Fixed assets		534,816
		2,225,184

XML 22 R12.htm IDEA: XBRL DOCUMENT

Goodwill

6 Months Ended

Jun. 30, 2023

Goodwill

Goodwill

7. Goodwill

Business Acquisition

CannaKorp Inc.

Effective January 25, 2019, the Company entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with CannaKorp Inc., a Delaware corporation (“CannaKorp”). Company had previously entered into a Letter of Intent with CannaKorp dated November 30, 2018, which was disclosed in the Company’s report on Form 8-K filed December 4, 2018.

The purchase consideration of 30,407,412 shares and 7,211,213 warrants of the Company’s common stock are valued as detailed below:


		$
Number of Common Stock		30,407,712
Market price on the date of issuance		0.108
Fair value of Common Stock		3,284,033


		$
Number of warrants		7,211,213
Fair value price per warrant		0.108
Fair value of warrant		778,811

Fair value of Common Stock		3,284,033
Fair value of warrant		778,811
Purchase consideration		4,062,844

The fair value of these warrants was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:

●

Forfeiture rate of 0%;

●

Stock price of $0.108 per share;

●

Exercise price between the range of $0.13 to $0.15 per share

●

Volatility at 635.49%

●

Risk free interest rate of 2.55%;

●

Expected life of 2 years; and

●

Expected dividend rate of 0%

During the year ended December 31, 2021, all of the CannaKorp Warrants expired, none were exercised.

Visava Inc./Canary Rx Inc.


		$
Number of Common Stock		25,500,000
Market price on the date of issuance		0.067
Fair value of Common Stock		1,695,750


		$
Number of warrants		25,000,000
Fair value price per warrant		0.065
Fair value of warrant		1,623,092

Fair value of Common Stock		1,695,750
Fair value of warrant		1,623,092
Purchase consideration		3,318,842

The fair value of these warrants was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:

●

Forfeiture rate of 0%;

●

Stock price of $0.067 per share;

●

Exercise price of $0.10 per share

●

Volatility at 329%

●

Risk free interest rate of 2.66%;

●

Expected life of 2 years; and

●

Expected dividend rate of 0%

During the year ended, December 31, 2022, all of the Visava Warrants expired, none were exercised.

Goodwill

XML 23 R13.htm IDEA: XBRL DOCUMENT

Related Party Transactions and Balances

6 Months Ended

Jun. 30, 2023

Related Party Transactions and Balances

8. Related Party Transactions and Balances

During the six months ended June 30, 2023, the Company expensed $155,515 (June 30, 2022: $83,516) in management service fee for services provided by the current key officers of the company.

The breakdown of the related party balance as of June 30, 2023 of $11,336,630 (December 31, 2022: $10,346,465) is below:

Debt purchase by CL Investors Inc.

The repayment schedule of the minimum principal payments is shown below:


2023	$	552,583
2024		3,613,227
2025		3,706,326
Total		7,872,136
Current portion		(1,540,099)
Non-current portion	$	6,332,037

Shareholder loan


	Interest rate		Maximum loan		Outstanding loan
			CAD	USD	CAD	USD
Tranche 1	16.00	%	1,043,593	788,226	1,043,593	788,226
Tranche 2	43.26	%	1,592,787	1,203,032	1,592,787	1,203,032
Tranche 3	43.26	%	250,000	188,825	250,000	188,825
Tranche 4	43.26	%	500,000	377,650	500,000	377,650
Tranche 5	43.26	%	500,000	377,650	400,000	302,120
Total			3,886,380	2,935,383	3,786,380	2,859,853

Outstanding management service fee

The balance owing to key officers of the Company is $647,194 (December 31, 2022: $585,261). The outstanding balance is primarily the outstanding management service fee.

Balances outstanding related to subsidiaries

Balances outstanding related to directors

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

+ Details

XML 24 R14.htm IDEA: XBRL DOCUMENT

Operating Lease Right-Of-Use Assets and Lease Liability

6 Months Ended

Jun. 30, 2023

Operating Lease Right-Of-Use Assets and Lease Liability

Operating Lease Right-Of-Use Assets and Lease Liability

9. Operating Lease Right-Of-Use Assets and Lease Liability

These leases will expire between 2023 and 2030. The weighted average discount rate used for these leases was 16% (average borrowing rate of the Company). Maturities of lease liabilities were:


2023	$	165,264
2024		330,107
2025		333,408
2026		336,742
Thereafter		1,147,370
Total lease payments		2,312,891
Less imputed interest		(905,947)
Present value of lease liabilities		1,406,944
Current portion		(118,047)
Non-current portion	$	1,288,897

Below is the reconciliation of the net operating lease presented on the unaudited condensed consolidated interim statement of operations:


	For the	For the	For the	For the
	three months ended	three months ended	six months ended	six months ended
	June 30, 2023	June 30, 2022	June 30, 2023	June 30, 2022
	$	$	$	$
Gross operating lease expense	—	66,672	119,562	134,199
Gross rent and utilities expenses	28,400	132,169	(35,207)	254,382
Recoverable expenses from JVCo related to rent and utilities	—	(209,219)	(67,045)	(422,486)
	28,400	(10,378)	17,310	(33,905)

XML 25 R15.htm IDEA: XBRL DOCUMENT

Convertible Promissory Notes

6 Months Ended

Jun. 30, 2023

Convertible Promissory Notes

Convertible Promissory Notes

10. Convertible Promissory Notes

Interest amounting to $9 was accrued for the six months ended June 30, 2023 (June 30, 2022: $18).

Principal amount outstanding as of June 30, 2023 and December 31, 2022 was $480. At both reporting dates, the entire balance was current.

All notes maturing prior to the date of this report are outstanding.

Derivative liability


	Derivative				Derivative
	liability as at	Conversions / Redemption			liability as at
	December 31,	during the	Change due to	Fair value	June 30,
	2022	period	Issuances	adjustment	2023
	$	$	$	$	$
Note D	1,446	—	—	134	1,580
Note F	10,034	—	—	777	10,811
Note G	3,645	—	—	282	3,927
	15,125	—	—	1,193	16,318

Key assumptions used for the valuation of convertible notes

Derivative element of the convertible notes was fair valued using a multinomial lattice model. Following assumptions were used to fair value these notes as of June 30, 2023:

●

Projected annual volatility of 329% to 329%;

●

Risk free interest rate of 5.06% to 5.06%;

●

Stock price of $0.006 to 0.006;

●

Liquidity term of 0.25 to 0.25 years;

●

Dividend yield of 0%; and

●

Exercise price of $0.0012 to $0.0151.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//470/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

+ Details

XML 26 R16.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

6 Months Ended

Jun. 30, 2023

Stockholders' Equity

Stockholders' Equity

11. Stockholders’ Equity

Capitalization

Preferred Stock

●

Par value: $0.0001

●

Authorized: 20,000,000

●

Issued: 1,000,000 shares were outstanding as of June 30, 2023 and December 31, 2022

Common Stock

●

Par value: $0.0001

●

Authorized: 850,000,000

●

Issued: 617,025,999 shares are outstanding as at June 30, 2023 and December 31, 2022

Preferred Stock

Series A Preferred Stock (“Series A Stock”)

Common Stock

Holders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the stockholders. Holders of common stock do not have cumulative voting rights.

2023

2022

Shares to be issued include the following:


	Shares	Amount		Description
				80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.

Services	115,000	$	73,000	35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.
Private placements	346,296	$	18,787	Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.
Settlement of loans of CannaKorp	930,240	$	80,838	Refer to Note 14 for details.
Agreement with Serious Seeds	218,736		2,668	As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.
	1,610,272	$	175,293

Warrants

2023


	As at	As at
	June 30, 2023	March 31, 2023
Forfeiture rate	0%	0%
Stock price	$0.006	$0.003
Exercise price	$0.250 to $0.300	$0.250 to $0.300
Volatility	273% to 342%	244% to 305%
Risk free interest rate	5.40%	4.64%
Expected life (years)	0.02 to 1.68	0.02 to 1.93
Expected dividend rate	0%	0%

2022


	As at	As at	As at	As at
	December 31,	September 30,	June 30,	March 31,
	2022	2022	2022	2022
Forfeiture rate	0%	0%	0%	0%
Stock price	$0.004	$0.005	$0.008	$0.009
Exercise price	$0.200 to $0.300	$0.200 to $0.300	$0.050 to $0.300	$0.023 to $0.250
Volatility	253% to 312%	214% to 279%	192% to 306%	192% to 306%
Risk free interest rate	4.73%	4.05%	2.92%	2.28%
Expected life (years)	0.02 to 1.93	0 to 1.94	0 to 1.94	0 to 1.93
Expected dividend rate	0%	0%	0%	0%

The fair value of the warrants issued during the year issued was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:

2023


	During quarter	During quarter
	ended	ended
	June 30, 2023	March 31, 2023
Forfeiture rate	0%	0%
Stock price	$0.003 to $0.003	$0.003 to $0.005
Exercise price	$0.350	$0.300
Volatility	342%	305%
Risk free interest rate	3.82% to 4.51%	4.24% to 4.89%
Expected life (years)	2	2
Expected dividend rate	0%	0%
Fair value of warrants	$138	$160

2022


	During quarter	During quarter	During quarter	During quarter
	ended	ended	ended	ended
	December 31, 2022	September 30, 2022	June 30, 2022	March 31, 2022
Forfeiture rate	0%	0%	0%	0%
Stock price	$0.004 to $0.006	$0.007 to $0.008	$0.005 to $0.010	$0.008 to $0.013
Exercise price	$0.300	$0.300	$0.300	$0.250
Volatility	279%	279%	299%	306%
Risk free interest rate	4.23% to 4.66%	2.97% to 3.50%	2.50% to 2.73%	0.88% to 1.50%
Expected life (years)	2	2	2	2
Expected dividend rate	0%	0%	0%	0%
Fair value of warrants	$176	$288	$306	$430

Breakdown of warrants outstanding as of June 30, 2023 and December 31, 2022 are detailed below:


			Remaining	Remaining
			contractual life	contractual life
	Warrants	Warrants	term as at	term as at
	outstanding as at	outstanding as at	June 30,	December 31,
	June 30,	December 31,	2023	2022
	2023	2022	(years)	(years)
Private placements	—	43,549,993	N/A	0.11 to 0.47
Serious Seeds	400,008	400,008	0.02 to 1.93	0.02 to 1.93
CLI	10,000,000	10,000,000	2.12	2.62
Total	10,400,008	53,950,001

During the six months ended June 30, 2023, 5,416,668 warrants expired (related to private placements and Serious Seeds).

Movement of the warrant liability is detailed below:


Warrant liability as at December 31, 2022		489
Warrant liability for new issuance		298
Change in fair value		144
Warrant liability as at June 30, 2023		931

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

+ Details

XML 27 R17.htm IDEA: XBRL DOCUMENT

Earnings (Loss) Per Share

6 Months Ended

Jun. 30, 2023

Earnings (Loss) Per Share

Earnings (Loss) Per Share

12. Earnings (Loss) Per Share

XML 28 R18.htm IDEA: XBRL DOCUMENT

Contingencies and commitments

6 Months Ended

Jun. 30, 2023

Contingencies and commitments

Contingencies and commitments

13. Contingencies and commitments

Contingencies

Covid-19 Pandemic

Commitments

In consideration of the Company’s appointment as Serious’ exclusive distributor in Canada, the Company will pay Serious certain royalties as follows:


1^st year:		2.00% of gross sales
2^nd year:		2.25% of gross sales
3^rd year:		2.50% of gross sales
4^th year:		2.75% of gross sales
5^th and following years:		3.00% of gross sales

XML 29 R19.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2023

Subsequent Events

Subsequent Events

14. Subsequent Events

XML 30 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

Use of Estimates

Cash

Cash

Restricted cash represents deposits made to the Company’s bank as a requirement to use the bank’s credit card which is not available for immediate or general business use.

Fixed Assets

Fixed Assets

Depreciation is calculated using the following terms and methods:


Furniture & office equipment	Straight-line	7 years
Machinery & equipment	Straight-line	3-5 years
Software	Straight-line	3 years
Leasehold improvements	Straight-line	Lease period

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The three levels of the fair value hierarchy are as follows:

●

Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

●

Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

●

Revenue recognition

The Company generated revenue of $758,984 during the six month ended June 30, 2023 whereas $nil in June 30, 2022.

Equity Method Investments

Equity Method Investments

Recently Issued Accounting Standards

- Definition

Disclosure of accounting policy for revenue from contract with customer.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-17

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 19
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-19

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-18

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-18

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-20

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-20

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-20

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-20

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (e)
-SubTopic 10
-Topic 235
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483426/235-10-50-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org//606/tableOfContent

+ Details

XML 31 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies

Schedule of property, plant and equipment useful life


Furniture & office equipment	Straight-line	7 years
Machinery & equipment	Straight-line	3-5 years
Software	Straight-line	3 years
Leasehold improvements	Straight-line	Lease period

XML 32 R22.htm IDEA: XBRL DOCUMENT

Fixed Assets (Tables)

6 Months Ended

Jun. 30, 2023

Fixed Assets

Schedule of fixed assets


	Furniture &	Machinery &		Leasehold
	fixture	Equipment	Software	improvements	Total
	$	$	$	$	$
Cost	1,452,252	770,161	43,553	6,851,094	9,117,060
Accumulated depreciation	(481,941)	(747,730)	(43,490)	(2,070,664)	(3,343,825)
	970,311	22,431	63	4,780,430	5,773,235

XML 33 R23.htm IDEA: XBRL DOCUMENT

Joint Venture (Tables)

6 Months Ended

Jun. 30, 2023

Joint Venture

Schedule of the activity of the period of JVCo


Period ended	January 1 to April 27, 2023		Six months ended June 30, 2022
	CAD	USD	CAD	USD
Sales	1,068,799	791,285	2,681,955	2,109,626
Cost of goods sold	620,344	459,271	1,332,020	1,047,767
Gross profit	448,455	332,014	1,349,935	1,061,859
Operation expenses	383,358	283,819	965,882	759,763
Net income (loss)	65,097	48,195	384,053	302,096

Eligible recoverable expenses	1,437,054	1,060,833	2,475,041	1,920,632
Recoverable amount	1,437,054	1,060,833	2,475,041	1,920,632
Income (loss) on equity	32,549	24,098	192,026	151,048

Schedule of fair value of net assets


		Fair value
		$
Assets acquired:
Inventory		1,690,368
Fixed assets		534,816
		2,225,184

XML 34 R24.htm IDEA: XBRL DOCUMENT

Goodwill (Tables)

6 Months Ended

Jun. 30, 2023

Goodwill

Schedule of business acquisitions


		$
Number of Common Stock		30,407,712
Market price on the date of issuance		0.108
Fair value of Common Stock		3,284,033


		$
Number of warrants		7,211,213
Fair value price per warrant		0.108
Fair value of warrant		778,811

Fair value of Common Stock		3,284,033
Fair value of warrant		778,811
Purchase consideration		4,062,844

Schedule of recognized identified assets acquired and liabilities assumed


		$
Number of Common Stock		25,500,000
Market price on the date of issuance		0.067
Fair value of Common Stock		1,695,750


		$
Number of warrants		25,000,000
Fair value price per warrant		0.065
Fair value of warrant		1,623,092

Fair value of Common Stock		1,695,750
Fair value of warrant		1,623,092
Purchase consideration		3,318,842

XML 35 R25.htm IDEA: XBRL DOCUMENT

Related Party Transactions and Balances (Tables)

6 Months Ended

Jun. 30, 2023

Schedule of repayment of the minimum principal payments


2023	$	552,583
2024		3,613,227
2025		3,706,326
Total		7,872,136
Current portion		(1,540,099)
Non-current portion	$	6,332,037

Schedule of each tranche of the shareholders loan


	Interest rate		Maximum loan		Outstanding loan
			CAD	USD	CAD	USD
Tranche 1	16.00	%	1,043,593	788,226	1,043,593	788,226
Tranche 2	43.26	%	1,592,787	1,203,032	1,592,787	1,203,032
Tranche 3	43.26	%	250,000	188,825	250,000	188,825
Tranche 4	43.26	%	500,000	377,650	500,000	377,650
Tranche 5	43.26	%	500,000	377,650	400,000	302,120
Total			3,886,380	2,935,383	3,786,380	2,859,853

XML 36 R26.htm IDEA: XBRL DOCUMENT

Operating Lease Right-Of-Use Assets and Lease Liability (Tables)

6 Months Ended

Jun. 30, 2023

Operating Lease Right-Of-Use Assets and Lease Liability

Schedule of maturities of lease liabilities


2023	$	165,264
2024		330,107
2025		333,408
2026		336,742
Thereafter		1,147,370
Total lease payments		2,312,891
Less imputed interest		(905,947)
Present value of lease liabilities		1,406,944
Current portion		(118,047)
Non-current portion	$	1,288,897

Schedule of reconciliation of net operating lease


	For the	For the	For the	For the
	three months ended	three months ended	six months ended	six months ended
	June 30, 2023	June 30, 2022	June 30, 2023	June 30, 2022
	$	$	$	$
Gross operating lease expense	—	66,672	119,562	134,199
Gross rent and utilities expenses	28,400	132,169	(35,207)	254,382
Recoverable expenses from JVCo related to rent and utilities	—	(209,219)	(67,045)	(422,486)
	28,400	(10,378)	17,310	(33,905)

XML 37 R27.htm IDEA: XBRL DOCUMENT

Convertible Promissory Notes (Tables)

6 Months Ended

Jun. 30, 2023

Convertible Promissory Notes

Schedule of fair value of the derivative liability


	Derivative				Derivative
	liability as at	Conversions / Redemption			liability as at
	December 31,	during the	Change due to	Fair value	June 30,
	2022	period	Issuances	adjustment	2023
	$	$	$	$	$
Note D	1,446	—	—	134	1,580
Note F	10,034	—	—	777	10,811
Note G	3,645	—	—	282	3,927
	15,125	—	—	1,193	16,318

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References + Details

XML 38 R28.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2023

Stockholders' Equity

Schedule of shares to be issued


	Shares	Amount		Description
				80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.

Services	115,000	$	73,000	35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.
Private placements	346,296	$	18,787	Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.
Settlement of loans of CannaKorp	930,240	$	80,838	Refer to Note 14 for details.
Agreement with Serious Seeds	218,736		2,668	As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.
	1,610,272	$	175,293

Schedule of fair value of the warrants

2023


	As at	As at
	June 30, 2023	March 31, 2023
Forfeiture rate	0%	0%
Stock price	$0.006	$0.003
Exercise price	$0.250 to $0.300	$0.250 to $0.300
Volatility	273% to 342%	244% to 305%
Risk free interest rate	5.40%	4.64%
Expected life (years)	0.02 to 1.68	0.02 to 1.93
Expected dividend rate	0%	0%

2022


	As at	As at	As at	As at
	December 31,	September 30,	June 30,	March 31,
	2022	2022	2022	2022
Forfeiture rate	0%	0%	0%	0%
Stock price	$0.004	$0.005	$0.008	$0.009
Exercise price	$0.200 to $0.300	$0.200 to $0.300	$0.050 to $0.300	$0.023 to $0.250
Volatility	253% to 312%	214% to 279%	192% to 306%	192% to 306%
Risk free interest rate	4.73%	4.05%	2.92%	2.28%
Expected life (years)	0.02 to 1.93	0 to 1.94	0 to 1.94	0 to 1.93
Expected dividend rate	0%	0%	0%	0%

2023


	During quarter	During quarter
	ended	ended
	June 30, 2023	March 31, 2023
Forfeiture rate	0%	0%
Stock price	$0.003 to $0.003	$0.003 to $0.005
Exercise price	$0.350	$0.300
Volatility	342%	305%
Risk free interest rate	3.82% to 4.51%	4.24% to 4.89%
Expected life (years)	2	2
Expected dividend rate	0%	0%
Fair value of warrants	$138	$160

2022


	During quarter	During quarter	During quarter	During quarter
	ended	ended	ended	ended
	December 31, 2022	September 30, 2022	June 30, 2022	March 31, 2022
Forfeiture rate	0%	0%	0%	0%
Stock price	$0.004 to $0.006	$0.007 to $0.008	$0.005 to $0.010	$0.008 to $0.013
Exercise price	$0.300	$0.300	$0.300	$0.250
Volatility	279%	279%	299%	306%
Risk free interest rate	4.23% to 4.66%	2.97% to 3.50%	2.50% to 2.73%	0.88% to 1.50%
Expected life (years)	2	2	2	2
Expected dividend rate	0%	0%	0%	0%
Fair value of warrants	$176	$288	$306	$430


			Remaining	Remaining
			contractual life	contractual life
	Warrants	Warrants	term as at	term as at
	outstanding as at	outstanding as at	June 30,	December 31,
	June 30,	December 31,	2023	2022
	2023	2022	(years)	(years)
Private placements	—	43,549,993	N/A	0.11 to 0.47
Serious Seeds	400,008	400,008	0.02 to 1.93	0.02 to 1.93
CLI	10,000,000	10,000,000	2.12	2.62
Total	10,400,008	53,950,001

Schedule of movement of the warrant liability


Warrant liability as at December 31, 2022		489
Warrant liability for new issuance		298
Change in fair value		144
Warrant liability as at June 30, 2023		931

XML 39 R29.htm IDEA: XBRL DOCUMENT

Contingencies and commitments (Tables)

6 Months Ended

Jun. 30, 2023

Contingencies and commitments

Schedule of royalties payable


1^st year:		2.00% of gross sales
2^nd year:		2.25% of gross sales
3^rd year:		2.50% of gross sales
4^th year:		2.75% of gross sales
5^th and following years:		3.00% of gross sales

XML 40 R30.htm IDEA: XBRL DOCUMENT

Organization, Nature of Business, Going Concern and Management Plans (Details)					3 Months Ended			6 Months Ended			12 Months Ended
	Aug. 14, 2020 USD ($) shares	Aug. 14, 2020 CAD ($) shares	Aug. 08, 2019 USD ($) shares	Jun. 27, 2018 $ / shares shares	Jun. 30, 2023 USD ($) ft² shares	Jun. 30, 2022 USD ($)	Jun. 30, 2020 USD ($) shares	Jun. 30, 2023 USD ($) ft² shares	Jun. 30, 2023 CAD ($) shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 shares	Jun. 30, 2023 CAD ($) ft² shares	Apr. 27, 2023 USD ($)	May 01, 2019 ft²	Jan. 25, 2019 $ / shares shares	Sep. 30, 2017 ft²
Organization, Nature of Business, Going Concern and Management Plans
Area of land \| ft²					44,000			44,000						44,000		44,000		44,000
Working capital deficit					$ 5,099,244			$ 5,099,244
Accumulated deficit					$ 30,565,571			30,565,571			$ 30,783,678
Revenue through investment in a joint venture								$ 791,285		$ 2,109,626
Warrants exercised during the period \| shares											0	0	0
Common stock, shares issued \| shares					617,025,999			617,025,999			617,025,999			617,025,999
Warrants purchase \| shares								7,211,213	7,211,213
Other receivable					$ 3,777			$ 3,777			$ 3,692
Other Receivable, after Allowance for Credit Loss, Related Party, Type [Extensible Enumeration]					Related Party [Member]			Related Party [Member]			Related Party [Member]			Related Party [Member]
Debt issuance cost	$ 251,518				$ 12,354	$ 12,994		$ 24,757		26,243
Settlement liabilities, current and noncurrent								0				$ 10,000
Release and settlement amount from Thrive Cannabis															$ 776,382
CannaKorp Inc
Organization, Nature of Business, Going Concern and Management Plans
Equity method investment, ownership percentage																	100.00%
CLI
Organization, Nature of Business, Going Concern and Management Plans
Debt issued								2,190,370	$ 2,900,000
Principal balance					8,006,180			8,006,180						$ 10,600,000
Other receivable					$ 3,777			3,777						$ 5,000
CLI \| Amended agreement
Organization, Nature of Business, Going Concern and Management Plans
Shares and warrant issued for acquisition of subsidiary (in shares) \| shares	10,000,000	10,000,000
Debt issuance cost	$ 251,518
Rubin schneidermann \| CLI \| Amended agreement \| Series A preferred stock
Organization, Nature of Business, Going Concern and Management Plans
Shares issued for prior private placements (in shares) \| shares	10,000,000	10,000,000
Number of shares sold \| shares	500,000	500,000
Consideration for the shares sold	$ 75,530	$ 100,000
Over the Counter
Organization, Nature of Business, Going Concern and Management Plans
Warrants exercised during the period \| shares												0
Common stock, shares issued \| shares																	30,407,412
Sale of stock, price per share \| $ / shares																	$ 0.10
Visava Inc
Organization, Nature of Business, Going Concern and Management Plans
Class of warrant or right, number of securities called by warrants or rights \| shares				25,000,000
Shares issued, price per share \| $ / shares				$ 0.10
Visava Inc \| Visava and Canary
Organization, Nature of Business, Going Concern and Management Plans
Equity method investment, ownership percentage				100.00%
Canada Inc
Organization, Nature of Business, Going Concern and Management Plans
Revenue through investment in a joint venture								$ 791,285		$ 2,109,626
Visava and Canary \| CLI
Organization, Nature of Business, Going Concern and Management Plans
Percentage of issued and outstanding capital to be transferred in lieu of repayment of debt					75.00%			75.00%						75.00%
Percentage of issued and outstanding capital, option granted to acquire					25.00%			25.00%						25.00%
Canary
Organization, Nature of Business, Going Concern and Management Plans
Interest rate					5.00%			5.00%						5.00%
Debt term								60 months	60 months
Canary \| CLI \| First year of the term
Organization, Nature of Business, Going Concern and Management Plans
Debt instrument, maximum amount to be paid					$ 853,489			$ 853,489						$ 1,130,000
Debt instrument, percentage of net revenue to be paid					50.00%			50.00%						50.00%
Debt instrument, threshold period for payment of balance amount								30 days	30 days
Canary \| CLI \| Second year of the term
Organization, Nature of Business, Going Concern and Management Plans
Debt instrument, maximum amount to be paid					$ 1,586,130			$ 1,586,130						$ 2,100,000
Debt instrument, percentage of net revenue to be paid					50.00%			50.00%						50.00%
Debt instrument, threshold period for consecutive monthly installments payable								12 months	12 months
Debt instrument, threshold period for payment of balance amount								30 days	30 days
Canary \| CLI \| Third year of the term
Organization, Nature of Business, Going Concern and Management Plans
Debt instrument, maximum amount to be paid					$ 2,432,066			$ 2,432,066						$ 3,220,000
Debt instrument, percentage of net revenue to be paid					50.00%			50.00%						50.00%
Debt instrument, threshold period for consecutive monthly installments payable								12 months	12 months
Debt instrument, threshold period for payment of balance amount								30 days	30 days
Canary \| CLI \| Fourth year of the term
Organization, Nature of Business, Going Concern and Management Plans
Debt instrument, maximum amount to be paid					$ 2,326,324			$ 2,326,324						$ 3,080,000
Debt instrument, percentage of net revenue to be paid					50.00%			50.00%						50.00%
Debt instrument, threshold period for consecutive monthly installments payable								12 months	12 months
Debt instrument, threshold period for payment of balance amount								30 days	30 days
Canary \| CLI \| Fifth year of the term
Organization, Nature of Business, Going Concern and Management Plans
Debt instrument, threshold period for consecutive monthly installments payable								12 months	12 months
Debt instrument, threshold period for payment of balance amount by the end of the fifth year								5 days	5 days
Visava Inc
Organization, Nature of Business, Going Concern and Management Plans
Noncontrolling interest, ownership percentage by noncontrolling owners				46.27%
Shares issued for prior private placements (in shares) \| shares				25,500,000
Maximum \| Canary
Organization, Nature of Business, Going Concern and Management Plans
Equity interest in joint venture															100.00%
Minimum \| Canary
Organization, Nature of Business, Going Concern and Management Plans
Equity interest in joint venture															50.00%
Cgreen Inc
Organization, Nature of Business, Going Concern and Management Plans
Percentage of royalties on all subleasing revenues			7.00%
Term of license			10 years
Stock issuable as consideration for agreement \| shares			10,000,000
Percentage of royalties on net sales			7.00%
Shares not issued \| shares							10,000,000
Outstanding royalty payable							$ 1,191,860
Settlement amount							$ 100,000
Settlement period							30 days
Monthly installment of settlement amount							$ 10,000
Gain on settlement							1,704,860
Cgreen Inc \| Within ten (10) days of the effective date
Organization, Nature of Business, Going Concern and Management Plans
Shares issued for prior private placements (in shares) \| shares			3,500,000
Advance royalties			$ 300,000
Cgreen Inc \| On January 10, 2020
Organization, Nature of Business, Going Concern and Management Plans
Shares issued for prior private placements (in shares) \| shares			3,500,000
Advance royalties			$ 300,000
Cgreen Inc \| Not later than June 10, 2020
Organization, Nature of Business, Going Concern and Management Plans
Shares issued for prior private placements (in shares) \| shares			3,000,000
Advance royalties			$ 400,000
Cgreen Inc \| Not later than November 10, 2020
Organization, Nature of Business, Going Concern and Management Plans
Advance royalties			$ 500,000
Cgreen Inc \| Within thirty (30) days of the effective date
Organization, Nature of Business, Going Concern and Management Plans
Settlement amount							$ 130,000
Canary
Organization, Nature of Business, Going Concern and Management Plans
Release and settlement amount from Thrive Cannabis															$ 1,051,000

XML 41 R31.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details)	3 Months Ended	6 Months Ended
Summary of Significant Accounting Policies (Details)	Jun. 30, 2023 USD ($)	Jun. 30, 2023 USD ($) customer	Jun. 30, 2022 USD ($) customer	Jun. 30, 2023 CAD ($)	Jun. 30, 2022 CAD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash				$ 0	$ 0
Revenue through investment in a joint venture		$ 791,285	$ 2,109,626
REVENUE	$ 758,984	758,984	0
Canada Inc
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Revenue through investment in a joint venture		$ 791,285	$ 2,109,626
Number of customer to whom entire revenue is sold \| customer		8	3
Furniture & office equipment
Fixed Assets and Capital Work In Progress
Estimated useful life				7 years
Machinery & equipment \| Minimum
Fixed Assets and Capital Work In Progress
Estimated useful life				3 years
Machinery & equipment \| Maximum
Fixed Assets and Capital Work In Progress
Estimated useful life				5 years
Software
Fixed Assets and Capital Work In Progress
Estimated useful life				3 years

XML 42 R32.htm IDEA: XBRL DOCUMENT

Inventory (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Inventory
Inventory	$ 1,814,902	$ 0

XML 43 R33.htm IDEA: XBRL DOCUMENT

Sales Tax Recoverable and Payable (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Sales Tax Recoverable and Payable
Sales tax recoverable, gross	$ 1,034	$ 0
Allowance on value added tax recoverable	0	0
Gross sales tax payable		$ 35,254
Gross Sales
Sales Tax Recoverable and Payable
Sales tax recoverable, gross	1,034
Gross sales tax payable	$ 0

XML 44 R34.htm IDEA: XBRL DOCUMENT

Fixed Assets (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
FIXED ASSETS
Cost	$ 9,117,060
Accumulated depreciation	(3,343,825)
Fixed assets, net	5,773,235	$ 5,554,225
Furniture & fixture
FIXED ASSETS
Cost	1,452,252
Accumulated depreciation	(481,941)
Fixed assets, net	970,311
Machinery & Equipment
FIXED ASSETS
Cost	770,161
Accumulated depreciation	(747,730)
Fixed assets, net	22,431
Software
FIXED ASSETS
Cost	43,553
Accumulated depreciation	(43,490)
Fixed assets, net	63
Leasehold improvements
FIXED ASSETS
Cost	6,851,094
Accumulated depreciation	(2,070,664)
Fixed assets, net	$ 4,780,430

XML 45 R35.htm IDEA: XBRL DOCUMENT

Fixed Assets - Additional Information (Details)	3 Months Ended		6 Months Ended
Fixed Assets - Additional Information (Details)	Jun. 30, 2023 USD ($) ft²	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) ft²	Jun. 30, 2022 USD ($)	May 01, 2019 ft²	Sep. 30, 2017 ft²
FIXED ASSETS
Area of land \| ft²	44,000		44,000		44,000	44,000
Depreciation expense	$ 229,568	$ 225,335	$ 442,254	$ 452,959
JVCo assets consolidated, cost	723,231		723,231
JVCo assets consolidated, depreciation	$ 15,371		15,371
Canary
FIXED ASSETS
Depreciation expense recorded			426,631	452,245
CannaKorp Inc
FIXED ASSETS
Depreciation expense recorded			$ 252	$ 714

XML 46 R36.htm IDEA: XBRL DOCUMENT

Joint Venture - Additional Information (Details)			6 Months Ended
Joint Venture - Additional Information (Details)	Apr. 27, 2023 USD ($)	May 14, 2020	Jun. 30, 2023 USD ($)	Jun. 30, 2023 CAD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 CAD ($)	Apr. 28, 2023	Dec. 31, 2022 USD ($)
Joint Venture, JVCo
Term of the loan		5 years
Recovery of investment			$ 439,640		$ 1,190,277
Release and settlement amount from Thrive Cannabis	$ 776,382
Investment in joint venture	1,023,608							$ 775,577
Receivable from joint venture	706,598							$ 630,180
Remaining balance in joint venture	953,824
Gain from termination of joint venture	1,428,185
Canary
Joint Venture, JVCo
Release and settlement amount from Thrive Cannabis	$ 1,051,000
Canary
Joint Venture, JVCo
Portion of outstanding balance of the loan guaranteed (as a percent)		50.00%
Canary
Joint Venture, JVCo
Term of the loan			12 months	12 months
Loans advanced amounts			$ 253,026			$ 335,000
Maximum amount of loan			$ 906,360			1,200,000
Interest rate (as a percent)			7.00%	7.00%
Interest income			$ 8,628	$ 11,629
Interest receivable			$ 51,971			$ 68,809
Equity interest in joint venture	50.00%						100.00%
Canada Inc
Joint Venture, JVCo
Portion of outstanding balance of the loan guaranteed (as a percent)			50.00%	50.00%
Canary and Thrive Cannabis
Joint Venture, JVCo
Amount received from joint venture			$ 1,577,214	$ 2,125,482
Recovery of investment			1,018,996	1,373,218
Interest income			$ 558,218	$ 752,264

XML 47 R37.htm IDEA: XBRL DOCUMENT

Joint Venture - Summarizes the activity of the period of JVCo (Details)	1 Months Ended		3 Months Ended		6 Months Ended
	Apr. 27, 2023 USD ($)	Apr. 27, 2023 CAD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2022 CAD ($)	Apr. 27, 2023 CAD ($)	Jun. 30, 2022 CAD ($)
Joint Venture, JVCo
Sales			$ 758,984		$ 758,984	$ 0
Cost of goods sold			369,261		369,261
Gross profit			389,723		389,723
Operation expenses			500,448	$ 286,490	841,160	634,683
Net income (loss)			$ 963,816	247,600	$ 218,107	(312,099)
Canary
Joint Venture, JVCo
Sales	$ 791,285	$ 1,068,799				2,109,626	$ 2,681,955
Cost of goods sold	459,271	620,344				1,047,767	1,332,020
Gross profit	332,014	448,455				1,061,859	1,349,935
Operation expenses	283,819	383,358				759,763	965,882
Net income (loss)	48,195	65,097				302,096	384,053
Eligible recoverable expenses	1,060,833			1,920,632		1,920,632		$ 1,437,054	$ 2,475,041
Recoverable amount	1,060,833			$ 1,920,632		1,920,632		$ 1,437,054	$ 2,475,041
Income (loss) on equity	$ 24,098	$ 32,549				$ 151,048	$ 192,026

XML 48 R38.htm IDEA: XBRL DOCUMENT

Joint Venture -Agreement and obtaining 100 percentage shares of the JVCo (Details)	Apr. 27, 2023 USD ($)
Joint Venture
Inventory	$ 1,690,368
Fixed assets	534,816
Assets acquired	$ 2,225,184

XML 49 R39.htm IDEA: XBRL DOCUMENT

Goodwill - Purchase consideration (Details) - USD ($)	Mar. 01, 2019	Aug. 02, 2018	Jun. 27, 2018
CannaKorp Inc
Goodwill
Purchase consideration	$ 4,062,844
Visava Inc
Goodwill
Number of Common stock			25,500,000
Purchase consideration		$ 3,318,842
Common stock \| CannaKorp Inc
Goodwill
Number of Common stock	30,407,712
Share price	$ 0.108
Fair value of Common Stock	$ 3,284,033
Common stock \| Visava Inc
Goodwill
Number of Common stock		25,500,000
Share price		$ 0.067
Fair value of Common Stock		$ 1,695,750
Warrant \| CannaKorp Inc
Goodwill
Number of Common stock	7,211,213
Share price	$ 0.108
Fair value of warrant	$ 778,811
Warrant \| Visava Inc
Goodwill
Number of Common stock		25,000,000
Share price		$ 0.065
Fair value of warrant		$ 1,623,092

XML 50 R40.htm IDEA: XBRL DOCUMENT

Goodwill - Additional Information (Details)				6 Months Ended	12 Months Ended
Goodwill - Additional Information (Details)	Mar. 01, 2019 USD ($) $ / shares Y shares	Aug. 02, 2018 USD ($) $ / shares Y	Jun. 27, 2018 $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($) shares	Dec. 31, 2019 USD ($) $ / shares
Goodwill
Goodwill				$ 269,175	$ 263,117
Warrants purchase \| shares				7,211,213
Warrants exercised during the period \| shares					0	0	0
Warrants issued to purchase shares of common stock \| shares				10,400,008	53,950,001
Business acquisition equity interest issuable percentage			46.27%
Forfeiture rate
Goodwill
Derivative liability, measurement input	0	0
Stock price
Goodwill
Derivative liability, measurement input \| $ / shares	0.108	0.067
Exercise price
Goodwill
Derivative liability, measurement input \| $ / shares		0.10
Exercise price \| Minimum
Goodwill
Derivative liability, measurement input \| $ / shares	0.13
Exercise price \| Maximum
Goodwill
Derivative liability, measurement input \| $ / shares	0.15
Volatility
Goodwill
Derivative liability, measurement input	6.3549	3.29
Risk free interest rate
Goodwill
Derivative liability, measurement input	0.0255
Expected life
Goodwill
Derivative liability, measurement input \| Y	2	2
Expected dividend rate
Goodwill
Derivative liability, measurement input	0	0
CannaKorp Inc
Goodwill
Purchase consideration	$ 4,062,844
Fair value of net liabilities	2,534,121
Goodwill	6,071,627
CannaKorp Inc \| Common Stock Purchase Warrants
Goodwill
Number of shares \| shares				30,407,412
Purchase consideration	30,407,412
Visava Inc
Goodwill
Number of shares \| shares			25,500,000
Purchase consideration		$ 3,318,842
Fair value of net liabilities		275,353
Goodwill		3,594,195
Impairment of goodwill						$ 263,117
Percentage of voting interests acquired			100.00%
Visava Inc \| Common Stock Purchase Warrants
Goodwill
Number of shares \| shares			25,000,000
Class of warrant or right, exercise price of warrants or rights \| $ / shares			$ 0.10
Visava Inc \| Canary Rx Inc
Goodwill
Purchase consideration		3,318,842
Fair value of net liabilities		275,353
Goodwill		$ 3,594,195
Impairment of goodwill					$ 3,315,749
Canary Rx Inc
Goodwill
Percentage of voting interests acquired				100.00%
CannaKorp Inc
Goodwill
Class of warrant or right, exercise price of warrants or rights \| $ / shares								$ 0.15
Goodwill	6,071,627						$ 0	$ 4,585,702
Warrants exercised during the period \| shares						0
Goodwill of period increase (decrease)	$ 369,315
Impairment of goodwill							$ 0	$ 1,485,925
CannaKorp Inc \| Common Stock Purchase Warrants
Goodwill
Warrants purchase \| shares	7,211,213
Warrants issued to purchase shares of common stock \| shares				7,211,213
Shares issued, price per share \| $ / shares				$ 0.10
Visava Inc
Goodwill
Shares issued, price per share \| $ / shares			$ 0.10
Visava Inc \| Risk free interest rate
Goodwill
Fair value assumptions rate		2.66%

XML 51 R41.htm IDEA: XBRL DOCUMENT

Related Party Transactions and Balances (Details)						3 Months Ended			6 Months Ended			12 Months Ended
Related Party Transactions and Balances (Details)	Feb. 16, 2023 CAD ($)	Aug. 14, 2020 USD ($) shares	Aug. 14, 2020 CAD ($) shares	Jun. 15, 2020 USD ($)	Jun. 15, 2020 CAD ($)	Jun. 30, 2023 USD ($) shares	Mar. 31, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) shares	Jun. 30, 2023 CAD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 shares	Dec. 31, 2020 shares	Dec. 31, 2019 USD ($) $ / shares shares	Jun. 30, 2023 CAD ($) shares	Jun. 15, 2020 CAD ($)
Related Party Transactions and Balances
Debt outstanding amount						$ 3,777			$ 3,777			$ 3,692
Other Receivable, after Allowance for Credit Loss, Related Party, Type [Extensible Enumeration]						Related Party [Member]			Related Party [Member]			Related Party [Member]				Related Party [Member]
Interest expense						$ 369,092		$ 272,373	$ 722,698		$ 561,061
Number of shares issued \| shares						617,025,999			617,025,999			617,025,999				617,025,999
Debt issuance cost		$ 251,518				$ 12,354		$ 12,994	$ 24,757		26,243
Outstanding balance of debt issuance costs						107,552			107,552
Debt issuance costs, current						50,679			50,679
Debt issuance costs, non-current						56,873			56,873
Interest expense on loan									494,865	$ 655,190
Accrued interest expense						941,134			941,134							$ 1,246,042
Amount of advance in seventh amendment	$ 500,000.00
Lender's fee	$ 50,000
Warrants exercised during the period \| shares												0	0	0
CannaKorp Inc
Related Party Transactions and Balances
Total amount subject to loan settlement															$ 817,876
Payment of consideration in cash															$ 954,374
Shares issued for settlement \| shares															920,240
Warrants issued for settlement \| shares															920,240
Loss on loan settlement															$ (136,498)
Outstanding balance of loan						65,000	$ 65,000		65,000			$ 65,000
Warrants exercised during the period \| shares													0
Exercise prices \| $ / shares															$ 0.15
Related party late payment penalties amount						25,000	$ 25,000					25,000
Interest and bank charges
Related Party Transactions and Balances
Interest expense									194,412	262,011
Management Services
Related Party Transactions and Balances
Amounts due to related parties						11,336,630			11,336,630			10,346,465
Norlandam Marketing Inc.
Related Party Transactions and Balances
Outstanding balance of loan						0			0
GTA Angel Group
Related Party Transactions and Balances
Amounts due to related parties						25,605			25,605
Purchase goods, value									0
CLI
Related Party Transactions and Balances
Debt issued									2,190,370	$ 2,900,000
Principal balance						8,006,180			8,006,180							10,600,000
Debt outstanding amount						3,777			3,777							5,000
Shareholder advances [Note 15]						$ 438,434			$ 438,434							$ 580,477
CLI \| Visava and Canary
Related Party Transactions and Balances
Percentage of issued and outstanding capital to be transferred in lieu of repayment of debt						75.00%			75.00%							75.00%
Percentage of issued and outstanding capital, option granted to acquire						25.00%			25.00%							25.00%
CLI \| Debt Purchase and Assignment Agreement
Related Party Transactions and Balances
Debt issued				$ 2,190,370	$ 2,900,000
Principal balance				$ 8,006,180													$ 10,600,000
CLI \| Amended debt purchase and assignment agreement
Related Party Transactions and Balances
Annual interest rate						5.00%			5.00%							5.00%
CLI \| Amended debt purchase and assignment agreement \| Visava and Canary
Related Party Transactions and Balances
Percentage of issued and outstanding capital to be transferred in lieu of repayment of debt						75.00%			75.00%							75.00%
Percentage of issued and outstanding capital, option granted to acquire						25.00%			25.00%							25.00%
CLI \| Rubin schneidermann \| Amended debt purchase and assignment agreement
Related Party Transactions and Balances
Shares and warrant issued for acquisition of subsidiary (in shares) \| shares		10,000,000	10,000,000
CLI \| Rubin schneidermann \| Amended debt purchase and assignment agreement \| Series A preferred stock
Related Party Transactions and Balances
Number of shares issued \| shares		500,000	500,000
Consideration for the shares sold		$ 75,530	$ 100,000
Former CEO, President, CFO and Other Current Key Officers
Related Party Transactions and Balances
Management service fee									$ 155,515		$ 83,516
Outstanding management service fee						$ 647,194			$ 647,194			$ 585,261

XML 52 R42.htm IDEA: XBRL DOCUMENT

Related Party Transactions and Balances - Repayment schedule of the minimum principal payments (Details)	Jun. 30, 2023 USD ($)
Related Party Transactions and Balances
2023	$ 552,583
2024	3,613,227
2025	3,706,326
Total	7,872,136
Current portion	(1,540,099)
Non-current portion	$ 6,332,037

- Definition

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

XML 53 R43.htm IDEA: XBRL DOCUMENT

Related Party Transactions and Balances - Shareholder loan (Details)	Jun. 30, 2023 USD ($)	Jun. 30, 2023 CAD ($)
Related Party Transactions and Balances
Amount of accrued interest converted into principal	$ 679,770	$ 900,000
Maximum loan	2,935,383	3,886,380
Outstanding loan	2,859,853	3,786,380
Tranche 1
Related Party Transactions and Balances
Maximum loan	788,226	1,043,593
Outstanding loan	$ 788,226	$ 1,043,593
Interest rate	16.00%	16.00%
Tranche 2
Related Party Transactions and Balances
Maximum loan	$ 1,203,032	$ 1,592,787
Outstanding loan	$ 1,203,032	$ 1,592,787
Interest rate	43.26%	43.26%
Tranche 3
Related Party Transactions and Balances
Maximum loan	$ 188,825	$ 250,000
Outstanding loan	$ 188,825	$ 250,000
Interest rate	43.26%	43.26%
Tranche 4
Related Party Transactions and Balances
Maximum loan	$ 377,650	$ 500,000
Outstanding loan	$ 377,650	$ 500,000
Interest rate	43.26%	43.26%
Tranche 5
Related Party Transactions and Balances
Maximum loan	$ 377,650	$ 500,000
Outstanding loan	$ 302,120	$ 400,000
Interest rate	43.26%	43.26%

XML 54 R44.htm IDEA: XBRL DOCUMENT

Operating Lease Right-Of-Use Assets and Lease Liability (Details)	6 Months Ended
	Jun. 30, 2023 USD ($) lease	Jun. 30, 2023 CAD ($) lease	Jun. 30, 2023 CAD ($)	Dec. 31, 2022 USD ($)	Jan. 01, 2020 USD ($)	Jan. 01, 2020 CAD ($)
Operating Lease Right-Of-Use Assets and Lease Liability
Number of operating lease facilities \| lease	2	2
Operating lease right-of-use assets \| $	$ 55,237			$ 62,728
Weighted average discount rate	16.00%		16.00%
Canary Rx Inc
Operating Lease Right-Of-Use Assets and Lease Liability
Agreement increased the minimum rent including applicable taxes	$ 26,436	$ 35,000
Percentage of increase in minimum rent	1.00%	1.00%
Term of contract	10 years		10 years
Forgiveness amount due to implementation of new lease	$ 746,458		$ 988,293
ASU 2016-02
Operating Lease Right-Of-Use Assets and Lease Liability
Operating lease right-of-use assets					$ 1,705,628	$ 2,258,212
Reduction in right-to-use asset					$ 1,578,517	$ 2,089,921

XML 55 R45.htm IDEA: XBRL DOCUMENT

Operating Lease Right-Of-Use Assets and Lease Liability - Maturities (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Operating Lease Right-Of-Use Assets and Lease Liability
2023	$ 165,264
2024	330,107
2025	333,408
2026	336,742
Thereafter	1,147,370
Total lease payments	2,312,891
Less imputed interest	(905,947)
Present value of lease liabilities	1,406,944
Current portion	(118,047)	$ (110,586)
Non-current portion	$ 1,288,897	$ 1,319,619

XML 56 R46.htm IDEA: XBRL DOCUMENT

Operating Lease Right-Of-Use Assets and Lease Liability - Reconciliation of net operating lease (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating Lease Right-Of-Use Assets and Lease Liability
Gross operating lease expense		$ 66,672	$ 119,562	$ 134,199
Gross rent and utilities expenses	$ 28,400	132,169	(35,207)	254,382
Recoverable expenses from JVCo related to rent and utilities		(209,219)	(67,045)	(422,486)
Net operating lease expense	$ 28,400	$ (10,378)	$ 17,310	$ (33,905)

XML 57 R47.htm IDEA: XBRL DOCUMENT

Convertible Promissory Notes - Recorded and fair valued derivative liability (Details)	6 Months Ended
	Jun. 30, 2023 USD ($)
Convertible Promissory Notes
Derivative liability, beginning of the period	$ 15,125
Conversions / Redemption during the period	0
Change due to Issuances	0
Fair value adjustment	1,193
Derivative liability, end of the period	16,318
Note D
Convertible Promissory Notes
Derivative liability, beginning of the period	1,446
Conversions / Redemption during the period	0
Change due to Issuances	0
Fair value adjustment	134
Derivative liability, end of the period	1,580
Note F
Convertible Promissory Notes
Derivative liability, beginning of the period	10,034
Conversions / Redemption during the period	0
Change due to Issuances	0
Fair value adjustment	777
Derivative liability, end of the period	10,811
Note G
Convertible Promissory Notes
Derivative liability, beginning of the period	3,645
Conversions / Redemption during the period	0
Change due to Issuances	0
Fair value adjustment	282
Derivative liability, end of the period	$ 3,927

XML 58 R48.htm IDEA: XBRL DOCUMENT

Convertible Promissory Notes - Additional information (Details)	6 Months Ended
	Jun. 30, 2023 USD ($) $ / shares Y	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Convertible Promissory Notes
Interest amount \| $	$ 9	$ 18
Dividend yield
Convertible Promissory Notes
Derivative liability, measurement input	0
Minimum \| Volatility
Convertible Promissory Notes
Derivative liability, measurement input	3.29
Minimum \| Risk free interest rate
Convertible Promissory Notes
Derivative liability, measurement input	0.0506
Minimum \| Stock price
Convertible Promissory Notes
Derivative liability, measurement input	0.006
Minimum \| Liquidity term
Convertible Promissory Notes
Derivative liability, measurement input \| Y	0.25
Minimum \| Exercise price
Convertible Promissory Notes
Derivative liability, measurement input	0.0012
Maximum \| Volatility
Convertible Promissory Notes
Derivative liability, measurement input	3.29
Maximum \| Risk free interest rate
Convertible Promissory Notes
Derivative liability, measurement input	0.0506
Maximum \| Stock price
Convertible Promissory Notes
Derivative liability, measurement input	0.006
Maximum \| Liquidity term
Convertible Promissory Notes
Derivative liability, measurement input	0.25
Maximum \| Exercise price
Convertible Promissory Notes
Derivative liability, measurement input	0.0151
Convertible promissory note
Convertible Promissory Notes
Principal amount outstanding \| $	$ 480		$ 480
Principal balance of convertible promissory notes \| $	$ 0	$ 0

XML 59 R49.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Details) - USD ($)	3 Months Ended						6 Months Ended		12 Months Ended
Stockholders' Equity (Details) - USD ($)	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2017	Dec. 31, 2021
Stockholders' Equity
Preferred stock, par value	$ 0.0001		$ 0.0001				$ 0.0001		$ 0.0001
Preferred stock, shares authorized	20,000,000		20,000,000				20,000,000		20,000,000
Preferred Stock, Shares Issued	1,000,000		1,000,000				1,000,000		1,000,000
Preferred stock, shares outstanding	1,000,000		1,000,000				1,000,000		1,000,000
Common stock, par value	$ 0.0001		$ 0.0001				$ 0.0001		$ 0.0001
Common stock, shares authorized	850,000,000		850,000,000				850,000,000		850,000,000
Common stock, shares issued	617,025,999		617,025,999				617,025,999		617,025,999
Common stock, shares outstanding	617,025,999		617,025,999				617,025,999		617,025,999
Conversion of stock, shares converted							100
Shares issued as consideration for consideration of the intellectual property rights	$ 48				$ 114		$ 111	$ 267
Shares issued as consideration for advisory and other services (in shares)							115,000
Shares issued as consideration for advisory and other services							$ 73,000
Value of shares, outstanding	$ (6,566,588)	$ (7,307,490)	$ (6,559,825)		$ (2,481,289)	$ (2,701,783)	$ (6,566,588)	$ (2,481,289)	$ (6,559,825)		$ (2,152,112)
Advisory and consultancy services
Stockholders' Equity
Shares issued as consideration for advisory and other services (in shares)							80,000
Shares issued as consideration for advisory and other services							$ 52,000
Series A preferred stock
Stockholders' Equity
Conversion of stock, shares converted							1
Website development services
Stockholders' Equity
Shares issued as consideration for advisory and other services (in shares)										35,000
Shares issued as consideration for advisory and other services										$ 247,306
Gain on settlement of website development service cost										226,306
Common stock
Stockholders' Equity
Shares, outstanding	617,025,999	617,025,999	617,025,999		617,025,999	617,025,999	617,025,999	617,025,999	617,025,999		617,025,999
Value of shares, outstanding	$ 61,703	$ 61,703	$ 61,703		$ 61,703	$ 61,703	$ 61,703	$ 61,703	$ 61,703		$ 61,703
Common stock \| Private placements
Stockholders' Equity
Shares issued as consideration for advisory and other services							$ 18,787
Shares to be issued							346,296
Common stock \| Website development services
Stockholders' Equity
Shares issued as consideration for advisory and other services										$ 21,000
Warrant
Stockholders' Equity
Convertible notes, warrants and preferred stock into common shares							10,400,008		53,950,001
Convertible notes
Stockholders' Equity
Convertible notes, warrants and preferred stock into common shares							28,129,370		17,258,122
Preferred stock warrants
Stockholders' Equity
Convertible notes, warrants and preferred stock into common shares							100,000,000		100,000,000
Shares to be issued
Stockholders' Equity
Shares issued as consideration for consideration of the intellectual property rights (in shares)	15,624	15,624	15,624	15,624	15,624	15,624	31,248	31,248
Shares issued as consideration for consideration of the intellectual property rights	$ 48	$ 63	$ 73	$ 120	$ 114	$ 153	$ 111	$ 267
Shares, outstanding	1,610,272	1,594,648	1,579,024		1,547,776	1,532,152	1,610,272	1,547,776	1,579,024		1,516,528
Value of shares, outstanding	$ 175,293	$ 175,245	$ 175,182		$ 174,989	$ 174,875	$ 175,293	$ 174,989	$ 175,182		$ 174,722
Shares to be issued \| Settlement of loans
Stockholders' Equity
Shares issued as consideration for advisory and other services							$ 80,838
Shares issued on settlement of debt							930,240
Serious seeds
Stockholders' Equity
Shares to issue as consideration for intangible assets (in shares)							218,736
Shares to issue as consideration for intangible assets							$ 2,668

XML 60 R50.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Warrants (Details) - USD ($)						3 Months Ended						6 Months Ended
Stockholders' Equity - Warrants (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023
Stockholders' Equity
Forfeiture rate						0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Exercise price	$ 0.300	$ 0.300	$ 0.300	$ 0.300	$ 0.250	$ 0.350	$ 0.300	$ 0.300	$ 0.300	$ 0.300	$ 0.250	$ 0.350
Volatility						342.00%	305.00%	279.00%	279.00%	299.00%	306.00%
Risk free interest rate										2.73%
Expected life (years)						2 years	2 years	2 years	2 years	2 years	2 years
Expected dividend rate						0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Fair value of warrants	$ 160	$ 176	$ 288	$ 306	$ 430	$ 138	$ 160	$ 176	$ 288	$ 306	$ 430	$ 138
Minimum
Stockholders' Equity
Stock price	$ 0.003	$ 0.004	$ 0.007	$ 0.005	$ 0.008	$ 0.003	$ 0.003	$ 0.004	$ 0.007	$ 0.005	$ 0.008	$ 0.003
Risk free interest rate						3.82%	4.24%	4.23%	2.97%	2.50%	0.88%
Maximum
Stockholders' Equity
Stock price	$ 0.005	$ 0.006	$ 0.008	$ 0.010	$ 0.013	$ 0.003	$ 0.005	$ 0.006	$ 0.008	$ 0.010	$ 0.013	$ 0.003
Risk free interest rate						4.51%	4.89%	4.66%	3.50%		1.50%
Warrant
Stockholders' Equity
Forfeiture rate	0.00%	0.00%	0.00%	0.00%	0.00%							0.00%
Stock price	$ 0.003	$ 0.004	$ 0.005	$ 0.008	$ 0.009	$ 0.006	$ 0.003	$ 0.004	$ 0.005	0.008	$ 0.009	$ 0.006
Risk free interest rate	4.64%	4.73%	4.05%	2.92%	2.28%							5.40%
Expected dividend rate	0.00%	0.00%	0.00%	0.00%	0.00%							0.00%
Warrant \| Minimum
Stockholders' Equity
Exercise price	$ 0.250	$ 0.200	$ 0.200	$ 0.050	$ 0.023	0.250	0.250	0.200	0.200	0.050	0.023	$ 0.250
Volatility	244.00%	253.00%	214.00%	192.00%	192.00%							273.00%
Expected life (years)	7 days	7 days	0 years	0 years	0 years							7 days
Warrant \| Maximum
Stockholders' Equity
Exercise price	$ 0.300	$ 0.300	$ 0.300	$ 0.300	$ 0.250	$ 0.300	$ 0.300	$ 0.300	$ 0.300	$ 0.300	$ 0.250	$ 0.300
Volatility	305.00%	312.00%	279.00%	306.00%	306.00%							342.00%
Expected life (years)	1 year 11 months 4 days	1 year 11 months 4 days	1 year 11 months 8 days	1 year 11 months 8 days	1 year 11 months 4 days							1 year 8 months 4 days

XML 61 R51.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Warrants outstanding (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Stockholders' Equity
Warrants outstanding	10,400,008	53,950,001
Serious seeds
Stockholders' Equity
Warrants outstanding	400,008	400,008
Private placements
Stockholders' Equity
Warrants outstanding		43,549,993
Number of warrants expired	5,416,668
Minimum \| Serious seeds
Stockholders' Equity
Remaining contractual life term	7 days	7 days
Minimum \| Private placements
Stockholders' Equity
Remaining contractual life term		1 month 9 days
Maximum \| Serious seeds
Stockholders' Equity
Remaining contractual life term	1 year 11 months 4 days	1 year 11 months 4 days
Maximum \| Private placements
Stockholders' Equity
Remaining contractual life term		5 months 19 days
CLI
Stockholders' Equity
Warrants outstanding	10,000,000	10,000,000
Remaining contractual life term	2 years 1 month 13 days	2 years 7 months 13 days

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef
-Topic 272
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483014/272-10-45-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 272
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482987/272-10-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

+ Details

XML 62 R52.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Movement of the warrant liability (Details)	6 Months Ended
	Jun. 30, 2023 USD ($)
Movement of the warrant liability
Warrant liability, Beginning balance	$ 489
Warrant liability for new issuance	298
Change in fair value	144
Warrant liability, Ending balance	$ 931

XML 63 R53.htm IDEA: XBRL DOCUMENT

Contingencies and commitments (Details)			6 Months Ended		12 Months Ended
Contingencies and commitments (Details)	Jul. 27, 2020 USD ($)	Dec. 06, 2018 $ / shares shares	Jun. 30, 2023 USD ($) shares	Jun. 30, 2023 CAD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 CAD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2019 CAD ($)	Jun. 30, 2023 CAD ($) shares	Dec. 31, 2022 shares
Loss Contingencies
Approximate lawsuit, amount			$ 1,406,977	$ 1,862,805
Amount payable			$ 11,098
Common stock, shares issued \| shares			617,025,999						617,025,999	617,025,999
Warrants issued to purchase shares of common stock \| shares			10,400,008						10,400,008	53,950,001
Canary case, one
Loss Contingencies
Approximate lawsuit, amount							$ 1,586,130	$ 2,100,000
CannaKorp Inc
Loss Contingencies
Approximate lawsuit, amount			$ 150,000
Amount payable			188,865
Cgreen Inc
Loss Contingencies
Settlement amount	$ 100,000
Monthly installment of settlement amount	10,000
Canary
Loss Contingencies
Approximate lawsuit, amount					$ 98,777	$ 130,778
Amount payable			$ 104,345						$ 138,150
Serious Seeds
Loss Contingencies
Common stock, shares issued \| shares		5,208
Serious Seeds \| Common Stock Purchase Warrants
Loss Contingencies
Common stock, shares issued \| shares			0						0
Warrants issued to purchase shares of common stock \| shares		16,667
Warrants exercise period		2 years
Serious Seeds \| Minimum \| Common Stock Purchase Warrants
Loss Contingencies
Exercise prices \| $ / shares		$ 0.20
Serious Seeds \| Maximum \| Common Stock Purchase Warrants
Loss Contingencies
Exercise prices \| $ / shares		$ 0.35
Within 30 days of the Effective Date \| Cgreen Inc
Loss Contingencies
Settlement amount	$ 130,000
Settlement period	30 days
1st year
Loss Contingencies
Percentage of royalties on gross sales			2.00%	2.00%
2nd year
Loss Contingencies
Percentage of royalties on gross sales			2.25%	2.25%
3rd year
Loss Contingencies
Percentage of royalties on gross sales			2.50%	2.50%
4th year
Loss Contingencies
Percentage of royalties on gross sales			2.75%	2.75%
5th and following years
Loss Contingencies
Percentage of royalties on gross sales			3.00%	3.00%

XML 64 tmb-20230630x10q_htm.xml IDEA: XBRL DOCUMENT 0001586554 srt:MinimumMember us-gaap:MeasurementInputExercisePriceMember 2019-03-01 0001586554 srt:MaximumMember us-gaap:MeasurementInputExercisePriceMember 2019-03-01 0001586554 us-gaap:MeasurementInputSharePriceMember 2019-03-01 0001586554 us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-03-01 0001586554 us-gaap:MeasurementInputPriceVolatilityMember 2019-03-01 0001586554 us-gaap:MeasurementInputExpectedTermMember 2019-03-01 0001586554 us-gaap:MeasurementInputExpectedDividendRateMember 2019-03-01 0001586554 cbdy:MeasurementInputForfeitureRateMember 2019-03-01 0001586554 us-gaap:MeasurementInputSharePriceMember 2018-08-02 0001586554 us-gaap:MeasurementInputPriceVolatilityMember 2018-08-02 0001586554 us-gaap:MeasurementInputExpectedTermMember 2018-08-02 0001586554 us-gaap:MeasurementInputExpectedDividendRateMember 2018-08-02 0001586554 us-gaap:MeasurementInputExercisePriceMember 2018-08-02 0001586554 cbdy:MeasurementInputForfeitureRateMember 2018-08-02 0001586554 cbdy:WebsiteDevelopmentServicesMember us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateTwoMember 2019-08-08 2019-08-08 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateThreeMember 2019-08-08 2019-08-08 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateOneMember 2019-08-08 2019-08-08 0001586554 cbdy:VisavaIncMember 2018-06-27 2018-06-27 0001586554 cbdy:AdvisoryAndConsultancyServicesMember 2023-01-01 2023-06-30 0001586554 us-gaap:RetainedEarningsMember 2023-06-30 0001586554 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001586554 us-gaap:RetainedEarningsMember 2023-03-31 0001586554 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001586554 us-gaap:RetainedEarningsMember 2022-12-31 0001586554 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001586554 us-gaap:RetainedEarningsMember 2022-06-30 0001586554 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001586554 us-gaap:RetainedEarningsMember 2022-03-31 0001586554 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001586554 us-gaap:RetainedEarningsMember 2021-12-31 0001586554 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001586554 us-gaap:PreferredStockMember 2023-06-30 0001586554 us-gaap:CommonStockMember 2023-06-30 0001586554 cbdy:SharesToBeIssuedMember 2023-06-30 0001586554 us-gaap:PreferredStockMember 2023-03-31 0001586554 us-gaap:CommonStockMember 2023-03-31 0001586554 cbdy:SharesToBeIssuedMember 2023-03-31 0001586554 us-gaap:PreferredStockMember 2022-12-31 0001586554 us-gaap:CommonStockMember 2022-12-31 0001586554 cbdy:SharesToBeIssuedMember 2022-12-31 0001586554 us-gaap:PreferredStockMember 2022-06-30 0001586554 us-gaap:CommonStockMember 2022-06-30 0001586554 cbdy:SharesToBeIssuedMember 2022-06-30 0001586554 us-gaap:PreferredStockMember 2022-03-31 0001586554 us-gaap:CommonStockMember 2022-03-31 0001586554 cbdy:SharesToBeIssuedMember 2022-03-31 0001586554 us-gaap:PreferredStockMember 2021-12-31 0001586554 us-gaap:CommonStockMember 2021-12-31 0001586554 cbdy:SharesToBeIssuedMember 2021-12-31 0001586554 us-gaap:WarrantMember 2023-06-30 0001586554 srt:MinimumMember 2023-06-30 0001586554 srt:MaximumMember 2023-06-30 0001586554 us-gaap:WarrantMember 2023-03-31 0001586554 srt:MinimumMember 2023-03-31 0001586554 srt:MaximumMember 2023-03-31 0001586554 us-gaap:WarrantMember 2022-12-31 0001586554 srt:MinimumMember 2022-12-31 0001586554 srt:MaximumMember 2022-12-31 0001586554 us-gaap:WarrantMember 2022-09-30 0001586554 srt:MinimumMember 2022-09-30 0001586554 srt:MaximumMember 2022-09-30 0001586554 us-gaap:WarrantMember 2022-06-30 0001586554 srt:MinimumMember 2022-06-30 0001586554 srt:MaximumMember 2022-06-30 0001586554 us-gaap:WarrantMember 2022-03-31 0001586554 srt:MinimumMember 2022-03-31 0001586554 srt:MaximumMember 2022-03-31 0001586554 srt:MinimumMember cbdy:SeriousSeedsIntellectualPropertyRightsMember 2023-01-01 2023-06-30 0001586554 srt:MaximumMember cbdy:SeriousSeedsIntellectualPropertyRightsMember 2023-01-01 2023-06-30 0001586554 srt:MinimumMember us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001586554 srt:MinimumMember cbdy:SeriousSeedsIntellectualPropertyRightsMember 2022-01-01 2022-12-31 0001586554 srt:MaximumMember us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001586554 srt:MaximumMember cbdy:SeriousSeedsIntellectualPropertyRightsMember 2022-01-01 2022-12-31 0001586554 cbdy:ClInvestorsInc.Member 2022-01-01 2022-12-31 0001586554 srt:MinimumMember 2023-04-01 2023-06-30 0001586554 srt:MaximumMember 2023-04-01 2023-06-30 0001586554 srt:MinimumMember 2023-01-01 2023-03-31 0001586554 srt:MaximumMember 2023-01-01 2023-03-31 0001586554 srt:MinimumMember 2022-10-01 2022-12-31 0001586554 srt:MaximumMember 2022-10-01 2022-12-31 0001586554 srt:MinimumMember 2022-07-01 2022-09-30 0001586554 srt:MaximumMember 2022-07-01 2022-09-30 0001586554 srt:MinimumMember 2022-04-01 2022-06-30 0001586554 srt:MinimumMember 2022-01-01 2022-03-31 0001586554 srt:MaximumMember 2022-01-01 2022-03-31 0001586554 srt:MinimumMember us-gaap:WarrantMember 2023-06-30 0001586554 srt:MaximumMember us-gaap:WarrantMember 2023-06-30 0001586554 srt:MinimumMember us-gaap:WarrantMember 2023-03-31 0001586554 srt:MaximumMember us-gaap:WarrantMember 2023-03-31 0001586554 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001586554 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001586554 srt:MinimumMember us-gaap:WarrantMember 2022-09-30 0001586554 srt:MaximumMember us-gaap:WarrantMember 2022-09-30 0001586554 srt:MinimumMember us-gaap:WarrantMember 2022-06-30 0001586554 srt:MaximumMember us-gaap:WarrantMember 2022-06-30 0001586554 srt:MinimumMember us-gaap:WarrantMember 2022-03-31 0001586554 srt:MaximumMember us-gaap:WarrantMember 2022-03-31 0001586554 us-gaap:SalesMember 2023-06-30 0001586554 cbdy:RubinSchindermannMember cbdy:ClInvestorsInc.Member us-gaap:SeriesAPreferredStockMember cbdy:AmendedDebtPurchaseAndAssignmentAgreementMember 2020-08-14 2020-08-14 0001586554 cbdy:RubinSchindermannMember cbdy:ClInvestorsInc.Member us-gaap:SeriesAPreferredStockMember cbdy:AmendedAgreementMember 2020-08-14 2020-08-14 0001586554 cbdy:GtaAngelGroupMember 2023-01-01 2023-06-30 0001586554 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2023-06-30 0001586554 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2023-06-30 0001586554 cbdy:FurnitureAndOfficeEquipmentMember 2023-06-30 0001586554 cbdy:ClInvestorsInc.Member 2023-01-01 2023-06-30 0001586554 cbdy:ClInvestorsInc.Member cbdy:DebtPurchaseAndAssignmentAgreementMember 2020-06-15 2020-06-15 0001586554 cbdy:ManagementServicesMember 2023-06-30 0001586554 cbdy:GtaAngelGroupMember 2023-06-30 0001586554 cbdy:ManagementServicesMember 2022-12-31 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001586554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001586554 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001586554 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001586554 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001586554 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001586554 cbdy:VisavaIncMember 2018-06-27 0001586554 cbdy:FormerChiefExecutiveOfficerPresidentChiefFinancialOfficersAndCurrentKeyOfficersMember 2023-06-30 0001586554 cbdy:FormerChiefExecutiveOfficerPresidentChiefFinancialOfficersAndCurrentKeyOfficersMember 2022-12-31 0001586554 cbdy:CannakorpIncMember 2023-01-01 2023-06-30 0001586554 cbdy:CanaryMember 2020-01-01 2020-12-31 0001586554 cbdy:LawsuitRelatingToCanaryOneMember 2019-01-01 2019-12-31 0001586554 cbdy:CannakorpIncMember 2023-06-30 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateFiveMember 2020-04-01 2020-06-30 0001586554 cbdy:InterestAndBankChargesMember 2023-01-01 2023-06-30 0001586554 cbdy:PreferredStockWarrantsMember 2023-01-01 2023-06-30 0001586554 cbdy:ConvertibleNotesMember 2023-01-01 2023-06-30 0001586554 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001586554 cbdy:PreferredStockWarrantsMember 2022-01-01 2022-12-31 0001586554 cbdy:ConvertibleNotesMember 2022-01-01 2022-12-31 0001586554 cbdy:CannakorpIncMember 2019-03-01 2019-03-01 0001586554 cbdy:CanaryRxIncMember cbdy:VisavaIncMember 2022-01-01 2022-12-31 0001586554 cbdy:VisavaIncMember 2021-01-01 2021-12-31 0001586554 cbdy:CannakorpIncMember 2020-01-01 2020-12-31 0001586554 cbdy:CannakorpIncMember 2020-12-31 0001586554 cbdy:CannakorpIncMember 2019-03-01 0001586554 cbdy:CannakorpIncMember 2019-01-25 0001586554 cbdy:VisavaAndCanaryMember cbdy:VisavaIncMember 2018-06-27 0001586554 srt:MinimumMember us-gaap:MeasurementInputSharePriceMember 2023-06-30 0001586554 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-06-30 0001586554 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2023-06-30 0001586554 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2023-06-30 0001586554 srt:MinimumMember us-gaap:MeasurementInputExercisePriceMember 2023-06-30 0001586554 srt:MaximumMember us-gaap:MeasurementInputSharePriceMember 2023-06-30 0001586554 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-06-30 0001586554 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2023-06-30 0001586554 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2023-06-30 0001586554 srt:MaximumMember us-gaap:MeasurementInputExercisePriceMember 2023-06-30 0001586554 us-gaap:MeasurementInputExpectedDividendRateMember 2023-06-30 0001586554 cbdy:NoteGMember 2023-06-30 0001586554 cbdy:NoteFMember 2023-06-30 0001586554 cbdy:NoteDMember 2023-06-30 0001586554 cbdy:NoteGMember 2022-12-31 0001586554 cbdy:NoteFMember 2022-12-31 0001586554 cbdy:NoteDMember 2022-12-31 0001586554 cbdy:ClInvestorsInc.Member cbdy:AmendedDebtPurchaseAndAssignmentAgreementMember 2023-06-30 0001586554 cbdy:LoanFromShareholderTrancheTwoMember 2023-06-30 0001586554 cbdy:LoanFromShareholderTrancheThreeMember 2023-06-30 0001586554 cbdy:LoanFromShareholderTrancheOneMember 2023-06-30 0001586554 cbdy:LoanFromShareholderTrancheFourMember 2023-06-30 0001586554 cbdy:LoanFromShareholderTrancheFiveMember 2023-06-30 0001586554 cbdy:CanaryMember 2023-06-30 0001586554 cbdy:ConvertiblePromissoryNotesMember 2023-06-30 0001586554 cbdy:ConvertiblePromissoryNotesMember 2022-12-31 0001586554 cbdy:ClInvestorsInc.Member cbdy:DebtPurchaseAndAssignmentAgreementMember 2020-06-15 0001586554 cbdy:ConvertiblePromissoryNotesMember 2023-01-01 2023-06-30 0001586554 cbdy:ConvertiblePromissoryNotesMember 2022-01-01 2022-06-30 0001586554 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-06-30 0001586554 cbdy:SeriousSeedsB.vMember cbdy:CommonStockPurchaseWarrantsMember 2023-06-30 0001586554 cbdy:RubinSchindermannMember cbdy:ClInvestorsInc.Member us-gaap:SeriesAPreferredStockMember cbdy:AmendedDebtPurchaseAndAssignmentAgreementMember 2020-08-14 0001586554 us-gaap:OverTheCounterMember 2019-01-25 0001586554 cbdy:SeriousSeedsB.vMember 2018-12-06 0001586554 cbdy:CommonStockPurchaseWarrantsMember cbdy:CannakorpIncMember 2023-06-30 0001586554 cbdy:SeriousSeedsIntellectualPropertyRightsMember 2023-06-30 0001586554 cbdy:ClInvestorsInc.Member 2023-06-30 0001586554 us-gaap:PrivatePlacementMember 2022-12-31 0001586554 cbdy:SeriousSeedsIntellectualPropertyRightsMember 2022-12-31 0001586554 cbdy:ClInvestorsInc.Member 2022-12-31 0001586554 cbdy:SeriousSeedsB.vMember cbdy:CommonStockPurchaseWarrantsMember 2018-12-06 0001586554 cbdy:VisavaIncMember 2018-06-27 0001586554 cbdy:SeriousSeedsB.vMember srt:MinimumMember cbdy:CommonStockPurchaseWarrantsMember 2018-12-06 0001586554 cbdy:SeriousSeedsB.vMember srt:MaximumMember cbdy:CommonStockPurchaseWarrantsMember 2018-12-06 0001586554 cbdy:VisavaIncMember cbdy:CommonStockPurchaseWarrantsMember 2018-06-27 0001586554 2021-12-31 0001586554 cbdy:CannakorpIncMember 2019-03-01 0001586554 cbdy:CanaryRxIncMember cbdy:VisavaIncMember 2018-08-02 0001586554 cbdy:VisavaIncMember 2018-08-02 0001586554 cbdy:CannakorpIncMember cbdy:CommonStockPurchaseWarrantsMember 2019-03-01 2019-03-01 0001586554 cbdy:CannakorpIncMember 2019-03-01 2019-03-01 0001586554 cbdy:CanaryRxIncMember cbdy:VisavaIncMember 2018-08-02 2018-08-02 0001586554 cbdy:VisavaIncMember 2018-08-02 2018-08-02 0001586554 cbdy:CannakorpIncMember us-gaap:WarrantMember 2019-03-01 0001586554 cbdy:VisavaIncMember us-gaap:WarrantMember 2018-08-02 0001586554 cbdy:CanaryRxIncMember 2023-06-30 0001586554 cbdy:VisavaIncMember 2018-06-27 0001586554 cbdy:CannakorpIncMember cbdy:CommonStockPurchaseWarrantsMember 2023-01-01 2023-06-30 0001586554 cbdy:CannakorpIncMember us-gaap:WarrantMember 2019-03-01 2019-03-01 0001586554 cbdy:CannakorpIncMember us-gaap:CommonStockMember 2019-03-01 2019-03-01 0001586554 cbdy:VisavaIncMember us-gaap:WarrantMember 2018-08-02 2018-08-02 0001586554 cbdy:VisavaIncMember us-gaap:CommonStockMember 2018-08-02 2018-08-02 0001586554 cbdy:VisavaIncMember cbdy:CommonStockPurchaseWarrantsMember 2018-06-27 2018-06-27 0001586554 cbdy:VisavaIncMember 2018-06-27 2018-06-27 0001586554 cbdy:CannakorpIncMember us-gaap:CommonStockMember 2019-03-01 0001586554 cbdy:VisavaIncMember us-gaap:CommonStockMember 2018-08-02 0001586554 2019-05-01 0001586554 2017-09-30 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateTwoMember 2019-08-08 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateThreeMember 2019-08-08 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateOneMember 2019-08-08 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateFourMember 2019-08-08 0001586554 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-06-30 0001586554 us-gaap:MachineryAndEquipmentMember 2023-06-30 0001586554 us-gaap:LeaseholdImprovementsMember 2023-06-30 0001586554 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001586554 2023-08-09 0001586554 cbdy:CommonStockPurchaseWarrantsMember cbdy:CannakorpIncMember 2019-03-01 2019-03-01 0001586554 cbdy:RubinSchindermannMember cbdy:ClInvestorsInc.Member cbdy:AmendedDebtPurchaseAndAssignmentAgreementMember 2020-08-14 2020-08-14 0001586554 cbdy:CgreenIncMember 2019-08-08 0001586554 cbdy:SharesToBeIssuedMember 2023-04-01 2023-06-30 0001586554 cbdy:SharesToBeIssuedMember 2023-01-01 2023-06-30 0001586554 cbdy:SharesToBeIssuedMember 2023-01-01 2023-03-31 0001586554 cbdy:SharesToBeIssuedMember 2022-10-01 2022-12-31 0001586554 cbdy:SharesToBeIssuedMember 2022-07-01 2022-09-30 0001586554 cbdy:SharesToBeIssuedMember 2022-04-01 2022-06-30 0001586554 cbdy:SharesToBeIssuedMember 2022-01-01 2022-06-30 0001586554 cbdy:SharesToBeIssuedMember 2022-01-01 2022-03-31 0001586554 cbdy:SeriousSeedsIntellectualPropertyRightsMember 2023-01-01 2023-06-30 0001586554 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2023-01-01 2023-06-30 0001586554 cbdy:SettlementOfLoanMember cbdy:SharesToBeIssuedMember 2023-01-01 2023-06-30 0001586554 us-gaap:WarrantMember 2023-03-31 2023-03-31 0001586554 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001586554 us-gaap:WarrantMember 2022-12-31 2022-12-31 0001586554 us-gaap:WarrantMember 2022-09-30 2022-09-30 0001586554 us-gaap:WarrantMember 2022-06-30 2022-06-30 0001586554 us-gaap:WarrantMember 2022-03-31 2022-03-31 0001586554 cbdy:CanaryRxIncMember 2023-04-27 0001586554 cbdy:CannakorpIncMember 2023-04-01 2023-06-30 0001586554 cbdy:CannakorpIncMember 2023-01-01 2023-03-31 0001586554 cbdy:CannakorpIncMember 2022-01-01 2022-12-31 0001586554 us-gaap:AccountingStandardsUpdate201602Member 2020-01-01 0001586554 cbdy:CanaryAndThriveCannabisMember 2023-01-01 2023-06-30 0001586554 cbdy:RoyaltiesPayableInYear5AndFollowingYearsMember 2023-01-01 2023-06-30 0001586554 cbdy:RoyaltiesPayableInYear4Member 2023-01-01 2023-06-30 0001586554 cbdy:RoyaltiesPayableInYear3Member 2023-01-01 2023-06-30 0001586554 cbdy:RoyaltiesPayableInYear2Member 2023-01-01 2023-06-30 0001586554 cbdy:RoyaltiesPayableInYear1Member 2023-01-01 2023-06-30 0001586554 cbdy:CgreenIncMember 2019-08-08 2019-08-08 0001586554 cbdy:ClInvestorsInc.Member cbdy:AmendedDebtPurchaseAndAssignmentAgreementMember cbdy:VisavaAndCanaryMember 2023-06-30 0001586554 cbdy:ClInvestorsInc.Member cbdy:VisavaAndCanaryMember 2023-06-30 0001586554 cbdy:CanaryRxIncMember 2023-04-28 0001586554 srt:MinimumMember cbdy:CanaryMember 2023-04-27 0001586554 srt:MaximumMember cbdy:CanaryMember 2023-04-27 0001586554 cbdy:CanaryRxIncMember 2023-04-27 0001586554 cbdy:NorlandamMarketingInc.Member 2023-06-30 0001586554 cbdy:CannakorpIncMember 2023-06-30 0001586554 cbdy:CannakorpIncMember 2023-03-31 0001586554 cbdy:CannakorpIncMember 2022-12-31 0001586554 cbdy:CanaryRxIncMember 2023-01-01 2023-06-30 0001586554 cbdy:CanadaIncMember 2022-01-01 2022-06-30 0001586554 cbdy:FormerChiefExecutiveOfficerPresidentChiefFinancialOfficersAndCurrentKeyOfficersMember 2023-01-01 2023-06-30 0001586554 cbdy:FormerChiefExecutiveOfficerPresidentChiefFinancialOfficersAndCurrentKeyOfficersMember 2022-01-01 2022-06-30 0001586554 cbdy:CanaryMember 2023-04-01 2023-04-27 0001586554 cbdy:CanaryRxIncMember 2023-01-01 2023-06-30 0001586554 2020-05-14 2020-05-14 0001586554 cbdy:CanadaIncMember 2023-01-01 2023-06-30 0001586554 cbdy:CanaryRxIncMember 2020-05-14 2020-05-14 0001586554 cbdy:CanaryRxIncMember 2023-06-30 0001586554 cbdy:CannakorpIncMember 2019-12-31 0001586554 cbdy:CgreenIncMember cbdy:EffectiveDateFiveMember 2020-07-27 2020-07-27 0001586554 cbdy:CgreenIncMember 2020-07-27 2020-07-27 0001586554 cbdy:CgreenIncMember 2020-04-01 2020-06-30 0001586554 2023-02-16 2023-02-16 0001586554 2023-04-27 0001586554 cbdy:WebsiteDevelopmentServicesMember 2017-01-01 2017-12-31 0001586554 cbdy:CanaryRxIncMember 2023-06-30 0001586554 srt:MinimumMember us-gaap:WarrantMember 2023-03-31 2023-03-31 0001586554 srt:MaximumMember us-gaap:WarrantMember 2023-03-31 2023-03-31 0001586554 srt:MinimumMember us-gaap:WarrantMember 2023-01-01 2023-06-30 0001586554 srt:MaximumMember us-gaap:WarrantMember 2023-01-01 2023-06-30 0001586554 2023-01-01 2023-03-31 0001586554 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 2022-12-31 0001586554 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 2022-12-31 0001586554 2022-10-01 2022-12-31 0001586554 srt:MinimumMember us-gaap:WarrantMember 2022-09-30 2022-09-30 0001586554 srt:MaximumMember us-gaap:WarrantMember 2022-09-30 2022-09-30 0001586554 2022-07-01 2022-09-30 0001586554 srt:MinimumMember us-gaap:WarrantMember 2022-06-30 2022-06-30 0001586554 srt:MaximumMember us-gaap:WarrantMember 2022-06-30 2022-06-30 0001586554 srt:MinimumMember us-gaap:WarrantMember 2022-03-31 2022-03-31 0001586554 srt:MaximumMember us-gaap:WarrantMember 2022-03-31 2022-03-31 0001586554 2022-01-01 2022-03-31 0001586554 us-gaap:MeasurementInputRiskFreeInterestRateMember cbdy:VisavaIncMember 2018-08-02 2018-08-02 0001586554 cbdy:CanaryMember 2023-04-27 0001586554 cbdy:CanaryMember 2022-06-30 0001586554 cbdy:CannakorpIncMember 2023-01-01 2023-06-30 0001586554 cbdy:CanaryMember 2023-01-01 2023-06-30 0001586554 cbdy:CannakorpIncMember 2022-01-01 2022-06-30 0001586554 cbdy:CanaryMember 2022-01-01 2022-06-30 0001586554 2023-04-01 2023-06-30 0001586554 cbdy:ClInvestorsInc.Member cbdy:AmendedAgreementMember 2020-08-14 2020-08-14 0001586554 2020-08-14 2020-08-14 0001586554 us-gaap:DebtInstrumentRedemptionPeriodOneMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-01-01 2023-06-30 0001586554 us-gaap:DebtInstrumentRedemptionPeriodTwoMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-01-01 2023-06-30 0001586554 us-gaap:DebtInstrumentRedemptionPeriodThreeMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-01-01 2023-06-30 0001586554 us-gaap:DebtInstrumentRedemptionPeriodFourMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-01-01 2023-06-30 0001586554 us-gaap:DebtInstrumentRedemptionPeriodFiveMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-01-01 2023-06-30 0001586554 us-gaap:DebtInstrumentRedemptionPeriodTwoMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-06-30 0001586554 us-gaap:DebtInstrumentRedemptionPeriodThreeMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-06-30 0001586554 us-gaap:DebtInstrumentRedemptionPeriodOneMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-06-30 0001586554 us-gaap:DebtInstrumentRedemptionPeriodFourMember cbdy:ClInvestorsInc.Member cbdy:CanaryMember 2023-06-30 0001586554 cbdy:CannakorpIncMember 2019-01-01 2019-12-31 0001586554 2022-01-01 2022-12-31 0001586554 us-gaap:OverTheCounterMember 2021-01-01 2021-12-31 0001586554 cbdy:CannakorpIncMember 2021-01-01 2021-12-31 0001586554 2021-01-01 2021-12-31 0001586554 2020-01-01 2020-12-31 0001586554 cbdy:SeriousSeedsB.vMember cbdy:CommonStockPurchaseWarrantsMember 2018-12-06 2018-12-06 0001586554 us-gaap:PrivatePlacementMember 2023-01-01 2023-06-30 0001586554 cbdy:NoteGMember 2023-01-01 2023-06-30 0001586554 cbdy:NoteFMember 2023-01-01 2023-06-30 0001586554 cbdy:NoteDMember 2023-01-01 2023-06-30 0001586554 2023-01-01 2023-06-30 0001586554 2023-03-31 0001586554 2022-09-30 0001586554 2022-06-30 0001586554 2022-03-31 0001586554 2018-06-27 0001586554 2023-04-27 2023-04-27 0001586554 2022-04-01 2022-06-30 0001586554 2022-12-31 0001586554 2022-01-01 2022-06-30 0001586554 2023-02-16 0001586554 2023-06-30 iso4217:CAD iso4217:USD pure shares cbdy:customer cbdy:lease utr:sqft iso4217:USD shares cbdy:Y

http://fasb.org/us-gaap/2023#RelatedPartyMember

1000000

0001586554 --12-31 2023 Q2 CBDY

617025999

http://fasb.org/us-gaap/2023#RelatedPartyMember

P10Y

0.50

false 10-Q true 2023-06-30 false 000-55066 TARGET GROUP INC. DE 46-3621499 20 Hempstead Drive Hamilton Ontario CA L8W 2E7 1 905 541-3833 Common Stock, Par Value $0.0001 Yes Yes Non-accelerated Filer true false false 617025999

1047833

223843

8686

8490

2068

1814902

42674

41714

1034

630180

3777

3692

2920974

909987

5773235

5554225

775577

269175

263117

55237

62728

6097647

6655647

9018621

7565634

506

2823400

2296935

35254

5061467 4468535

118047

110586

480

16318

15125

8020218

6927421

6275163

5877930

1288897

1319619

931

489

7564991

7198038

15585209

14125459

100

61703

175293 175182

24985697

-30565571

-30783678

-1223810

-998829

-6566588

-6559825

9018621

7565634

758984

369261

389723

15883

7454

16106

18693

77191

55631

155515

83516

53083 8056 53083 -9775

145987

105647

203927

172591

229568

225335

442254

452959

-28400 10378 -17310 33905 -56502 89143 -59131 68946

500448

286490

841160

634683

-4301

-834

-1326

16812

1428185 1428185

369092

272373

722698

561061

-48519

76027

-50794

41993

12507

637591

16782

697776

1750 2259

68115

104923

24152

151048

12354 12994 24757 26243

1074541

534090

669544

322584

963816

247600

218107

-312099

963816

247600

218107

-312099

-222962

-27220

-224981

-17345

740854

220380

-6874

-329444

0.0016

0.0004

-0.0005

617025999

0.0010

0.0003

0.0000

-0.0004

727426007

773218857

727426007

773218857

1000000

100

617025999

61703

1594648

175245

24985697

-31529387

-1000848

-7307490

15624 48 48

963816

-222962

1000000

100

617025999

61703

1610272

175293

24985697

-30565571

-1223810

-6566588

1000000

100

617025999

61703

1532152

174875

24985697

-26823313

-1100845

-2701783

15624 114 114

247600

-27220

1000000

100

617025999

61703

1547776

174989

24985697

-26575713

-1128065

-2481289

1000000

100

617025999

61703

1579024

175182

24985697

-30783678

-998829

-6559825

31248 111 111

218107

-224981

1000000

100

617025999

61703

1610272

175293

24985697

-30565571

-1223810

-6566588

1000000

100

617025999

61703

1516528

174722

24985697

-26263614

-1110720

-2152112

31248 267 267

-312099

-17345

1000000

100

617025999

61703

1547776

174989

24985697

-26575713

-1128065

-2481289

218107

-312099

-1326

16812

1428185

409

420

2259

442254

452959

119562

134199

24152

151048

24757 26243 -36448 -12058

534095

-1150218

160553 168507

-308828

-1199180

-5821 321

439640

1190277

445461

1189956

83163

667846

78660

139599

10000

667846

12224

804479

3000

19707

-2019

232333

122151

1056519

123132

114

2084621

1. Organization, Nature of Business, Going Concern and Management PlansOrganization and Nature of BusinessTarget Group Inc. (“Target Group” or “the Company”) was incorporated on July 2, 2013, under the laws of the state of Delaware to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions.Target Group Inc. is a diversified and vertically integrated, progressive company with a focus on both national and international presence. The Company owns and operates Canary Rx Inc, a Canadian licensed producer, regulated under The Cannabis Act (Bill C-45). Canary Rx Inc, operates a 44,000 square foot facility located in Norfolk County, Ontario, and has partnered with Dutch breeder, Serious Seeds B.V. (“Serious Seeds”), to cultivate exclusive & world-class proprietary genetics. The Company has begun structuring multiple international production and distribution platforms and intends to continue rapidly expanding its global footprint as it focuses on building an iconic brand portfolio whose focus aims at developing cutting-edge intellectual property among the medical and recreational cannabis markets. Target Group is committed to building industry-leading companies that transform the perception of cannabis and responsibly elevate the overall consumer experience.The Company’s current business is to produce, manufacture, distribute, and conduct sales of cannabis products. As of the current period end, the company has produced and sold cannabis products of $791,285 (Period ended June 30, 2022: $2,109,626) through its investment in a joint venture.On July 3, 2018, the Company filed an amendment in its articles of incorporation to change its name to Target Group Inc. The Company was able to secure an OTC Bulletin Board symbol CBDY from the Financial Industry Regulatory Authority (FINRA).Visava Inc./Canary Rx Inc.On June 27, 2018, the Company entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with Visava Inc., a private Ontario, Canada corporation (“Visava”). Visava owns 100% of Canary Rx Inc., a Canadian corporation that holds a leasehold interest in a parcel of property located in Ontario’s Garden Norfolk County for the production of cannabis.The Exchange Agreement provides that, subject to its terms and conditions, the Company issued to the Visava shareholders an aggregate of 25,500,000 shares of the Company’s Common Stock in exchange for all of the issued and outstanding common stock held by the Visava shareholders. In addition, to its common stock the Company issued to the Visava shareholders, prorata Common Stock Purchase Warrants (“Visava Warrants”) purchasing an aggregate of 25,000,000 shares of the Company’s Common Stock at a price per share of $0.10 for a period of two years following the issuance date of the Warrants. Upon the closing of the Exchange Agreement, the Visava shareholders held approximately 46.27% of the issued and outstanding Common Stock of the Company and Visava continues its business operations as a wholly-owned subsidiary of the Company. The transaction was closed effective August 2, 2018. During the year ended December 31, 2020, all of the Visava Warrants expired, none were exercised.CannaKorp Inc.Effective January 25, 2019, the Company entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with CannaKorp Inc., a Delaware corporation (“CannaKorp”). The Company had previously entered into a Letter of Intent with CannaKorp dated November 30, 2018, which was disclosed in the Company’s report on Form 8-K filed December 4, 2018.The Exchange Agreement provided that, subject to its terms and conditions, the Company issued to the CannaKorp shareholders an aggregate of 30,407,412 shares of the Company’s common stock, based on a price per share of $0.10, in exchange for 100% of the issued and outstanding common stock of CannaKorp held by the CannaKorp shareholders. In addition, the Company issued Common Stock Purchase Warrants (“CannaKorp Warrants”) in exchange for all outstanding and promised CannaKorp stock options. The CannaKorp Warrants granted the holders thereof the right to purchase up to approximately 7,211,213 shares of the Company’s common stock. The Company also assumed all outstanding liabilities of CannaKorp. Upon the closing of the Exchange Agreement, CannaKorp continued its business operations as a subsidiary of the Company. The transaction was closed effective March 1, 2019. During the year ended December 31, 2021, all of the CannaKorp Warrants expired, none were exercised.cGreen, Inc. Exclusive License AgreementEffective August 8, 2019, the Company entered into an Exclusive License Agreement (“License Agreement”) with cGreen, Inc., a Delaware corporation (“cGreen”). The License Agreement grants to the Company an exclusive license to manufacture and distribute the patent-pending THC antidote True FocusTM in the United States, Europe and the Caribbean. The term of the license was ten (10) years and four (4) months from the effective date of August 8, 2019. In consideration of the license, the Company would issue 10,000,000 shares of its common stock as follows: (i) 3,500,000 within ten (10) days of the effective date; (ii) 3,500,000 shares on January 10, 2020; and (iii) 3,000,000 shares not later than June 10, 2020. In addition, the Company would pay cGreen royalties of 7% of the net sales of the licensed products and 7% of all sublicensing revenues collected by the Company. The Company would pay cGreen an advance royalty of $300,000 within ten (10) days of the effective date; $300,000 on January 10, 2020; and $400,000 on or before June 10, 2020, and $500,000 on or before November 10, 2020. All advance royalty payments would be credited against the royalties owed by the Company through December 31, 2020. During the quarter ended December 31, 2019, the intangible asset was written off based on management’s review and evaluation of its recoverability.During the quarter ended June 30, 2020, the Company was in arbitration with cGreen for the breaches of the terms of the License Agreement, however, through an early mediation, both companies reached a settlement agreement to settle the breaches of the contract on July 27, 2020 (“Effective Date”). As per the settlement agreement, the License Agreement was terminated and the Company did not have to issue the 10 million shares nor pay the outstanding royalty payable in the amount of $1,191,860. As consideration, the Company paid $130,000 within 30 days of the Effective Date and started paying $100,000 in monthly installments of $10,000 commencing in April 2021 to cGreen resulting in a gain on settlement in the amount of $1,704,860. As at June 30, 2023, there was no outstanding balance, the balance has been paid in full and the claim was closed during the quarter ended March 31, 2022 (December 31, 2021: $10,000).Joint Venture Agreement TerminationEffective May 14, 2020, Canary entered into a Joint Venture Agreement (“Joint Venture”) with 9258159 Canada Inc., a corporation organized under the laws of the Province of Ontario, Canada (referred to as “Thrive”) and 2755757 Ontario Inc., a corporation organized under the laws of the Province of Ontario, Canada (referred to as “JVCo”). Canary and Thrive each hold 50% of the voting equity interest in JVCo. The term of the Joint Venture is five (5) years from its effective date of May 14, 2020.On April 27, 2023, Canary and Thrive Cannabis entered into a Release and Settlement Agreement (“Settlement Agreement”) in which Thrive Cannabis has transferred its shares in the capital of JVCo and rights of assets held by JVCo.Pursuant to the above Settlement Agreement, Thrive Cannabis paid Canary $1,051,000 to release Thrive Cannabis from any mortgages, charges, pledges, security interests, liens, encumbrances, writs of execution, actions, claims, demands and equities of any nature related to JVCo from their share of ownership of JVCo.The Company was accounting for the JV transactions using the equity method under ASC 323 Investments — Equity Method and Joint Ventures. As a consequence of the above agreement, as the joint venture (a separate legal entity) has become a subsidiary of the company as of April 27, 2023, therefore, the company will use the acquisition method of accounting (using a step acquisition method) under ASC 805 Business Combination.Following the completion of the Settlement Agreement, Canary’s equity interest in JVCo increased from 50% to 100%. Effective April 28, 2023, the Company started consolidating result’s of operations of the JVCo and eliminated any intercompany transactions and balances between the Company (Target and Canary) and JVCo.CL Investors Debt Purchase and Assignment AgreementOn June 15, 2020, the Company, its first–tier subsidiaries Visava Inc. (“Visava”) CannaKorp Inc. (“CannaKorp”), and the Company’s second-tier subsidiary, Canary Rx Inc. (“Canary”), entered into a Debt Purchase and Assignment Agreement (“Agreement”) with CL Investors Inc. (“CLI”), a corporation organized under the laws of the Province of Ontario, Canada. While June 15, 2023 was the preliminary date of the agreement and the agreement was not finalized until the later date as indicated below. The CEO and director of the Company is a shareholder and the Secretary of CLI, and the brother of the CEO is the President and sole director of CLI therefore the below loan from CLI is classified under related party transactions.Pursuant to the Agreement, CLI purchased from the Company for the sum of $2,190,370 (CAD $2,900,000) a debt obligation owing from Canary to the Company in the principal balance of $8,006,180 (CAD $10,600,000 (“Canary Debt”)). Upon receipt of the consideration, the Company loaned the full sum to Canary under terms of an unsecured, non-interest-bearing promissory note, subject to a covenant by the Company not to take any collection action so long as the Canary Debt remains unpaid to CLI. As of June 30, 2023, $3,777 (CAD $5,000) is still outstanding from CLI which is presented as other receivable on the unaudited condensed consolidated interim balance sheet.As a condition of the closing of the Agreement, the terms of the Canary Debt were amended to provide for interest at 5% per annum with a maturity date of 60 months from the date of the Agreement (“Term”). The Canary Debt will be repaid according to the following schedule:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</td><td style="padding:0pt;">In the first year of the Term, Canary will pay CLI the greater of $853,489 (CAD 1,130,000) and fifty percent (50%) of the Net Revenue (hereinafter defined), provided that where the latter amount exceeds the former amount, Canary will, by the end of such first year, pay CLI no less than the former amount and Canary will, within thirty (30) days following the end of such first year, pay CLI the balance of such amount owing for such first year;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</td><td style="padding:0pt;">In the second year of the Term, Canary will pay CLI the greater of $1,586,130 (CAD 2,100,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2021, provided that where the latter amount exceeds the former amount, Canary will, within thirty (30) days following the end of such second year, pay CLI the balance of such amount owing for such second year;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c)</td><td style="padding:0pt;">In the third year of the Term, Canary will pay CLI the greater of $2,432,066 (CAD 3,220,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2022, provided that where the latter amount exceeds the former amount, Canary will, by the end of such third year, pay CLI no less than the former amount and Canary will, within thirty (30) days following the end of such third year, pay CLI the balance of such payments owing for such third year;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d)</td><td style="padding:0pt;">In the fourth year of the Term, Canary will pay CLI the greater of $2,326,324 (CAD 3,080,000) and fifty percent (50%) of the Net Revenue, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2023, provided that where the latter amount exceeds the former amount, Canary will, within thirty (30) days following the end of such fourth year, pay CLI the balance of such amount owing for such fourth year; and</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">e)</td><td style="padding:0pt;">In the fifth year of the Term, Canary will pay CLI the balance owing under this Note, by way of twelve (12) consecutive monthly installments payable on the 14th day of each month commencing on August 14, 2024, for an amount calculated by dividing twelve (12) into the sum of all amounts owing under this Note at the beginning of the fifth year of the Term on account of Principal and Interest, provided that where further amounts are owing under this Note at the end of such fifth year, Canary will pay CLI all such further amounts within five (5) days following the end of such fifth year.</td></tr></table><div style="margin-top:12pt;"></div>For the purpose of this Note, “Net Revenue” will mean any and all revenue generated from Canary’s Licensed Facility (hereinafter defined) to which it is entitled to net of applicable taxes and third-party expenses.The repayment of the Canary Debt, as amended, is guaranteed by Visava and the Company’s wholly-owned subsidiary CannaKorp. and secured by (i) a general security interest in the assets of the Company, Canary, Visava and CannaKorp., respectively; and (ii) a pledge by the Company of all of the issued and outstanding common stock of Canary, Visava and CannaKorp. held by the Company. In addition to the foregoing guarantees, security interest and stock pledge, CLI has been granted an option, in lieu of repayment of the amended Canary Debt, to demand, in its sole and absolute discretion the transfer, assignment and conveyance of 75% of the issued and outstanding capital stock of Visava and Canary. Furthermore, the President and sole director of CLI has been granted an option to acquire the remaining 25% of the issued and outstanding capital stock of Visava and Canary.Effective August 14, 2020, the Agreement was amended (“Amendment”) to provide that CLI will purchase from Rubin Schindermann, a director of the Company, 500,000 shares of the Company’s Series A Preferred Stock in consideration of the payment by CLI to Rubin Schindermann of $75,530 (CAD $100,000) and the issuance to Schindermann of 10,000,000 shares of the Company’s common stock. In consideration of the foregoing, Mr. Schindermann resigned as a director of the Company and from any and all administrative and executive positions with the Company’s subsidiaries Visava., Canary Rx. and CannaKorp., respectively. In addition, the Company issued Common Stock Purchase Warrant for 10,000,000 shares of Target common stock to CLI as consideration for the Agreement (“CLI Warrants”). Refer to Note 11 for additional details on the CLI Warrants. The combined impact of both transactions resulted in debt issuance cost of $251,518. This debt issuance cost will be amortized over the term of the debt on a straight-line basis.The transactions contemplated by the Agreement and the Amendment closed on August 14, 2020.Going ConcernThe Company has earned minimal revenue since inception to date and has sustained operating losses during the six months ended June 30, 2023. The Company had a working capital deficit of $5,099,244 and an accumulated deficit of $30,565,571 as of June 30, 2023. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations and/or obtaining additional financing from its members or other sources, as may be required.The unaudited accompanying condensed consolidated interim financial statements have been prepared assuming that the Company will continue as a going concern up to at least 12 months from the balance sheet date; however, the above condition raises substantial doubt about the Company’s ability to do so. The unaudited condensed consolidated interim financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.In order to maintain its current level of operations, the Company will require additional working capital from either cash flow from operations, sale of its equity or issuance of debt. If the Company is unable to acquire additional working capital, it will be required to significantly reduce its current level of operations.

44000

791285 2109626

25500000

25000000

0.10

0.4627

30407412

0.10

7211213 0 10000000

3500000

3000000

0.07 0.07

300000

400000

500000

10000000 1191860

130000

P30D

100000

10000

1704860

0 10000 1051000 0.50 1

2190370

2900000

8006180

10600000

3777

5000

0.05

P60M

853489 1130000 0.50 P30D 1586130 2100000 0.50 P12M P30D 2432066 3220000 0.50 P12M P30D 2326324 3080000 0.50 P12M P30D P12M P5D 0.75 0.25

500000

75530

100000

10000000

10000000 251518 5099244

-30565571

2. Summary of Significant Accounting PoliciesBasis of Presentation and ConsolidationThe unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and the rules and regulations of the SEC and are expressed in US dollars. Accordingly, the unaudited condensed consolidated interim financial statements do not include all information and footnotes required by US GAAP for complete annual financial statements. The unaudited condensed consolidated interim financial statements reflect all adjustments, consisting of only normal recurring adjustments, considered necessary for a fair presentation. Interim operating results are not necessarily indicative of results that may be expected for the year ending December 31, 2023, or for any other interim period. The unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements of the Company and the notes thereto as of and for the year ended December 31, 2022.The unaudited condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Visava Inc./Canary Rx Inc/ CannaKorp, Inc and JVCo. Significant intercompany accounts and transactions have been eliminated.Use of EstimatesThe preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.CashThe Company places its cash with high-quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation (FDIC) limit as of June 30, 2023 and June 30, 2022.Cash and cash equivalents include cash on hand and deposits at banking institutions as well as all highly liquid short-term investments with original maturities of 90 days or less. The Company did not have cash equivalents as of June 30, 2023 and 2022.Restricted cash represents deposits made to the Company’s bank as a requirement to use the bank’s credit card which is not available for immediate or general business use.Fixed AssetsFixed assets are reported at cost, less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of assets, commencing when the assets become available for productive use, based on the following estimated useful lives:Depreciation is calculated using the following terms and methods:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;">Furniture & office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">7 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;">Machinery & equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">3-5 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;">Software </td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">3 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;">Leasehold improvements</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Lease period</td></tr></table>An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising from the derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the profit or loss in the period the asset is derecognized. The assets’ residual values, useful lives and methods of depreciation are reviewed at each reporting date, and adjusted prospectively, if appropriate.Fair Value of Financial InstrumentsThe Company follows guidance for accounting for fair value measurements of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the unaudited condensed consolidated interim financial statements on a recurring basis. Additionally, the Company adopted guidance for fair value measurement related to nonfinancial items that are recognized and disclosed at fair value in the unaudited condensed consolidated interim financial statements on a nonrecurring basis. The guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements).The three levels of the fair value hierarchy are as follows:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Level 3 inputs are unobservable inputs for the asset or liability. The carrying amounts of financial assets such as cash approximate their fair values because of the short maturity of these instruments.</td></tr></table><div style="margin-top:10pt;"></div>The estimated fair value of cash and accounts payable and accrued liabilities approximate their carrying values due to the short-term maturity of these instruments. The derivative liabilities of the promissory convertible notes and warrant liabilities are valued Level 3, refer to Note 10 and 11 for further details.Revenue recognitionThe Company adopted ASC 606 effective January 1, 2019, using the modified retrospective method after electing to delay the adoption of the accounting standard as the Company qualified as an “emerging growth company”. Since the Company did not have any contracts as of the effective day, therefore, there was no material impact on the consolidated financial statements upon adoption of the new standard. Revenue is recognized when performance obligations under the terms of the contracts with our customers are satisfied. Our performance obligation generally consists of the promise to sell our finished products to our customers, wholesalers, distributors or retailers. Control of the finished products is transferred upon shipment to, or receipt at, our customers’ locations, as determined by the specific terms of the contract. Once control is transferred to the customer, we have completed our performance obligation, and revenue is recognized. The Company generated revenue of $758,984 during the six month ended June 30, 2023 whereas $nil in June 30, 2022.In addition, Canary generated revenue of $791,285 (though its investment in JVCo) during the six months ended June, 30 2023 (six months ended June 30, 2022: $2,109,626) and is represented as a share of income (losses) from joint venture on the unaudited condensed consolidated interim statement of operations. The revenue was concentrated to eight customers (2022: three). The revenue represents the sale of cannabis products. Since the customers have received the product and there are no further obligations as per the agreement, revenue was recognized. Refer to Note 6 for additional details.Equity Method InvestmentsThe Company uses the equity method of accounting for investments when the Company has the ability to significantly influence, but not control, the operations or financial activities of the investee. As part of this evaluation, the Company considers the participating and protective rights in the venture as well as its legal form. The Company records the equity method investments at cost and subsequently adjust their carrying amount each period for the Company’s share of the earnings or losses of the investee and other adjustments required by the equity method of accounting. Distributions received from the equity method investments are recorded as reductions in the carrying value of such investments and are classified on the unaudited condensed consolidated interim statements of cash flows pursuant to the cumulative earnings approach. Under this approach, distributions received are considered returns on investment and are classified as cash inflows from operating activities unless the cumulative distributions received, less distributions received in prior periods that were determined to be returns of investment, exceed the cumulative equity in earnings recognized from the investment. When such an excess occurs, the current period distributions up to this excess are considered returns of investment and are classified as cash inflows from investing activities.The Company monitors equity method investments for impairment and records reductions in their carrying values if the carrying amount of an investment exceeds its fair value. An impairment charge is recorded when such impairment is deemed to be other than temporary. To determine whether an impairment is other than temporary, we consider our ability and intent to hold the investment until the carrying amount is fully recovered. Circumstances that indicate an impairment may have occurred include factors such as decreases in quoted market prices or declines in the operations of the investee. The evaluation of the investment for potential impairment requires us to exercise significant judgment and to make certain assumptions. The use of different judgments and assumptions could result in different conclusions. The Company has recorded no impairment losses related to our equity method investments during the six months ended June 30, 2023, and 2022.Recently Issued Accounting StandardsThe FASB recently issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, which requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. The amendments in ASU 2020-06 are effective for public entities for fiscal years beginning after December 15, 2021, with early adoption permitted (for “emerging growth company” beginning after December 15, 2023). The Company will be evaluating the impact this standard will have on the Company’s unaudited condensed consolidated interim financial statements.

Basis of Presentation and ConsolidationThe unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and the rules and regulations of the SEC and are expressed in US dollars. Accordingly, the unaudited condensed consolidated interim financial statements do not include all information and footnotes required by US GAAP for complete annual financial statements. The unaudited condensed consolidated interim financial statements reflect all adjustments, consisting of only normal recurring adjustments, considered necessary for a fair presentation. Interim operating results are not necessarily indicative of results that may be expected for the year ending December 31, 2023, or for any other interim period. The unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements of the Company and the notes thereto as of and for the year ended December 31, 2022.The unaudited condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Visava Inc./Canary Rx Inc/ CannaKorp, Inc and JVCo. Significant intercompany accounts and transactions have been eliminated.

Use of EstimatesThe preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.

CashThe Company places its cash with high-quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation (FDIC) limit as of June 30, 2023 and June 30, 2022.Cash and cash equivalents include cash on hand and deposits at banking institutions as well as all highly liquid short-term investments with original maturities of 90 days or less. The Company did not have cash equivalents as of June 30, 2023 and 2022.Restricted cash represents deposits made to the Company’s bank as a requirement to use the bank’s credit card which is not available for immediate or general business use.

Fixed AssetsFixed assets are reported at cost, less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of assets, commencing when the assets become available for productive use, based on the following estimated useful lives:Depreciation is calculated using the following terms and methods:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;">Furniture & office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">7 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;">Machinery & equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">3-5 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;">Software </td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">3 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;">Leasehold improvements</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Lease period</td></tr></table>An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising from the derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the profit or loss in the period the asset is derecognized. The assets’ residual values, useful lives and methods of depreciation are reviewed at each reporting date, and adjusted prospectively, if appropriate.

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;">Furniture & office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">7 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;">Machinery & equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">3-5 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;">Software </td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;">3 years</td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;">Leasehold improvements</td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Straight-line</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;">Lease period</td></tr></table>

P7Y

P3Y

P5Y

P3Y

Fair Value of Financial InstrumentsThe Company follows guidance for accounting for fair value measurements of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the unaudited condensed consolidated interim financial statements on a recurring basis. Additionally, the Company adopted guidance for fair value measurement related to nonfinancial items that are recognized and disclosed at fair value in the unaudited condensed consolidated interim financial statements on a nonrecurring basis. The guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements).The three levels of the fair value hierarchy are as follows:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Level 3 inputs are unobservable inputs for the asset or liability. The carrying amounts of financial assets such as cash approximate their fair values because of the short maturity of these instruments.</td></tr></table><div style="margin-top:10pt;"></div>The estimated fair value of cash and accounts payable and accrued liabilities approximate their carrying values due to the short-term maturity of these instruments. The derivative liabilities of the promissory convertible notes and warrant liabilities are valued Level 3, refer to Note 10 and 11 for further details.

Revenue recognitionThe Company adopted ASC 606 effective January 1, 2019, using the modified retrospective method after electing to delay the adoption of the accounting standard as the Company qualified as an “emerging growth company”. Since the Company did not have any contracts as of the effective day, therefore, there was no material impact on the consolidated financial statements upon adoption of the new standard. Revenue is recognized when performance obligations under the terms of the contracts with our customers are satisfied. Our performance obligation generally consists of the promise to sell our finished products to our customers, wholesalers, distributors or retailers. Control of the finished products is transferred upon shipment to, or receipt at, our customers’ locations, as determined by the specific terms of the contract. Once control is transferred to the customer, we have completed our performance obligation, and revenue is recognized. The Company generated revenue of $758,984 during the six month ended June 30, 2023 whereas $nil in June 30, 2022.In addition, Canary generated revenue of $791,285 (though its investment in JVCo) during the six months ended June, 30 2023 (six months ended June 30, 2022: $2,109,626) and is represented as a share of income (losses) from joint venture on the unaudited condensed consolidated interim statement of operations. The revenue was concentrated to eight customers (2022: three). The revenue represents the sale of cannabis products. Since the customers have received the product and there are no further obligations as per the agreement, revenue was recognized. Refer to Note 6 for additional details.

758984

791285 2109626 8 3

Equity Method InvestmentsThe Company uses the equity method of accounting for investments when the Company has the ability to significantly influence, but not control, the operations or financial activities of the investee. As part of this evaluation, the Company considers the participating and protective rights in the venture as well as its legal form. The Company records the equity method investments at cost and subsequently adjust their carrying amount each period for the Company’s share of the earnings or losses of the investee and other adjustments required by the equity method of accounting. Distributions received from the equity method investments are recorded as reductions in the carrying value of such investments and are classified on the unaudited condensed consolidated interim statements of cash flows pursuant to the cumulative earnings approach. Under this approach, distributions received are considered returns on investment and are classified as cash inflows from operating activities unless the cumulative distributions received, less distributions received in prior periods that were determined to be returns of investment, exceed the cumulative equity in earnings recognized from the investment. When such an excess occurs, the current period distributions up to this excess are considered returns of investment and are classified as cash inflows from investing activities.The Company monitors equity method investments for impairment and records reductions in their carrying values if the carrying amount of an investment exceeds its fair value. An impairment charge is recorded when such impairment is deemed to be other than temporary. To determine whether an impairment is other than temporary, we consider our ability and intent to hold the investment until the carrying amount is fully recovered. Circumstances that indicate an impairment may have occurred include factors such as decreases in quoted market prices or declines in the operations of the investee. The evaluation of the investment for potential impairment requires us to exercise significant judgment and to make certain assumptions. The use of different judgments and assumptions could result in different conclusions. The Company has recorded no impairment losses related to our equity method investments during the six months ended June 30, 2023, and 2022.

Recently Issued Accounting StandardsThe FASB recently issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, which requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. The amendments in ASU 2020-06 are effective for public entities for fiscal years beginning after December 15, 2021, with early adoption permitted (for “emerging growth company” beginning after December 15, 2023). The Company will be evaluating the impact this standard will have on the Company’s unaudited condensed consolidated interim financial statements.

3. InventoryAs of June 30, 2023, the inventory in the amount of $1,814,902 (2022: $nil) consists of work-in-progress and finished cannabis goods which is transferred from JVCo to Canary as a result of the JV Settlement Agreement, refer to Note 6 for additional detail.

1814902

4. Sales Tax Recoverable and PayableAs of June 30, 2023, the Company had $1,034 of gross sales tax recoverable compared to December 31, 2022 there was $nil, while the Company had $nil of gross sales tax payable as of June 30, 2023.Recoverable is due to the sales tax paid by the Company on expenses incurred during the year which are recoverable from the government while payable is due to the sales tax received (after deducting sales tax paid on expenses incurred by the Company) during the year which are payable from the government due to sales conducted through the Joint Venture.The Company has recorded $nil (December 31, 2022: $nil) of allowance as of June 30, 2023.

1034

0 0

5. Fixed AssetsThe Company’s subsidiary, Canary, initiated construction on its leased 44,000 square foot cannabis cultivation facility in September of 2017. Since then, extensive demolition and structural upgrades have been carried out at the site. On May 1, 2019, the Company completed the construction of its 44,000 square foot cannabis cultivation facility and on May 14, 2019, the Company submitted a Site Evidence Package to Health Canada as part of the steps to obtain the license to cultivate cannabis at the Company’s facility. On October 8, 2019, the Company was granted licenses to cultivate, process and sell cannabis pursuant to the Cannabis Act (Bill C-45). Canary currently operates as a licensed producer/wholesaler of craft cannabis in Ontario and has since been granted its sales amendment from Health Canada to sell directly to provincial retail boards for consumer products.Canary has recorded a depreciation expense of $426,631 during the six months ended June 30, 2023 (June 30, 2022: $452,245) while CannaKorp has recorded a depreciation expense of $252 during the six months ended June 30, 2023 (June 30, 2022: $714). JVCo assets are consolidated with cost $723,231 and depreciation $15,371.Below is a breakdown of the consolidated fixed asset, category wise:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.61%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.61%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;">Furniture & </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;">Machinery &</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;">Leasehold</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.61%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;">fixture</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;">Equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;">improvements</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:50.61%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:50.61%;background:#cceeff;margin:0pt;padding:0pt;">Cost</td><td style="vertical-align:bottom;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> 1,452,252</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"> 770,161</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"> 43,553</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;margin:0pt;padding:0pt;"> 6,851,094</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;margin:0pt;padding:0pt;"> 9,117,060</td></tr><tr><td style="vertical-align:bottom;width:50.61%;margin:0pt;padding:0pt;">Accumulated depreciation</td><td style="vertical-align:bottom;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (481,941)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (747,730)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (43,490)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,070,664)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (3,343,825)</td></tr><tr><td style="vertical-align:bottom;width:50.61%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 970,311</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 22,431</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 63</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,780,430</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,773,235</td></tr></table>

44000

426631 452245 252 714 723231 15371

1452252

770161

43553

6851094

9117060

481941

747730

43490

2070664

3343825

970311

22431

4780430

5773235

6. Joint VentureHistorical informationEffective May 14, 2020, Canary entered into a Joint Venture Agreement (“Joint Venture”) with 9258159 Canada Inc., a corporation organized under the laws of the Province of Ontario, Canada (referred to as “Thrive Cannabis”) and 2755757 Ontario Inc., a corporation organized under the laws of the Province of Ontario, Canada (referred to as “JVCo”). Canary and Thrive Cannabis each hold 50% of the voting equity interest in JVCo. The term of the Joint Venture is five (5) years from its effective date of May 14, 2020.Under the Joint Venture, JVCo is permitted to use the rooms, of Canary’s licensed cannabis cultivation facilities located in Simcoe, Ontario, Canada (“Licensed Site Portion”) to operate and manage the Licensed Site Portion for the cultivation and process of cannabis pursuant to Canary’s license issued by Health Canada. During the term of the Joint Venture, JVCo will be responsible for the administration, operation and management of the Licensed Site Portion and all proceeds from the sale of the cannabis and related cannabis products cultivated therein will be payable to the JVCo.In addition, Canary, Thrive Cannabis, and JVCo entered into a Unanimous Shareholder Agreement dated May 14, 2020, governing the management and administration of the business of JVCo.During the period ended June 30, 2023, the Joint Venture partners, Canary and Thrive Cannabis entered into an agreement. Pursuant to this agreement the Company received a total of $1,577,214 (CAD 2,125,482) of which $1,018,996 (CAD 1,373,218) were reduced from investment in joint venture as these represented recovery of investment and $558,218 (CAD 752,264) were classified as other income representing recovery of interest expense charged on shareholder loan, which was primarily provided to support Joint Venture operations. Also refer to shareholder loan in Note 8.As per the Joint Venture, Canary provided the JVCo with a Hard Cost Loan with the maximum amount of $906,360 (CAD 1,200,000). This loan bore an interest rate of 7% per annum, matured in 12 months from the effective date, and was secured against the personal property of the JVCo and Thrive had guaranteed one-half (1/2) of the outstanding balance of the loan. As of April 27, 2023, the loan advanced amounts to $253,026 (CAD 335,000) and interest income charged for the six months ended in the amount of $8,628 (CAD 11,629) is included in other income on the unaudited condensed consolidated interim statement of operations and comprehensive loss and interest receivable in the amount of $51,971 (CAD 68,809) was included in receivable from joint venture on the unaudited condensed consolidated interim balance sheet. After April 27, 2023, as mentioned below, JVCo become a subsidiary of the company as result the above loan and interest receiveable were eliminated upon consolidation.The Company recorded JVCo’s results through April 27, 2023 using the equity table and below is the table which summarizes the activity of the period (through April 27, 2023):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> January 1 to April 27, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Six months ended June 30, 2022</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">CAD </td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">USD </td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">CAD </td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">USD </td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Sales</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 1,068,799</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 791,285</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 2,681,955</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 2,109,626</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;">Cost of goods sold</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 620,344</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 459,271</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,332,020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,047,767</td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 448,455</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 332,014</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 1,349,935</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 1,061,859</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;">Operation expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 383,358</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 283,819</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 965,882</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 759,763</td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Net income (loss)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 65,097</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 48,195</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 384,053</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 302,096</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Eligible recoverable expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 1,437,054</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 1,060,833</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 2,475,041</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 1,920,632</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;">Recoverable amount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 1,437,054</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 1,060,833</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"> 2,475,041</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"> 1,920,632</td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Income (loss) on equity</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 32,549</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 24,098</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 192,026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 151,048</td></tr></table>Termination of joint venture agreement during quarter ended June 30, 2023On April 27, 2023, Canary and Thrive Cannabis entered into a Release and Settlement Agreement (“Settlement Agreement”) in which Thrive Cannabis has transferred its shares in the capital of JVCo and rights of assets held by JVCo. Pursuant to the above Settlement Agreement, Thrive Cannabis paid Canary $1,051,000 to release Thrive Cannabis from any mortgages, charges, pledges, security interests, liens, encumbrances, writs of execution, actions, claims, demands and equities of any nature related to JVCo from their share of ownership of JVCo.The Company was accounting for the Joint Venture transactions using the equity method under ASC 323 Investments — Equity Method and Joint Ventures. As a consequence of the above agreement, as the joint venture (a separate legal entity) has become a subsidiary of the company as of April 27, 2023, therefore, the company will use the acquisition method of accounting (using a step acquisition method) under ASC 805 Business Combination.Following the completion of the Settlement Agreement, Canary’s equity interest in JVCo increased from 50% to 100%. Effective April 28, 2023, the Company started consolidating result’s of operations of the JVCo and eliminated any intercompany transactions and balances between the Company (Target and Canary) and JVCo.As a consequence of the above Settlement Agreement and after obtaining 100% shares of the JVCo, the Company acquired the following assets:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;">Fair value</td></tr><tr><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:top;width:86.45%;background:#cceeff;margin:0pt;padding:0pt;">Assets acquired:</td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;">Inventory</td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"> 1,690,368</td></tr><tr><td style="vertical-align:top;width:86.45%;background:#cceeff;margin:0pt;padding:0pt;">Fixed assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 534,816</td></tr><tr><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"> 2,225,184</td></tr></table>As of April 27, 2023, the Company had a carrying value of the investment in Joint Venture and receivable from Joint Venture on the consolidated balance sheets amounting to $1,023,608 and $706,598, respectively. Pursuant to the above Settlement Agreement, the Company received $776,382 against these balances. Accordingly, the remaining balance of $953,824 was compared to the fair value of the net assets acquired and this resulted in net recognition of $1,428,185 as a non-operating gain reported in the Consolidated Statement of Operations as net gain from termination of the Joint Venture.

0.50 P5Y 1577214 2125482

1018996

1373218

558218

752264

906360 1200000

0.07

P12M

253026

335000

8628

11629

51971

68809

<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> January 1 to April 27, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Six months ended June 30, 2022</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">CAD </td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">USD </td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">CAD </td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">USD </td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Sales</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 1,068,799</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 791,285</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 2,681,955</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 2,109,626</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;">Cost of goods sold</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 620,344</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 459,271</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,332,020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,047,767</td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 448,455</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 332,014</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 1,349,935</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 1,061,859</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;">Operation expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 383,358</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 283,819</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 965,882</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 759,763</td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Net income (loss)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 65,097</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 48,195</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 384,053</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 302,096</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Eligible recoverable expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 1,437,054</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 1,060,833</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 2,475,041</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 1,920,632</td></tr><tr><td style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt;">Recoverable amount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 1,437,054</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 1,060,833</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"> 2,475,041</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"> 1,920,632</td></tr><tr><td style="vertical-align:bottom;width:49.8%;background:#cceeff;margin:0pt;padding:0pt;">Income (loss) on equity</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 32,549</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 24,098</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"> 192,026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;background:#cceeff;margin:0pt;padding:0pt;"> 151,048</td></tr></table>

1068799

791285

2681955

2109626

620344

459271

1332020

1047767

448455

332014

1349935

1061859

383358

283819

965882

759763

65097

48195

384053

302096

1437054 1060833 2475041 1920632 1437054 1060833 2475041 1920632 32549 24098 192026 151048 1051000 0.50 1 1 <table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;">Fair value</td></tr><tr><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:top;width:86.45%;background:#cceeff;margin:0pt;padding:0pt;">Assets acquired:</td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;">Inventory</td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"> 1,690,368</td></tr><tr><td style="vertical-align:top;width:86.45%;background:#cceeff;margin:0pt;padding:0pt;">Fixed assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 534,816</td></tr><tr><td style="vertical-align:top;width:86.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"> 2,225,184</td></tr></table> 1690368 534816 2225184

1023608

706598 776382 953824 1428185

7. GoodwillBusiness AcquisitionASC Topic 805, “Business Combinations” requires that all business combinations be accounted for using the acquisition method and that certain identifiable intangible assets acquired in a business combination be recognized as assets apart from goodwill. ASC Topic 350, “Intangibles-Goodwill and Other” (“ASC 350”) requires goodwill and other identifiable intangible assets with indefinite useful lives not be amortized, such as trade names, but instead tested at least annually for impairment (which the Company tests each year end, absent any impairment indicators) and be written down if impaired. ASC 350 requires that goodwill be allocated to its respective reporting unit and that identifiable intangible assets with finite lives be amortized over their useful lives.CannaKorp Inc.Effective January 25, 2019, the Company entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with CannaKorp Inc., a Delaware corporation (“CannaKorp”). Company had previously entered into a Letter of Intent with CannaKorp dated November 30, 2018, which was disclosed in the Company’s report on Form 8-K filed December 4, 2018.The Exchange Agreement provides that, subject to its terms and conditions, the Company issued to the CannaKorp shareholders an aggregate of 30,407,412 shares of the Company’s common stock, based on a price per share of $0.10, in exchange for 100% of the issued and outstanding common stock of CannaKorp held by the CannaKorp shareholders. In addition, the Company issued Common Stock Purchase Warrants (“CannaKorp Warrants”) in exchange for all outstanding and promised CannaKorp stock options. The CannaKorp Warrants granted the holders thereof the right to purchase up to approximately 7,211,213 shares of the Company’s common stock. The Company also assumed all outstanding liabilities of CannaKorp. Upon the closing of the Exchange Agreement, CannaKorp continued its business operations as a subsidiary of the Company. The transaction was closed effective March 1, 2019.Due to the publicly traded nature of the Company’s shares of the common stock, the equity issuance of the shares was considered to be a more reliable measurement of the fair market value of the transaction compared to having a separate valuation of the net assets. This acquisition was accounted for using the acquisition method of accounting. As of March 1, 2019, the fair value of the net liabilities was $2,534,121 and the purchase consideration was fair valued as $4,062,844, shown below, leading to a goodwill allocation of $6,071,627.The purchase consideration of 30,407,412 shares and 7,211,213 warrants of the Company’s common stock are valued as detailed below:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Number of Common Stock</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 30,407,712</td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;">Market price on the date of issuance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 0.108</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Fair value of Common Stock</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 3,284,033</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Number of warrants</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 7,211,213</td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;">Fair value price per warrant</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 0.108</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Fair value of warrant</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 778,811</td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Fair value of Common Stock</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 3,284,033</td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;">Fair value of warrant</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 778,811</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Purchase consideration</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,062,844</td></tr></table>The fair value of these warrants was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Forfeiture rate of 0%;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Stock price of $0.108 per share;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Exercise price between the range of $0.13 to $0.15 per share</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Volatility at 635.49%</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Risk free interest rate of 2.55%;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Expected life of 2 years; and</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Expected dividend rate of 0%</td></tr></table><div style="margin-top:12pt;"></div>During the year ended December 31, 2019, the goodwill was revaluated after the completion of CannaKorp’s audit of the year ended December 31, 2018. This resulted in changing the balance on the acquisition date, March 1, 2019, thereby increasing the goodwill by $369,315 to $6,071,627.However, during the same year the Company identified circumstances that would call for an evaluation of goodwill impairment and therefore impaired $1,485,925 reducing the goodwill related to the CannaKorp to $4,585,702.Further, during the year ended December 31, 2020, the Company identified circumstances that would call for an evaluation of goodwill impairment and therefore impaired the remaining balance of goodwill related to the CannaKorp to $nil.During the year ended December 31, 2021, all of the CannaKorp Warrants expired, none were exercised.Visava Inc./Canary Rx Inc.On June 27, 2018, the Company entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with Visava Inc., a private Ontario, Canada corporation (“Visava”). Visava owns 100% of Canary Rx Inc., a Canadian corporation that holds a leasehold interest in a parcel of property located in Ontario’s Garden Norfolk County for the production of cannabis.Pursuant to the Agreement, the Company acquired 100% of the issued and outstanding shares of Visava Inc. in exchange for the issuance of 25,500,000 shares of the Company’s Common Stock and issued to the Visava shareholders, prorata Common Stock Purchase Warrants (“Visava Warrants”) purchasing an aggregate of 25,000,000 shares of the Company’s Common Stock at a price per share of $0.10 for a period of two years following the issuance date of the Visava Warrants. As a result of this transaction, Visava Inc. became a wholly-owned subsidiary of the Company and the former shareholders of Visava Inc. owned approximately 46.27% of the Company’s shares of Common Stock. The transaction was closed effective August 2, 2018. During the year ended, December 31, 2020, all of the Visava Warrants expired, none were exercised.This acquisition was accounted for using the acquisition method of accounting. As of August 2, 2018, the fair value of the net liabilities was $275,353 and the purchase consideration was fair valued as $3,318,842, shown below, leading to a goodwill allocation of $3,594,195.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Number of Common Stock</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 25,500,000</td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;">Market price on the date of issuance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 0.067</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Fair value of Common Stock</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 1,695,750</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Number of warrants</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 25,000,000</td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;">Fair value price per warrant</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 0.065</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Fair value of warrant</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 1,623,092</td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Fair value of Common Stock</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;margin:0pt;padding:0pt;"> 1,695,750</td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;">Fair value of warrant</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,623,092</td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;">Purchase consideration</td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,318,842</td></tr></table>The fair value of these warrants was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Forfeiture rate of 0%;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Stock price of $0.067 per share;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Exercise price of $0.10 per share</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Volatility at 329%</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Risk free interest rate of 2.66%;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Expected life of 2 years; and</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Expected dividend rate of 0%</td></tr></table><div style="margin-top:12pt;"></div>During the year ended December 31, 2022, the Company identified circumstances that would call for an evaluation of goodwill impairment and therefore impaired $3,315,749 reducing the goodwill related to the Canary to $263,117 (December 31, 2021: the Company has identified no circumstances which would call for further evaluation of goodwill impairment related to Canary).During the year ended, December 31, 2022, all of the Visava Warrants expired, none were exercised.GoodwillThe Company tests for impairment of goodwill at the reporting unit level. In assessing whether goodwill is impaired, the Companyutilizes the two-step process as prescribed by ASC 350. The first step of this test compares the fair value of the reporting unit, determined based upon discounted estimated future cash flows, to the carrying amount, including goodwill. If the fair value exceeds the carrying amount, no further work is required and no impairment loss is recognized. If the carrying amount of the reporting unit exceeds the fair value, the goodwill of the reporting unit is potentially impaired and step two of the goodwill impairment test would need to be performed to measure the amount of an impairment loss, if any. In the second step, the impairment is computed by comparing the implied fair value of the reporting unit’s goodwill with the carrying amount of the goodwill. If the carrying amount of the reporting unit’s goodwill is greater than the implied fair value of its goodwill, an impairment loss in the amount of the excess is recognized and charged to the statement of operations.

30407412

0.10

7211213

2534121

4062844

6071627

30407412

7211213

30407712

0.108

3284033

7211213

0.108

778811

3284033

778811

4062844

0.108

0.13

0.15

6.3549

0.0255

369315

6071627

1485925

4585702

25500000

25000000

0.10

0.4627

275353

3318842

3594195

25500000

0.067

1695750

25000000

0.065

1623092

1695750

1623092

3318842

0.067

0.10

3.29

0.0266

3315749

263117

8. Related Party Transactions and BalancesDuring the six months ended June 30, 2023, the Company expensed $155,515 (June 30, 2022: $83,516) in management service fee for services provided by the current key officers of the company.The breakdown of the related party balance as of June 30, 2023 of $11,336,630 (December 31, 2022: $10,346,465) is below:Debt purchase by CL Investors Inc.On June 15, 2020, the Company and its subsidiaries, entered into a Debt Purchase and Assignment Agreement (“Agreement”) with CL Investors Inc. (“CLI). June 15th was the preliminary date of the agreement and the agreement was not finalized until the later date as indicated below.The CEO and director of the Company is a shareholder and , the Secretary of CLI, and the brother of the CEO is the President and sole director of CLI, therefore, the loan from CLI is classified under related party transactions.Pursuant to the agreement, CLI purchased from the Company for the sum of $2,190,370 (CAD $2,900,000) a debt obligation owing from Canary, the Company’s second- tier subsidiary, to the Company in the principal balance of $8,006,180 (CAD $10,600,000 (“Canary Debt”)). Upon receipt of the monetary consideration, the Company loaned the full sum to Canary under terms of an unsecured, non-interest-bearing promissory note, subject to a covenant by the Company not to take any collection action so long as the Canary Debt remains unpaid to CLI. As of June 30, 2023, $3,777 (CAD $5,000) is still outstanding from CLI.The Canary debt owed to CLI from Canary bears an interest rate of 5% per annum and matures on August 14, 2025. The repayment of the debt is guaranteed by the Company and its subsidiaries plus secured by a general security interest in the assets of the Company and its subsidiaries and a pledge by the Company of all of the issued and outstanding common stock of Canary, Visava and CannaKorp Inc. held by the Company. In addition to the above, CLI has been granted an option, in lieu of repayment of the amended Canary Debt, to demand, in its sole and absolute discretion the transfer, assignment and conveyance of 75% of the issued and outstanding capital stock of Visava and Canary. Furthermore, the President and sole director of CLI has been granted an option to acquire the remaining 25% of the issued and outstanding capital stock of Visava and Canary.Interest expense charged for the six months ended in the amount of $194,412 (CAD $262,011) is included in interest and bank charges on the unaudited condensed consolidated interim statement of operations and comprehensive loss and accrued interest in the amount of $438,434 (CAD 580,477) is included in accounts payable and accrued liabilities on the unaudited condensed consolidated interim balance sheet.The repayment schedule of the minimum principal payments is shown below:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"> 552,583</td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">2024</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 3,613,227</td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">2025</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,706,326</td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 7,872,136</td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">Current portion</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,540,099)</td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">Non-current portion</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,332,037</td></tr></table>Effective August 14, 2020, the Agreement was amended (“Amendment”) to provide that CLI will purchase from Rubin Schindermann, a director of the Company, 500,000 shares of the Company’s Series A Preferred Stock in consideration of the payment by CLI to Rubin Schindermann of $75,530 (CAD $100,000) and the issuance to Mr. Schindermann of 10,000,000 shares of the Company’s common stock. In consideration of the foregoing, Mr., Schindermann resigned as a director of the Company and from all administrative and executive positions with the Company’s subsidiaries. In addition, the Company issued Common Stock Purchase Warrant for 10,000,000 shares of Target common stock to CLI as consideration for the Agreement. Refer to Note 11 for additional details on warrants. The combined impact of both transactions resulted in a debt issuance cost of $251,518. This debt issuance cost will be amortized over the term of the debt on a straight-line basis. As at June 30, 2023, the balance is $107,552 of which $50,679 is current while $56,873 is non-current.Shareholder loanOne of the Company’s shareholders provided a loan to the Company. The loan is secured by all assets owned by the Company and its subsidiaries including leasehold improvements and matures on September 28, 2023 and therefore is presented as current. The loan was provided in five tranches and the latest amendment increased the maximum loan amount by $679,770 (CAD 900,000) while the rest of terms remained unchanged. The specific details of each tranche of the loan are shown below:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Interest rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Maximum loan</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Outstanding loan</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">CAD</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">USD</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">CAD</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">USD</td></tr><tr><td style="vertical-align:bottom;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Tranche 1 </td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 16.00</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 1,043,593</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 788,226</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 1,043,593</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 788,226</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;">Tranche 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 43.26</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 1,592,787</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 1,203,032</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 1,592,787</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 1,203,032</td></tr><tr><td style="vertical-align:bottom;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Tranche 3</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 43.26</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 250,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 188,825</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 250,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 188,825</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;">Tranche 4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 43.26</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 500,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 377,650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 500,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 377,650</td></tr><tr><td style="vertical-align:bottom;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Tranche 5</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 43.26</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 500,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 377,650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 400,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 302,120</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 3,886,380</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;">2,935,383</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;">3,786,380</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;">2,859,853</td></tr></table>Interest expense charged for the six months ended June 30, 2023 in the amount of $494,865 (CAD $655,190) is included in interest and bank charges on the unaudited condensed consolidated interim statement of operations and comprehensive loss and accrued interest in the amount of $941,134 (CAD 1,246,042) is included in accounts payable and accrued liabilities on the unaudited condensed consolidated interim balance sheet.The Seventh Amending Agreement, dated February 16, 2023 (“Seventh Amendment”), filed herewith as Exhibit 10.34, memorializes Tranche 4 of the subject shareholder loan, and is the subject of Form 8-K Report and subsequent Form 8-K/A Reports, dated February 22, March 13, and August 4, 2023, respectively. The amount of the Advance in the Seventh Amendment was incorrectly reported on February 22 and March 13, 2023, and Exhibit 10.32 was also inaccurate with respect ot the amount of the Advance. The amount of the Advance is CDN$500,000.00 as reported on Form 8-K/A, dated August 4, 2023, and as reflected at Exhibit 10.34, filed herewith, and further, the amount of the Lender’s Fee was CDN$50,000.Outstanding management service feeThe balance owing to key officers of the Company is $647,194 (December 31, 2022: $585,261). The outstanding balance is primarily the outstanding management service fee. Balances outstanding related to subsidiariesDuring the year ended December 31, 2019, the Company settled with the loan holders provided to the Company’s subsidiary, CannaKorp. The total amount subject to settlement was $817,876 which includes accrued interest and accrued payroll. The company settled by paying $954,374 as consideration of cash, 920,240 shares (recorded in shares to be issued) and warrants of 920,240 shares with an exercise price of $0.15 per share. This resulted in a settlement loss of $136,498. These warrants expired during the year ended December 31, 2021. Of the total settlement amount, as of June 30, 2023 and December 31, 2022, $65,000 was outstanding to be paid. This amount includes late payment penalties of $25,000. During the year ended December 31, 2021, all of the warrants expired, none were exercised.Balances outstanding related to directorsDuring the six months ended June 30, 2023, the Company has purchased $nil of consulting services from GTA Angel Group which is owned by the Company’s CEO’s brother. The balance outstanding as of June 30, 2023 is $25,605 and is included in accounts payable and accrued liabilities.The Company subleases its principal executive office premise from Norlandam Marketing Inc., a company owned by one of the directors. During the quarter ended March 31, 2021, the premises were subleased to a third party that makes rent payments directly to Norlandam Marketing Inc. The balance outstanding as of June 30, 2023 is $nil.

155515 83516

11336630

10346465

2190370

2900000

8006180

10600000

3777

5000

0.05

0.75 0.25

194412

262011

438434

580477

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"> 552,583</td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">2024</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 3,613,227</td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">2025</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,706,326</td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"> 7,872,136</td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;">Current portion</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,540,099)</td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;">Non-current portion</td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,332,037</td></tr></table>

552583

3613227

3706326

7872136

1540099

6332037

500000

75530

100000

10000000 10000000 251518

107552

50679

56873

679770 900000 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Interest rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Maximum loan</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Outstanding loan</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">CAD</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">USD</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">CAD</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">USD</td></tr><tr><td style="vertical-align:bottom;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Tranche 1 </td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 16.00</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 1,043,593</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 788,226</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 1,043,593</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 788,226</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;">Tranche 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 43.26</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 1,592,787</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 1,203,032</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 1,592,787</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 1,203,032</td></tr><tr><td style="vertical-align:bottom;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Tranche 3</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 43.26</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 250,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 188,825</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 250,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 188,825</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;">Tranche 4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 43.26</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 500,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 377,650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 500,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 377,650</td></tr><tr><td style="vertical-align:bottom;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Tranche 5</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 43.26</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;">%</td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 500,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 377,650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 400,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"> 302,120</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"> 3,886,380</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;">2,935,383</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;">3,786,380</td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;">2,859,853</td></tr></table>

0.1600

1043593

788226

1043593

788226

0.4326

1592787

1203032

1592787

1203032

0.4326

250000

188825

250000

188825

0.4326

500000

377650

500000

377650

0.4326

500000

377650

400000

302120

3886380

2935383

3786380

2859853

494865

655190

941134 1246042 500000.00 50000

647194

585261

817876

954374

920240 920240

0.15

-136498 65000 65000 65000 25000 25000 25000 0

25605

9. Operating Lease Right-Of-Use Assets and Lease LiabilityThe Company adopted ASC 842 as of January 1, 2019, using a modified retrospective approach and applying the standard’s transition provisions at January 1, 2020, the effective date. The Company made an accounting policy election to exclude from balance sheet reporting those leases with initial terms of 12 months or less. The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and non-lease components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components is recognized when the obligation is probable.Right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company’s leases, the incremental borrowing rate is used based on the information available at the adoption date in determining the present value of lease payments. The lease term for all of the Company’s leases includes the non-cancellable period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company’s leases as the reasonably certain threshold is not met.The Company does not own any real property. It currently leases two office/facility spaces. For accounting purposes, this lease is treated as an operating leases. Upon adoption of ASC 842, the Company recognized $1,705,628 (CAD $2,258,212) of right-to-use assets as operating leases and operating lease obligations. The right-to-use asset was reduced by $1,578,517 (CAD $2,089,921) due to recognition of the prior deferred rent liability which was eliminated upon adoption of ASC 842. Details of these leases are detailed below:During the quarter ended March 31, 2021, the Company subleased its executive premises to a third party that makes rent payments directly to the landlord. However, if the sub-lessee cancels its sub-lease agreement with the landlord during the Company’s lease term with the landlord (ending on August 30, 2023), the Company will be responsible for making rent payments for the period from the date of cancellation by the sub-lessee to August 30, 2023.The Company’s subsidiary, Canary, is a party to a 10-year lease agreement (initiated in July 2014) with respect to its facility to produce craft cannabis at scale. The lease agreement was amended effective January 1, 2020, where the amended 10-year term starts on May 1, 2020 and provides the Company with an option to extend for three (3) additional terms of ten (10) years. Additionally, effective January 1, 2020, the amended agreement increased the minimum rent to $26,436 (CAD $35,000) plus applicable taxes per month and on each anniversary date, commencing from January 1, 2021, the minimum rent will increase by 1.00%. Furthermore, only the current 10-year term has been factored into the calculation of the lease liability. Effective May 1, 2020, due to the implementation of the new lease, $746,458 (CAD $988,293) was forgiven by the landlord and one vendor.These leases will expire between 2023 and 2030. The weighted average discount rate used for these leases was 16% (average borrowing rate of the Company). Maturities of lease liabilities were:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:85.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:85.63%;background:#cceeff;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 165,264</td></tr><tr><td style="vertical-align:bottom;width:85.63%;margin:0pt;padding:0pt;">2024</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 330,107</td></tr><tr><td style="vertical-align:bottom;width:85.63%;background:#cceeff;margin:0pt;padding:0pt;">2025</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"> 333,408</td></tr><tr><td style="vertical-align:bottom;width:85.63%;margin:0pt;padding:0pt;">2026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 336,742</td></tr><tr><td style="vertical-align:bottom;width:85.63%;background:#cceeff;margin:0pt;padding:0pt;">Thereafter</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,147,370</td></tr><tr><td style="vertical-align:bottom;width:85.63%;margin:0pt;padding:0pt;">Total lease payments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 2,312,891</td></tr><tr><td style="vertical-align:bottom;width:85.63%;background:#cceeff;margin:0pt;padding:0pt;">Less imputed interest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (905,947)</td></tr><tr><td style="vertical-align:bottom;width:85.63%;margin:0pt;padding:0pt;">Present value of lease liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"> 1,406,944</td></tr><tr><td style="vertical-align:bottom;width:85.63%;background:#cceeff;margin:0pt;padding:0pt;">Current portion</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (118,047)</td></tr><tr><td style="vertical-align:bottom;width:85.63%;margin:0pt;padding:0pt;">Non-current portion</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,288,897</td></tr></table>Below is the reconciliation of the net operating lease presented on the unaudited condensed consolidated interim statement of operations:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">For the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">For the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">For the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">For the</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">three months ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">three months ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">six months ended</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">six months ended</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2022</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:47.11%;background:#cceeff;margin:0pt;padding:0pt;">Gross operating lease expense</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;background:#cceeff;margin:0pt;padding:0pt;"> 66,672</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"> 119,562</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"> 134,199</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;">Gross rent and utilities expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;"> 28,400</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;"> 132,169</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"> (35,207)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"> 254,382</td></tr><tr><td style="vertical-align:bottom;width:47.11%;background:#cceeff;margin:0pt;padding:0pt;">Recoverable expenses from JVCo related to rent and utilities</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (209,219)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (67,045)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (422,486)</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,400</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (10,378)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,310</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (33,905)</td></tr></table>As explained in Note 6, the JVCo reimburses a certain percentage of gross expenses incurred by Canary which includes rent and utilities. Due to this unique circumstance and since operating lease expense are related to rent expenses, the Company has decided to group the operating lease expenses, all lease-related expenses and the recoverable amount from JVCo to show a net operating lease expense.

1705628

2258212

1578517 2089921

P10Y

26436 35000 0.0100

P10Y

746458 988293

0.16

165264

330107

333408

336742

1147370

2312891

905947

1406944

118047

1288897

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">For the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">For the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">For the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">For the</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">three months ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">three months ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">six months ended</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">six months ended</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2022</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:47.11%;background:#cceeff;margin:0pt;padding:0pt;">Gross operating lease expense</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;background:#cceeff;margin:0pt;padding:0pt;"> 66,672</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"> 119,562</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"> 134,199</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;">Gross rent and utilities expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;"> 28,400</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;margin:0pt;padding:0pt;"> 132,169</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"> (35,207)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"> 254,382</td></tr><tr><td style="vertical-align:bottom;width:47.11%;background:#cceeff;margin:0pt;padding:0pt;">Recoverable expenses from JVCo related to rent and utilities</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (209,219)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (67,045)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (422,486)</td></tr><tr><td style="vertical-align:bottom;width:47.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,400</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (10,378)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,310</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (33,905)</td></tr></table> 66672 119562 134199 28400 132169 -35207 254382 209219 67045 422486 28400 -10378 17310 -33905

10. Convertible Promissory NotesInterest amounting to $9 was accrued for the six months ended June 30, 2023 (June 30, 2022: $18).Principal amount outstanding as of June 30, 2023 and December 31, 2022 was $480. At both reporting dates, the entire balance was current.All notes maturing prior to the date of this report are outstanding.Derivative liabilityDuring the six months ended June 30, 2023, there were no conversion of principal balance of convertible promissory notes (June 30, 2022: $nil). The Company recorded and fair valued the derivative liability as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:90%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;">Derivative</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;">Derivative</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;">liability as at</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;">Conversions / Redemption</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;">liability as at</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;">December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;">during the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;">Change due to</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;">Fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Issuances</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:33.82%;background:#cceeff;margin:0pt;padding:0pt;">Note D</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;background:#cceeff;margin:0pt;padding:0pt;"> 1,446</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"> 134</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"> 1,580</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;">Note F</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"> 10,034</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;">—</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"> 777</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"> 10,811</td></tr><tr><td style="vertical-align:bottom;width:33.82%;background:#cceeff;margin:0pt;padding:0pt;">Note G</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;background:#cceeff;margin:0pt;padding:0pt;"> 3,645</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;background:#cceeff;margin:0pt;padding:0pt;">—</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"> 282</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"> 3,927</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,125</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,193</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 16,318</td></tr></table>Key assumptions used for the valuation of convertible notesDerivative element of the convertible notes was fair valued using a multinomial lattice model. Following assumptions were used to fair value these notes as of June 30, 2023:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Projected annual volatility of 329% to 329%;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Risk free interest rate of 5.06% to 5.06%;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Stock price of $0.006 to 0.006;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Liquidity term of 0.25 to 0.25 years;</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Dividend yield of 0%; and</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Exercise price of $0.0012 to $0.0151.</td></tr></table>

480

<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:90%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;">Derivative</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;">Derivative</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;">liability as at</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;">Conversions / Redemption</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;">liability as at</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;">December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;">during the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;">Change due to</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;">Fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;">June 30, </td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Issuances</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;">$</td></tr><tr><td style="vertical-align:bottom;width:33.82%;background:#cceeff;margin:0pt;padding:0pt;">Note D</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;background:#cceeff;margin:0pt;padding:0pt;"> 1,446</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"> 134</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"> 1,580</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;">Note F</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"> 10,034</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;margin:0pt;padding:0pt;">—</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"> 777</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"> 10,811</td></tr><tr><td style="vertical-align:bottom;width:33.82%;background:#cceeff;margin:0pt;padding:0pt;">Note G</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;background:#cceeff;margin:0pt;padding:0pt;"> 3,645</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;background:#cceeff;margin:0pt;padding:0pt;">—</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"> 282</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"> 3,927</td></tr><tr><td style="vertical-align:bottom;width:33.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,125</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:18.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,193</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 16,318</td></tr></table>

1446

0 0 134

1580

10034

0 0 777

10811

3645

0 0 282

3927

15125

0 0 1193

16318

3.29

0.0506

0.006

0.25

0.0012

0.0151

11. Stockholders’ EquityCapitalizationPreferred Stock<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Par value: $0.0001</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Authorized: 20,000,000</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Issued: 1,000,000 shares were outstanding as of June 30, 2023 and December 31, 2022</td></tr></table><div style="margin-top:12pt;"></div>Common Stock<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Par value: $0.0001</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Authorized: 850,000,000</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Issued: 617,025,999 shares are outstanding as at June 30, 2023 and December 31, 2022</td></tr></table><div style="margin-top:12pt;"></div>As of June 30, 2023, convertible notes, warrants and preferred stock outstanding could be converted into 28,129,370 (December 31, 2022: 17,258,122), 10,400,008 (December 31, 2022: 53,950,001) and 100,000,000 (December 31, 2022: 100,000,000) shares of common stock, respectively.Preferred StockShares of preferred stock may be issued from time to time in one or more series as may be determined by the board of directors. The board of directors may fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof without any further vote or action by the stockholders of the Company, except that no holder of preferred stock shall have pre-emptive rights. Any shares of preferred stock so issued would typically have priority over the common stock concerning dividend or liquidation rights. The board of directors does not at present intend to seek stockholder approval prior to any issuance of currently authorized stock unless otherwise required by law.Series A Preferred Stock (“Series A Stock”)Dividends shall be declared and set aside for any shares of Series A Stock in the same manner and amount as for the Common Stock. Series A Stock, as a class, shall have voting rights equal to a multiple of 2X the number of shares of Common Stock issued and outstanding that are entitled to vote on any matter requiring shareholder approval. The Series A Stockholders shall not vote as a separate class but shall vote together with the common stock on all matters, including any amendment to increase or decrease the authorized capital stock. Upon the voluntary or involuntary dissolution, liquidation or winding up of the corporation, the assets of the Company available for distribution to its shareholders shall be distributed to the holders of common stock and the holders of the Series A Stock ratable without any preference to the holders of the Series A Stock. Shares of Series A Stock can be converted at any time into fully paid and nonassessable shares of Common Stock at the rate of one hundred (100) shares of Common Stock for each one (1) share of Series A Stock.Common StockHolders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the stockholders. Holders of common stock do not have cumulative voting rights.Subject to preferences that may be applicable to any outstanding shares of preferred stock, the holders of common stock are entitled to share ratable in dividends, if any, as may be declared from time to time by the board of directors in its discretion from funds legally available therefore.Holders of common stock have no pre-emptive rights to purchase the Company’s common stock. There are no conversion or redemption rights or sinking fund provisions with respect to the common stock. The Company may issue additional shares of common stock which could dilute its current shareholder’s share value.2023During the quarter ended June 30, 2023, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by the President of Serious Seeds B.V., Simon Smit (“Smit”), to the Company’s subsidiary, Canary. These were recorded at a fair value of $48, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.During the quarter ended March 31, 2023, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $63, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.2022During the quarter ended March 31, 2022, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $153, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.During the quarter ended June 30, 2022, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $114, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.During the quarter ended September 30, 2022, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $120, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issuedDuring the quarter ended December 31, 2022, the Company issued 15,624 shares of common stock to be issued as consideration of the intellectual property rights granted by Smit to the Company’s subsidiary, Canary. These were recorded at a fair value of $73, based on the market price of the Company’s stock on the date of the agreement. These are currently recorded under shares to be issued and will be allocated between common stock and additional paid-in capital once the shares are issued.Shares to be issued include the following:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Shares</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Description</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;">Services</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"> 115,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"> 73,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;">Private placements</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 346,296</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 18,787</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;">Settlement of loans of CannaKorp</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"> 930,240</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"> 80,838</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;">Refer to Note 14 for details.</td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;">Agreement with Serious Seeds</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 218,736</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,668</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,610,272</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 175,293</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr></table>WarrantsThe warrants (with an exercise price in United States Dollar) were re-classified as a liability as of December 31, 2019, and therefore have been revalued on each quarter end. The fair value of the warrants was measured on reporting dates using the Black-Scholes option pricing model using the following assumptions:2023<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;">As at</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;">As at</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, 2023</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Forfeiture rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:19%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Stock price</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;">$0.006 </td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;">$0.003 </td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Exercise price</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">$0.250 to $0.300</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;background:#cceeff;margin:0pt;padding:0pt;">$0.250 to $0.300</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Volatility</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;">273% to 342%</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;">244% to 305%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Risk free interest rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">5.40%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;background:#cceeff;margin:0pt;padding:0pt;">4.64%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Expected life (years)</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;">0.02 to 1.68</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;">0.02 to 1.93</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Expected dividend rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr></table>2022<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">As at</td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">As at</td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">As at</td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">As at</td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">December 31,</td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">September 30,</td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">June 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">March 31, </td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:35.12%;background:#cceeff;margin:0pt;padding:0pt;">Forfeiture rate</td><td style="vertical-align:bottom;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;">Stock price</td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">$0.004 </td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">$0.005 </td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">$0.008 </td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">$0.009 </td></tr><tr><td style="vertical-align:bottom;width:35.12%;background:#cceeff;margin:0pt;padding:0pt;">Exercise price</td><td style="vertical-align:bottom;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">$0.200 to $0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">$0.200 to $0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">$0.050 to $0.300</td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;">$0.023 to $0.250</td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;">Volatility</td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"> 253% to 312%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"> 214% to 279%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"> 192% to 306%</td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">192% to 306%</td></tr><tr><td style="vertical-align:bottom;width:35.12%;background:#cceeff;margin:0pt;padding:0pt;">Risk free interest rate</td><td style="vertical-align:bottom;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">4.73%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">4.05%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">2.92%</td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;">2.28%</td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;">Expected life (years)</td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">0.02 to 1.93</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">0 to 1.94</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">0 to 1.94</td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">0 to 1.93</td></tr><tr><td style="vertical-align:bottom;width:35.12%;background:#cceeff;margin:0pt;padding:0pt;">Expected dividend rate</td><td style="vertical-align:bottom;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr></table>The fair value of the warrants issued during the year issued was measured at the date of acquisition using the Black-Scholes option pricing model using the following assumptions:2023<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:19.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:19.03%;margin:0pt;padding:0pt;">During quarter</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:19%;margin:0pt;padding:0pt;">During quarter</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:19.03%;margin:0pt;padding:0pt;">ended</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:19%;margin:0pt;padding:0pt;">ended</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:19.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, 2023</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Forfeiture rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Stock price</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;margin:0pt;padding:0pt;">$0.003 to $0.003</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;margin:0pt;padding:0pt;">$0.003 to $0.005</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Exercise price</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">$0.350 </td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;background:#cceeff;margin:0pt;padding:0pt;">$0.300 </td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Volatility</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;margin:0pt;padding:0pt;">342%</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;margin:0pt;padding:0pt;">305%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Risk free interest rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">3.82% to 4.51%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;background:#cceeff;margin:0pt;padding:0pt;">4.24% to 4.89%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Expected life (years)</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;margin:0pt;padding:0pt;">2</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;margin:0pt;padding:0pt;">2</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Expected dividend rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Fair value of warrants</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;margin:0pt;padding:0pt;">$138</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;margin:0pt;padding:0pt;">$160</td></tr></table>2022<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">During quarter</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">During quarter</td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">During quarter</td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">During quarter</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">ended</td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">ended</td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">ended</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">December 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, 2022</td></tr><tr><td style="vertical-align:bottom;width:34.78%;background:#cceeff;margin:0pt;padding:0pt;">Forfeiture rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;">Stock price</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">$0.004 to $0.006</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$0.007 to $0.008</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$0.005 to $0.010</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$0.008 to $0.013</td></tr><tr><td style="vertical-align:bottom;width:34.78%;background:#cceeff;margin:0pt;padding:0pt;">Exercise price</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;background:#cceeff;margin:0pt;padding:0pt;">$0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">$0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">$0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">$0.250</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;">Volatility</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">279%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">279%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">299%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">306%</td></tr><tr><td style="vertical-align:bottom;width:34.78%;background:#cceeff;margin:0pt;padding:0pt;">Risk free interest rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;background:#cceeff;margin:0pt;padding:0pt;">4.23% to 4.66%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">2.97% to 3.50%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">2.50% to 2.73%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0.88% to 1.50%</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;">Expected life (years)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">2</td></tr><tr><td style="vertical-align:bottom;width:34.78%;background:#cceeff;margin:0pt;padding:0pt;">Expected dividend rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;">Fair value of warrants</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">$176</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$288</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$306</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$430</td></tr></table>Breakdown of warrants outstanding as of June 30, 2023 and December 31, 2022 are detailed below:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">Remaining</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">Remaining</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">contractual life</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">contractual life</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">Warrants</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">Warrants</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">term as at</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">term as at</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">outstanding as at</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">outstanding as at</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">June 30,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">December 31,</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">June 30,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">December 31,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">(years)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">(years)</td></tr><tr><td style="vertical-align:bottom;width:53.31%;background:#cceeff;margin:0pt;padding:0pt;">Private placements</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;margin:0pt;padding:0pt;"> 43,549,993</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;">0.11 to 0.47</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;">Serious Seeds</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"> 400,008</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"> 400,008</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">0.02 to 1.93</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">0.02 to 1.93</td></tr><tr><td style="vertical-align:bottom;width:53.31%;background:#cceeff;margin:0pt;padding:0pt;">CLI</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 10,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 10,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"> 2.12</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"> 2.62</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 10,400,008</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 53,950,001</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"> </td></tr></table>During the six months ended June 30, 2023, 5,416,668 warrants expired (related to private placements and Serious Seeds).Movement of the warrant liability is detailed below:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:88.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:88.24%;background:#cceeff;margin:0pt;padding:0pt;">Warrant liability as at December 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;background:#cceeff;margin:0pt;padding:0pt;"> 489</td></tr><tr><td style="vertical-align:bottom;width:88.24%;margin:0pt;padding:0pt;">Warrant liability for new issuance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;margin:0pt;padding:0pt;"> 298</td></tr><tr><td style="vertical-align:bottom;width:88.24%;background:#cceeff;margin:0pt;padding:0pt;">Change in fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 144</td></tr><tr><td style="vertical-align:bottom;width:88.24%;margin:0pt;padding:0pt;">Warrant liability as at June 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 931</td></tr></table>

0.0001

20000000

1000000

0.0001

850000000

617025999

28129370

17258122

10400008

53950001

100000000

100

15624 48 15624 63 15624 153 15624 114 15624 120 15624 73 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Shares</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Description</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;">Services</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"> 115,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"> 73,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;">Private placements</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 346,296</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 18,787</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;">Settlement of loans of CannaKorp</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"> 930,240</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"> 80,838</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;">Refer to Note 14 for details.</td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;">Agreement with Serious Seeds</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 218,736</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,668</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,610,272</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 175,293</td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr></table>

80000

52000

115000

73000

35000

247306

21000

226306 346296

18787

930240

80838

218736 2668

1610272

175293

2023<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;">As at</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;">As at</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, 2023</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Forfeiture rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:19%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Stock price</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;">$0.006 </td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;">$0.003 </td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Exercise price</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">$0.250 to $0.300</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;background:#cceeff;margin:0pt;padding:0pt;">$0.250 to $0.300</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Volatility</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;">273% to 342%</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;">244% to 305%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Risk free interest rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">5.40%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;background:#cceeff;margin:0pt;padding:0pt;">4.64%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Expected life (years)</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;margin:0pt;padding:0pt;">0.02 to 1.68</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;margin:0pt;padding:0pt;">0.02 to 1.93</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Expected dividend rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr></table>2022<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">As at</td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">As at</td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">As at</td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">As at</td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">December 31,</td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">September 30,</td><td style="vertical-align:bottom;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">June 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">March 31, </td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:35.12%;background:#cceeff;margin:0pt;padding:0pt;">Forfeiture rate</td><td style="vertical-align:bottom;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;">Stock price</td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">$0.004 </td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">$0.005 </td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">$0.008 </td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">$0.009 </td></tr><tr><td style="vertical-align:bottom;width:35.12%;background:#cceeff;margin:0pt;padding:0pt;">Exercise price</td><td style="vertical-align:bottom;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">$0.200 to $0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">$0.200 to $0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">$0.050 to $0.300</td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;">$0.023 to $0.250</td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;">Volatility</td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"> 253% to 312%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"> 214% to 279%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;"> 192% to 306%</td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">192% to 306%</td></tr><tr><td style="vertical-align:bottom;width:35.12%;background:#cceeff;margin:0pt;padding:0pt;">Risk free interest rate</td><td style="vertical-align:bottom;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">4.73%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">4.05%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">2.92%</td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;">2.28%</td></tr><tr><td style="vertical-align:bottom;width:35.12%;margin:0pt;padding:0pt;">Expected life (years)</td><td style="vertical-align:bottom;width:1.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">0.02 to 1.93</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">0 to 1.94</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;margin:0pt;padding:0pt;">0 to 1.94</td><td style="vertical-align:bottom;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">0 to 1.93</td></tr><tr><td style="vertical-align:bottom;width:35.12%;background:#cceeff;margin:0pt;padding:0pt;">Expected dividend rate</td><td style="vertical-align:bottom;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.55%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr></table>2023<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:19.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:19.03%;margin:0pt;padding:0pt;">During quarter</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:19%;margin:0pt;padding:0pt;">During quarter</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:19.03%;margin:0pt;padding:0pt;">ended</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:19%;margin:0pt;padding:0pt;">ended</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:19.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, 2023</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Forfeiture rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Stock price</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;margin:0pt;padding:0pt;">$0.003 to $0.003</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;margin:0pt;padding:0pt;">$0.003 to $0.005</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Exercise price</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">$0.350 </td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;background:#cceeff;margin:0pt;padding:0pt;">$0.300 </td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Volatility</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;margin:0pt;padding:0pt;">342%</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;margin:0pt;padding:0pt;">305%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Risk free interest rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">3.82% to 4.51%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;background:#cceeff;margin:0pt;padding:0pt;">4.24% to 4.89%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Expected life (years)</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;margin:0pt;padding:0pt;">2</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;margin:0pt;padding:0pt;">2</td></tr><tr><td style="vertical-align:bottom;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;">Expected dividend rate</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:55.4%;margin:0pt;padding:0pt;">Fair value of warrants</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19.03%;margin:0pt;padding:0pt;">$138</td><td style="vertical-align:bottom;width:3.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:19%;margin:0pt;padding:0pt;">$160</td></tr></table>2022<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">During quarter</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">During quarter</td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">During quarter</td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">During quarter</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">ended</td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">ended</td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">ended</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">December 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">June 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">March 31, 2022</td></tr><tr><td style="vertical-align:bottom;width:34.78%;background:#cceeff;margin:0pt;padding:0pt;">Forfeiture rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;">Stock price</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">$0.004 to $0.006</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$0.007 to $0.008</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$0.005 to $0.010</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$0.008 to $0.013</td></tr><tr><td style="vertical-align:bottom;width:34.78%;background:#cceeff;margin:0pt;padding:0pt;">Exercise price</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;background:#cceeff;margin:0pt;padding:0pt;">$0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">$0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">$0.300</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">$0.250</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;">Volatility</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">279%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">279%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">299%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">306%</td></tr><tr><td style="vertical-align:bottom;width:34.78%;background:#cceeff;margin:0pt;padding:0pt;">Risk free interest rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;background:#cceeff;margin:0pt;padding:0pt;">4.23% to 4.66%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">2.97% to 3.50%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">2.50% to 2.73%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0.88% to 1.50%</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;">Expected life (years)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">2</td></tr><tr><td style="vertical-align:bottom;width:34.78%;background:#cceeff;margin:0pt;padding:0pt;">Expected dividend rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;background:#cceeff;margin:0pt;padding:0pt;">0%</td></tr><tr><td style="vertical-align:bottom;width:34.78%;margin:0pt;padding:0pt;">Fair value of warrants</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.25%;margin:0pt;padding:0pt;">$176</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$288</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$306</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.24%;margin:0pt;padding:0pt;">$430</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">Remaining</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">Remaining</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">contractual life</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">contractual life</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">Warrants</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">Warrants</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">term as at</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">term as at</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">outstanding as at</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">outstanding as at</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">June 30,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">December 31,</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">June 30,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;">December 31,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">2022</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">(years)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">(years)</td></tr><tr><td style="vertical-align:bottom;width:53.31%;background:#cceeff;margin:0pt;padding:0pt;">Private placements</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;margin:0pt;padding:0pt;"> 43,549,993</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;">0.11 to 0.47</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;">Serious Seeds</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"> 400,008</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"> 400,008</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">0.02 to 1.93</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;">0.02 to 1.93</td></tr><tr><td style="vertical-align:bottom;width:53.31%;background:#cceeff;margin:0pt;padding:0pt;">CLI</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 10,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 10,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"> 2.12</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;background:#cceeff;margin:0pt;padding:0pt;"> 2.62</td></tr><tr><td style="vertical-align:bottom;width:53.31%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 10,400,008</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 53,950,001</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.59%;margin:0pt;padding:0pt;"> </td></tr></table>

0 0

0.006

0.003

0.250

0.300

0.250

0.300

2.73

3.42

2.44

3.05

0.0540

0.0464

P0Y7D P1Y8M4D P0Y7D P1Y11M4D

0 0 0 0

0.004

0.005

0.008

0.009

0.200

0.300

0.200

0.300

0.050

0.300

0.023

0.250

2.53

3.12

2.14

2.79

1.92

3.06

1.92

3.06

0.0473

0.0405

0.0292

0.0228

P0Y7D P1Y11M4D P0Y P1Y11M8D P0Y P1Y11M8D P0Y P1Y11M4D

0 0

0.003

0.005

0.350

0.300

3.42

3.05

0.0382

0.0451

0.0424

0.0489

P2Y P2Y

138 160 0 0 0 0

0.004

0.006

0.007

0.008

0.005

0.010

0.008

0.013

0.300

0.250

2.79

2.99

3.06

0.0423

0.0466

0.0297

0.0350

0.0250

0.0273

0.0088

0.0150

P2Y P2Y P2Y P2Y

176 288 306 430

43549993

P0Y1M9D

P0Y5M19D

400008

P0Y7D

P1Y11M4D

P0Y7D

P1Y11M4D

10000000

P2Y1M13D

P2Y7M13D

10400008

53950001

5416668

489

298

144

931

12. Earnings (Loss) Per ShareFASB ASC 260, Earnings Per Share provides for calculations of “basic” and “diluted” earnings per share. Basic earnings per share include no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity similar to fully diluted earnings per share. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

13. Contingencies and commitmentsContingenciesDuring the year ended December 31, 2019, a terminated employee of Canary has filed a lawsuit against the Company amounting to approximately $1,586,130 (CAD 2,100,000) in Ontario, Canada. Currently, the Company is defending its position and believes that the ultimate decision will be in favor of the Company. Due to the uncertainty of timing and the amount of estimated future cash flows, if any, relating to this claim, no provision has been recognized.A complaint for damages of $150,000 was lodged against CannaKorp by the former Chief Financial Officer of CannaKorp for outstanding professional fees. No claim has been registered. The management is of the view that no material losses will arise in respect of the legal claim at the date of these unaudited condensed consolidated interim financial statements. As of June 30, 2023, $188,865 has been recorded in CannaKorp’s payable based on past accruals and outstanding invoices. Due to the uncertainty of timing and the amount of estimated future cash flows, if any, relating to this claim, no further amount has been recognized.A claim for damages of $1,406,977 (CAD $1,862,805) was lodged against Company and its directors by the former Chief Financial Officer of the Company for wrongful dismissal. The management is of the view that no material losses will arise in respect of the legal claim at the date of these unaudited condensed consolidated interim financial statements. As of June 30, 2023, $11,098 has been recorded in Target’s payable based on past accruals. Due to the uncertainty of timing and the amount of estimated future cash flows, if any, relating to this claim, no further amount has been recognized.During the year ended December 31, 2020, a claim for damages of $98,777 (CAD $130,778) was lodged against Canary by a vendor for breach of contract. The management is of the view that no material losses will arise in respect of the legal claim at the date of these unaudited condensed consolidated interim financial statements. As of June 30, 2023, $104,345 (CAD $138,150) has been recorded in the Canary’s payable based on past accruals. Due to the uncertainty of timing and the amount of estimated future cash flows, if any, relating to this claim, no further amount has been recognized.As explained in Note 1, on July 27, 2020 (“Effective Date”), the Company entered into a settlement agreement with cGreen, Inc., a Delaware corporation (“cGreen”). As consideration, the Company paid $130,000 within 30 days of the Effective Date and paid $100,000 in monthly installments of $10,000 commenced in April 2021 to cGreen. During the quarter ended March 31, 2022, the outstanding balance was paid in full and the claim is closed.Covid-19 PandemicOn March 11, 2020, the World Health Organization declared the ongoing COVID-19 outbreak as a global health emergency. This resulted in governments worldwide enacting emergency measures to combat the spread of the virus, including the closure of certain non-essential businesses.During the period and year ended June 30, 2023 and December 31, 2022, respectively, the pandemic and its lasting impacts did not have a material impact on the Company’s operations. As of June 30, 2023 and December 31, 2022, the Company did not observe any material impairment of its assets or a significant change in the fair value of assets due to the COVID-19 pandemic or its lasting impacts. Despite the WHO’s declaration, on or about May 5, 2023, of the end of the COVID-19 global pandemic, the lasting impacts of COVID-19 on the United States, Canada, and the broader global economy, including supply chain disruption, may have a significant continuing negative effect on the Company and may materially impact the Company in the future. The Company had taken, and will again, as necessary, continue to take, steps to minimize the potential impact of the pandemic including safety measures with respect to personal protective equipment, the reduction in travel and the implementation of a virtual office including regular video conference meetings and participation in virtual customer meetings and other virtual events.It is not possible to predict the lasting impacts that COVID-19 will have on the Company’s business, balance sheet and operating results in the future. In addition, it is possible that estimates in the Company’s Financial statements will change in the near term as a result of the lasting impacts of COVID-19, and the effect of any such changes could be material, which could result in, among other things, impairment of long-lived assets including goodwill. The Company is closely monitoring the lasting impacts of the pandemic on all aspects of its business.CommitmentsAs per the Distribution, Collaboration and Licensing Agreement (“Agreement”) entered with Serious Seeds B.V. (“Serious Seeds”), effective December 6, 2018, the Company will issue to Serious Seeds B.V. each month 5,208 shares of common stock, beginning on the thirteen (13th) months following the effective date of the Agreement and continuing through the sixtieth (60th) month of the initial term. Furthermore, Serious Seeds will be issued warrants in each of the foregoing months to purchase 16,667 shares of Target common stock at varying exercise prices ranging from $0.20 to $0.35 per share. All of the warrants must be exercised on or before the two (2) year anniversary date of each of the warrant issuance dates. As of June 30, 2023, none of the above shares have been issued.In consideration of the Company’s appointment as Serious’ exclusive distributor in Canada, the Company will pay Serious certain royalties as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:3.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:30.96%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.17%;background:#cceeff;margin:0pt;padding:0pt;">1st year:</td><td style="vertical-align:bottom;width:3.86%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:30.96%;background:#cceeff;margin:0pt;padding:0pt;">2.00% of gross sales</td></tr><tr><td style="vertical-align:bottom;width:65.17%;margin:0pt;padding:0pt;">2nd year:</td><td style="vertical-align:bottom;width:3.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:30.96%;margin:0pt;padding:0pt;">2.25% of gross sales</td></tr><tr><td style="vertical-align:bottom;width:65.17%;background:#cceeff;margin:0pt;padding:0pt;">3rd year:</td><td style="vertical-align:bottom;width:3.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:30.96%;background:#cceeff;margin:0pt;padding:0pt;">2.50% of gross sales</td></tr><tr><td style="vertical-align:bottom;width:65.17%;margin:0pt;padding:0pt;">4th year:</td><td style="vertical-align:bottom;width:3.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:30.96%;margin:0pt;padding:0pt;">2.75% of gross sales</td></tr><tr><td style="vertical-align:bottom;width:65.17%;background:#cceeff;margin:0pt;padding:0pt;">5th and following years:</td><td style="vertical-align:bottom;width:3.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:30.96%;background:#cceeff;margin:0pt;padding:0pt;">3.00% of gross sales</td></tr></table>

1586130

2100000

150000

188865

1406977

1862805

11098

98777

130778

104345

138150

130000

P30D

100000

10000

5208

16667

0.20

0.35

P2Y

14. Subsequent EventsThe Company’s management has evaluated subsequent events up to August 9, 2023, the date the unaudited condensed consolidated interim financial statements were issued, pursuant to the requirements of ASC 855 and there is no subsequent events to report.

EXCEL 65 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
[;)&2]Y M&$G)>W:P >98_ZU?DC,&GK)@=YE@(O;=Q-/5[Z'[E; MH_5?1W,)G *$6ZE M17+" BM4)2V7*[ *.A/8,D/)D^D*^ M*:_K8!P=N^9FCPZ,P%J$>\1,\PUS104$9PLNN-W!=8WV]V?D21+DUGVD@LS' MQMP M8<)%U;O\FC=T9DLEJ'";,WC_;IQ$Z?G__F\=Z[\0^8H[L\WZ57.\!D*XQQR+ MTC\+WTKK+> CI]8]/2SFQ]O0$%DSN:+CKM!=ML/J31.-9JF)YW-+/@D.DY*. M0N7-]-:8RET7TZRP_#.](O2,VC9 ^@*U\\TC5R[@&N)NOS_TRW%RWOSCM$\[ M@W%4B]U ''4C6GLN-QJ-W-8XCFO!CY!VA_W!"[EDG-#.)!DU!.)!-TY>"L;= M>))"/.RF\;B1_1E=N*CA\+$V4)E6#7/'S>P^X=JY52=4ZY)1#^$/T%<$?$76 M%9=V0E7&ES0HJ#?@DC*5$EDP:SDEE\"![UHZ%7JP5'GP:KLT16JNCAU(.I1(^@DZ\%1\A?^I>*Y8T#8A1.. M>A1!+TG_'3)MCM+7?,-S*IBPXRAR+^W,NIIU$/GPA#KC!I];CQ/_9-$P'L30 M>^T-#ENM4H%ZY1M">AG<>U1W3U*W64;QN6#\QO>(4,X%+4HUZHT$ MNFX"ZXE5I6^\Z(VB-LX/U]0WHW8"M+]4%,_]Q!EH.O'Y7U!+ P04 " "7 M@0E7@^GJ<" - /-0 &0 'AL+W=O6(J+7A&@XK$ J"Z4G!97ET^HKJWNO35ZJIO==0.NFI9+(0I9&J9%JL M7A^=A2_.$^Q/'?Z08F.<=X:2+)6ZPL)/V>NC !D2N4AKI,#A<2W>B#Q'0L#& MQY;F43\E#G3?.^H_D.P@RY(;\4;E?\JL7K\^FA^Q3*QXD]=B+A\RVM^^DJK M#=/8&ZCA"XE*HX$Y6:)1+FH-K1+&U:<7M4JOUBK/A#9_8^\^-K*^?752 V5L M/TE;*N>62C1"9EY3.ZB M_F >[Z82ACYS*7W_W3P*9R];>NP-KV3-<_D7)Z=X#SX@M!:9'<.^_VXQG2U> MLO=-^(%>Q+X01"$?=-94Z^5EG^)[ 58QX,V_-\W_V1,@TUAWV+6')3% M-D(+!F'!U+S,9'G)N&%JQ<#2HK?T@)L_VQ?%8JLIKH6NYS 4K52V,QS9<:U[6ALA4 MO?X-">=.G:HFS]A2=$2@DRQKQ:*Y%T8++YX%[-D>&Z#XF1=-L$MT[+$P\!(2 M?GZP[R3V%J2?\)C8"8.ML@[2WK8?=QH#H5-K'Q+!@U!M*D'!-K_U]Q!VT8_: ME;W@MRBM)..PE58%JR'^,Q"9GK)D"I2K-"L46 G<3Z+!3#"YK=!@D M!! R0ERY6F*\JK2" &(9PRZH992 R<$ZP:D*VL0@/6V*7-A0 MHD8TT MH"(!?&H+O9QO( 9;ZY_M.< SC,A1\++O0-54&;X\9F];X4UK# )VFG,D@% R ML%#C!KJP%8)@8)$A2708@@8'YREX6:+00($7JBF1"%%H@=+'5W^'BD,(HK]C88N8H5B=JUB!$#5$EF0UHN*:0XF$ M9DMP0-N-NM3J4I CHG/NXQ@9@ZZ6,="8+-.\L:D$^ 53E%F!R 1!H G6T8:\ M&6QLWY&@ [?4YFM+W&>_5\H:]5KE8$181N-@66Z+&:@2"C9XN=ZCD&.KUJ;J M0D2J=*5T&^IH:@, VXT@C%]SF7-,8@@9F )"U9+F(#EJX^K=16[7TUH.23HQ M:J"W+DSNQ+ =2 .KQ(8;&+>1^< <^S1\)P7M4$]Y.MFS)#AWZ&&94=CXU$95,^P3'0M^NYS[H_ M'/CC5@&'L_2>4^$,!.]^SG:F 9RQY])VS-CAY..[DP^FS!3Y&06/M($HP2FY M#.((&*=9_@L".L[DIER*!&VB![_.(;.@RMNH[<:,T03EW8V_'858\3N\02CM MLA+Z](I17G77'FV(WE^VC*Y%D"BZ#C@)^#XY$XU>-1C]K0H /.( M<163;DMU('F3/AN=KKL8T[IVNSTP SH4,$%ZU !0L_Y@VB "4A+I/B%CI9'E M%2H?>6<8=:6AA0S%R'9!V'GGWDQ]F$%E4B9@/,LD3H&1[S" -VL)(+5KY$Q" MP!.DS#9GN_&H%]&:E/8,OEW)OVVT33.T/-.82@3N8'>7\6XL;%-5./&F43+& MG?63+JNA=DO,V;H-Q38NX>(DQ^.)AE8AJH*@<]LI]1(W"=NE+*PBD !(UOJ^ M:@P\!2#EW/_#]]B%)/>'->5VA0&%;EWA==K?M;MIED!80NKP8'-8PI-L BBA M#1M@5>FL#85LQ66[Z4(VGB1SCXY$*!8@\8+K*X&K+VE74 *'B@;P;:1-/> \"M;:J$%1;X0H]].- S*, MZ,_!'[MTJRB;;!?VR(J=Q!\'S2\<_*O;+?W744-0^ \8?1I_BT:G+?[#+!]] MK98/)]^DZ1^4)+Y>HX?)_XWN&/U"5'5[+/:U6SX*OCW+CQM^[SCT:[7[[)N, M\A<'9K9G-W;(2L'4&X#&"X9"!_'+1WNV4Y_9<[FW K:#TFZP/I72?'#CNT-<23Q"Z MBA!Q(E,R\.IG;W.]2B>YLP5(C#P ;X>1+9*S;<7N.)*Y &J'-VR>FB MQ.V^,WDTQ;S\"T M;D1#M53[H_N34T?T'C0I-VL,>REM;@%N0EZC@[ZG2-A% +KZ^)P0,#!=1[V/ M+^@2N;!7;=2QPJTVM*]%.1HY!L#(%2_M21XO2_YWI2NV@)5"E+B( S^=QW/V M <^GT":_XLE;F-C355%SF>-M2Q>=/I'.\BTSU#?$I> MV4.F-(_IUNA/57L+Y"2(WD6]:0@JFT4NOF830%P\ZN=_=M>JR'A_Q_J,5,=+ M)FZ$3O&BQG(,UOV]E#5=R@!CAKV%\,[U<1?CGM/1OUQ)Z_NM=-%EYW@FW/Z.Q1W!+AJ06ID%1')ZO.NF(L O0"H*<7@IM&6P):5$J3*V?$ M=V,Z'SX'_[IZ?I&N58ZQPR80E!8[%"H3N=.YSV9XX-_8XSRSS6QT./:ED?>, MKLX/EX87ZL.#$_:#TBLAZT:WA^;=H. I_K,GW-:,/3SP X#IL!BS=T.;.ZW1 MA.([O,5N)MAM^$/A&359O=?,+'Z*/>(D>KJM3!);&4R>L@_27+$58)H<#J]U MAU),_"38#DW\*8Q]=X,'I&#A7*X$>X;AV!QOY?:#",F'/KCV?N4BWH[OKTYW M%7?@E8XT'GLM8\V\_W>WW\!_MKG:W5OM8:6KV,)E+_JY(MU3V$79824-7T>Q MEPR+DV%Q/BPN[D)F,(;,L89@#,OH2K8!47T(RY,6RZ&+Y=!B.9HMMI7A(FH! M/AVIO _UB8^.LRVAI_13^@N7 3^:/]PCG(P0M#7) VH^TV4.O]X3PMLEY.YR MJ_M6P@WP[55AERMY^K&1AI8R_XN!OMTJ=^GLGNKN:9>9ATN?FQ8>XJ*=,^#; M2,/D#L>,)P/G&DD/@[3PH'00^W/K1HD_"5T/B9*V>KZXSQV ML;V<8>R$KG :N+AY_-SQ9?AZ?#3>5=K__F__8'!X0+QS2?#8^:?#\,XJ:-8W M["2A2=<0#I,&].L:[EI![>2:NXMC^<=-,!WGF\<_&/O7Y0> O$5".\9JQ)VR9:\WM_IA,?F]# MO^GL7_ 3U/:C8>>UZ[__9?$=WQH?7"(?;B4C[2YQVYH.M]WSP&D.#@HC<*+8 MFR0+;P'+HU]/SL =PA"](?"3V<[Q0_=1\1#G[-,?&2<$KG)+T#B)N*OMY\ MID7.VZ_5#AQ!4L*7IG!A(\\EN\N<>$0N.?2?L ^!\<6 4 MGON48K/]K'4;8>?LS9J7EW06XJQ>>\,DR2@7P^#0C5C$O34._1KBQ/F12B'T M)?T4!\^IFK*VOU?I:_M?^YS9'[ELN]N?"D$FO90E?B.U@J&!/YL"8T=H'VE5-T5<(+^-U"G_P902P,$% @ EX$)5WD* MG%#V @ [ 8 !D !X;"]W;W)K&ULK55M:]LP M$/XKAPNE@RUVG#8K;1)(^L(V5@@-VSXKUCD6E25/DI/FW^\DQTX&26"P+[9> M[GGN>63?:;31YLT6B [>2ZGL."J$$K,G&=@]%KC TKIB4C&[QUGU*7TP,-QR_X4_R@+9VA7$,Y-GIA10JTL7'W7 MUGZ .1I8%,S@*'9$[X/B;$-'*%1:>%$?^-SXF69VVM-4V2\\2 M?JM5#P;)1TB3='"&;]!Y'02^P?_PVE!='Z?RI7)G*Y;A.*):L&C6&$TN+_K# MY/Z,T.M.Z/4Y]G\3>IZJG_;@)!T\3Q(!W2,7=Q^X#*Z+7@:('*'S(F MLUHR7TT6= Z7%[=IFMQ348@LC/OWP!1OU[F0M4/>[F#+7A&[]>P]F'GHD1T0 M*I,U1U : DTH8*(6%C)=5IX7EEO:(W4$!47MBS"Z1+B2P21;,R'94B(X[3$E M,5 U96^%EAR-]7!7(&Q"W1(=6Z.A-M3%>AUDLW;646:?Q)^!AY!,H7D/'AN# MQ_13:_%]IPG7#I433.ZMT.%9S&HCG* -MY;646^ G9>PE/LT7@._A3"TPV4I9'ZK;.1:Y3RX,8)Y["W3DC (^M8C> ML1\\/NA )9I5Z+/^6]7*-3F!,TZ7V^B< T MO;69.%V%?K;4CKIC&!9T':'Q ;2?:[*TF_@$W04W^0-02P,$% @ EX$) M5T0:;4,4"0 -1D !D !X;"]W;W)K&ULW5EK M;]LX%OTKA&=V, 746+;S<-HD0)I,MYG=F133>7RF)4HF2I$J2<7U_/H]EQ1E M.76"+K# [LZ7Q#+)^SSWW$OY8F/L1[<6PK//C=+NG)U$;Y[;Z\N3.>5U.*]9:YK&FZW M;X0RF\O);)*^^$76:T]?3*\N6EZ+#\+_UKZW>)H.4DK9".VDT[LK+24X&"24*3Q(X_CV(&Z$4"8(9GWJ9DT$E M'1Q_3M+?!M_ARXH[<6/4'[+TZ\O)851+OQEF[AW MD4]8T3EOFOXP+&BDCO_YYSX.HP/+IP[,^P/S8'=4%*R\Y9Y?75BS899V0QI] M"*Z&TS!.:DK*!V^Q*G'.7]T8[:6NA2ZD<(SKDA6F::1'W+V[F'JHH(W3HA?W M)HJ;/R'NE/T$@6O'?M"E*/?/3V':8-\\V?=F_JS 'SM]Q!9YQN;Y?/&,O,7@ M[R+(6_RG_(WBC@^+HY)YY5I>B,L):L()^R F5]]],SO-7S]C[/%@[/%STO]] M8Y\7-ULF%\+MA7<,D$Y9;>B$,U*6+:8459FYQGCS L+<'*/ M==&TRFR%8*9B-URCTMF:.U9)A47.%-^X3GK&:S"&\T'ZC6E:KK>,-Z8+!C!O M&&];:SY+%)Y06_;M+#M9GF:S1M\;)2 \(Q4HH*1[@N5_S:!EJ.UB 4X4,1+21 M2F$C*:WX@['DYDC#$:(FR/QP6A?">OCIMV&;;$@M::+5Z"TM"!>UE*SJ?&<% M*[A;LPJ$Z3(F*YR &U8HGF+CUW"D4%PV&=.&(5 /T3J*]$H(XLO"U%K^*?WY)R&Y<=Y8MWI:0\% 98URY^K*?&EL&:;N ???-PU \BU?*1%:37DZSY;Y MR8N#6$P, 1^H;$L)'=Y8]_78'-, &;.Q1M=5IR#+-=(YKOY*H)ME^?GR,.9^ MY;86_BL!]S^+JZ]J3O.S%)@:@# M0 -(<.#'#D/(_"R"BGU/GL[SUS]4E0C7"H;A6X0O9Z]?[(\<0H>.1FG 4,.< M\%Y%>/#:BOAI(_V:%7_'H\[8G2Z."+:W<&;#R5/T!V-Y&%.2YK@Y:0RF4])E M*>+&?1M:+LL(\M#KH0W>890J^7: Z+XO(0/]L7[0PI&&AGL$@NJ"*Q6'QL#F M<0O-DA@>8_2N6RL5Q6M&Z8@&[]7MIXY;Q*8OW9^X13GU=3N/]H\[W8HKP%>$ M"@V&T0364>7T6(DU$I)N'*7S!E-1^7)VSMYCBVAD@3&Q5S,;Z(%._F&L*MD[ MP172<&]K#CS$<&/L4YRR%ZS1M2%+;NY_O[LEN3"/6. C@TF .6'FV%(,J$J(GF)]H0CT2XQ@T$H3%E1ARA#3 M$:WNT4-8?$RT\RP1%Q"4INXVQ3VU;04:"%,+8%F$-E["+*I&P([OB#&N4]V- M4#RPBVE[D!^FKZ?L&Q=$4FQ6X:X+242K'"*/7#5A;#W9\H=U0VX&>("@0?"@H0@E*#T",YW]X/G$8Y]@2,Z M9- ** 2JM^PDL7>/"Z$'B R:>XPF V)0'F>%!OD!XM&UWW3H,!^H<;ATR\J& MTEM9P\$\23PH59MF.\:DZ]H6Q(& (5B8N&S71B\:ODWIWXMLN(EV=%2C P9> M$H&A'J$BV$!"4OJ(GB)\]BY^?8I"[XB-.BVM44J>?R3J)5FQ&U/OSZBN-8"$ MX=#"F]ZFF$\O/F+$6;2,66<)QM5\.H[#P2OA1G8=&D"8 MR 727;@RX?[D>WH6GSK9$CIC]L!.77S#13Y:A')'B= ?>TUD,T(ET85'%\8# MC<8C6W#[ZH N;"@%T8VNT+>(<1LA"!^N[PG6RT*V/*E,\N++*H!@;[L)33?M MP>4Z#!UW83:B L3]VTD:%:\;*4$9\RF+HSD^Q(L\AP\K'ZMP=&K6CT/F-HHEAZ=Q([ M2+1GF/R>+LM=Y:6:" ,0J@R]+:J@>:!3]$YCJ(R,;=:2-H2%7EF .?IZW:>* M1H.:VLD>"2IL>*F OC+QV@XWM3$E^;9?5:D/HQPA7>*NEEK, ;_VJH->QE ) MAB)PB8)31JFM[UY8@?[;8#2F%NF\E:LNINW&* 5J[*3_&4#'YD=Y_C>RO;: +GA& M0 MC*^,!W.%CQC>D'C:@/7*@'/[!U(P_%)R]2]02P,$% @ EX$)5]\+6G]W M @ F 4 !D !X;"]W;W)K&ULI53;;MLP#/T5 MP@7Z5,2.D[19FQA(L@[;@ )!L\NS8M.Q4$MR=4G:OQ\E.UZ&M<& O5B4R'-X M:(F<'91^,A6BA1=12S./*FN;VS@V>86"F8%J4)*G5%HP2UN]BTVCD14!).HX M39+K6# NHVP6SM8ZFREG:RYQK<$X(9A^76*M#O-H&!T/'OFNLOX@SF8-V^$& M[?=FK6D7]RP%%R@-5Q(TEO-H,;Q=CGU\"/C!\6!.;/"5;)5Z\ILOQ3Q*O""L M,;>>@=&RQQ76M2; M**C\R"S+9EH=0/MH8O-&*#6@21R7_E(V5I.7$\YF&[!>%EC\B8])3J\I/6I:IF<)OSHY@%%R!6F2CL[P MC?H:1X%O]#\UMA3CMRE\:]R:AN4XC^CM&]1[C+++B^%UC=P@?VONX DND!2&"X21S!??P7-'U2]-:1M6\"*Q<6M1<0,DEDSEG M-1A+#A$2'% C<&,<%E?0.&T_ %!+ P04 M" "7@0E7.ZE/CC,2 "=-P &0 'AL+W=O+Q,WZ6>*A"1<*$(A2,OJ MK^^SNP (RK2XNF63T_/G;Y M0B\S=V17NL*7F:V768/'>G[L5K7."IZT+(]/QN/SXV5FJKU7+_C=A_K5"]LV MI:GTAUJY=KG,ZLUK7=KUR[W)7GCQT#J.5 JS MU)4SME*UGKWKDM'?^KUC+V[,F>REO7V*6?# Z6II+_LSNOB&3"Q?B!"2=^P@GS M+0LQEV^R)GOUHK9K5=-H4*,_6%2>#>9,1;MRT]3X:C"O>74CNZ'L3-V8>65F M)L^J1EWEN6VKQE1S]<&6)C?:J?WPU\&+XP9+$X'CW"_S6I8Y>6"9<_6;K9J% M4V^K0A?]^<=@.?)]$OA^?;*3X*]M=:1.QR-U,CXYW4'O-.KAE.F=?K<>AH07 MVD^&:9-C/7>K+-W>N_5SW^;G(\O=W#^)'+^9!?U5Z\S9QSQ_8%H M5TTFUEX5ZMI6#DP7_&:([1]"6/U[H55;96UA&EVHW&*'*R=_^5%X,%6C:[-4 M,U-E56ZR4CD0U/#OQJE%=JO55.M*03^KK.;Q<-CKVH#( MJH15SG6EZZPL-_1=KV0MU8"G3Q4S=$/KL!Q72["09VK_Y[]=G)R,+S_=J+]? M77W@I\GE@4*,&^#35!+[@O!$NFYI:7JJ];PM^2,O01]OWE[S)\BA]!WMN!.F ML%YARS*KW1$;5EU EG(SXEG?I\'"JLHV&).7;:$5]'&/[YFU#<: [UI_;0TI M>;I17@VZ74&F#Z575@O[02D<_8+L1=RDH,Y=9\0>"'+\?,0GC>(>A2UMA M4RN2H<24O*UK^G!_0J%)EDKG4#2Y,(F2J5EF:K5*+/=(O?=,(:75&:^"SXC> MCK>*]!>(&*QLJ@+&0CF#F DCFT76(/YN8*ZTN1!#%[PB[>%&9[72%6VK>@-2 MRZFNU>E$@M1(813S5B',8'AG;.#'V.)'J-8M;%L6Q!RE:#(ZS/VCK20%LAL1 MH\D2'>%!@MZFKV$:Q'=P #$D$D(W5F4\3HRLKPF0W5;$R8^0,Q@Z"R-Q89!7 M@]?K!9QNPV%X,:H#.>;8E(ZT1VSD#-2U'5@EL.0>.PD"I"%.U M7?KI<1-V&>QY--CSG>9VG;G%D)$^/HL-,WCVJ@28JTIM3K.L*07I+/2@'A!":)N#F&:2TRZU3Z3 MB@9M;>:PUA)&U,#9-7+\=DE05;,) 5 9#XO>)$^DDSPK:DGW(4C0##UK2UC;K4ZB,"$UZ!5Q$.36"RT W3,] MU?BHM[9A5=NBY8J=2(ZX\B[(#VCB# G=KHG6\,+/OTVFC@SY@P1,BTA\:? M'I[Y&3=VUJQIH\/*_8'A[:D?_D\-S0$!(2,MH=1;GX'ZDWB03R>1PA4TAX1% MN]AQ9<@WH5H+$/1?TN8*"D8^A;O"3[!QO+N55;.6E8&1E5V:'+M^6ST>Z6SL%)VQ':C_9X\S):,YFF@+U5#=K M[>VNPNC(,G22:UUT.1D!HM[0H@ABK>ZM<4#B^\ 5D7AE.TW.FQ#J)J=2'O=_?&KT6O]>PJ@0G$"(9"8CBZ@F# MP+6C/0!IJD -/'6%=RBL,797B+N((>YB=Y"B^NMS4.&[B(*0.YNZ92,*LM=+N$%;=Y5/A]T28-B]W(:5CU"K (&[ MK@(\*^!8WKSH42#B\:GL94+1V];W84\REZ2>GE*7!ZY7%.Q3U$D9]M525\#R<''&1N>+"FA+ MQ @(E]EFH&?+ (ZVO"55NJ06;BL[I=XFIW"O%[_0:7\AD;U9U!IKT8 (M <5 M3Q:3N>#+E)F?G3]]=JF"$'XM&M97SGZGMH._J"G>]-0;%CZUR)"-+ZD88,G MU!W(/(\2I)#R?9+R[?^4KA#6K.YML\\YA-,A21 ]>E2B^M""D;23R ._UH97 M*("5\P9% 3<\P]-#G)ZFG [M\L,KRD['C)I4N?="JVN1LC)?T'$NNF-D1Y1- M&G 8,&:MBZF92YI0LVS\6Z>Y*/))0?CHP&)B9]0 "$58[."LL@T+Z%_6K=YJ M"-SCKX\:J%Z/94M2#4J6ROE#R(0+>HYS9M#K2C$\Z[0/9E<4LN1G*"URO,03JU;58N,-\1[H]4K_C MXS#YY+C('S9LN19[K:/V":T L0D3%*$#!T:"HYZ^%@! .GC#VL7*B.])5[5K_[^(.C@GD: MUOS('Y<-V$._HR0[U.AN,)C\Z>G9Q>C9Q9.T#^K,';RW@C'(04._S;0F$X<* M?JH,G85M-][>D^4*Y!TIW_I_8.5GD]')Q9G:1T!HYPNN5KO6&9/^?&T/!CES M"6LCK"ZL[0]^C\P]5S^=C";C9Z/SDW,!9:PMWQOSL0.6D4G[&K&!VB?[5'UJ MH#BNE?^P ,4*0G 1;O\DD(X^SL=P]/,=B,0O]T4> MAGH'_>E)LX]5!@>27%Q5R%PNND4:_3K";';L#+>Z".Y+XP.() M.7GY,"/E9F=F?$[:P4/*8#T,)'QHZA<14JL;^0";T;$(ZY>PX9A86*0I)CX'M-#Y3UF3!L8L3'"AIJ9/[EWI.Q^,(.BX0>$7_/(B]11@BR M^LO!SL5:8,9-HU5;NS:3$P6)/MP_)RN)NN5" #MSI#YYV&*ZEPDZN M+@ DM'7%K8HDL0R(%LHC\B7BD+7326-@'#8 M*#7GF@)L@BZ@(KYSX 69)8*,^##-1^E4AV(9=-@6M)E Q&A ':$C]1^*.E(H M=D=T>=X2\A+JP"E0G7>3OD3M2C:2XH1,?6@;9G]E&V1*?QOZT0$9WS N?-@G MY !JA>HTKAUBRCWW&"@ZS:SO-SYT\-V,5";9$(EE:4N*.O[=ZCFBR3Q"-7;3 M==R 9!QWMN%!P0J2+@8B(Z$G6J+T-!BZ MC;WOS!L?GUG22BCJ/-/QKD7+=8R^TW5.%4_:Q?NC+>;1]L)%C%RN$*17,/PE M'NG"A'.6;OK]*QMROT!N&Y"8W1P"D67K[A_1+[+$](#D$E%\0DOZS607#SO6 M8^ \U@VC[GQZ%YY+KM=.'NE9Y)+3H^/!E+F?(FMJYD^W_1!7)Z*1]9]G;2^TJ,??S>U6R3;LV4 MV1(^';#B%A^%)A1-^1="<[5>VMO@!Q!7\E6?EVN_I6(8S[_1(D;^2D4,,11] MI(-N@Q0L@AP#LP[SCMY,4V/4ZXESZ]!'@@I^ZYS<4-.PZ8@4%@2J[ZF([Q+T M-#&T T%JWGO/=DHJ5?2,3[E)6E;C=:D."=P MS\:;=J/]_5).)=&_MAH8;"O@K@@(_M;X*S N1R[AA"]=.EXOZ3$G%N85(4XG MC6"4QMS+8P,<-'XV[*""*'<\EY@BH5,.U7==_XB#4!T]TL(CQ4)Y\SN89?Q[ MRNM)ARN80&K/P4'SVG OLU,XB>'30B"=^WLO_^8&?**VWLT$#@XA62TM'=X] MK@WI[VZ"OPXNK/9!HM>-Y4M(.S;[8)06H#.]II;T/9V+R-Q]]L[1"Q^#=N9O M(70JV I'H7>2&-2VWYR<(U2\#0C^ P;?4!7JHROO0B\8Q%L:0 !E2P)'^$\M M&2EA]]]^N#FX%_)234\W20_?S [].!WN2&PY2.1@V?+))G9VJ?UB3C=-J3OH MU-8KZZOEP"Q?HO#L@C7!P8RI T?A3K@0DYO7?'//B^0>4S4;7VS8"R/3$DDP MLLX>:1P=5LK5GJE&>N6+G7),$6]:3\X8S$Q&$K@QN-QTC?H5@?"&1-DGDM]T M!O'H6J<'?>RV-K#6:8=4PT[)$0-78?&0A,<*FNXUE6*(^*X; (,X[CCYQ10) MSK\+8Y!:-?+CJ?@V_O;L2GYQU0V7'Z[]EI'>J"DTP]3QT=.S/>DBA0=@&?[] M%6)A8Y?\YT)G\&\:@._TPXSP0 O$7^2]^A]02P,$% @ EX$)5Q :##V M @ V04 !D !X;"]W;W)K&ULI51M3]LP$/XK MIR"A30(2DA80M)$H&QK3D"JZE\]N7)]>+B;.WSO\Y-B9K3VX3-9*/3KC+I\'D1.$ M C/K&!@MSWB#0C@BDO$T< 9C2 ?ZWGR5M9>"SS#%_ MBP])\*@ZWJA>Q'L)O[;R!)+H".(H3O;P)6,5$L^7_'<5=B7?4-L8U,\8I(<'IV?1U1[EDU'Y9!][NJ(NS5N!3GJCJ5>U?3V"1CCY3.: M3RUOJ(DLM :+5H#@!>Y*8G^8PX.+.$JNX%_7VU9+;EN-<,CJYHK444EQ2PV1 M,]P]_^1X.B!6JK =F'B@'_K_2=-YZ.<^NZ;]<_[OW0 MNV>ZY-* P(*@TL*KQS;M6ED:!WU8T>U$[![HOE+(;PP48IWGZ M&U!+ P04 " "7@0E7W65QNLL" "N!@ &0 'AL+W=OXSS>9M@EW/JWY!E:@?]5WTD3NH)+D)50J%Q62D,ZQ M]"V^!?S.8:OV]LAVLA;BT0;?DYE#K"$H(-96@9OE&:Z@**R0L?'4:SK#D9:X MO]^IW[2]FU[67,&5*/[DBX0Q.4"@/8&VOKN#6I=?N>;SJ11;)"W:J-E-VVK+ M-N;RRCZ4E9:FFAN>GM_D+Y"@A5*@%3I[X.L"U&CJ:B-M 6[N*%Y/*(-W_PYA]3GZ_,34N: I!(4=KZY =] M'EP8(4>A":%^]4OWQZ=R74VU$>]@.*:4"' M3!01[(4>\AD. H9"/ X\3";^ )A@SXLP"0E:Q'%3-@77YODE8%Z3..?MX-E! MS_RQAR>^-WK+1'Z$(T9&IL:P/[$;BHDY,PS]/1C#S-3'-!B]ZW1BP,SSAIA2 M[#,/A0SY.!H3$Y"A%N H8IBRX*-WUMV;(27(33LI%8I%4^ENG S981@ONAGT M!N\F^2V7F[Q2J(#44,EY9&:?[*9C%VA1MQ-I+;29;^TV,Q\4D!9@ZJD0>A?8 M X9/U/PO4$L#!!0 ( )>!"5>%V]HVK0, "4) 9 >&PO=V]R:W-H M965T M9I\9B[:)2J)*4K;[]SN4;-E%72,+]$7B4',.S\QP2(VV2G\U:R$L[*JR-F-O M;6US[?MFL185-U>J$35^62I=<8NF7OFFT8(7':@J?1H$B5]Q67N343?WJ"H>))[E:6S?A3T8-7XFYL%^:1XV6/[ 4LA*U MD:H&+99C;QI>W\3.OW-XEF)K3L;@(GE1ZJLS[HNQ%SA!HA0+ZQ@XOC9B)LK2 M$:&,;WM.;UC2 4_'!_:[+G:,Y84;,5/EO[*PZ[&7>5"()6]+^Z2V?XE]/)W MA2I-]X1M[\M2#Q:ML:K:@U%!)>O^S7?[/)P LN 7 +H'T$YWOU"G\I9;/AEI MM07MO)'-#;I0.S2*D[4KRMQJ_"H19RI'PH:VO( H(T(!&%_BB M(="HXXM>$^BY^'HX.P]WO7%M&KX08P\WOQ%Z([S)NS=A$GRX((X-XM@E]LD< M>ZUH2P%J"78M^KTJ[?>#W0@M5>&LA^>9.J?^,O^[-QD-H@_PN]Z/O1[A:CU, M/O"ZQ;Z&$*R"::-E"33MZS?XS.4.JGZC]& LLSB4F0YNL^DM?)G?#N\YQUT) M(0F2C*1Y#FD>$IK%0$F2A22/W2@,IE5*% :/*H\*$!B1B;+!9 MG!.:AH,=DBBB)*#!R4S 4I(F*?RIE3'0:+64]DC ,L)P]8/=P4-V2LARDD?Q M*6$2DBS.X3,6E7[K#1Z6"AOZN'>3'!LH MR>!.[K!W>_W#YSABN$M_WC644!J3,&/G$NJ?7%V5T*ON@C:P<.7M;[%A=O@' MF/97W]&]_X'XQ/5*U@9*L41H<)5B%G5_*?>&54UW$;XHB]=J-USC?XS0S@&_ M+Y6R!\,M,/P93?X#4$L#!!0 ( )>!"5=82^PR!P, 'D( 9 >&PO M=V]R:W-H965T#(CTHJ MNPA*Y^JS*+)Y"16WI[H&A9:U-A5W.#6;R-8&>-$&53)BE$ZCB@L5+.?MVK59 MSG7CI%!P;8AMJHJ;GY<@]781Q,%NX9/8E,XO1,MYS3=P ^Y+?6UP%@THA:A M6:$5,;!>!!?QV>7$^[<.7P5L[=Z8^$I66M_ZR;MB$5!/""3DSB-P?-S!%4CI M@9#&]QXS&%+ZP/WQ#OUU6SO6LN(6KK3\)@I7+H)90 I8\T:Z3WK[%OIZ6H*Y MEK;])]O.-TL#DC?6Z:H/1@:54-V3_^C?PU[ C-X3P/H UO+N$K4L7W+'EW.C MM\1X;T3S@[;4-AK)">4WY<89M J,<\LW6A=;(25Y]IFO)-CG\\@AK#=&>0]Q MV4&P>R"FY(-6KK3DE2J@^#L^0CH#)[;C=,E& =\WZI0D-"2,LF0$+QEJ3%J\ MY$B-ATKK(M/#D?Y$G-F:Y[ (4/(6S!T$RY,G\92>C_!*!U[I&/KR!D]8T4@@ M>DU6C46KM2C3[XVPPDO6'B(\#GGR9,9HG,9V1UUP8'*69*%+([QE^SGZJC5Z-K[':2SLV79+)S%\7_Y'D1^ M'/*Z,7F)=P/)<==$ 8:W5PZ&3EDX2]-=KA'13 ;13!XL&@.YWBCQ"PJ"2943 M:X%#;BVX7DC&SU5!I. K(5%58+V]J?X]J)VXQE,_6EQL$DXH#2FE#Q47G69C M^Q.'TQ>3,)O0QXD+>=&>UQ%UT>GD'BD@%9:$] 5[B*[^\#X&=H^RDC")47HI M.Z2H:*\=5& V;=.SB- HUW6&877HJQ==._GCWC5EW*:-4)9(6&,H/&ULK5;; M;MLX$/T50KV@!;061>KFU#80)[MH"Z0;).GN,R/1EE"*5$FJ3OZ^0\E2G/BR M7>P^).1Z6US5D0F+SD-3,3U7 )EI72-;,@ MZG5@&LU9T8%J$1",DZ!FE?06LTYWK1S\.X>_*KXQ.WOD M*KE7ZIL3/A5S#[N$N."Y=0P,EA_\@@OAB""-[UM.;PSI@+O[@?V/KG:HY9X9 M?J'$WU5AR[F7>:C@*]8*>Z,V'_FVGB[!7 G3_4>;WC=./)2WQJIZ"X8,ZDKV M*WO8GL,.(,-' &0+(%W>?: NRTMFV6*FU09IYPUL;M.5VJ$AN4JZIMQ:#=8* M<'9QPP6SO$#73-M'=*>9-*P[+X.8+-"2"29S;M"[.W8ON'D_"RQ$==@@WT98 M]A'(D0@)NE+2E@;]+@M>/,<'D.V8,AE27I*3A)];.4$4^XA@0D_PT?$(:,=' M_]L1'*J\)XX.$[MY.C,-R_G<@X$Q7/_@WN+MJS#!'TZD'8UI1Z?8%[MUJ[N M1NENRE]ZO@O].,(^GD[?HR]*_I8?\7^-(!XE/J;IB=[$8V_B7^X-9WF)+-PJ MT WM,273O%2BX-H@H9@\U)73(7ZU*__7^DE:#I?8(@W#,FJOV$-WSUP-H_+/ MUAH+HU/)]7/#L%Z<7Z*OMY?C>K<]G1"%R01C] :%/HZH'T\I2K,,[DDR8OQSL/$\UU^ON$38H5ZVT_4LU:L=W_KQ_WI[<^X^$*Z;7%?PP"[X" M*)ZD,"2Z?WA[P:JF>^SNE86GL]N6\*W"M7, ^THI.P@NP/CUL_@)4$L#!!0 M ( )>!"5=?J 6TL0, "8* 9 >&PO=V]R:W-H965TU+U7;W/CLP"=:"S=FF:?_] MCH&0M"&YGG1?,//VS(QG//9L(]4/G0,8\E060L^=W)CJTO-TFD/)](6L0*!D M)57)#))J[>E* K%C-9FX(+N%5$UV7)U/,U%'(S M=P)GR[CCZ]Q8AK>856P-]V"^5;<**:]'R7@)0G,IB(+5W+D*+J_'5K]1^,YA MH_?^B4/2_R5S1W?!@0%I,8B,%P>X0:*P@)A&/]TF$[OTAKN_V_1?V]R MQUR63,.-+/[FF, M$91.FBA_988M9DINB++:B&9_FE0;:PR."UN4 M>Z-0RM'.++Y6H)CA8DT^ 29'FJJ6GG\;KU2(]XC,EG*4RNR6\B@^REO8?1]RG0;0K7]"3@QUI< MD-!W"?5I> (O[+A )\3:!?[$"L<#PM"-_,0*XP%A[$XB2AYRP(&T,J . M5 (WB"9N./')@S2LZ'*OV#,.%JSC0;QN&% WF0987:T)+ZO:0$:X0&S0YD!_ M-/7'[C2:G)%;6T%AR",K:AC"@X8K_W@I()^4@URZ1'=89U= MX4___:$D-O.K'49N,)UVX$U#VJE8 MFVV[=_B[OJ<)-KR_!T#=()[NFCS$(>%CC_?ZX\@-$TKNL/L>,7:\<':@*R5+ M\O'[C437!;.'U,BA*(YE-Z+^U*7!=.=N%$_PC(WW&!&E;I3$9P<;_BJ34>#C MB$EV>@&.G&!/CD,,!\79T*GT]N[N$M2Z>:%HDLI:F/8:[[G](^BJO?MWZNT+ MZC-3:RXTEG>%IO[%!$^?:E\E+6%DU;P$EM+@NZ+YS?$A!\HJH'PEI=D2UD'_ M-%S\!%!+ P04 " "7@0E7&UE/_-H" !L!P &0 'AL+W=O]3;*&[YHM!&$:2CABW@#O2/9BI1"AQ*SBNH%1^?T M=)(8?^OPD\-*[>R)J60FQ+T1KO.Q%QI"4$*F#0+#90D74)8&"&G\66-Z+J4) MW-UOT*]L[5C+C"FX$.4OGNMB[ T]DL.B7H+4?%8"F4I1<:6$?"3?A 9%/GQGJ%@&V3VY$K0M%/M4YY/_&!TC1\8PV/"?10<"O;7U,XM G41C%!_!B M5W=L\>(WU+VOW XMV8]F.N=4-2R#L8>MH4 NP4N/WM%^>': :^*X)H?0TSOL MQ+Q%HF).YHQ+LF1E:R5= %Y!R9?,W&U2/^RHXG./HW3 *XS/RO]?+ M+=LWN+@""5.$::?O3M,,"D4"<@LY5(UM^M?2>@EXRRF#:@:2Q-1WRKR5O%[8 M0W!$"E8O\$SP>+1PVJOMH6U4>)_!WN>GF?!^1TYH\%>(W(G72K6LSK S-QJ6 M_\89@4-2[P+$SU#?OWIG.H!<$NHG2=^J:73F5AHG:.D-P\[MBM#0#U'WU&\P M&!C3D-+.\3.)_7[2>^87#2.TG$0#1X#V?!H]=Z0^/8D)[?LQ'>[KJ&!G E8@ M%W;.*Y*)MM;=,'1:]Y2<=Q-TZ]Z]0S=,+CC>HQ+F&!H>#WH>D=UL[P0M&CM/ M9T+C=+;; I]#D,8![7.!):\%D\ ]L.E?4$L#!!0 ( )>!"5<@#8JT+P< M -L9 9 >&PO=V]R:W-H965TV_;-A#_*H3; M="W@R1+UL-PF =*TQ;JM19%T[=^T1-M$)%$EZ;CY]KNC'I9LV4F;#@."B#R2 MQWO\[HZD3S=2W>@5YX9\S[-"GXU6QI0O)Q.=K'C.M"-+7L#(0JJ<&>BJY427 MBK/4+LJS"77=:)(S48S.3RWMDSH_E6N3B8)_4D2O\YRIN]<\DYNSD3=J"%=B MN3)(F)R?EFS)K[GYI_RDH#=IN:0BYX46LB"*+\Y&%][+UQ'.MQ.^"+[1G39! M3>92WF#G?7HVHW9+7-AM-]S?6=U!ESG3 M_%)F7T5J5F>C>$12OF#KS%S)S1^\UB=$?HG,M/U/-M7<(!J19*V-S.O%($$N MBNK+OM=VZ"R(W0,+:+V 6KFKC:R4;YAAYZ=*;HC"V< -&U95NQJ$$P4ZY=HH M&!6PSIQ?&YG?_@+Y# M:E9<@F$N&"DO=N_(K_J>UT)=9'+=6'(&ZX3)4H;9#_* M*7;'KNLV6H*^BP:_& M=ZVEN3$9AP1J&C58Y; 4U(=T#N:9:P&RI_P6DG-I9^IF]VJN*);(]RD-IF/? MC:QA=ZR(C!O_]0W2$6 #\CRE7F5NF J.0M8"TC)90NG I9WI.YO3"#<'N94E MP19WG"G",<< _!*>S[DBOH=9PILZY),2MRA#F4&((D--_" :TUG4,:(7CZ?Q M%%P+!0:R004J-$NYOWHCS,KNVU&]!4W"] H6R83S5"/<.-29%*6 TJD(RS*9 M5-SGW&PX+_H@1^RR-!4X@V6D9"+]72#74ACH]UW7< >)L@S=C2&1<0,441D? MMA02QE>\Z+H&_M70< !A76!DDA4V]"Y94;"_I"K)#!(N#;J(@SB-_9A<\05H M!#[Y*,% 7F#ME7+#1 9!=[%4O'8WVNL:)5EK^*)=*-K;C_;@3L=1%),+;>.W M[PA1&*C64+[7:!=K32A."NNL)DL%D0YJS^_(=2[,'C*%_I5AC?&$SK2N:-3< MQKHWCCPPV91V\34- 7'^KL)'ZD/8UH?PP?5A/Q8W3*%I]%"9.,IWN*IAW7UT M3@/W0O8=[D&%YVV%)Q^82E9U*$,73EX++LP:\SCZHUGDGN"?+>:U2UO#NPZ< M1_M=G[S]SE4"M6)_,@UMYH26W\VQNP-?9 ; S/!TU")WZI_@##^@)UMB$%1$ M-SPA5T+?D 6@Q4(93&KZ6H1.X&Z7!DX$:]]^+P'Q@-M,+#AYCHE.O]CJ[;@4 MV7L.!,T^<>9OUZ?B%L()DLNNX0::8&OZ:"Z:IT3V<79<-&ZC0Z1Y"YJ$!]Q"6,92J 43U M$);#&LM>%\M>A64ZG6V)WHS6 (\.$.]#?>!@X&Q[&"GMELZL*X!#XX='1"?7 MNC4E> #E)T/F8"#]?+9\4YUOOJV9 KO=1VZ^U2EHN/>SN?4A.&\0A:T# ^$1 M=/MA#Z$'-FTJ\U=/S M._$/M\7_-@$_#E^_'HW'>CNG>+!&OP)84A?.M _G7Y[$&PSO'"6F[6%>,W#L&+*3L(]W#R7Q;I[N=V:S;A@]*$E3OXZ7*.KEYVF5Z9VPF_9L M#TM%+[>[3AR?5&D6QQ\>=(\.Q)\,SVG'VS3N>-COXB#PM][XO[Y7'%]<,1(/ M4PY]X:9E%*NN5=85]PY\;4S5-@ S.5Z*X#S7:3;SY=IH Q=;E*8:V:>TP3QX M_AL>M75K]_Q64QH\-=^!1P!JN/WV3AN]SN7?[[?'(?NJU7NC&2!1Q^OHX424?)9XXX>IS7:A/YZ%V/3( MD7MCU-X;HP??&W-YVWL:JH,!W,[F-JL,71^/L[\/=E]WMZB!L)_ZVR04SP96 MX=- P3?V8LZ*3AJELYA4,66HM DXPM8ZCI3N*.KZJ>$JF-D M:9_OY](8F=OFBK.4*YP XPLI3=/!#=K?<\[_!5!+ P04 " "7@0E7/SUC M_T8" !O!0 &0 'AL+W=O]&"Z< M<^ZYX,M\J\VCK1$=/$NA[(+4SC6726*+&B6S(]V@\CL;;21S/C158AN#K(PD M*1*:IA>)9%R1?![7[DT^UZT37.&] =M*R<,J M7*'[T=P;'R6]2LDE*LNU H.;!;D>7RXG 1\!/SEN[6 .H9*UUH\A^%HN2!H, MH<#"!07FAR>\02&"D+?Q>Z])^I2!.)P?U+_$VGTM:V;Q1HM?O'3U@LP(E+AA MK7 />GN+^WJF0:_0PL8O;#ML]I% T5JGY9[L'4BNNI$][\]A0)BEKQ#HGD"C M[RY1=/F).9;/C=Z""6BO%B:QU,CVYK@*E[)RQN]RSW/YC5:.JPI5P=$"4R44 M6DKN_+D["V^_L[5 ^VZ>.)\K,))BK[OL=.DKNA=PYY5K"Y]5B>6__,1[[(W2 M@]$E/2GXK54CR-+W0%.:G=#+^L*SJ)?]3^''ZNWD)L?E0N]LY9O:TW/G9C*;9 M%;PVCL$ZH*,T?1,25D9;"Y;Y'P$H^(,ZP.B(3E\@,C!#Q/2EQ@1*DQ M'2*R(SZ.'6DR: *)IHJM;OVMMLIU_="O]J_)===$?^'=4W3'3,65!8$;3TV] M10*F:^\N<+J)+;76SC=HG-;^1403 'Y_H[4[!"%!_\;F?P!02P,$% @ MEX$)5^'?\;[K)0 C]4" !D !X;"]W;W)K&UL MQ=UK<^)6HN[QKZ+J,[4KJ>I*(W'/[G15TKK?+]DS+W:=%S*6&TTP.$*XXU/Y M\$?"8"&0%]#Y9SPO,IA&OR59]B.\T"-]_+HJ?EO/LZR4_KA?+-<_O9N7Y<./ M'SZL9_/L/EW_L'K(EM6_W*V*^[2LOBR^?%@_%%EZNUWH?O%!Z?5&'^[3?/GN MT\?M-J4R[R9186TGIS?Y\63[]DB]77G][)[_9/Q/F7>5D_\>'3QX?T M2Y9DY?\\A$7UU8<7Y3:_SY;K?+64BNSNIW<_RS\FLC*LE]B^Y)]Y]G5]\%BJ MM^5FM?JM_L*Z_>E=KUZE;)'-RMI(J_][S#YGBT5-52OR^TY]]S)HO>#AX[VN M;[>^VIJ;=)U]7BW^E=^6\Y_>3=Y)M]E=NEF4\>JKF>VV:+N"L]5BO?VO]'7W MVMX[:;99EZO[W<+5&MSGR^?_3__8?2<.%E"FKRR@[!90+EV@OUN@?^D"@]T" M@Z,%^LHK"PQW"PR/%^B_LL!HM\#H>)5>&V&\6V!\Z39,=@M,+EVEZ6Z!Z:4C MR+W]GNM=NA7RR\Z^>&_+^]TM7[R_Y?T.ET_VN/S:(OM=+I_L\]>^7_)^I\O' M>_WUS=_O=OEXO\OCUQ;9[WCY>,^_^L,H[W>]?+SOZW_I7F2_\^7MWO_P_-N[ M_=57TS+]]+%8?96*^O655S_8YL=V^>HW/E_669>41?6O>;5<^2DHOJ3+_/^E M=>Z\E_RTW!29M+J3?MFLJU>NU^\E8Y4OOTB?5\M95E31M+R5O'19Q6 5>*44 M+M+E6OI.S_;GQ6&^ MUT)ON7;?GYOAF=^7Q^*_6]8\T/2P41B MQDN?I)Z\^ZW?KU0'$Y_9R+3^?1_NG$M^WQ,QF&0/^^^:/'YEQ5H9W'\YJO6W MM_RSYQ@,1"$HM(+":Q!,):@3]X"?R!2/_T MMOTT.Z9"82V(>B?DD%ERTFT)RR.BB(6-RR.3IHMZMC>?Y657 JA:P.0Q%02TTA,?\9&!_MLV)M.E<'@* +) M04T2LR[< IL+ MM,QN1:DK1*Y-71)324PC,7UTDEG]WG T'([EH]@E1S5)S!J='.R[-\$F1W5( MS.W:"^-)?S2>M#?!(T?U22P@L9#$(A*+22R!L%:FCE\R=2S,U#A[S):;3"KG MQ6KS92[ER\=L76[G9O.EE$K_7N75P^HU]<1N5]H*^6O3EL14$M-(3"U"7'-0C,9_$ A(+22PBL9C$$@AK MQ?'D)8XGXLF%M"C29;F6LC^R8I:OZW>ZFZ*>;BCGF?20%?FJGG5]]6/ 7X3\ MM7%,8BJ):22FDYA!8B:)621FDYA#8N[DY.^ HSE&[^PK_+.O",A5#DDL(K&8 MQ!((:P7K]"58I\)@_;RZOU\MI76YFOWV?G\V1;Y>;S)QG@K5:_.4Q%02TTA, MGY[\]HSD<4\93J?3H]D$4K0^@?V2]Z9,#S%V+7IB6HJJFFHIJ.:@6HFJED[ M[?#W>ZS(LB+WCU+VTAOZ)@^J@6H%J):A&HQJB64U@Y6I0E6Y8)@C5^"];V4WI75 M,S\O%JNOZ7*627>K0OI<9+=Y*;FKNND09\_G)H1I43Z]EWY]>LBD_]7^*.N^ M7J3+_(RSZIWP+--4=1/UMVPY6JY^[(S M+(4#7/U>E]145--034!L=T$$U%]6\G=8Z1/9.VE,^.FB M:B&J1:@6HUI":>UP;OIILKB@5OT!D=6?S-4AO&Z".KU?;:K_NRM6]]*O\R)_ MS*3/Z7)9I7?W9W=H>0W55%334$U'-0/53%2S4,U&-0?57%3S4,U'M0#50OFT M"CD>C_J3H^G["!TU1K6$TMIAWE3>9''G;1O1SJIXD*SEK#.GT;H;JJFHIJ&: MCFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)I;73O"G;R<_ED?_TU=)D MM(6':BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUI":>V#0%/Q MD\4=/^WW35X^2?=9.5_='A2NWTNKK\NL6,_SA[KI-ZN>JH*_,^[1EA^JJ:BF MH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5J\TR:'GW:TIXP2:L!VAC=M M0OE,G="U.H,9K0NBFHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K% MJ)906OOF(4V74>F]R62,@K8>44U%-0W5=%0S4,U$-0O5;%1S4,U%-0_5?%0+ M4"U$M0C58E1+**U]$&CZDXJX/_ER:G?G+:U^$2]]=9:CU4E4TU!-1S4#U4Q4 MLW9:ZY1N>=KKCX]/5E1.FXS*M'=Z$I^#KI^+:AZJ^:@6H%J(:A&JQ:B64%H[ M@94F@<5]I[#(E[/$5U(-^FB+MATYC!:C40U%=4T5--WVF$Z37J]D3PYOJ,( M.JR):M:E&V&CPSJHYJ*:AVH^J@4[K7VN^JCC2!>BXT:H%J-:0FGMC&T*C(JX MP'C)54+$Q-41BY8<44U#-5TY+1)V7"4$'=-$-4LY;25V7"4$'=-!-1?5/%3S M42WH^&D;=@0K6H1$M1C5$DIK!VM3A*P>GOD<4/I3^OD^JV]I+:5?BFP[.=R9 MKT+IZGPE-175-%334)L]W":BS_>OS=:_W=PRH+_V7SG[?Y.N\/D+41X;UYF:= MW^9I\21]ER]W%\7^7GAY;.7TEG7;BSJ<_#WW^>)7JN)-NCK$T-FU^Y2.^\9U7;M/ M/-C5[[C1:B2JZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B64%H[K)MJ MI"*N1L:;F_J]\VR^S/+;K+A/E\OJ'?0KD^S5U -5"5(M0 M+4:UA-):!X%^4]#LBV\VF;3NTEO/N3\4^?-_'],RDQX6U=AUWJ\OGG+OG]Y& M$4I]XM?J8JWXMK<1C4=U0Q4,U'-0C4;U1Q4 6OCF2T&HEJ M!JJ9J&:AFHUJ#JJYJ.:AFH]J :J%J!:A6HQJ":6U(UEI(EEY*HIJ.:@6HFJEFH9J.:@VHN MJGFHYJ-:@&HAJD6H%J-:0FGM4&Y:F?TSK*=-#_\.^N'X#FO4D.T(;ZJ@?7$5])_Y.GU,7[OKO7CAJQ,:+7.BFH9J M.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J,:HEE-:.\J;,V7^;,FOI>635\HFVV*O*ROZ3)+%XOL5KIYVB^P?EEB M+9R$%Z_'M4<%5%-131N<5E2585=%54?'-5#-1#4+U6Q4C0QJH9J*: MA6HVJCFHYJ*:AVH^J@6H%J):A&HQJB64UHYPI8EP<6VTF82OXGKW13T[\SE= MIL539VJC-^I$-175-%334MY M_E#/VLRJIZK@[XQ[X0!7QSVIJ:BF[;3)P4S-R3P-.:"!:B:J6:AFHYJ#:BZJ M>:CFHUJ :B&J1:@6HUI":>T,;SJG W'GM)Z/N7WU9$GQPE?G,UHH134-U714 M,U#-1#4+U6Q45-]W0P>ILY&;2;BFHJ MJFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%J-:0FGM@T#37QV(^ZMQ M]I@M-YE4SHO5YLO\8%:F>BBETK^K0T I5:^ICPZ=:8\V6%%-134-U714,U#- M1#5K<'K'V_%45B;#]GR6C8[J=(RJR+WI2!FUAW7183U4\U$M0+40U2)4BU$M MH;1V1#?]U,%%_=3F;)CG&Y5VAC%:5D4U%=4T5--1S4 U$]4L5+-1S4$U%]4\ M5/-1+4"U$-4B5(M1+:&T=JXW9=7!VY15!VA9%=545--034U -5"5(M0+4:UA-):!X%A4U8=BLNJXDXO1_&1S,8!CJFB6K615M@HV,ZJ.:BFH=J M/JH%%^VK$!TS0K48U1)*:V=T4R\=BNNEUV3T>VGUL+WSW9?Z2@+5ZZK,3F>_ M;_+NV7/QR%?G,5H]134-U?2=UOX-44[R&.V>HIIUT1;8Z)@.JKFHYJ&:CVK! M1?LJ1,>,4"U&M832VGFL-'E\YA:CKW9"Q0M>':=H)Q35-%334!IA-:/12]E[?JVU%GZU(J MTK)[AD2X_-5I3FHJJFFHIN^T]M^LO9,9$G),$]6LB[; 1L=T4,U%-0_5?%0+ M+MI7(3IFA&HQJB64UD[5IJ4Y%+RFE*I@O>],5+2DB6HJJFFHIJ.:@6HF MJEEG?KI&/>E^M2SG77]]V7]A60?="A?5/%3S42U M1#5(E2+42VAM'9*-P7, MX9F;?QZW\+YU01'&Y:HIJ*:AFHZJAFH9J*:A6HV MJCFHYJ*:AVH^J@6H%J):A&HQJB64UD[YIF$Y'+_--#=:O$0U%=4T5--1S4 U M$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1+:&T]D&@Z7 .Q1W.[81,OER7Q>;Y MBH?WZ1_Y_>9>2N]7FRKEG\_L?DCSV\ZH1VN=J*:BFH9J^DX[[(!/AOW!9'H\ M"XX6-E'-NG ;;'14!]5<5/-0S4>UH&-OR7+_]#Y9(3ILA&HQJB64UD[>IF4Y M%!9X3I/WH74V]S(KI6)_#11Q"*.U2E1344U#-7VGM3\:.OD<$FU+HIIUR0;8 MZ) .JKFHYJ&:CVK!);LJ1(>,4"U&M8326M$[:KJ-(W&W\21ZRWDUS'RUN*U# M.%_=2G>K0CIH+=ZDBW0YRW9OBKM"6#SBM2&,:BJJ::BFHYJ!:B:J66=^)OL] MZ39]ZOSD\IN7=- M<%'-0S4?U0)4"U$M0K48U1)*:^=ZTX<UH&-W*7*OXZ-+=-@(U6)42RBMG;U--[)Z M^!_YZ%(\SM4Q3&HJJFFHIN\T\4>7Z) FJEF7;("-#NF@FHMJ'JKYJ!97L]5RG:CFHUJ :B&J1:@6HUI":>U<;WJ7(_&=+8_.4OEUGA<7GJ2" M%BM1344U#=5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B5$LHK9WR3;%R M-'F;DU30RB6JJ:BFH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:@FE MM0\"3<=S=&7'\[J35-!B)ZJIJ*:AFK[36B<,#/I*;S0Z_H04+7>BFG7I1MCH ML ZJN:CFH9J/:D''[NHK2M=)*FC)$]5B5$LHK96]XZ;D.;ZRY/FM)ZF(Q[DV MAE%-134-U?1QU\T"CT]208AM>IAC<0_S[S])1;P"5VO,CZCP))6_L*R# M;H6+:AZJ^:@6H%J(:A&JQ:B64%H[ZI4FZL6WO/P;3E(1CWAUMJ,U3%334$U' M-0/53%2SSOQ,"DY2^>8E'70+7%3S4,U'M0#50E2+4"U&M832VKG>U"O'XGKE M\2T@5INBG%]TEHH8OCJ^T6HEJFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HA MJD6H%J-:0FGMF&^:G-7#MSA+93 M?6745P;''Y&B55!4LR[="!L=UD$U%]4\5/-1+>C87?W>I.,L%738"-5B5$LH MK9V]3U -5"5(M0+4:UA-+:4=^4,<=7WN42.$L%[6&B MFHIJ&JKIJ&:@FHEJUIF?2=%9*M^ZI(-N@8MJ'JKYJ!:@6HAJ$:K%J)906CO7 MFW[E6-RO/#Y+);^[]"05M%J):BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ M:B&J1:@6HUI"::V4GS1-SDGO34Y2F:#%3E1344U#-1W5#%0S4/QP6G6Z>I&5[@>>7=1X&T+HI MJJFHINTTN;?E]G61P4@9MQLC.CJL@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H M%J-:0FGMA&^*JQ-Q<369IQ4KY>OU)MM-R!?Y\W\?TS*3'A;5V,^?N7Z7+Z7U M]N7?2W_N'G5&.UIA1345U;2=-CQ(=F4X[)T6L75T7 /53%2S4,U&-0?57%3S M4,U'M0#50E2+4"U&M832VMG>-&,GXNJ@M[O^RY_2\PGVG6&-=EM1344U#=5T M5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B5$LHK1WH3?]U\C8W(YV@)5A4 M4U%-0S4=U0Q4,U'-0C4;U1Q4+0GBVHJJFFHIJ.:@6HFJEFH9J.: M@VHNJGFHYJ-:@&KA3CN\ZIG:CFHUJ :B&J1:@6HUI":>U ;XJL M4_E-YF*F:'T5U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M1K6$ MTMH' :4Y"(B+?]\R%R,FKPYXM*:*:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6 MH%JXTX17H(_0(6-42RBMG=M-3W5ZYK:H7XHL6[[64Q4O?'5"HSU55--034U -5"5(M0+4:UA-+:4=[T5*N';S(/,T / J2F MHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J)936/@@T/=6IN*<: MMNZV5ZR>TD699VMI5>7]8B&M-S>++%W7AX'=7?BZ(Q_MI**:NM/:?_'UQKW6 M_XX^C]?05=!1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1+:&T=K(W_=2I MN)_Z:U;S;+K:*2A*Z*CFH%J)JI9J&:C MFH-J+JIYJ.:C6H!J(:I%J!:C6D)I[?!N"JA3<0$U*5>SW[;7%J@OUBZEZ^V% MW?/;K-A.UVPO-Y#64_';J1C1-07$ UV=\6A-=:<=7@5 WKTA/WX_CE904=,DG8J;I+MK?RU7Y?[Z7\*WX&B'%-545--034S M7,!R(S7()Q1U$N'T2Y^(:125:6B^?Y[^?;WG4'.%H*93F5Y326TUG. M8#ESS[4"O.O]-SNNS7(.R[DLY[&S7,!R M(S7()Q1XG>/TAT<3?4J^_?OGC:WKDZ72SV-Z=>7_9&':V.LIS*J)^\3T>KH2SGL)S+5TEC-8SMQSK8\ZQ[U!UTPY.;#-<@[+ MN2SGL9S/<@'+A2P7L5S,<@G&'27X\"#!Q1W/YIHMTI_2O_)R7@5Z63WQG=S[ M?OM'=OTNO9QG4G9WE\W*_#&KGBU?^4 4;7JRG,IR&LOI+&>PG,ER%LO9+.>P MG,MR'LOY+!>P7,AR$^YP7J/?=0MJC1U89SF#Y4R6LUC.9CF'Y5R6\UC.9[F Y4*6BU@N M9KD$XX[B?G(0]^(VZL^WCVGU#K_IH78'.-H]93EUSQU^L-COSF^T<QG,UR#LNY+.>QG,]R Q7,QR"<8=Y??T(+_%#=36G'ZPE.QTN4F+ M)TGNO9>4GM+KCG.TB,IR*LMI+*>SG,%R)LM9+&>SG,-R+LMY+.>S7,!R(S7()Q[="7#]JK2SG MLUS BY'K YRM MSNZX\Y/WZ+@ZRQDL9[*&$A.93F-Y726 M,UC.9#F+Y6R6.(O/]FI13MUSA[/X@^[\9ANS*&>PG,ER%LO9+.>PG,MR'LOY M+!>P7,AR$L_N;ZBOQ3#[;CT4YE>4TEM-9 MSF YD^4LEK-9SF$YE^4\EO-9+F"YD.4BEHM9+L&XHR/ 08E6GKS13#[;NT4Y ME>4TEM-9SF YD^4LEK-9SF$YE^4\EO-9+F"YD.4BEHM9+L&XHP/#03M7%K=S M+YS:8>NX**?NN<.IG5=.L&>+MBAGL)S)Y@.5"EHM8+F:Y!...#@<']5I%?IMY'H7MV**R_DL%[!4,EC/W7.O6AOVN>QNBX]HLY["R_DL%[!Y@.5"EHM8+F:Y!...HOV@95L]?ILYFP%[8" YE>4TEM-9SF YD^4L MEK-9SF$YE^4\EO-9+F"YD.4BEHM9+L&XHP/#0ML&_CKX_D; MZ:Y8W4N_SHOZ\]SJKX-E>I._M6N^'?%!=!0 URD !D !X;"]W;W)K&ULM9IK M;^(X%(;_BL6N1K/2JI!P*70 B2;.#*N%HC*=T7YTP8!WDIBQ'6BE_?'K7)J0 M-C6P>_C2)L'GL7W><(Q?N;_GXH?<4*K04^"'WEPS]8;%3^H#_M;LJ9SJAZV,Z'OZCEER0(:2L9#).AJ4!M9-YYM MQP%)BV^,[N7!-8JG\LCYC_AFO!S4&O&(J$\7*D80_6]''>K[,4F/XV<&K>5] MQH&'UR]T+YF\GLPCD=3A_G>V5)M!K5M#2[HBD:_N^?X+S2;4CGD+[LOD+]JG M;3NZQT4D%0^R8'T?L##]3YZR1!P$Z(E6!]A9@/TJH/E>#\TLH'EJ0"L+:)TZ MI'86T#XUH),%=)+$\?:,07Z$Y6X=LQ18D5&BT6/ H5"QFFC"0[61"(=+NJR(=\SQ'4-\7<\XG[;],NU;VPC\(PJO4+/Q M.[(;=A,]S%WT\=>J>3G_ 9/)1D4%SSV=9Y_"P^>,SQF]-TWOG&%58DHJ-/.7 MKYEPF^^]? ^3R>C^+W3GH?GX\W3LC9W1]"L:.<[=P_3K>/H9S>[^'#MC/*]Z MY5)VJYH=5^0;N24+.JCIDBNIV-':\,,O5J?QJ4IG2)@+"<.0, $5E*[E:O= M,M&'#I&;*AV-4>?J" ES(6$XA7426+S>[X:-?GUW*(ZI12GC[3SC;6/&[^F. MAA%%:B-XM-X@%NZH5/IW@=*7B*"_.=.7NHV*!*V2QH@_5YKVF^E=]RR[VRYG MP7W;S+8:O8[=*;?#D&/S@& EE3JY2AVS2O@;GC[@JOQWWJ:LW>UU6^54.&FS M]I%F[MMFK]Y ;!SHN3D%@I5R>IWG]/I(K0G)DJ!QN*A*JS'VW-<:$N9"PC D MS ."E=3LYFIV+_@[H0NI-B3,A81A2)@'!"NIW&4:=I%#Q2$>\<7S8H2'&TW_ :6V8H$AD2C*))/>7 MZ!_35N;6W-VYNF6TP]6N^TJSBB;-5W*!CLF#HI4%.]CJ6T;!O$B$+/[2H \D MV'[2RNG=/D7T9\2V\=>K4A0C\FQ1(&DN* V#TCPH6EEJNY#:-JZ8'GNB2S22 MDBJ)2+A$#MDR17STG8L?^F<1F@F^UAW+2LUM4,TA:2XH#8/2/"A:6?/"3+&, MN_5"TLN:%)669/:G3JS6H^01*'KE2/$@N M-Y0LJ8@;Z,]7G*N7F[B#_"SG\%]02P,$% @ EX$)5^,J^ 3T 0 Q@0 M !D !X;"]W;W)K&ULK91=;YLP%(;_BN5-4RMU M,1]IUF6 M"::UDF3HD;=KATX!*O&9K8)[;^?;0BB:MKU8C?@8Y_GY;S&QTDG MU;VN QZJ+G0*:Z,:9:$Z+R"FNJ9;$#8E5*JFAH;JCW1C0):>*CF) J"!:DI M$SA+_-Q&98EL#6<"-@KIMJZI>KP&+KL4A_@X<4*,_81+)/D@=]W+12_(_6C%#,7!!8J"*#Z!K]Z.1T]Q8HV-[J+1 M7>3UXG^Y.^6D1^>G4=<]2]W0'%)LVT.#.@#./KP+%\&74[[^D]@3E_'H,GY- M_767/;KPJ&OI0Q9>A?//@=W>P]3 \[Q@S.BK(I-3YCK$U5[)C3B4%HFF'VZ MQ$CU7=,'1C;^X.VDL6QZLK^PM02P,$% @ MEX$)5W>JR&"@ @ @H !D !X;"]W;W)K&UL MK9;_CYHP&,;_E88MRUUR$P3QRPU)[C3[EBPQNMM^KO"JY IE;17OOU];L-.) MY+SPB[3P/D^?3Z6E04'9,]\ "+1/2<;'UD:(_-ZV>;2!%/,.S2&33U:4I5C( M+EO;/&> 8RU*B>TZ3M].<9)98:#OS5@8T*T@208SAO@V33%[>01"B['5M0XW MYLEZ(]0-.PQRO(8%B*=\QF3/-BYQDD+&$YHA!JNQ]="]GXQ4O2[XE4#!C]I( MD2PI?5:=;_'8FZT6M(DF?H7%X+) MIXG4B7"!"7#T$^_1'"*Z X:7!!#.8C3#+[I],P6!$\)OT4?TM)BBF_>W@2WD MT,K CJIA'LMAW O#?-]F'>0Y=\AU7*]&/FF63R&2\JZ6NZ=R6P(;:M=0N]K/ M>RMU'6%IV:NW5*OMGN2 MGOVCOT-K1CFO R_=^MI-[0J[L.MXO<#>'0.=%SFFXB1ESZ3L-:9\('*'P5D$ M2*[V'29;^0?%,<3_!Z]+7#K[M6'*N$T5)W%]$]=OC/M%S1[B9FKSRR]2H]&U M+Y)_-N^>[_J]>IB^@>F_ D:_)W4 C>)K 5HR.^$<&,Y!^_O H$WZELQ.Z(>& M?MCJ/C \6S,U^T#CD&\$&AF@45MK<-2P794@C4-="V(??:'5Z>@'9NLDXXC M2MH[G8&<55:>.,J.H+G^:"^ID$< W=S(0QHP52"?KR@5AXXZ!YAC7_@74$L# M!!0 ( )>!"5=34,MV 0 %<7 9 >&PO=V]R:W-H965TV.+V8LEW&4TCL. M1)XDA/_^2&-VF%O0>KKP/7K827W!7LPR\D#75/[([K@ZL^N439305$0L!9QN MY]8-O%XB3Q<4=_P=T8-H'0.-O9W94HVB[[7#*O%CF8B>2?PS3Z\ =MX!Y"#<4[XTEZ]HJ,IA M48Z.RVW%5@.B&A 5>?@YP"__WJ[ S7I]^]>Z#Z:L=ONK]2*Z%AD)Z=Q2JT10 MOJ?6XO4?T'<^]*&-%'8$BFM0;$I?+)F0?8!EE5]4Z46]7TPA#!S?F=G[=N_& M](&]NW7OKK'WFS#,DSPF4LW%#54#A!'1J[R/ITSR6CSO,7;Q!'DG0,8A!P)Y M-9!G!"J7%2F6U3N0TMXGXW5(O"# ")^">)TGZ'F>BUK 1SWZ=8^^N<>NDB&2GLB#FHF8.SW@;!F* CA1V!3FK0R:"WP:0S MYZ#KJ:F$3N:<,7U@[].Z]^EH;X-I]VW@3N#4A2<\QA$'\D"G^9%USG\=5!EM MEFG@8'B*8AYK*$M+&*"1Y1L)=^H2_UV]-FY_Y5&FQ*Z?R9CUT@4U5MHQ>6,2 M\#R5@*.ZQ%AIQ["-3CW&HH2B->D"S>ZS95AY(OVR82U^\C"ZA&[#Q M#7B><,!1C6.LM&/8QCG@,.F 7>MPL>?ATSEY">F C77 \;0#]GD'=J>=-\8E MO ,UWH%&\ [4]0[_]-&8QQG*T3@',CO'5TH$W;%X Z(DXVQ/M6^(7IA1A6.L MM&/LUM;%F7L7XVY>7$(X4",<:)APH*YP^!,/.E/W=(Y>PCA08QQH/.- /<:! MG,#Q_0[4)90#-&ULK9EKCYLX%(;_BL6N5JW4'<#<)K-)I"1<.EV--&JVW?WJ!F>""CB+ MG0VSP>,^*KWQ#J4 O69KSB;818GNGZWRU MH1GA-VQ+<_G+FA49$?*T>-+YMJ D+D59JF/#$N>Z)**3]O'0I[I#25.,IKSA.6H MH.N)-C/O(M-2@C+BRK.KF/)YJA>D13NA(*0>37,UW0-%4D MV8]_:ZC6Y%3"X^,#/2P'+P?SA7"Z8.G?22PV$^U60S%=DUTJ/K+]>UH/R%&\ M%4MY^8GV5:PM@U<[+EA6BV4/LB2OOLE+?2&.!-@](\"U '<%^(S J@76I1GL M6F!?FL&I!4Y'8'IG!&XM<+N":59U=4MK?"+(=%RP/2I4M*2I@]+? M4BT=27)5BDM1R%\3J1/3,'FA,9IQ3@5'OZ-9'">J1$B*[O.JT%7!O/&I($G* MWXYU(9,JJ;ZJ$\RK!/A, @L]L%QL. KRF,8]>G]8[P[H=3G89L3X,.(Y'@1^ MV.4WR#+>(6Q@"WU:^NC-KV_16OSVB^G=_M'3P<7E/'S@]8T3N%L!3+?"8J367?7*.W$"!A/B0L@(2%D+ ("-8J#KLI#GN( M/IW)R1FQ-4I)'J/_ALIW7H&<$J2F[^>I;1N&,=:?CPM@,-VU!7!1R@ R97A1 MRNA[42TOG,8+9] +G\H.KI)J/J$O]$Z=[4@:0*4-(6 0$:QE]VQA].VCT@N3R&;+/ MR$'=M6L?2)@/"0L@82$D+ *"M,SOS0\Y^9,56W2?KWJ='=1?[2PDS0>E!:"T$)060=':58)?JP3_ MU'11RZ&*!)+F@]("4%H(2HN@:.TB>7W79@Z^K?F!20/T]1LHS:]IK5<(#N[. M&*=!GFEWIPO0%V90M,IC_6AK(*/%4[GKHYX(=[FHWK(VK2/&4Y!RE="U3&3>>G'>+:F>H.A%L6VY,?&%"L*P\ MW% 2TT(%R-_7C(G#B4K0[,]-_P=02P,$% @ EX$)5_X&%X5+" S%@ M !D !X;"]W;W)K&ULM9QK;^,V&D;_"N%=%+- M-Y8HZ^)I8B"QKH,=8##3SGYF;"96JTLJR<[DWR]UB67*"F-UG_;#Q';T'E+5 MB43QD7G]G!=_E#O.*_(C3;+R9K:KJJ>/\WFYV?&4E5?Y$\_$;Q[R(F65>%L\ MSLNG@K-M4Y0F??2E6U_F^2N*,?RE(N4]35KS<\21_OIGI ML]^YDE2DT0__NR@LV.; M=>'IZU>ZW^R\V)E[5O)UGOPWWE:[FYDS(UO^P/9)]35_#GFW0V;-V^1)V?Q+ MGMMMK>6,;/9EE:==L>A!&F?M3_:C^Q]Q4D#I&P6T*Z"# MUXH\#H"HQ+6UAT M!8M+"\RNP+RTP.H*K$L+[*[ 'N[TXHT"IRMP+FUAV14L&QW:X]<0[SZI]PUV&]<6 MLH1$6?NW5#OYP>45BY/R7]?S2K1:U\XW70MNVP)]HP6+?,ZS:E<2+]ORK5P_ M%[T]=IF^=OF.*H&W3\45H?;/A&K4(+]]<\F'?X[U:ZW&?&8O1%\T%&ULK]35 MG_;9%3&T=SOA3<&L;]_"^)=CJ*(W :8WX24'R&DQ(^61NMSE&]$+7;4SDC?& M476CX1J7J/XS^?1]G8]T[JZ%+,8A];7G8_G$-OQF)BXN)2\.?+;ZZ1^ZI?TR MIB 2YB)A'A+F(V$!$A8B81$()MF[.-J[4-%7O_(B)?D#J7:<)#G+QM15$J:J MJ^Z.25XX*\HQ39&]\) P'PD+D+ 0"8M ,$E3\ZBIJ?3B*]_D!UZ\U*K&V8&7 ME1@95V.R*CE3947"W!9F-;#Z9N&P6AA+:R%&"8=3-9%M^N=MZOI2H[8M-QH@ M&PV1L @$DZRSCM99[UB7<'''0UBV)26OJH37UA&6YGOQXZ'(4_+KKA!W563- MLHS=QV,GKCOK[!C8MF4X5#X$:V57IKJ&A'E(F(^$!4A8B(1%()BDK7W4UE9J M&QU/D.)<27YOQJ>'=GPZYF<+,T_/$6* ;6G.0%!EHU,%1<(\),Q'P@(D+$3" M(GODK&2:)Q<&23WGJ)[SWG6:QP=VG_#V]/BN?,Z9?+9FF\I6I[J'A'E( MF(^$!4A8B(1%SIE[EJ'ICC;NWO+HWO(=]^I9V#A[)/1JU4%DZ]YX;27"C-@])\*"V TD(H+4+19'5IKRY%3-%W%)3'2)H+I7E0 MF@^E!5!:"*5%*)KL<9\TZ[3)EV=[R@&$="4"4ISH30/2O.AM !*"Z&T"$63U>T3*-V$#"*@ M 124YD)I'I3F0VD!E!9":1&*)GO<9UJZ.M3ZDA>O\PWYOBHK,9@XG3,[>1: M/.Y9P;**\RWYP$K"R!,O-N(/8.SAG3MULY/%;VG.R2!%NQK,5_>NU/G0O B@MA-(B%$U^LK]/W*@Z'>HB[[2;,1B?' MU*"IFD)I;D<[G;BCIJ%1:_ $(;15'TH+1O;!,,RSN<<0VFJ$HLGZ]=$954=G MG]F/.-VGKQ.UXDSYUEE2#9JL'S1*ZVBGAVZI688U?( 5VJH/I04=30K0J::- M^ ?-OU TV;\^_Z+*7&(5B7MXP:U(P2I^P:V\&C?90F@0UM'DB0'-UJ3_]*&2 M?Z'(A_8[@-)"*"U"T60]^UB+JF.MHYYQMLG3T0=?U(3)1D*#+7J>ISD6=88* MCJ1NND670^F@2124%D)I$8HF2]7_NX^I%G.R.9[WW'_SK MD,KI\+6ZWJOROU=P7QZF8GBP^-BSJ:/'-ZP<.E:MAD^: Q#Y3F06D^E!9 :2&4%J%H\F(]?11D:(C1@P'- M@: T%TKSH#0?2@N@M!!*BU TV>,^4S+4F=)MFR6ULU=B7'#9UZW5T,E:0_,E MXSQ?TDW;IOK@N[C>R(94I^9BN*2&#^U? *6%4%J$HLDR]@&3H0Z8+E^>1PV: M+" T6NIH\DH8NK-<#@/VL0T-VZ"Z,Q00&B%!:2&4%J%HLH G:_#]WQ&2FC#9 M/.P2?.?AD&DZ9SYY(]O9)J768N@==N4\[-)YV+7SH"G2_&3%TY07C\URN279 MU)?:=B71XZ?')7EOFX5H!Y^[^D>_75BWQ[3K_'YFQ6.V;ZK\J5E7]3ZOJCQM7NXXV_*BWD#\_B'/J]&ULK9OO;^(V&(#_%8M-TTVZ*[;SNVN16D("D6X[776WSRFX);H0_OK MYX04B./ZPO9^:4GP^]@QCV/'+UP]\_);M69,H)=-7E37H[40V\OQN%JNV2:M M+OB6%?*=!UYN4B$/R\=QM2U9NFJ"-OF88NR.-VE6C"97S;E/Y>2*[T2>%>Q3 MB:K=9I.6/VY9SI^O1V3T>N)S]K@6]8GQY&J;/K([)KYL/Y7R:'R@K+(-*ZJ, M%ZAD#]>C&W*9$+\.:$I\S=AS=?(:U9=RS_FW^F"QNA[AND4L9TM1(U+Y[XE- M69[7)-F.[RUT=*BS#CQ]_4J/FHN7%W.?5FS*\[^SE5A?C_P16K&'=)>+S_QY MSMH+DN=5\Q<][\MZ=(26NTKP31LL6[#)BOW_]*7MB), ^E8 ;0/HT "K M#;"&!MAM@#TTP&D#G*$!;AO@#@WPV@!O:(#?!OA# X(V(!@:0/#K)X<;@_8? M>>-+F(IT%0)]9878E0Q] M0'?-.,G^8142:[;7-Q,_$']HCK>LS/BJ/DJ^3CEZ%S*19GGU^]58R,;4R/&R MK?AV7S%]HV*"/O)"K"LT*U9LI8D/S?'6S^(C<[QKB!_+3CST)'WMR5MJ!-YL MRPM$O?>(8FJA+WO>KKE^FYV"F-V]A0C,FV147R,(_;G:^K+;IDEV/ MY/1;L?*)C2:__4)<_(=.;4A8" F;0<(B2%@,"9M#PA:0L 0(UAD*]F$HV";Z MY"[-6:63WQAVKOR0L' /@ M+E&4A*PS&E9G#%GG'!*V@(0E0+".O>[!7M=H;USRJD+;DC]D0N>M,?I<;R%A MH=MWR \\:BG>0M89#:LSAJQS#@E;0,(2(%C'6^_@K6?T]B_YR)HV6S'L9=/4;HX8$><*!PD+_9Y)@6OY MQ%6$\WN*4-MSL2IG?; (Q4&@& =YI0M(6 ($ZQ@7'(P+S"O+ MM$C+'SK-C''G:@8)"R%A,TA8! F+(6%S2-@"$I8 P3KV$WSR0_[;KU<9U-GH"0GVG.]E.->4( M=GU/G95#2%H'2XI;66?80'+A461[--7U'79\$CM+)"]#V)5"TKG+T MJ!P%V.)J(:>=:#L!]8CJ7[^<2[%EVZI^QD:=K1\D+0*EQ9H>(=CV/-=3]=,4 MM"R**5;U@VQ? D7KZG?,>!%C%N&G>U1M>&=;1G8*L57Q^N7D$[>MCMW0W)RS MQ0/-48'28DV/R*F ^([Z@*8K:-E!8/7N>Z#9)2A:5[QC?HF8$TS#-IE:2&?R M\.6C=:#JUR]G^9;E^*I^D*F1&2@M J7%FA[QG,!SU0TI3;G =7R?JO*!)I6@ M:%WYCFDE8LXK#=IO(OU,BETO1U3U^L5>:AYD6F,&2HM :;&F0RPYBP:] M]9ZFG&]CQU+- TT(0=&ZYAU30L2<$YKEV6-VGS-4LB5_DK? ^K7Q#MC/B\AI M!,N;F^HA: 8(E#;3741 L6LI=YD(M-IX:+5ST&H7+:WS$&A;'G:415.B*4AM MS\'V<5G?U>R8P2'F%,[G$[O2#=\5^L5=/VGQAEN@^1E0VHST\SAON 59;:SK M.[U;H"D?W=7JW=*DMXQN'7,UQ)RL69Q.G*A>P'W?94*[ETXTN0P;![ZJ5[^8 M11V[MV<"F7V8@=(B4%JLZ1#BR,=67W5+4TY*J&ZM+$!;ET#1]OZ-3[Z)O6'E M8_/-_PHMZYO6_OMJA[.'7Q?<--^I5\[?DLLIT9P/R>5,=SXBE_/];PJ.U>Y_ MXO Q+1^SHD(Y>Y!-P!>>'.7E_E<#^P/!M\WWP^^Y$'S3O%RS=,7*NH!\_X%S M\7I05W#X[<;D7U!+ P04 " "7@0E7>LF, T " 8!0 &0 'AL+W=O M'?[^R$J&*AVI?89]_SAR4NLN1FI!B7MK)6NN:50;T+3:.2%!]55R*)H&M9*?!;.N:Z]<+K-1^$<3!V\*]V)36+819VO -/J!];.XT16'/4H@:I1%*@L;U M(EC&\XO$Y?N$)X%[^=JIEQ0U>JNJ/*&RY"&8!%+CFV\K>J_TO[.KQ!G-5&?^%?9<; M!9!OC55U!R8'M9#MR _=?S@",/8!@'4 YGVW0M[E%;<\2[7:@W;9Q.8FOE2/ M)G-"ND-YL)IV!>%L=JN$M/"$TFXUPO?E1B/2/[? 90%J9>E8A=Q '$70H,YI MAXX*3,DU&E!KL"7"[=.E@K,KI.3*?$U#2[X<>YAW'BY:#^P##\M&CX"=?P,6 ML3$\/ES!V>=W-"&5U=?&^MJ8YQW_3VU#MEKX9!CNVF%N&I[C(J#[;E#O,,B^ M?(JGT<\3YL:]N?$I]NQ&[LB8TJ]#QEKHU$-=6^VR>/HC&D]G:;@;T)STFI.3 MFM?B@ 5P8]":(=D6G1S))N/)+)X.JR:]:G)2=>GUJ/]>MD)C,22<_%,O8RR) M9Y-WRN'117=OQF^N-T(:J'!-R&AT3D2Z[<,VL*KQ=W^E+'62GY;T=*%V";2_ M5LJ^!:Z=^L&ULM9IM;YM(%$;_RHA=K5JI:Y@!#,G:EEJC M=MM55U&CMI\G>!RC .,=QG97VA^_PTN L?$DN#?Y$(/-?:XY'JZ/+&8'+AZ* M#6,2_+K:"T555E*4V<9RI MG=$DMQ:SZKD;L9CQG4R3G-T(5.RRC(I_W[&4'^86MAZ?^)+<;V3YA+V8;>D] MNV7RZ_9&J#V[35DE&HNO(Q*6!=41WQ)V*'K;J#R5.\X?RIV/ MJ[GEE.^(I2R69015#WNV9&E:)JGW\4\3:K4]R\+^]F/Z^^KDU?H] M6?U( M?S0@>@7X7 %I"LAS"]RFP'UN@=<4>!69^E0J#A&5=#$3_(!$>;1**S5>W(6?:?*9B@AS\!A$'7PV4+\WE;W?WJIQ4 MY>% >60N_[3+)X@$0^6VXM5"(RTT4N5Y9_*6-,_I7UQLT<<\'H)A+"\OY>MB M2V,VM]2U6C"Q9];BMU_PU/EC" UD6 04IF%S6VQNE>X^L=:&B+F0Q"##(J P MC9C7$O.,"VWXDASB5^=,JYQRUN\7GC,EH>?-['T?C;'?6#1 81H:OT7C&]%\ M2PJZI^A^D*.'X;X&7/&\H,,B^HPOS<:B.\[Y5\[&S0V8>Z. P]HD^Z"*BIAN:J17-E%H3>8D'_H2=]P9@V%A!D6 04IE'$3B>G MSL4#JRD%@@::%D&EZ=AZ3H^!IE83U!\.KN,Y08"/+J>EN>5H0$!I.J#.W[%9 MX&\W5#"T%4G,!JG4U1CWL#@3[(3'3$#5'"I-9]+).3::[.(]303:TW3'>@OG M]NS"<4_'L-)-QW6/&8'*.%2:SJC3<6SV\:.Y;G90<];H 05J[E!I.L?.W;%_ M^5P'=7?0M @J3]']M_2M;),V7=W&4TDY>0==+).ADCZX=Z? W2.?7T( A#C(_I M@&HZ5)I.I]-T8M;T;IR;#=T<,WHH@1HZ5)J.L#-T-ACADZ,Z0H4/UU0%UADY^RM#-U:.IG#%T_YC)2Q@ZZ0R=C#%TTS ' ME7,R).?$=:Z.?TF':EOCL7LW*Y2WEGRFXC[)"Y2RM8IW)H%:Q**^6Z/>D7Q; MW;]PQZ7D6;6Y873%1'F >GW-N7S<*6^):.^96?P/4$L#!!0 ( )>!"5># MQ>&QH \ "[B 9 >&PO=V]R:W-H965T \6+="-15*4Y&YBH#'G;1==! E.#_8C(]$V$;WXD%22 OWQAY)H MC8:2QJ9RGWYH'8=S#5T_ID=\2.KMMU7YI7K,\SKXOI@OJW=7CW7]].OU=35] MS!=9]6;UE"^;O[E?E8NL;OY8/EQ73V6>S;:#%O/K:# 872^R8GEU^W;[N0_E M[=O5NIX7R_Q#&53KQ2(K_WR?SU??WEV%5\^?^%@\/-:;3US?OGW*'O)/>?WW MIP]E\Z?KO3(K%OFR*E;+H,SOWUW]%OYJ)O%FP':+/XK\6W7P<;#Y4CZO5E\V M?S"S=U>#S1[E\WQ:;XBL^<_7_"Z?SS=2LQ__;-&K_9R;@8EY_7'W3>?L%)1MONII7VW\'WW;;CL=7P71= MU:M%.[C9@T6QW/TW^][^CS@8,(S.#(C: 5%G0)R<&1"W ^+N@',S#-L!P^XN M#I;4&ZV;K3-!]L$;4F.7NQV@3QY_2O,Z*>?7SV^NZF7 S['K:XF*'1V?P4?#[:ED_ M5H%8SO+9B?'2/SZ,/,!U\Y7NO]SH^@F'"=OK[\>AO'49G$8CMW-%+EKFL0,A#DQ2_8Q2[PQ^T=6EMFRKH*G M=3E];!:YP5_G#^3OO5;?X)%82F)BAR4'B1I'81B%<2=YY*2*Q#2)&0AS\CG: MYW/TNGSFW_-R6E3Y+)BMRV+Y$-2/>?"4E\5JYHVLE^\;61)+24R0F!P=Y7_0 M.9B^N(5^<0L#[;(3J_$^5N/7Q:JHJG63J7IE#X#MPGUU'TQ7BT7S@JUYS3C] MX@V9=[*^(2.QE,3$^.A[&@Z&@^:?2>? >+QA$M\DS89A)T?D[FD2,Q#FI'.R M3^?$F\[WZZKY3%4%V?2?ZZ+:GD0(\N;#^L^@6-9Y,V.]36[V>;X]"$[S99T] MY*>BZ9VI;S1)+-UAX>#P$/%F.(HZ"S=!3BI)3)&8)C$#84YZ;_;IO?&F5Z[* M^[RHUV4>E%E],I1>H&\H22PE,4%BDL04B6D2,Q#F)#<]9'* %$ZJEJ"903:*:0C6-:H;2 MW C;-BH<7;XX0*LF5$M13:":1#6%:AK5#*6YX;6=5^@OO;#% 5IWM5H8NTN- M[@("+;)03:*:0C6-:H;2W #;6BST]V+N J+)Z>_%LEBL%R=#BA9?J):BFD U MB6H*U32J&4ISPVQ;LO#F\J4$6I"A6HIJ M4DJBE4TZAF*,V]Z-_V9)&WRL"6 M$NTTW5_^G0OM[OQ[TS?!J"903:*:0C6-:H;2W 3;LBSREV7':XGL^[FUA)_J M>SA&M135!*I)5%.HIE'-4)H;9MNY1='%:XD(+=Q0+44U@6H2U12J:50SE.:& MUQ9ND;<3X=82\&41OXDZFZ7^/>V=1[1D M0S6%:AK5#*6Y>;0E6^0OV3X6U9?@OLQS>Z?.N;L@_%+O8RMZWQBJ"523J*90 M3:.:H30WR[9OBR:7+PS0?@W54E03J"913:&:1C5#:6YX;;\6^6]#^Y&%P)!EUU@PO;Y+Z][%W$M%:#-44JFE4,Y3F M)O'@D87^6FR_$)@57XM9OIR=/8_@AWH?5-EG&+(/,62?8L@^QI!]CB'[(,-_ M1S\6VWXL'EZ^(D#;,51+44V@FD0UA6H:U0REN>&U[5CLOVOM!\XCQ,'E35+__O5.(5ISH9I"-8UJAM+<%-J:*_;77'?9C)KZ-UG MJ):BFD UB6H*U32J&4IS$VR+L7A\^2( ;<)0+44U@6H2U12J:50SE.:&US9A ML?_.LP_/#P>=KI95\VJLW+Z5P\DH[Z##QU$/!Z-H,AQV?_.CE1>J"523J*90 M3:.:H30WI;;RBE]X\F)6E,'7;+[.-T^O7>;U?L5:G+YDMO6<&.:^T@K^"N]U#P'>/M=NO YX?('XRO6C)A6HI MJ@E4DZBF4$VCFJ$T-^*VY!I>?KO8$+U=#-525!.H)E%-H9I&-4-I;GAM+S;T M]V+_MUY\SLO- K=]HP;?&S/XK=YI1JLQ5!.M=KADB@?#P;A9S'??+PFMO5!- MHYJA-#>I!^_@Y6TF>IPT:*&7OWEW_BE[1Q MN%!-HII"-8UJAM+IM@$;4@V8'^H=T^,^+8[#R638O6@6G5:@FD0UA6H:U0REN2FU M#=@0;L#\7N^PGNC3QDF31;NSL-W3L.B\$M44 MJFE4,Y3F)M6V7ZU^"W'VBO=VFVF]4O?@0 M9?_TO<.--F:M=G,0[J,WBA+HE!+5%*II5#.4YN;:%F&)OPASE\?9,BO_##Y^ M/W=1@A_KG5*T"4,U@6H2U12J:50SE.;&V;9ER>5/3DS0?@S54E03J"913:&: M1C5#:6YX;8F6^$NTUU>]?JAWE(_;L]-5+SJM0#6):@K5-*H92G-2.K+UVOU>W[".CCNUDU4O.JM -8EJ"M4TJAE*<[-J*[61OU+S+0?\0WO'\K@, M.EWUHM,*5).HIE!-HYJA-#>7MD4;^5NTUU>]?JAW2M'2#-4$JLE6ZUR^EHR[ M[S&AT&DUJAE*S'M4/NZN3C^QSC]'[[RA31BJ2513J*9; M[?"T7.<".7-BDV$R2<:#Z'2.QK:Y&ON;J^?KO/>'PUDP6Y>;5U7U8W-HS,MB M-?->@>CW^QX!42U%-8%J$M74^+@![&1(HQ,:2G-C:TNL\>M*K,VO[3:DQ7): MYILK!7Z:Y;N/?CZ9UQ.EU.@F#KMOI^C?@=Y)1!LN5).HIE!-HYJA-#>TMN$: M4PV7'^I]4$4;+E03J"913:&:'A^W;]U?\R3Y"8ZLUP\ MMI2;^$NY@[O&LV9!L7C:/-J@.G\P1ANX5@L'SN_[030:=6[.1:<5J"913:&: M1C5#:;NH7E>/>5ZG69W=OEWDY4-^E\_G53!=K9<-OSGZ[C\;E/E]$^7PU]^B MJ^NCS\OP5Q-N/G]MF=NW3]E#_GM6/A1-FN?Y?4,.WFQ.6V\OJGW^0[UZ:N)W M%7Q>U?5JL?WP,<]F>;G9H/G[^]6J?O[#9H)OJ_++=K=O_P502P,$% @ MEX$)5Z"S74<*%P DX0! !D !X;"]W;W)K&UL MM=UK[XC7M[=E_4=YY>?'I.[]$M: M_N,QS*N?SE^4Q?(AS8KE.I/R]/;SV97\,9XJ]0+;1_QSF7XO]FY+]:;>S0;U&Z2J=ES615']\2Z_3U:J6JO7XSPX]>QFS7G#_]K.N;S>^VIB; MI$BOUZM_+1?E_>>SBS-ID=XFFU49K[^;Z6Z#QK4W7Z^*[?^E[[O'#LZD^:8H MUP^[A:LU>%AF3W\FO^V>B+T%%.65!93= LKA K-7%ACN%ACV76"T6V#4=Y7& MNP7&?1>8[!:8]%VEZ6Z!:=\1+G8+7/1=8+9;8-9WE>3!\YX;]!U#?MG9O?>V M_+R[Y=[[6W[>X?+1'I=?6^1YE\M'^_S519YWNGRXUT>O_E-_WNUR[_TN/^]X MN?>>EY]WO;S=]^=/+\7MZUA-RN3R4[[^+N7UXRNOOK$-@^WRU$\32$\LH00\E;9^5](6G9(EUT+&^+EY^\M;PG7EY6!,!Y M]7R]/&G*\Y/VLR(4]?3F)TF>?)"4@3*4KJ]4Z:]_Z7IBKL7,U>:N8D9;9B#] MX\N6D8K[)$^+#DT]1=NMU.N:)M;L359IX_:Z=3#Z*U^$^__EH).'SYM3'$SFZ>>SZCB\2/-OZ=GE?_^7/!G\;U? DIA*8AJ)Z21FD)A) M8A:)V23FD)A+8AZ)^206D%A(8A&)Q1#6BN'12PR/1'KU6^BFE-:;LBBKU%UF M=U+RL-YD95?L"J%38Y?$5!+32$PG,>,)FVRQ>C;IV^5P.IU^.O^V'Z?DB!:) MV7U6WR%'=$G,ZUC]R4QIK[Y/CAB06$AB$8G%$-:*O_%+_(V%\1>4]VDNQ>D\ M77Y+;E;I!RFY+:M[KE:K]??Z %2Z7>?2=9XNEJ7DKHOB@]0ZE+ MKDV%N>9OZKB5UK?/\[[+HMA4:?S[ZU.V/PO%4W..Q%02TTA,)S'C"1OOO; G M\G2@C&>SV4'4D<-:)&;WW@:''-8E,:_W-OCDL &)A206]7Y"8FC85N9=O&3> MQ=NSCG7.;=]BS]=%YX2CT#@UY2Z.CQ+&\E@^^/6ODF-J)*:3F''\;,C*<#PZ MR"YR2*MKR-GL8$B[8S>-IN/#64)RQ=R+HY>,,E%&!X>/'CFD3V(!B84D%I%8 M#&&MO)J]Y-5,/$VX]P')S=,GT_4!V^(HQCJ/UH3VJ3E&8BJ):22FDY@Q.WJ% MRX/I>'SXKI0+#FJAFMUO$QQT M4!?5/%3S42U M1#5(E2+*:T=H'OGV,NG!VBVSOXN"E$A>7*(DIJ*:AJJZ:AF M[+16 DTN#C^=,-%!+52S^VV"@P[JHIJ':CZJ!:@6HEJ$:C&EM4-4:4)4.>D3 M9&F=2:MUDG6&IY Z.3Q)344U#=5T5#-0S40U"]7LG;:?L:/9Z&(R/@Q9Y6B" M=#(>R[-!^W$NNG8>JOFH%J!:B&H1JL64UH[/IK C"T]$O[R:S_/Z@^EECQ-Q MQ-3)\8F6=%!-0S4=U8R=MA\JLY$L#P\_YT%'M5#-[KD-#CJJBVH>JOFH%J!: MB&K13FM_9CB:#$8'$]\Q-6P[&9L.3=W_%R7CMC-3?R*4++YMWZ$O,ZE(OU5O MS.^EY"'-%@^OO4%#_U][ :_$*G)R I*:AFHYJ!JJ9J&:AFHUJ#JJY MJ.:AFH]J :J%J!:A6DQI[CNR^)QUMPK5-/^?0KI-NP] Q]W!>IBK:($& MU314TU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4BRFMG:M-R486MVS^E>1Y MDI5%]>8^S>?+HGJ_O]CD]7E/Y7TJ/:;YT(U6)*:\=CT]61Q66=ZR3+ M$F>=/TI6-N^,/[2:@VHJJFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H M%E-:.W^;WI#\=)K_.WQKG(S6B5!-134-U714,U#-1#4+U6Q4YQ4;&[^+YV74KG>GF E%6E9KM)7 M/P1#"U*HIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%NZT_<][+N3IQ732 MGMN(T%%C2FM_AWQ3JU+$M:HP^5%G:GWBP;PZ!%XN=M\[5Y]^,$^*^ZZP%9.G MABVJJ:BFH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA3MM/VQGX]%P>G!.7H2. M&E-:.VR;"I8BKF!]:7T[4_VUH,U1K? 3,;%[M M;Z&:BFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:J!Q7\KHS%RUY45H[=7?3D:'7\L=HPK7R?XVG<1B+63@Y;45%33 M4$U'-6.GM;Y:=WS4*#%W#YN('V:AZV;W6S<''=1%-:_?\^:C@P:H%J):A&HQ MI;43KZEK*>*ZUI^N%8C]DS,0K7VAFH9J.JH9J&:BFH5J-JHYJ.:BFH=J_DX3 M-1#0 4-4BU MIK1VZ#9=+D7H6JJFHIJ&: MCFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH4[;;:?_S_)X\-W\V@GC-+:,=MTPA1Q M)^RYD_"X[234MZN;3R=F/:99LBJ75?:^?EEEL7YRZJ*-,5334$U'-4,YOG". MTO7N?GKT+K7C81:Z;C:J.:CFHIK7;R_XZ* !JH6H%J%:3&GMH&S*6XKXJD\O MW[]:5[5NDNRK-*^.1>]>.1A%ZUJHIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^ MJ@6H%J):A&HQI;6SN*EK*4_5A'.^B:^>AFH]J :J%J!:A6DQI[=AL MZEE#<3W+2[+D[JD8\*7"EZ\V^%@X[KHIK7M16#X6@R M.KQ,HX^.&Z!:B&H1JL64U@[)IIA5W12%I+_.JP/41?(@>4G^-2WK@H*5S7_J MC$B %JK9;Z^^@P[HHIJ' M:CZJ!:@6HEJ$:C&EM7.SZ8D-Q3TQXY2D:\WCYU9B7;!4$U%-0W5 M=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58DIK)W!30!N^V]7#AF@=#=54 M5--034U -5"5(M0+::T=C(W=;2A^.IA?^#L M!+2%AFHJJFFHIJ.:L=/:A?W)8'PXM8#6RU#-[K<)#CJHBVH>JOFH%J!:B&H1 MJL64UHK04=,;&[UQ,;!-/K]/BE2Z6Z\7Q0?I6[+:=);'Q,ZIR8EJ*JIIJ*:C MFH%J)JI9J&:/CDMAAW.WZ( NJGFHYJ-:@&HAJD6H%E-:.UR;=ME(W"Z[=JW. M*$7;9*BFHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&EM5-7:5+W MW=ID([1-AFHJJFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%E-:.YF; M-ME(W"93TYMR=UG&SO1%JV.HIJ*:AFHZJAFH9J*:A6KVZ+B8I:CF MHUJ :B&J11T[7QY,.G[3Q=2X[51L>EXC\97!MD>2Z[U*P>M72A!+)V!I.I]/#8$3[6JAF]]H"!QW3134/U7Q4"U M1+6H8\\?7UXB MIL9L)V+3KQJ)^U5?Z@MTW:]7BS27DL6W[12G]*N_+E-)'O^[,QC1BA6JJ:BF MH9J.:L9.VW]O.1I>C(:CPVA$>U:H9O?FQK52%RCNG8MZ7?IG\LB^99L/P:Z3K(D_]&9BVB="M545--0 M34U -5"5(M0+::T=A(W=:K1N]6I1FB="M54 M5--034U -5"5(M0+::T=C(W=:J1N$X5IOD\ MS7^B=9X\+LMD5?>M;E*IK./[-LWSZI'+3%HMTTV];)X^ M7\NV^F&1WG1/S*)=+%1344U#-1W5C)UVL??^;?#3]+"*A8YIH9K=:PL<=$P7 MU3Q4\U$M0+40U:)>>SZFQFREZKAI6(W?:%B=D*H?I/5C?2@LW56Y6A\D5RF; MS/^S6>:='_N+1SXU05%-134-U714,W9:^U^AJUYV-JS':"-C6J\9LU*NEW:?N1_TM=M0[0JZ)8WF7;P\RKNSS= M7L:K,R;1OA6JJ:BFH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5I,:>UX M5IIX?K>^U1CM6Z&:BFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL64 MUD[FIF\U_E-]*_'2)Z#I:OKH70_L:OH8Z/J9J&:AFHUJ#JJY MJ.:AFH]J :J%J!:A6DQI[%T;9^^E=@X.3E)344U;:?M!V)G'4A' MAS50S40U"]5L5'-0S44U#]5\5 M0+42U"-7BCA?T4<6K'9U-*6LL+F4]S=-> M/:39(EUL/_:7'O?G:Y-FOC81SM>BC2U44U%-0S4=U0Q4,U'-0C4;U1Q4:CFHUJ :B&J1:@64UHKF2=-'6W"U=& DJ]X;4Y->H MY(N.::&:W6L+''1,%]4\5/-1+4"U$-6B7GL^IL9LIVI349N(*VKO6/(5CWQR M@J+M-5334$U'-6.GO5'R1<>T4,WNM04..J:+:AZJ^:@6H%J(:E&O/1]38[83 M5&D25-B%V$WVQIN;Z@BSF-]GZ7*1Y@])EB&GE(D'/SE$T:(9JFFHIJ.:@6HF MJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%E-:.[R;HMED^%[3O1.TA(9J*JIIJ*:C MFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!936CN9FSI;=5-T6+V]+,13"G]/ M\GK"X7EVXG:=/TT[%,OM;,3Z5BHV-\5RL4SR'])?Z\/P[;)_JP[ GVYUQK=P M^)/C^TEK7W]HT-&_57L_4D/74$U -5"5(M0 M+::T=NPV5;A)GRH<,9M1+? ES9=5AE])U:KN/H8KRO7\:V<>H]TY5%-134,U M'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*UF-+:N=YTYR;OUIV;H-TY5%-1 M34,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*UF-+:R=QTYR;B[IR_>;A) M\^TLQM.4QVZ:0SAY@?;H=MKA94*/IR[Z/4Y#UTY'-0/53%2S4,U&-0?57%3S M4,U'M0#50E2+4"VFM':,-IV[R1N=N^I0MIZK2+9SPO4<<7F?/D=JL5YU?I&D MV#PY1Y^T_6\HFH['PZ,8/7Z8W!FC:/\-U0Q4,U'-0C4;U1Q4GK_*$Z&KW6@@]26 U016I6?I"N]6 [3Q!4H5K] M[2;/ZQE>)_TA!;>WRWF:=Q^FHHTX5%-134,U'=4,5#-1S4(U&]4<5'-1S4,U M']4"5 M1+4*UF-):63UM&G'3P7O-Z4[1=ANJJ:BFH9J.:@:JF:AFH9J-:@ZJ MN:CFH9J/:@&JA:@6H5I,:>UD;EIU4W&KSDNRY.[I+(@:KPZ0I=NTLR0GADX. M8K0DAVH:JNFH9J":B6H6JMD[K37Y-!Z/Y<,Z'3JJVS'JQ7 L3]J#>NB@/JH% MJ!:B6H1J,:6ULU-ILE/C M@[HQ.JJ%:G;/;7#045U4\SJV87PQ5B9R>QM\=-0 U4)4BU MIK2GB#PO[M.T M5),RN?STD.9WZ76Z6A72?+W)RGHG[MTKY>EM%:'RQROE[/SH_FOYHRIWW*_) M'_6N^PWYH]5UORU_=+ON]^2/X?;^\V8U+S\]5A'M)?G=,BND57I;K7+]-1=G M4KZ\NW_YH5P_?CZK?K'9\FBS2O'U#]_>UZ73[_4 _P?9U_W3XM ME_\/4$L#!!0 ( )>!"5?QJ']I@0( )D& 9 >&PO=V]R:W-H965T M\[S'QF:V$_)9E0 :O52,J[E7:EU/?5_E M)51$78L:N)E9"UD1;;IRXZM: BF6PE$@U M547D?@%,[.;>V#L,K.BFU'; SV8UV< ]Z,=Z*4W/[[,4M *NJ.!(PGKN?1E/ M%ZF-=P&_*>S441O92IZ$>+:=[\7<"ZPA8)!KFX&8UQ9N@3&;R-CXV^7T>J05 M'KB=TWZ.J);+Y<,.6>:-?%!A[* M&Z5%U8F-@XKR]DU>NG4X$F#\A@!W NQ\MR#G\HYHDLVDV"%IHTTVVW"E.K4Q M1[G=E'LMS2PU.IVM@!$-!5H2J??H01*NB%LOA0@OT((PPG-0:(164).]V0Z- M[)=1- R06"-=@K5%JZ9"M:0\IS5AJ(M4Z.H.-*%,?9SYVKBU3#_OG"U:9_@- M9S\:?HW"X!/" 0[1X_T=NGK_*HUOBNTKQGW%V.4-_Z_B(<-MXLEP8GM\IJHF M.6I5L5/9$[C-H@A'J8G=#M F M/6URB389HK6JZ(@6QN,0XV08%_6XZ!(N&L)%I[@DB$,<#^/B'A>?Q3T(3=@0 M+S[A)6F"Q^$;O*3G)6=YMXV4]N#40MH/;8BG)5Q2'(0["U_OJ']TT]M+^2>2&FI/#8&V4P75B*I#M1=AVM*C=Y?,D MM+G*7+,T_PZ0-L#,KX70AXZ]S_J_4?8/4$L#!!0 ( )>!"5<\N!KR400 M ,@9 9 >&PO=V]R:W-H965T?Q M9O*5#>,I$?*4;^U\ MSRE9%TEI8B/'\>R4Q)FUG!?7'OERS@XBB3/ZR$%^2%/"O]_3A)T6%K3>+CS% MVYU0%^SE?$^V])F*K_M'+L_L6F4=IS3+8Y8!3C<+ZP[>KK"C$HJ(?V)ZRAO' M0)7RPM@W=?)YO; E-D MRVKB3/T;GP67K\8R3RR?:$($78-'PL5W\# 9&MP3Q*2130'OX+G M'>%TQY(UY2!A) .?'J@@<9+_/+>%=*+T[*A:];Y<%5U8]<]#=@.P\PM #L+@ MZ_,#^/2C26;U$9G5G4'&EOVHFX+JIJ!"%X]KBJGN4GAF%E8S>9OO2407EARZ MG/(CM98__0 ]YS=3]1.)M7J ZQ[@/O7E7EYX>^[\SM8[/2;ECHJ)\ZK%7#K*YA MUEO#%_(:IX>TV*XF#AX((]M[;G]MK[ZR!R(3=4 MG&TO6G2[%@,W#-QSB]TX[/=8]&J+7J]%M?>M-_>A>GTBL5:5?5^E? M:][]*7LPD5BK!T'=@V#4K 2=#>8' 4+>V3[LAD%GAMT0F_=A6+L+1X]*V+F' M&!UVPWH=0D>3U.GU^/GM_LCE9C(RL
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end XML 66 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 67 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 68 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 341 326 1 false 90 0 false 9 false false R1.htm 00090 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation DOCUMENT AND ENTITY INFORMATION Cover 1 false false R2.htm 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 3 false false R4.htm 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Sheet http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Statements 4 false false R5.htm 00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 10101 - Disclosure - Organization, Nature of Business, Going Concern and Management Plans Sheet http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlans Organization, Nature of Business, Going Concern and Management Plans Notes 6 false false R7.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 10301 - Disclosure - Inventory Sheet http://www.targetgroupinc.com/role/DisclosureInventory Inventory Notes 8 false false R9.htm 10401 - Disclosure - Sales Tax Recoverable and Payable Sheet http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayable Sales Tax Recoverable and Payable Notes 9 false false R10.htm 10501 - Disclosure - Fixed Assets Sheet http://www.targetgroupinc.com/role/DisclosureFixedAssets Fixed Assets Notes 10 false false R11.htm 10601 - Disclosure - Joint Venture Sheet http://www.targetgroupinc.com/role/DisclosureJointVenture Joint Venture Notes 11 false false R12.htm 10701 - Disclosure - Goodwill Sheet http://www.targetgroupinc.com/role/DisclosureGoodwill Goodwill Notes 12 false false R13.htm 10801 - Disclosure - Related Party Transactions and Balances Sheet http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalances Related Party Transactions and Balances Notes 13 false false R14.htm 10901 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability Sheet http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiability Operating Lease Right-Of-Use Assets and Lease Liability Notes 14 false false R15.htm 11001 - Disclosure - Convertible Promissory Notes Notes http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotes Convertible Promissory Notes Notes 15 false false R16.htm 11101 - Disclosure - Stockholders' Equity Sheet http://www.targetgroupinc.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 11201 - Disclosure - Earnings (Loss) Per Share Sheet http://www.targetgroupinc.com/role/DisclosureEarningsLossPerShare Earnings (Loss) Per Share Notes 17 false false R18.htm 11301 - Disclosure - Contingencies and commitments Sheet http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitments Contingencies and commitments Notes 18 false false R19.htm 11401 - Disclosure - Subsequent Events Sheet http://www.targetgroupinc.com/role/DisclosureSubsequentEvents Subsequent Events Notes 19 false false R20.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPolicies 20 false false R21.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 30503 - Disclosure - Fixed Assets (Tables) Sheet http://www.targetgroupinc.com/role/DisclosureFixedAssetsTables Fixed Assets (Tables) Tables http://www.targetgroupinc.com/role/DisclosureFixedAssets 22 false false R23.htm 30603 - Disclosure - Joint Venture (Tables) Sheet http://www.targetgroupinc.com/role/DisclosureJointVentureTables Joint Venture (Tables) Tables http://www.targetgroupinc.com/role/DisclosureJointVenture 23 false false R24.htm 30703 - Disclosure - Goodwill (Tables) Sheet http://www.targetgroupinc.com/role/DisclosureGoodwillTables Goodwill (Tables) Tables http://www.targetgroupinc.com/role/DisclosureGoodwill 24 false false R25.htm 30803 - Disclosure - Related Party Transactions and Balances (Tables) Sheet http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesTables Related Party Transactions and Balances (Tables) Tables http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalances 25 false false R26.htm 30903 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability (Tables) Sheet http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityTables Operating Lease Right-Of-Use Assets and Lease Liability (Tables) Tables http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiability 26 false false R27.htm 31003 - Disclosure - Convertible Promissory Notes (Tables) Notes http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesTables Convertible Promissory Notes (Tables) Tables http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotes 27 false false R28.htm 31103 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.targetgroupinc.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.targetgroupinc.com/role/DisclosureStockholdersEquity 28 false false R29.htm 31303 - Disclosure - Contingencies and commitments (Tables) Sheet http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsTables Contingencies and commitments (Tables) Tables http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitments 29 false false R30.htm 40101 - Disclosure - Organization, Nature of Business, Going Concern and Management Plans (Details) Sheet http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails Organization, Nature of Business, Going Concern and Management Plans (Details) Details http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlans 30 false false R31.htm 40201 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 31 false false R32.htm 40301 - Disclosure - Inventory (Details) Sheet http://www.targetgroupinc.com/role/DisclosureInventoryDetails Inventory (Details) Details http://www.targetgroupinc.com/role/DisclosureInventory 32 false false R33.htm 40401 - Disclosure - Sales Tax Recoverable and Payable (Details) Sheet http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails Sales Tax Recoverable and Payable (Details) Details http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayable 33 false false R34.htm 40501 - Disclosure - Fixed Assets (Details) Sheet http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails Fixed Assets (Details) Details http://www.targetgroupinc.com/role/DisclosureFixedAssetsTables 34 false false R35.htm 40502 - Disclosure - Fixed Assets - Additional Information (Details) Sheet http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails Fixed Assets - Additional Information (Details) Details 35 false false R36.htm 40601 - Disclosure - Joint Venture - Additional Information (Details) Sheet http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails Joint Venture - Additional Information (Details) Details 36 false false R37.htm 40603 - Disclosure - Joint Venture - Summarizes the activity of the period of JVCo (Details) Sheet http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails Joint Venture - Summarizes the activity of the period of JVCo (Details) Details 37 false false R38.htm 40604 - Disclosure - Joint Venture -Agreement and obtaining 100 percentage shares of the JVCo (Details) Sheet http://www.targetgroupinc.com/role/DisclosureJointVentureAgreementAndObtaining100PercentageSharesOfJvcoDetails Joint Venture -Agreement and obtaining 100 percentage shares of the JVCo (Details) Details 38 false false R39.htm 40701 - Disclosure - Goodwill - Purchase consideration (Details) Sheet http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails Goodwill - Purchase consideration (Details) Details 39 false false R40.htm 40702 - Disclosure - Goodwill - Additional Information (Details) Sheet http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails Goodwill - Additional Information (Details) Details 40 false false R41.htm 40801 - Disclosure - Related Party Transactions and Balances (Details) Sheet http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails Related Party Transactions and Balances (Details) Details http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesTables 41 false false R42.htm 40802 - Disclosure - Related Party Transactions and Balances - Repayment schedule of the minimum principal payments (Details) Sheet http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails Related Party Transactions and Balances - Repayment schedule of the minimum principal payments (Details) Details 42 false false R43.htm 40803 - Disclosure - Related Party Transactions and Balances - Shareholder loan (Details) Sheet http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails Related Party Transactions and Balances - Shareholder loan (Details) Details 43 false false R44.htm 40901 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability (Details) Sheet http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails Operating Lease Right-Of-Use Assets and Lease Liability (Details) Details http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityTables 44 false false R45.htm 40902 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability - Maturities (Details) Sheet http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails Operating Lease Right-Of-Use Assets and Lease Liability - Maturities (Details) Details http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityTables 45 false false R46.htm 40903 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability - Reconciliation of net operating lease (Details) Sheet http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails Operating Lease Right-Of-Use Assets and Lease Liability - Reconciliation of net operating lease (Details) Details 46 false false R47.htm 41001 - Disclosure - Convertible Promissory Notes - Recorded and fair valued derivative liability (Details) Notes http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails Convertible Promissory Notes - Recorded and fair valued derivative liability (Details) Details 47 false false R48.htm 41002 - Disclosure - Convertible Promissory Notes - Additional information (Details) Notes http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails Convertible Promissory Notes - Additional information (Details) Details 48 false false R49.htm 41101 - Disclosure - Stockholders' Equity (Details) Sheet http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails Stockholders' Equity (Details) Details http://www.targetgroupinc.com/role/DisclosureStockholdersEquityTables 49 false false R50.htm 41102 - Disclosure - Stockholders' Equity - Warrants (Details) Sheet http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails Stockholders' Equity - Warrants (Details) Details 50 false false R51.htm 41103 - Disclosure - Stockholders' Equity - Warrants outstanding (Details) Sheet http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails Stockholders' Equity - Warrants outstanding (Details) Details 51 false false R52.htm 41104 - Disclosure - Stockholders' Equity - Movement of the warrant liability (Details) Sheet http://www.targetgroupinc.com/role/DisclosureStockholdersEquityMovementOfWarrantLiabilityDetails Stockholders' Equity - Movement of the warrant liability (Details) Details 52 false false R53.htm 41301 - Disclosure - Contingencies and commitments (Details) Sheet http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails Contingencies and commitments (Details) Details http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsTables 53 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 9 fact(s) appearing in ix:hidden were eligible for transformation: cbdy:LoansToJointVenturePortionOfOutstandingBalanceGuaranteed, cbdy:TermOfLicense, dei:TradingSymbol, us-gaap:CommonStockSharesIssued, us-gaap:GoodwillImpairmentLoss, us-gaap:InventoryNet, us-gaap:PreferredStockSharesIssued - tmb-20230630x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 7 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration, us-gaap:AccountsPayableNoncurrentRelatedPartyTypeExtensibleEnumeration, us-gaap:InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration, us-gaap:OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration, us-gaap:OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration - tmb-20230630x10q.htm 9 tmb-20230630x10q.htm tmb-20230630.xsd tmb-20230630_cal.xml tmb-20230630_def.xml tmb-20230630_lab.xml tmb-20230630_pre.xml tmb-20230630xex10d34.htm tmb-20230630xex31d1.htm tmb-20230630xex31d2.htm tmb-20230630xex32d1.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 71 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tmb-20230630x10q.htm": { "axisCustom": 0, "axisStandard": 27, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 732, "http://xbrl.sec.gov/dei/2023": 29 }, "contextCount": 341, "dts": { "calculationLink": { "local": [ "tmb-20230630_cal.xml" ] }, "definitionLink": { "local": [ "tmb-20230630_def.xml" ] }, "inline": { "local": [ "tmb-20230630x10q.htm" ] }, "labelLink": { "local": [ "tmb-20230630_lab.xml" ] }, "presentationLink": { "local": [ "tmb-20230630_pre.xml" ] }, "schema": { "local": [ "tmb-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 522, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 20, "http://www.targetgroupinc.com/20230630": 2, "http://xbrl.sec.gov/dei/2023": 6, "total": 28 }, "keyCustom": 101, "keyStandard": 225, "memberCustom": 49, "memberStandard": 28, "nsprefix": "cbdy", "nsuri": "http://www.targetgroupinc.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - DOCUMENT AND ENTITY INFORMATION", "menuCat": "Cover", "order": "1", "role": "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation", "shortName": "DOCUMENT AND ENTITY INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Fixed Assets", "menuCat": "Notes", "order": "10", "role": "http://www.targetgroupinc.com/role/DisclosureFixedAssets", "shortName": "Fixed Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Joint Venture", "menuCat": "Notes", "order": "11", "role": "http://www.targetgroupinc.com/role/DisclosureJointVenture", "shortName": "Joint Venture", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Goodwill", "menuCat": "Notes", "order": "12", "role": "http://www.targetgroupinc.com/role/DisclosureGoodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Related Party Transactions and Balances", "menuCat": "Notes", "order": "13", "role": "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalances", "shortName": "Related Party Transactions and Balances", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability", "menuCat": "Notes", "order": "14", "role": "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiability", "shortName": "Operating Lease Right-Of-Use Assets and Lease Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - Convertible Promissory Notes", "menuCat": "Notes", "order": "15", "role": "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotes", "shortName": "Convertible Promissory Notes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - Stockholders' Equity", "menuCat": "Notes", "order": "16", "role": "http://www.targetgroupinc.com/role/DisclosureStockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11201 - Disclosure - Earnings (Loss) Per Share", "menuCat": "Notes", "order": "17", "role": "http://www.targetgroupinc.com/role/DisclosureEarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11301 - Disclosure - Contingencies and commitments", "menuCat": "Notes", "order": "18", "role": "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitments", "shortName": "Contingencies and commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11401 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "19", "role": "http://www.targetgroupinc.com/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "20", "role": "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - Fixed Assets (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.targetgroupinc.com/role/DisclosureFixedAssetsTables", "shortName": "Fixed Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:ScheduleOfActivityOfJointVentureCompanyTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - Joint Venture (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.targetgroupinc.com/role/DisclosureJointVentureTables", "shortName": "Joint Venture (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:ScheduleOfActivityOfJointVentureCompanyTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30703 - Disclosure - Goodwill (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.targetgroupinc.com/role/DisclosureGoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - Related Party Transactions and Balances (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesTables", "shortName": "Related Party Transactions and Balances (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30903 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityTables", "shortName": "Operating Lease Right-Of-Use Assets and Lease Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31003 - Disclosure - Convertible Promissory Notes (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesTables", "shortName": "Convertible Promissory Notes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:ScheduleOfSharesToBeIssued", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31103 - Disclosure - Stockholders' Equity (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:ScheduleOfSharesToBeIssued", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:RoyaltiesPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31303 - Disclosure - Contingencies and commitments (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsTables", "shortName": "Contingencies and commitments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:RoyaltiesPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_Tl8ArsnNLkaBL5bT65kLGg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "menuCat": "Statements", "order": "3", "role": "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_Tl8ArsnNLkaBL5bT65kLGg", "decimals": "0", "lang": null, "name": "us-gaap:ProfessionalFees", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AreaOfLand", "reportCount": 1, "unitRef": "Unit_Standard_sqft_UU0KCT0e7kKg4bNbvVU31g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - Organization, Nature of Business, Going Concern and Management Plans (Details)", "menuCat": "Details", "order": "30", "role": "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "shortName": "Organization, Nature of Business, Going Concern and Management Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "lang": null, "name": "cbdy:SettlementLiabilitiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:CashFDICInsuredAmount", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_CAD_hhU9Z3JpZk6BIsA2_Xf-_A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Summary of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "31", "role": "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CashFDICInsuredAmount", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_CAD_hhU9Z3JpZk6BIsA2_Xf-_A", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryNet", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Inventory (Details)", "menuCat": "Details", "order": "32", "role": "http://www.targetgroupinc.com/role/DisclosureInventoryDetails", "shortName": "Inventory (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ValueAddedTaxReceivableCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Sales Tax Recoverable and Payable (Details)", "menuCat": "Details", "order": "33", "role": "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails", "shortName": "Sales Tax Recoverable and Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "cbdy:SalesTaxRecoverableTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "lang": null, "name": "cbdy:AllowanceOnValueAddedTaxRecoverable", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Fixed Assets (Details)", "menuCat": "Details", "order": "34", "role": "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails", "shortName": "Fixed Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AreaOfLand", "reportCount": 1, "unitRef": "Unit_Standard_sqft_UU0KCT0e7kKg4bNbvVU31g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - Fixed Assets - Additional Information (Details)", "menuCat": "Details", "order": "35", "role": "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "shortName": "Fixed Assets - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_dei_LegalEntityAxis_cbdy_CanaryMember_bAbX-dSXFkG8uitTv70vcg", "decimals": "0", "lang": null, "name": "cbdy:DepreciationExpenseRecorded", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_5_14_2020_To_5_14_2020_jNDVYUwadUSiWiCoBzVoZQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:LoansToJointVentureTermOfDebt", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Joint Venture - Additional Information (Details)", "menuCat": "Details", "order": "36", "role": "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "shortName": "Joint Venture - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_5_14_2020_To_5_14_2020_jNDVYUwadUSiWiCoBzVoZQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:LoansToJointVentureTermOfDebt", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_Tl8ArsnNLkaBL5bT65kLGg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40603 - Disclosure - Joint Venture - Summarizes the activity of the period of JVCo (Details)", "menuCat": "Details", "order": "37", "role": "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "shortName": "Joint Venture - Summarizes the activity of the period of JVCo (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "cbdy:ScheduleOfActivityOfJointVentureCompanyTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_4_27_2023_dei_LegalEntityAxis_cbdy_CanaryMember_Sw9cvPIK-kSqa1v0b3AmeQ", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "cbdy:ScheduleOfFairValueOfNetAssetsUponObtainingHundredPercentInJointVentureTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_27_2023_To_4_27_2023_aN3h7N-9rUq1jzGlsQ6ThQ", "decimals": "0", "first": true, "lang": null, "name": "cbdy:AssetAcquiredFairValueOfInventoryJointVenture", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40604 - Disclosure - Joint Venture -Agreement and obtaining 100 percentage shares of the JVCo (Details)", "menuCat": "Details", "order": "38", "role": "http://www.targetgroupinc.com/role/DisclosureJointVentureAgreementAndObtaining100PercentageSharesOfJvcoDetails", "shortName": "Joint Venture -Agreement and obtaining 100 percentage shares of the JVCo (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "cbdy:ScheduleOfFairValueOfNetAssetsUponObtainingHundredPercentInJointVentureTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_27_2023_To_4_27_2023_aN3h7N-9rUq1jzGlsQ6ThQ", "decimals": "0", "first": true, "lang": null, "name": "cbdy:AssetAcquiredFairValueOfInventoryJointVenture", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_3_1_2019_To_3_1_2019_us-gaap_BusinessAcquisitionAxis_cbdy_CannakorpIncMember_sqfALBcQgU-LX5L3SgxFsQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - Goodwill - Purchase consideration (Details)", "menuCat": "Details", "order": "39", "role": "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "shortName": "Goodwill - Purchase consideration (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_3_1_2019_To_3_1_2019_us-gaap_BusinessAcquisitionAxis_cbdy_CannakorpIncMember_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_us-gaap_CommonStockMember_VeV5QDRx8k6Fk47LAPIBhQ", "decimals": "INF", "lang": null, "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_4jBjGhZXP0mQ5HAOZvDaSg", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember_cwu7lyJ4VESHXPyHngPE_w", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT", "menuCat": "Statements", "order": "4", "role": "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_mcF6SGZngUu5nMLmWAn5Vw", "decimals": "0", "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40702 - Disclosure - Goodwill - Additional Information (Details)", "menuCat": "Details", "order": "40", "role": "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "shortName": "Goodwill - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_27_2018_qrI7fva0HUmYpvG8m8Ji2Q", "decimals": "4", "lang": null, "name": "cbdy:BusinessAcquisitionEquityInterestIssuablePercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_gld8uiCQuUa_gz9rOyvWLg", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherReceivables", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Related Party Transactions and Balances (Details)", "menuCat": "Details", "order": "41", "role": "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "shortName": "Related Party Transactions and Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "lang": null, "name": "us-gaap:LineOfCreditFacilityPeriodicPaymentInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - Related Party Transactions and Balances - Repayment schedule of the minimum principal payments (Details)", "menuCat": "Details", "order": "42", "role": "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails", "shortName": "Related Party Transactions and Balances - Repayment schedule of the minimum principal payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "cbdy:AccruedInterestConvertedIntoPrincipal", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40803 - Disclosure - Related Party Transactions and Balances - Shareholder loan (Details)", "menuCat": "Details", "order": "43", "role": "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails", "shortName": "Related Party Transactions and Balances - Shareholder loan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "cbdy:AccruedInterestConvertedIntoPrincipal", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "INF", "first": true, "lang": null, "name": "cbdy:NumberOfOperatingLeaseFacilities", "reportCount": 1, "unitRef": "Unit_Standard_lease_Mu_1l950DU632VLElNJt3g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability (Details)", "menuCat": "Details", "order": "44", "role": "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails", "shortName": "Operating Lease Right-Of-Use Assets and Lease Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_us-gaap_RelatedPartyTransactionAxis_cbdy_CanaryRxIncMember_0pnaF85oXEKo1AB3O2Ij4w", "decimals": "0", "lang": null, "name": "cbdy:OperatingLeaseRentExpenseNet", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability - Maturities (Details)", "menuCat": "Details", "order": "45", "role": "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails", "shortName": "Operating Lease Right-Of-Use Assets and Lease Liability - Maturities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "cbdy:LesseeOperatingLeaseReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_-G9S9IhYNEK8enUu9mdS6A", "decimals": "0", "first": true, "lang": null, "name": "cbdy:GrossOperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40903 - Disclosure - Operating Lease Right-Of-Use Assets and Lease Liability - Reconciliation of net operating lease (Details)", "menuCat": "Details", "order": "46", "role": "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails", "shortName": "Operating Lease Right-Of-Use Assets and Lease Liability - Reconciliation of net operating lease (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "cbdy:LesseeOperatingLeaseReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_-G9S9IhYNEK8enUu9mdS6A", "decimals": "0", "first": true, "lang": null, "name": "cbdy:GrossOperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_do0CDkVJE0ObRaDyvfvC4A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41001 - Disclosure - Convertible Promissory Notes - Recorded and fair valued derivative liability (Details)", "menuCat": "Details", "order": "47", "role": "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails", "shortName": "Convertible Promissory Notes - Recorded and fair valued derivative liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "lang": null, "name": "cbdy:EffectOfConversionOfConvertibleNotes", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41002 - Disclosure - Convertible Promissory Notes - Additional information (Details)", "menuCat": "Details", "order": "48", "role": "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "shortName": "Convertible Promissory Notes - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_k_quftCl9kWYAhB4vFqo3g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - Stockholders' Equity (Details)", "menuCat": "Details", "order": "49", "role": "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "INF", "lang": null, "name": "us-gaap:ConversionOfStockSharesConverted1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_4jBjGhZXP0mQ5HAOZvDaSg", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "5", "role": "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_Tl8ArsnNLkaBL5bT65kLGg", "decimals": "2", "first": true, "lang": null, "name": "cbdy:ShareBasedCompensationShareBasedPaymentsForfeitureRate", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_gld8uiCQuUa_gz9rOyvWLg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41102 - Disclosure - Stockholders' Equity - Warrants (Details)", "menuCat": "Details", "order": "50", "role": "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "shortName": "Stockholders' Equity - Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_4_1_2023_To_6_30_2023_Tl8ArsnNLkaBL5bT65kLGg", "decimals": "2", "first": true, "lang": null, "name": "cbdy:ShareBasedCompensationShareBasedPaymentsForfeitureRate", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_gld8uiCQuUa_gz9rOyvWLg", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_6X8B8wF9GkOYrQWjTGFe-Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_4jBjGhZXP0mQ5HAOZvDaSg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41103 - Disclosure - Stockholders' Equity - Warrants outstanding (Details)", "menuCat": "Details", "order": "51", "role": "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails", "shortName": "Stockholders' Equity - Warrants outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cbdy_SeriousSeedsIntellectualPropertyRightsMember_PpLOkon6oECj34pgt_uwvQ", "decimals": "0", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_4jBjGhZXP0mQ5HAOZvDaSg", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_do0CDkVJE0ObRaDyvfvC4A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41104 - Disclosure - Stockholders' Equity - Movement of the warrant liability (Details)", "menuCat": "Details", "order": "52", "role": "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityMovementOfWarrantLiabilityDetails", "shortName": "Stockholders' Equity - Movement of the warrant liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "As_Of_12_31_2022_do0CDkVJE0ObRaDyvfvC4A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LossContingencyDamagesSoughtValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41301 - Disclosure - Contingencies and commitments (Details)", "menuCat": "Details", "order": "53", "role": "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "shortName": "Contingencies and commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LossContingencyDamagesSoughtValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_y1nRE7NvnkytkfqNAvnFww", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Organization, Nature of Business, Going Concern and Management Plans", "menuCat": "Notes", "order": "6", "role": "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlans", "shortName": "Organization, Nature of Business, Going Concern and Management Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "7", "role": "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Inventory", "menuCat": "Notes", "order": "8", "role": "http://www.targetgroupinc.com/role/DisclosureInventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:SalesTaxRecoverableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Sales Tax Recoverable and Payable", "menuCat": "Notes", "order": "9", "role": "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayable", "shortName": "Sales Tax Recoverable and Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20230630x10q.htm", "contextRef": "Duration_1_1_2023_To_6_30_2023_bjsB0HKi-EmenUpLqgyJJQ", "decimals": null, "first": true, "lang": "en-US", "name": "cbdy:SalesTaxRecoverableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 90, "tag": { "cbdy_AccruedInterestConvertedIntoPrincipal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of accrued interest converted into principal.", "label": "Accrued Interest Converted into Principal", "terseLabel": "Amount of accrued interest converted into principal" } } }, "localname": "AccruedInterestConvertedIntoPrincipal", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_AdvancePaidToRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of advance paid to related party.", "label": "Advance Paid to Related Party", "terseLabel": "Amount of advance in seventh amendment" } } }, "localname": "AdvancePaidToRelatedParty", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_AdvisoryAndConsultancyServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to advisory and consultancy services.", "label": "Advisory And Consultancy Services [Member]", "terseLabel": "Advisory and consultancy services" } } }, "localname": "AdvisoryAndConsultancyServicesMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cbdy_AllowanceForSalesTaxRecoverable": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for sales tax recoverable.", "label": "Allowance for Sales Tax Recoverable", "negatedLabel": "Allowance of sales tax recoverable" } } }, "localname": "AllowanceForSalesTaxRecoverable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cbdy_AllowanceOnValueAddedTaxRecoverable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance on value added tax recoverable.", "label": "Allowance On Value Added Tax Recoverable", "verboseLabel": "Allowance on value added tax recoverable" } } }, "localname": "AllowanceOnValueAddedTaxRecoverable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_AllowanceRecoveryForSalesTaxRecoverable": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance recovery for sales tax recoverable.", "label": "Allowance Recovery for Sales Tax Recoverable", "negatedLabel": "Recovery of sales tax recoverable" } } }, "localname": "AllowanceRecoveryForSalesTaxRecoverable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "cbdy_AmendedAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to amended agreement.", "label": "Amended agreement [member]", "terseLabel": "Amended agreement" } } }, "localname": "AmendedAgreementMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_AmendedDebtPurchaseAndAssignmentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to amended debt purchase and assignment agreement.", "label": "Amended Debt Purchase and Assignment Agreement [Member]", "terseLabel": "Amended debt purchase and assignment agreement" } } }, "localname": "AmendedDebtPurchaseAndAssignmentAgreementMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_AssetAcquiredFairValueJointVenture": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value of fixed assets from the assets acquired, joint venture.", "label": "Asset Acquired, Fair Value, Joint Venture", "terseLabel": "Assets acquired" } } }, "localname": "AssetAcquiredFairValueJointVenture", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAgreementAndObtaining100PercentageSharesOfJvcoDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_AssetAcquiredFairValueOfFixedAssetsJointVenture": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value of fixed assets from the assets acquired, joint venture.", "label": "Asset Acquired, Fair Value of Fixed Assets, Joint Venture", "terseLabel": "Fixed assets" } } }, "localname": "AssetAcquiredFairValueOfFixedAssetsJointVenture", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAgreementAndObtaining100PercentageSharesOfJvcoDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_AssetAcquiredFairValueOfInventoryJointVenture": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value of inventory from the assets acquired, joint venture.", "label": "Asset Acquired, Fair Value of Inventory, Joint Venture", "terseLabel": "Inventory" } } }, "localname": "AssetAcquiredFairValueOfInventoryJointVenture", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAgreementAndObtaining100PercentageSharesOfJvcoDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_BusinessAcquisitionEquityInterestIssuablePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interests issuable to acquire the entity.", "label": "Business Acquisition Equity Interest Issuable Percentage", "terseLabel": "Business acquisition equity interest issuable percentage" } } }, "localname": "BusinessAcquisitionEquityInterestIssuablePercentage", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "cbdy_BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition, Fair Value Of Equity Interest Issued Or Issuable", "terseLabel": "Fair value of warrants" } } }, "localname": "BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_CanadaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the information about 9258159 Canada Inc (referred to as \"Thrive Cannabis\").", "label": "Canada Inc [Member]", "terseLabel": "Canada Inc" } } }, "localname": "CanadaIncMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cbdy_CanaryAndThriveCannabisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the information pertaining to canary and thrive cannabis member.", "label": "Canary And Thrive Cannabis [Member]", "verboseLabel": "Canary and Thrive Cannabis" } } }, "localname": "CanaryAndThriveCannabisMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "cbdy_CanaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Canary.", "label": "Canary [Member]", "verboseLabel": "Canary" } } }, "localname": "CanaryMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_CanaryRxIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the information pertaining to Canary RX Inc (\"Canary\").", "label": "Canary Rx Inc [Member]", "terseLabel": "Canary", "verboseLabel": "Canary Rx Inc" } } }, "localname": "CanaryRxIncMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_CannakorpIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member stands for CannaKorp.", "label": "Cannakorp Inc [Member]", "verboseLabel": "CannaKorp Inc" } } }, "localname": "CannakorpIncMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_CgreenIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to CGreen, Inc.", "label": "Cgreen Inc [Member]", "terseLabel": "Cgreen Inc" } } }, "localname": "CgreenIncMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_ChangeInFairValueOfDerivativeLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of derivative liability.", "label": "Change In Fair Value Of Derivative Liability", "terseLabel": "Fair value adjustment" } } }, "localname": "ChangeInFairValueOfDerivativeLiability", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_ChangeInOperatingLeaseLiabilityNet": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of change in operating lease liability, net.", "label": "Change in Operating Lease Liability, Net", "negatedLabel": "Change in operating lease liability, net" } } }, "localname": "ChangeInOperatingLeaseLiabilityNet", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cbdy_ClInvestorsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to CL Investors Inc.", "label": "CL Investors Inc [Member]", "terseLabel": "CLI" } } }, "localname": "ClInvestorsInc.Member", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "cbdy_ClassOfWarrantOrRightExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights expired during the period.", "label": "Class of Warrant or Right, Expired", "terseLabel": "Number of warrants expired" } } }, "localname": "ClassOfWarrantOrRightExpired", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "cbdy_ClassOfWarrantOrRightWarrantsExercisedDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to class of warrant or rights, exercised during the period.", "label": "Class of Warrant or Right, Warrants, Exercised During the Period", "terseLabel": "Warrants exercised during the period" } } }, "localname": "ClassOfWarrantOrRightWarrantsExercisedDuringPeriod", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "sharesItemType" }, "cbdy_ClassOfWarrantOrRightsPeriodFromWhichWarrantsOrRightsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of the warrants or rights are exercisable in 'PnYnMnDTnHnMnS' format.", "label": "Class Of Warrant Or Rights Period From Which Warrants Or Rights Exercisable", "terseLabel": "Warrants exercise period" } } }, "localname": "ClassOfWarrantOrRightsPeriodFromWhichWarrantsOrRightsExercisable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "durationItemType" }, "cbdy_CommonStockPurchaseWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for common stock purchase warrants.", "label": "Common Stock Purchase Warrants [Member]", "terseLabel": "Common Stock Purchase Warrants" } } }, "localname": "CommonStockPurchaseWarrantsMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "cbdy_CommonStockSharesIssuedForSettlementOfLoan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for settlement of loan.", "label": "Common Stock Shares Issued for Settlement of Loan", "terseLabel": "Shares issued for settlement" } } }, "localname": "CommonStockSharesIssuedForSettlementOfLoan", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "sharesItemType" }, "cbdy_ConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to convertible notes.", "label": "Convertible Notes [Member]", "terseLabel": "Convertible notes" } } }, "localname": "ConvertibleNotesMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cbdy_ConvertiblePromissoryNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to convertible promissory note.", "label": "Convertible Promissory Note [Member]", "terseLabel": "Convertible promissory note" } } }, "localname": "ConvertiblePromissoryNotesMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "cbdy_CostOfPropertyPlantAndEquipmentOfJointVentureConsolidated": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cost of joint venture assets consolidated.", "label": "Cost of Property Plant and Equipment of Joint Venture, Consolidated", "terseLabel": "JVCo assets consolidated, cost" } } }, "localname": "CostOfPropertyPlantAndEquipmentOfJointVentureConsolidated", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_DebtInstrumentMaximumAmountToBePaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to debt instrument, maximum amount to be paid.", "label": "Debt Instrument, Maximum Amount To Be Paid", "terseLabel": "Debt instrument, maximum amount to be paid" } } }, "localname": "DebtInstrumentMaximumAmountToBePaid", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_DebtInstrumentPercentageOfNetRevenueToBePaid": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to debt instrument, percentage of net revenue to be paid.", "label": "Debt Instrument, Percentage of Net Revenue To Be Paid", "terseLabel": "Debt instrument, percentage of net revenue to be paid" } } }, "localname": "DebtInstrumentPercentageOfNetRevenueToBePaid", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "percentItemType" }, "cbdy_DebtInstrumentThresholdPeriodForConsecutiveMonthlyInstallmentsPayable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to debt instrument, threshold period for consecutive monthly installments payable.", "label": "Debt Instrument, Threshold Period for Consecutive Monthly Installments Payable", "terseLabel": "Debt instrument, threshold period for consecutive monthly installments payable" } } }, "localname": "DebtInstrumentThresholdPeriodForConsecutiveMonthlyInstallmentsPayable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "durationItemType" }, "cbdy_DebtInstrumentThresholdPeriodForPaymentOfBalanceAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to debt instrument, threshold period for payment of balance amount.", "label": "Debt Instrument, Threshold Period for Payment of Balance Amount", "terseLabel": "Debt instrument, threshold period for payment of balance amount" } } }, "localname": "DebtInstrumentThresholdPeriodForPaymentOfBalanceAmount", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "durationItemType" }, "cbdy_DebtInstrumentThresholdPeriodForPaymentOfBalanceAmountByEndOfFifthYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to debt instrument, threshold period for payment of balance amount by the end of the fifth year.", "label": "Debt Instrument, Threshold Period for Payment of Balance Amount, By the End of the Fifth Year", "terseLabel": "Debt instrument, threshold period for payment of balance amount by the end of the fifth year" } } }, "localname": "DebtInstrumentThresholdPeriodForPaymentOfBalanceAmountByEndOfFifthYear", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "durationItemType" }, "cbdy_DebtIssuanceCosts": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to debt issuance costs.", "label": "Debt Issuance Costs", "terseLabel": "Debt issuance cost", "verboseLabel": "Debt issuance cost" } } }, "localname": "DebtIssuanceCosts", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "cbdy_DebtPurchaseAndAssignmentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to debt purchase and assignment agreement.", "label": "Debt Purchase and Assignment Agreement [Member]", "terseLabel": "Debt Purchase and Assignment Agreement" } } }, "localname": "DebtPurchaseAndAssignmentAgreementMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_DepreciationExpenseRecorded": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of depreciation expense recorded", "label": "depreciation expense recorded", "terseLabel": "Depreciation expense recorded" } } }, "localname": "DepreciationExpenseRecorded", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_DepreciationOfJointVentureConsolidated": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of depreciation of joint venture assets consolidated.", "label": "Depreciation of Joint Venture, Consolidated", "terseLabel": "JVCo assets consolidated, depreciation" } } }, "localname": "DepreciationOfJointVentureConsolidated", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_DerivativeLiabilityChangesDueToIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of derivative liability changes due to issuance.", "label": "Derivative Liability Changes Due To Issuance", "verboseLabel": "Change due to Issuances" } } }, "localname": "DerivativeLiabilityChangesDueToIssuance", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_EffectOfConversionOfConvertibleNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of effect of conversion of convertible notes which takes place during the reporting period.", "label": "Effect Of Conversion Of Convertible Notes", "verboseLabel": "Conversions / Redemption during the period" } } }, "localname": "EffectOfConversionOfConvertibleNotes", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_EffectiveDateFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the settlement amount payable within 30 days of the effective date.", "label": "Effective Date Five [Member]", "terseLabel": "Within thirty (30) days of the effective date", "verboseLabel": "Within 30 days of the Effective Date" } } }, "localname": "EffectiveDateFiveMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_EffectiveDateFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the shares issuable or royalties payable on or before November 10, 2020.", "label": "Effective Date Four [Member]", "terseLabel": "Not later than November 10, 2020" } } }, "localname": "EffectiveDateFourMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_EffectiveDateOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the shares issuable or royalties payable within 10 days of the effective date.", "label": "Effective Date One [Member]", "terseLabel": "Within ten (10) days of the effective date" } } }, "localname": "EffectiveDateOneMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_EffectiveDateThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the shares issuable or royalties payable on or before June 10, 2020.", "label": "Effective Date Three [Member]", "terseLabel": "Not later than June 10, 2020" } } }, "localname": "EffectiveDateThreeMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_EffectiveDateTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the shares issuable or royalties payable on January 10, 2020.", "label": "Effective Date Two [Member]", "terseLabel": "On January 10, 2020" } } }, "localname": "EffectiveDateTwoMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_EquityMethodInvestmentsRecoverableAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of recoverable of the equity method investment.", "label": "Equity Method Investments, Recoverable Amount", "verboseLabel": "Recoverable amount" } } }, "localname": "EquityMethodInvestmentsRecoverableAmount", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_FairValueAssumptionsRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption rate for warrants.", "label": "Fair Value Assumptions Rate", "terseLabel": "Fair value assumptions rate" } } }, "localname": "FairValueAssumptionsRate", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "cbdy_FairValueAssumptionsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represent expected term of warrants.", "label": "Fair Value Assumptions Term", "terseLabel": "Expected life (years)" } } }, "localname": "FairValueAssumptionsTerm", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "cbdy_FixedAssetsAndCapitalWorkInProgressAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "N\\A", "label": "Fixed Assets and Capital Work In Progress" } } }, "localname": "FixedAssetsAndCapitalWorkInProgressAbstract", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "cbdy_ForgivenessAmountDueToImplementationOfNewLease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of forgiveness due to implementation of new lease.", "label": "Forgiveness Amount Due To Implementation Of New Lease", "terseLabel": "Forgiveness amount due to implementation of new lease" } } }, "localname": "ForgivenessAmountDueToImplementationOfNewLease", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_FormerChiefExecutiveOfficerPresidentChiefFinancialOfficersAndCurrentKeyOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to former Chief Executive Officer, President, Chief Financial Officers and current key officers.", "label": "Former Chief Executive Officer, President, Chief Financial Officers And Current Key Officers [Member]", "terseLabel": "Former CEO, President, CFO and Other Current Key Officers" } } }, "localname": "FormerChiefExecutiveOfficerPresidentChiefFinancialOfficersAndCurrentKeyOfficersMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_FurnitureAndOfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to furniture and office equipment.", "label": "Furniture & office equipment", "terseLabel": "Furniture & office equipment" } } }, "localname": "FurnitureAndOfficeEquipmentMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cbdy_GainFromTerminationOfJointVenture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of gain from termination of joint venture.", "label": "Gain from Termination of Joint Venture", "terseLabel": "Gain from termination of joint venture" } } }, "localname": "GainFromTerminationOfJointVenture", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_GainLossOnSettlementOfLiability": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on settlement of liability during the period.", "label": "Gain Loss On Settlement Of Liability", "negatedLabel": "Gain on settlement" } } }, "localname": "GainLossOnSettlementOfLiability", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "cbdy_GainLossOnSettlementOfWebsiteDevelopmentServiceCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain loss on settlement of website development service cost.", "label": "Gain Loss On Settlement Of Website Development Service Cost", "terseLabel": "Gain on settlement of website development service cost" } } }, "localname": "GainLossOnSettlementOfWebsiteDevelopmentServiceCost", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_GeneralAndAdministrativeIncomeExpense": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative income (expense).", "label": "General And Administrative Income (Expense)", "negatedLabel": "Office and general" } } }, "localname": "GeneralAndAdministrativeIncomeExpense", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "cbdy_GrossOperatingLeaseExpense": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails": { "order": 1.0, "parentTag": "cbdy_OperatingLeaseExpensesTotal", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of gross operating lease expense. Excludes sublease income.", "label": "Gross Operating Lease Expense", "terseLabel": "Gross operating lease expense" } } }, "localname": "GrossOperatingLeaseExpense", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_GrossOperatingLeasesRentAndUtilitiesExpenses": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails": { "order": 2.0, "parentTag": "cbdy_OperatingLeaseExpensesTotal", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of gross operating lease rent and utilities expenses.", "label": "Gross Operating Leases Rent And Utilities Expenses", "terseLabel": "Gross rent and utilities expenses" } } }, "localname": "GrossOperatingLeasesRentAndUtilitiesExpenses", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_GtaAngelGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to GTA Angel Group.", "label": "GTA Angel Group [Member]", "verboseLabel": "GTA Angel Group" } } }, "localname": "GtaAngelGroupMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_IncreaseDecreaseInSalesTaxRecoverable": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of sales tax recoverable.", "label": "Increase (Decrease) in Sales Tax Recoverable", "terseLabel": "Change in sales tax recoverable" } } }, "localname": "IncreaseDecreaseInSalesTaxRecoverable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cbdy_InterestAndBankChargesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to Interest and Bank Charges.", "label": "Interest and Bank Charges [Member]", "terseLabel": "Interest and bank charges" } } }, "localname": "InterestAndBankChargesMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_InvestmentInJointVentureBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of investment in joint venture.", "label": "Investment in Joint Venture, Balance", "terseLabel": "Remaining balance in joint venture" } } }, "localname": "InvestmentInJointVentureBalance", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_LawsuitRelatingToCanaryOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for lawsuit relating to company's subsidiary \"Canary\", one.", "label": "Lawsuit Relating To Canary One [Member]", "terseLabel": "Canary case, one" } } }, "localname": "LawsuitRelatingToCanaryOneMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "domainItemType" }, "cbdy_LenderFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lender fees.", "label": "Lender Fees", "terseLabel": "Lender's fee" } } }, "localname": "LenderFees", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fourth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Four", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_LesseeOperatingLeaseReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for reconciliation of net operating lease.", "label": "Lessee, Operating Lease, Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of net operating lease" } } }, "localname": "LesseeOperatingLeaseReconciliationTableTextBlock", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "cbdy_LineOfCreditFacilityAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on line of credit.", "label": "Line of Credit Facility Accrued Interest", "terseLabel": "Accrued interest expense" } } }, "localname": "LineOfCreditFacilityAccruedInterest", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_LitigationSettlementMonthlyAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Monthly Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement Monthly Amount Awarded To Other Party", "terseLabel": "Monthly installment of settlement amount" } } }, "localname": "LitigationSettlementMonthlyAmountAwardedToOtherParty", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_LitigationSettlementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period within which the amount awarded to other party in judgment or settlement of litigation is to be paid by the company, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Litigation Settlement, Period", "terseLabel": "Settlement period" } } }, "localname": "LitigationSettlementPeriod", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "durationItemType" }, "cbdy_LoanFromShareholderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for loan to a shareholder.", "label": "Loan From Shareholder [Member]", "terseLabel": "Loan from a shareholder" } } }, "localname": "LoanFromShareholderMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "domainItemType" }, "cbdy_LoanFromShareholderTrancheFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to tranche five of loan from shareholder.", "label": "Loan From Shareholder Tranche Five [Member]", "terseLabel": "Tranche 5" } } }, "localname": "LoanFromShareholderTrancheFiveMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "domainItemType" }, "cbdy_LoanFromShareholderTrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to tranche four of loan from shareholder.", "label": "Loan From Shareholder Tranche Four [Member]", "terseLabel": "Tranche 4" } } }, "localname": "LoanFromShareholderTrancheFourMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "domainItemType" }, "cbdy_LoanFromShareholderTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to tranche one of loan from shareholder.", "label": "Loan From Shareholder Tranche One [Member]", "terseLabel": "Tranche 1" } } }, "localname": "LoanFromShareholderTrancheOneMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "domainItemType" }, "cbdy_LoanFromShareholderTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to tranche three of loan from shareholder.", "label": "Loan from Shareholder Tranche Three [Member]", "terseLabel": "Tranche 3" } } }, "localname": "LoanFromShareholderTrancheThreeMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "domainItemType" }, "cbdy_LoanFromShareholderTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to tranche two of loan from shareholder.", "label": "Loan From Shareholder Tranche Two [Member]", "terseLabel": "Tranche 2" } } }, "localname": "LoanFromShareholderTrancheTwoMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "domainItemType" }, "cbdy_LoanSettlementAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Settlement amount of loans.", "label": "Loan Settlement Amount", "terseLabel": "Total amount subject to loan settlement" } } }, "localname": "LoanSettlementAmount", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_LoansToJointVentureMaximumAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents maximum amount of loans that can be issued to the joint venture.", "label": "Loans To Joint Venture, Maximum Amount", "terseLabel": "Maximum amount of loan" } } }, "localname": "LoansToJointVentureMaximumAmount", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_LoansToJointVenturePortionOfOutstandingBalanceGuaranteed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding balance of the loans issued to the joint venture, guaranteed by the entity.", "label": "Loans To Joint Venture, Portion Of Outstanding Balance Guaranteed", "terseLabel": "Portion of outstanding balance of the loan guaranteed (as a percent)" } } }, "localname": "LoansToJointVenturePortionOfOutstandingBalanceGuaranteed", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "cbdy_LoansToJointVentureTermOfDebt": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of the loans issued to the joint venture, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Loans To Joint Venture, Term Of Debt", "terseLabel": "Term of the loan" } } }, "localname": "LoansToJointVentureTermOfDebt", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "cbdy_LossOnEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents loss on equity", "label": "Loss on Equity", "verboseLabel": "Income (loss) on equity" } } }, "localname": "LossOnEquity", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_LossOnLoanSettlement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss incurred on settlement of loan.", "label": "Loss on Loan Settlement", "terseLabel": "Loss on loan settlement" } } }, "localname": "LossOnLoanSettlement", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_ManagementServiceFeeExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management Service Fee Expenses", "terseLabel": "Management service fee" } } }, "localname": "ManagementServiceFeeExpenses", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_ManagementServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Management Services [Member]", "terseLabel": "Management Services" } } }, "localname": "ManagementServicesMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_MeasurementInputForfeitureRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for measurement input forfeiture rate.", "label": "Measurement Input Forfeiture Rate [Member]", "verboseLabel": "Forfeiture rate" } } }, "localname": "MeasurementInputForfeitureRateMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "cbdy_NorlandamMarketingInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Norlandam Marketing Inc.,.", "label": "Norlandam Marketing Inc. [Member]", "terseLabel": "Norlandam Marketing Inc." } } }, "localname": "NorlandamMarketingInc.Member", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_NoteDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Note D.", "label": "Note D [Member]", "terseLabel": "Note D" } } }, "localname": "NoteDMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "domainItemType" }, "cbdy_NoteFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Note F.", "label": "Note F [Member]", "terseLabel": "Note F" } } }, "localname": "NoteFMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "domainItemType" }, "cbdy_NoteGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Note G.", "label": "Note G [Member]", "terseLabel": "Note G" } } }, "localname": "NoteGMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "domainItemType" }, "cbdy_NumberOfMajorCustomer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of customer to whom entire revenue is sold.", "label": "Number of Major Customer", "terseLabel": "Number of customer to whom entire revenue is sold" } } }, "localname": "NumberOfMajorCustomer", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "integerItemType" }, "cbdy_NumberOfOperatingLeaseFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of operating lease facilities.", "label": "Number of Operating Lease Facilities", "terseLabel": "Number of operating lease facilities" } } }, "localname": "NumberOfOperatingLeaseFacilities", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "integerItemType" }, "cbdy_OperatingLeaseExpensesTotal": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease Expenses, Total", "totalLabel": "Net operating lease expense" } } }, "localname": "OperatingLeaseExpensesTotal", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_OperatingLeaseIncomeExpense": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income (expense).", "label": "Operating Lease Income (Expense)", "negatedLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseIncomeExpense", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "cbdy_OperatingLeaseRentExpenseNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Operating Leases Rent Expense Net", "label": "Operating Lease, Rent Expense Net", "verboseLabel": "Agreement increased the minimum rent including applicable taxes" } } }, "localname": "OperatingLeaseRentExpenseNet", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_OrganizationNatureOfBusinessGoingConcernAndManagementPlansLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Nature of Business, Going Concern and Management Plans [Line Items]", "terseLabel": "Organization, Nature of Business, Going Concern and Management Plans" } } }, "localname": "OrganizationNatureOfBusinessGoingConcernAndManagementPlansLineItems", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "cbdy_OrganizationNatureOfBusinessGoingConcernAndManagementPlansTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Nature of Business, Going Concern and Management Plans [Table]" } } }, "localname": "OrganizationNatureOfBusinessGoingConcernAndManagementPlansTable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "cbdy_OutstandingLoanAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of outstanding loan balance.", "label": "Outstanding Loan Amount", "terseLabel": "Outstanding balance of loan" } } }, "localname": "OutstandingLoanAmount", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_OutstandingRoyaltyPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Outstanding royalty payable", "label": "Outstanding Royalty Payable", "terseLabel": "Outstanding royalty payable" } } }, "localname": "OutstandingRoyaltyPayable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_OwnershipInterestInJointVenture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership interest held in joint venture.", "label": "Ownership Interest In Joint Venture", "terseLabel": "Equity interest in joint venture" } } }, "localname": "OwnershipInterestInJointVenture", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "percentItemType" }, "cbdy_PaymentForSettlementPayable": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to payment for settlement payable.", "label": "Payment for Settlement Payable", "negatedLabel": "Payment for settlement payable" } } }, "localname": "PaymentForSettlementPayable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cbdy_PaymentsForProceedsFromPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments for (Proceeds from) Property, Plant, and Equipment", "negatedLabel": "Amounts invested on fixed assets" } } }, "localname": "PaymentsForProceedsFromPropertyPlantAndEquipment", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cbdy_PercentageOfIncreaseInMinimumRent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount represents the percentage of increase in minimum rent.", "label": "Percentage of Increase in Minimum Rent", "terseLabel": "Percentage of increase in minimum rent" } } }, "localname": "PercentageOfIncreaseInMinimumRent", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "percentItemType" }, "cbdy_PercentageOfIssuedAndOutstandingCapitalOptionGrantedToAcquire": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Percentage Of issued and outstanding capital, option granted to acquire.", "label": "Percentage Of Issued And Outstanding Capital, Option Granted to Acquire", "terseLabel": "Percentage of issued and outstanding capital, option granted to acquire" } } }, "localname": "PercentageOfIssuedAndOutstandingCapitalOptionGrantedToAcquire", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "percentItemType" }, "cbdy_PercentageOfIssuedAndOutstandingCapitalToBeTransferredInLieuOfRepaymentOfDebt": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to percentage of issued and outstanding capital to be transferred in lieu of repayment of debt.", "label": "Percentage of Issued and Outstanding Capital to be Transferred in Lieu of Repayment of Debt", "terseLabel": "Percentage of issued and outstanding capital to be transferred in lieu of repayment of debt" } } }, "localname": "PercentageOfIssuedAndOutstandingCapitalToBeTransferredInLieuOfRepaymentOfDebt", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "percentItemType" }, "cbdy_PercentageOfRoyaltiesOnAllSubleasingRevenues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of royalties payment on all subleasing revenues.", "label": "Percentage of Royalties On All Subleasing Revenues", "terseLabel": "Percentage of royalties on all subleasing revenues" } } }, "localname": "PercentageOfRoyaltiesOnAllSubleasingRevenues", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "percentItemType" }, "cbdy_PercentageOfRoyaltiesOnGrossSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to percentage of royalties on gross sales.", "label": "Percentage of Royalties on Gross Sales", "terseLabel": "Percentage of royalties on gross sales" } } }, "localname": "PercentageOfRoyaltiesOnGrossSales", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "percentItemType" }, "cbdy_PercentageOfRoyaltiesOnNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of royalties payment on net sales.", "label": "Percentage of Royalties On Net Sales", "terseLabel": "Percentage of royalties on net sales" } } }, "localname": "PercentageOfRoyaltiesOnNetSales", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "percentItemType" }, "cbdy_PreferredStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to preferred stock warrants.", "label": "Preferred Stock Warrants [Member]", "terseLabel": "Preferred stock warrants" } } }, "localname": "PreferredStockWarrantsMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cbdy_ProceedsFromJointVenture": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount received from joint venture.", "label": "Proceeds from Joint Venture", "terseLabel": "Amount received from joint venture" } } }, "localname": "ProceedsFromJointVenture", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_ReceivablesFromJointVentureCurrent": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of current portion of receivables from joint venture as at the end of the reporting period.", "label": "Receivables from Joint Venture, Current", "terseLabel": "Receivable from joint venture" } } }, "localname": "ReceivablesFromJointVentureCurrent", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "cbdy_RecoverableExpensesFromJvCoRelatedToRentAndUtilities": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails": { "order": 3.0, "parentTag": "cbdy_OperatingLeaseExpensesTotal", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount pertaining to recoverable expenses from JV Co related to rent and utilities.", "label": "Recoverable Expenses From JV Co Related To Rent And Utilities", "negatedLabel": "Recoverable expenses from JVCo related to rent and utilities" } } }, "localname": "RecoverableExpensesFromJvCoRelatedToRentAndUtilities", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityReconciliationOfNetOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_ReductionInRightToUseAssetDueToRecognitionOfPriorDeferredRentLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of reduction in right of use assets due to recognition of prior deferred rent liability.", "label": "Reduction in Right to Use Asset Due to Recognition of Prior Deferred Rent Liability", "terseLabel": "Reduction in right-to-use asset" } } }, "localname": "ReductionInRightToUseAssetDueToRecognitionOfPriorDeferredRentLiability", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_RelatedPartyLatePaymentPenaltiesAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of late payment penalties included in total outstanding to be paid.", "label": "Related Party Late Payment Penalties Amount", "verboseLabel": "Related party late payment penalties amount" } } }, "localname": "RelatedPartyLatePaymentPenaltiesAmount", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_RelatedPartyPayablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of current portion of net related party payable as at the end of the reporting period.", "label": "Related Party Payables Net, Current", "terseLabel": "Payable to related parties, net" } } }, "localname": "RelatedPartyPayablesNetCurrent", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "cbdy_ReleaseAndSettlementAmountToComeOutOfJointVenture": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of release and settlement amount paid to come out of the joint venture.", "label": "Release And Settlement Amount To Come Out Of Joint Venture", "terseLabel": "Release and settlement amount from Thrive Cannabis" } } }, "localname": "ReleaseAndSettlementAmountToComeOutOfJointVenture", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_RevenueFromInvestmentsInJointVenture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the revenue through investment in joint venture.", "label": "Revenue From Investments in Joint Venture", "terseLabel": "Revenue through investment in a joint venture" } } }, "localname": "RevenueFromInvestmentsInJointVenture", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_RoyaltiesPayableInYear1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to royalties payable in year 1.", "label": "Royalties Payable In Year 1 [Member]", "terseLabel": "1st year" } } }, "localname": "RoyaltiesPayableInYear1Member", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "domainItemType" }, "cbdy_RoyaltiesPayableInYear2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to royalties payable in year 2.", "label": "Royalties Payable In Year 2 [Member]", "terseLabel": "2nd year" } } }, "localname": "RoyaltiesPayableInYear2Member", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "domainItemType" }, "cbdy_RoyaltiesPayableInYear3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to royalties payable in year 3.", "label": "Royalties Payable In Year 3 [Member]", "terseLabel": "3rd year" } } }, "localname": "RoyaltiesPayableInYear3Member", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "domainItemType" }, "cbdy_RoyaltiesPayableInYear4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to royalties payable in year 4.", "label": "Royalties Payable In Year 4 [Member]", "terseLabel": "4th year" } } }, "localname": "RoyaltiesPayableInYear4Member", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "domainItemType" }, "cbdy_RoyaltiesPayableInYear5AndFollowingYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to royalties payable in year 5 and following years.", "label": "Royalties Payable In Year 5 And Following Years [Member]", "terseLabel": "5th and following years" } } }, "localname": "RoyaltiesPayableInYear5AndFollowingYearsMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "domainItemType" }, "cbdy_RoyaltiesPayableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of royalties payable.", "label": "Royalties Payable [Table Text Block]", "terseLabel": "Schedule of royalties payable" } } }, "localname": "RoyaltiesPayableTableTextBlock", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "cbdy_RubinSchindermannMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Rubin Schneidermann.", "label": "Rubin Schneidermann [Member]", "terseLabel": "Rubin schneidermann" } } }, "localname": "RubinSchindermannMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_SalaryAndWageNonofficer": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. excludes allocated cost, labor-related non-salary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary and Wage, Nonofficer", "negatedLabel": "Salaries and wages" } } }, "localname": "SalaryAndWageNonofficer", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "cbdy_SalesTaxRecoverableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of sales tax recoverable", "label": "Sales Tax Recoverable and Payable" } } }, "localname": "SalesTaxRecoverableAbstract", "nsuri": "http://www.targetgroupinc.com/20230630", "xbrltype": "stringItemType" }, "cbdy_SalesTaxRecoverableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Sales Tax Recoverable [Line Items]", "terseLabel": "Sales Tax Recoverable and Payable" } } }, "localname": "SalesTaxRecoverableLineItems", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails" ], "xbrltype": "stringItemType" }, "cbdy_SalesTaxRecoverableTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of sale tax recoverable.", "label": "Sales Tax Recoverable [Table]" } } }, "localname": "SalesTaxRecoverableTable", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails" ], "xbrltype": "stringItemType" }, "cbdy_SalesTaxRecoverableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of sales tax recoverable.", "label": "Sales Tax Recoverable [Text Block]", "verboseLabel": "Sales Tax Recoverable and Payable" } } }, "localname": "SalesTaxRecoverableTextBlock", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayable" ], "xbrltype": "textBlockItemType" }, "cbdy_ScheduleOfActivityOfJointVentureCompanyTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of the activity of the period of JVCo.", "label": "Schedule of Activity of Joint Venture Company [Table Text Block]", "terseLabel": "Schedule of the activity of the period of JVCo" } } }, "localname": "ScheduleOfActivityOfJointVentureCompanyTableTextBlock", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureTables" ], "xbrltype": "textBlockItemType" }, "cbdy_ScheduleOfFairValueOfNetAssetsUponObtainingHundredPercentInJointVentureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of fair value of the net assets upon obtaining hundred percent in joint venture.", "label": "Schedule of Fair Value of Net Assets Upon Obtaining Hundred Percent in Joint Venture [Table Text Block]", "terseLabel": "Schedule of fair value of net assets" } } }, "localname": "ScheduleOfFairValueOfNetAssetsUponObtainingHundredPercentInJointVentureTableTextBlock", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureTables" ], "xbrltype": "textBlockItemType" }, "cbdy_ScheduleOfPositionOfJointVentureCompanyTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of position of the JVCo.", "label": "Schedule of Position of Joint Venture Company [Table Text Block]", "terseLabel": "Schedule of position of the JVCo" } } }, "localname": "ScheduleOfPositionOfJointVentureCompanyTableTextBlock", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureTables" ], "xbrltype": "textBlockItemType" }, "cbdy_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In addition to the PPE table that provides the details of each class of PPE if a separate table is also presented for the useful lives (outside of the PPE note, often included in the Summary of Significant Accounting Policies footnote), we would need to extend for the useful life table text block.", "label": "Schedule of Property, Plant and Equipment, Useful Life [Table Text Block]", "verboseLabel": "Schedule of property, plant and equipment useful life" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "cbdy_ScheduleOfShareholderLoanTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of shareholder loan.", "label": "Schedule of Shareholder Loan [Table Text Block]", "terseLabel": "Schedule of each tranche of the shareholders loan" } } }, "localname": "ScheduleOfShareholderLoanTableTextBlock", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesTables" ], "xbrltype": "textBlockItemType" }, "cbdy_ScheduleOfSharesToBeIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of shares to be issued.", "label": "Schedule of Shares To Be Issued [Table Text Block]", "terseLabel": "Schedule of shares to be issued" } } }, "localname": "ScheduleOfSharesToBeIssued", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "cbdy_SeriousSeedsB.vMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Serious Seeds B.V.", "label": "Serious Seeds B.v [Member]", "terseLabel": "Serious Seeds" } } }, "localname": "SeriousSeedsB.vMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "domainItemType" }, "cbdy_SeriousSeedsIntellectualPropertyRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Serious Seed's intellectual property rights.", "label": "Serious Seed [Member]", "terseLabel": "Serious seeds" } } }, "localname": "SeriousSeedsIntellectualPropertyRightsMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "cbdy_SettlementLiabilitiesCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts payable for money transfers, money orders, and consumer payment service arrangements, current and non-current.", "label": "Settlement Liabilities Current And Noncurrent", "terseLabel": "Settlement liabilities, current and noncurrent" } } }, "localname": "SettlementLiabilitiesCurrentAndNoncurrent", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_SettlementOfLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to settlement of loan.", "label": "Settlement of Loan [Member]", "terseLabel": "Settlement of loans" } } }, "localname": "SettlementOfLoanMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cbdy_ShareBasedCompensationShareBasedPaymentsForfeitureRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Share based Compensation Share based payments Forfeiture Rate.", "label": "Share based Compensation Share based payments Forfeiture Rate", "verboseLabel": "Forfeiture rate" } } }, "localname": "ShareBasedCompensationShareBasedPaymentsForfeitureRate", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "percentItemType" }, "cbdy_ShareNotIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares not issued.", "label": "Share Not Issued", "terseLabel": "Shares not issued" } } }, "localname": "ShareNotIssued", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "sharesItemType" }, "cbdy_SharesIssuedDuringPeriodNewSharesForSettlement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period new shares for settlement.", "label": "Shares Issued During Period New Shares For Settlement", "verboseLabel": "Shares issued on settlement of debt" } } }, "localname": "SharesIssuedDuringPeriodNewSharesForSettlement", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "cbdy_SharesToBeIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The aggregate number of shares to be issued.", "label": "Shares To Be Issued", "terseLabel": "Shares to be issued" } } }, "localname": "SharesToBeIssued", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "cbdy_SharesToBeIssuedAsCompensationSharesForAcquisitionOfIntangibleAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued as a compensation for acquisition of intangible assets.", "label": "Shares To Be Issued As Compensation, Shares, for Acquisition of Intangible Assets", "terseLabel": "Shares to issue as consideration for intangible assets (in shares)" } } }, "localname": "SharesToBeIssuedAsCompensationSharesForAcquisitionOfIntangibleAssets", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "cbdy_SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of shares to be issued as compensation to intellectual property rights.", "label": "Shares to be Issued as Compensation to Intellectual Property Rights Value", "terseLabel": "Shares issued as consideration for consideration of the intellectual property rights", "verboseLabel": "Shares issued as consideration for consideration of the intellectual property rights" } } }, "localname": "SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "cbdy_SharesToBeIssuedAsCompensationValueForAcquisitionOfIntangibleAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of of shares issued as a compensation for acquisition of intangible assets.", "label": "Shares To Be Issued As Compensation, Value, for Acquisition of Intangible Assets", "terseLabel": "Shares to issue as consideration for intangible assets" } } }, "localname": "SharesToBeIssuedAsCompensationValueForAcquisitionOfIntangibleAssets", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_SharesToBeIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to shares to be issued.", "label": "Shares to be Issued [Member]", "terseLabel": "Shares to be issued" } } }, "localname": "SharesToBeIssuedMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "cbdy_SharesToBeIssuedTotal": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to shares to be issued total value.", "label": "Shares to be Issued, Total", "terseLabel": "Shares to be issued" } } }, "localname": "SharesToBeIssuedTotal", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "cbdy_StockIssuableAsConsiderationForAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares issuable as consideration for licensing agreement.", "label": "Stock Issuable As Consideration For Agreement", "terseLabel": "Stock issuable as consideration for agreement" } } }, "localname": "StockIssuableAsConsiderationForAgreement", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "sharesItemType" }, "cbdy_StockToBeIssuedAsCompensationToIntellectualPropertyRightsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for compensation to intellectual property rights.", "label": "Stock to be Issued as Compensation to Intellectual Property Rights Shares", "terseLabel": "Shares issued as consideration for consideration of the intellectual property rights (in shares)", "verboseLabel": "Shares issued as consideration for consideration of the intellectual property rights (in shares)" } } }, "localname": "StockToBeIssuedAsCompensationToIntellectualPropertyRightsShares", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "cbdy_TermOfLicense": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the term of license.", "label": "Term Of License", "terseLabel": "Term of license" } } }, "localname": "TermOfLicense", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "durationItemType" }, "cbdy_TotalEligibleRecoverableExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of total eligible recoverable expenses as of the reporting date.", "label": "Total Eligible Recoverable Expenses", "verboseLabel": "Eligible recoverable expenses" } } }, "localname": "TotalEligibleRecoverableExpenses", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails" ], "xbrltype": "monetaryItemType" }, "cbdy_VisavaAndCanaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Visava and Canary.", "label": "Visava and Canary [Member]", "terseLabel": "Visava and Canary" } } }, "localname": "VisavaAndCanaryMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "cbdy_VisavaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for VisavaInc member.", "label": "Visava Inc [Member]", "verboseLabel": "Visava Inc" } } }, "localname": "VisavaIncMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "cbdy_WarrantsIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants of stock issued during the period pursuant to acquisitions.", "label": "Warrants Issued During Period, Shares, Acquisitions", "verboseLabel": "Shares and warrant issued for acquisition of subsidiary (in shares)" } } }, "localname": "WarrantsIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "sharesItemType" }, "cbdy_WarrantsIssuedForSettlementOfLoan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants issued for settlement of loan.", "label": "Warrants Issued for Settlement of Loan", "terseLabel": "Warrants issued for settlement" } } }, "localname": "WarrantsIssuedForSettlementOfLoan", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "sharesItemType" }, "cbdy_WarrantsPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents purchase of warrants.", "label": "Warrants Purchase", "terseLabel": "Warrants purchase" } } }, "localname": "WarrantsPurchase", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "sharesItemType" }, "cbdy_WebsiteDevelopmentServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to website development services.", "label": "Website Development Services [Member]", "verboseLabel": "Website development services" } } }, "localname": "WebsiteDevelopmentServicesMember", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cbdy_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's working capital deficit.", "label": "Working Capital Deficit", "terseLabel": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://www.targetgroupinc.com/20230630", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r677" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r676" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.targetgroupinc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r192", "r193", "r314", "r341", "r459", "r639", "r641" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r252", "r253", "r255" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r296", "r297", "r298", "r299", "r368", "r464", "r513", "r552", "r553", "r619", "r620", "r621", "r622", "r623", "r633", "r634", "r645", "r652", "r656", "r662", "r721", "r737", "r738", "r739", "r740", "r741", "r742" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r296", "r297", "r298", "r299", "r368", "r464", "r513", "r552", "r553", "r619", "r620", "r621", "r622", "r623", "r633", "r634", "r645", "r652", "r656", "r662", "r721", "r737", "r738", "r739", "r740", "r741", "r742" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum", "verboseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r244", "r465", "r507", "r508", "r509", "r510", "r511", "r512", "r636", "r653", "r661", "r684", "r717", "r718", "r724", "r746" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r244", "r465", "r507", "r508", "r509", "r510", "r511", "r512", "r636", "r653", "r661", "r684", "r717", "r718", "r724", "r746" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r296", "r297", "r298", "r299", "r366", "r368", "r370", "r371", "r372", "r463", "r464", "r513", "r552", "r553", "r619", "r620", "r621", "r622", "r623", "r633", "r634", "r645", "r652", "r656", "r662", "r665", "r712", "r721", "r738", "r739", "r740", "r741", "r742" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r296", "r297", "r298", "r299", "r366", "r368", "r370", "r371", "r372", "r463", "r464", "r513", "r552", "r553", "r619", "r620", "r621", "r622", "r623", "r633", "r634", "r645", "r652", "r656", "r662", "r665", "r712", "r721", "r738", "r739", "r740", "r741", "r742" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r192", "r193", "r314", "r341", "r459", "r640", "r641" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r211", "r369", "r682", "r704" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r252", "r253", "r255" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r211", "r369", "r682", "r683", "r704" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r706", "r733" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Relationship to Entity [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "ASU 2016-02" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of related party for accounts payable classified as current.", "label": "Accounts Payable, Current, Related Party, Type [Extensible Enumeration]" } } }, "localname": "AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableInterestBearingNoncurrent": { "auth_ref": [ "r31" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and due after one year (or beyond the operating cycle if longer) to vendors that bear interest at either a stated or an imputed rate.", "label": "Accounts Payable, Related Parties, Noncurrent", "terseLabel": "Payable to related parties, net - Non-current portion" } } }, "localname": "AccountsPayableInterestBearingNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableNoncurrentRelatedPartyTypeExtensibleEnumeration": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of related party for accounts payable classified as noncurrent.", "label": "Accounts Payable, Noncurrent, Related Party, Type [Extensible Enumeration]" } } }, "localname": "AccountsPayableNoncurrentRelatedPartyTypeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r247", "r248" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable, no allowance" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r52", "r155", "r499" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r34", "r35", "r99", "r164", "r495", "r521", "r525" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "verboseLabel": "Accumulated comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r4", "r14", "r35", "r397", "r400", "r452", "r516", "r517", "r690", "r691", "r692", "r701", "r702", "r703" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "verboseLabel": "Accumulated Comprehensive Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r94", "r660", "r749" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r373", "r374", "r375", "r539", "r701", "r702", "r703", "r726", "r754" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r199", "r200", "r201", "r202", "r211", "r249", "r250", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r291", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r382", "r383", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r418", "r419", "r421", "r422", "r423", "r424", "r435", "r436", "r440", "r441", "r442", "r443", "r448", "r449", "r450", "r451", "r452", "r467", "r468", "r469", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustment for non-cash items" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvanceRoyalties": { "auth_ref": [ "r470" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount paid to music publishers, record producers, songwriters, or other artists in advance of their earning royalties from record or music sales. Such an amount is based on contractual terms and is generally nonrefundable.", "label": "Advance Royalties", "terseLabel": "Advance royalties" } } }, "localname": "AdvanceRoyalties", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of Land", "verboseLabel": "Area of land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r127", "r157", "r189", "r230", "r238", "r242", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r386", "r390", "r420", "r490", "r577", "r660", "r674", "r719", "r720", "r735" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r152", "r167", "r189", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r386", "r390", "r420", "r660", "r719", "r720", "r735" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r189", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r386", "r390", "r420", "r719", "r720", "r735" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total long term assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "verboseLabel": "Long term assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BankOverdrafts": { "auth_ref": [ "r27", "r53" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.", "label": "Bank Overdrafts", "terseLabel": "Bank overdraft" } } }, "localname": "BankOverdrafts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation and Consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r380", "r654", "r655" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r62", "r64", "r380", "r654", "r655" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [ "r124" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "verboseLabel": "Fair value of Common Stock" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Number of Common stock", "verboseLabel": "Number of shares" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "verboseLabel": "Share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r1", "r2", "r12" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "verboseLabel": "Purchase consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r1", "r2" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Fair value of warrant" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r65", "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Fair value of net liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r135", "r492", "r550", "r571", "r660", "r674", "r685" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r40", "r109", "r185" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and restricted cash, end of year", "periodStartLabel": "Cash and restricted cash, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r3", "r109" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and restricted cash during the year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Cash" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "NON-CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r145", "r160", "r161", "r162", "r189", "r215", "r216", "r220", "r222", "r228", "r229", "r256", "r301", "r303", "r304", "r305", "r308", "r309", "r339", "r340", "r343", "r346", "r353", "r420", "r530", "r531", "r532", "r533", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r551", "r563", "r586", "r611", "r626", "r627", "r628", "r629", "r630", "r680", "r697", "r705" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r160", "r161", "r162", "r228", "r339", "r340", "r341", "r343", "r346", "r351", "r353", "r530", "r531", "r532", "r533", "r652", "r680", "r697" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Stockholders' Equity" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise prices", "verboseLabel": "Class of warrant or right, exercise price of warrants or rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Class of warrant or right, number of securities called by warrants or rights", "verboseLabel": "Warrants to purchase shares of common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants issued to purchase shares of common stock", "verboseLabel": "Warrants outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r32", "r84", "r491", "r562" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "verboseLabel": "Contingencies and commitments" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingencies and commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r116", "r293", "r294", "r632", "r713" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies and commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r663", "r664", "r665", "r667", "r668", "r669", "r670", "r701", "r702", "r726", "r747", "r754" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r93", "r563" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Number of shares issued", "verboseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r93", "r563", "r583", "r754", "r755" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r93", "r494", "r660" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r36", "r170", "r172", "r177", "r485", "r505" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r42", "r43", "r44" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted", "terseLabel": "Conversion of stock, shares converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Current", "verboseLabel": "Convertible promissory notes, net" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r105", "r465" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "COST OF GOOD SOLD", "verboseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Conversion [Line Items]", "terseLabel": "Convertible Promissory Notes" } } }, "localname": "DebtConversionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r42", "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Amount", "terseLabel": "Principal balance of convertible promissory notes" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionTable": { "auth_ref": [ "r42", "r44" ], "lang": { "en-us": { "role": { "documentation": "A table that contains information on an original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion [Table]" } } }, "localname": "DebtConversionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Promissory Notes" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r117", "r187", "r310", "r316", "r317", "r318", "r319", "r320", "r321", "r326", "r333", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Convertible Promissory Notes" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r21", "r89", "r90", "r128", "r129", "r194", "r311", "r312", "r313", "r314", "r315", "r317", "r322", "r323", "r324", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r438", "r647", "r648", "r649", "r650", "r651", "r698" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r78", "r80", "r311", "r438", "r648", "r649" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Principal amount outstanding", "verboseLabel": "Principal balance" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r29", "r312" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Annual interest rate", "verboseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r30", "r194", "r311", "r312", "r313", "r314", "r315", "r317", "r322", "r323", "r324", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r438", "r647", "r648", "r649", "r650", "r651", "r698" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Five [Member]", "terseLabel": "Fifth year of the term" } } }, "localname": "DebtInstrumentRedemptionPeriodFiveMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodFourMember": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Four [Member]", "terseLabel": "Fourth year of the term" } } }, "localname": "DebtInstrumentRedemptionPeriodFourMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "First year of the term" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Three [Member]", "terseLabel": "Third year of the term" } } }, "localname": "DebtInstrumentRedemptionPeriodThreeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "Second year of the term" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "verboseLabel": "Debt term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredFinanceCostsCurrentNet": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Current, Net", "terseLabel": "Debt issuance costs, current" } } }, "localname": "DeferredFinanceCostsCurrentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r79", "r722" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "verboseLabel": "Outstanding balance of debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Noncurrent, Net", "terseLabel": "Debt issuance costs, non-current" } } }, "localname": "DeferredFinanceCostsNoncurrentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r8", "r51" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r8", "r51" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation expense" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r725" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedTerseLabel": "Change in fair value of derivative and warrant liability" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r168" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "periodEndLabel": "Derivative liability, end of the period", "periodStartLabel": "Derivative liability, beginning of the period", "verboseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesRecordedAndFairValuedDerivativeLiabilityDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r168" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "verboseLabel": "Warrant liability" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityMeasurementInput": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure derivative liability.", "label": "Derivative Liability, Measurement Input", "terseLabel": "Derivative liability, measurement input" } } }, "localname": "DerivativeLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r178", "r203", "r204", "r205", "r206", "r207", "r213", "r215", "r220", "r221", "r222", "r226", "r413", "r414", "r486", "r506", "r642" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Earnings (loss) per share - basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r178", "r203", "r204", "r205", "r206", "r207", "r215", "r220", "r221", "r222", "r226", "r413", "r414", "r486", "r506", "r642" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Earnings (loss) per share - diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r212", "r223", "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureEarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r729" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "verboseLabel": "Effect of foreign currency translation" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r15", "r148", "r173", "r174", "r175", "r195", "r196", "r197", "r200", "r208", "r210", "r227", "r261", "r267", "r355", "r373", "r374", "r375", "r378", "r379", "r395", "r397", "r398", "r399", "r400", "r402", "r412", "r429", "r430", "r431", "r432", "r433", "r434", "r452", "r516", "r517", "r518", "r539", "r611" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of equity interests that are issued or issuable in a business combination.", "label": "Equity Interest Type [Axis]" } } }, "localname": "EquityInterestIssuedOrIssuableByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.", "label": "Equity Interest Issued or Issuable, Type [Domain]" } } }, "localname": "EquityInterestIssuedOrIssuableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "verboseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r235", "r251", "r686", "r707" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Investment in joint venture" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Joint Venture" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r143", "r254", "r257", "r681" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "verboseLabel": "Joint Venture" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVenture" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r6", "r77", "r253" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments [Policy Text Block]", "verboseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Movement of the warrant liability" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityMovementOfWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r17", "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of movement of the warrant liability" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Warrant liability for new issuance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityMovementOfWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "terseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityMovementOfWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r17" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Warrant liability, Ending balance", "periodStartLabel": "Warrant liability, Beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityMovementOfWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r11", "r20" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "verboseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r286", "r287", "r288", "r289", "r466", "r471" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r49", "r50" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r425", "r426", "r427", "r428", "r608" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Exchange loss (income)" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture And Fixtures [Member]", "terseLabel": "Furniture & fixture" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r714" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement", "terseLabel": "Gain on settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r156", "r272", "r484", "r646", "r660", "r710", "r711" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill.", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r271", "r274", "r284", "r646" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r8", "r273", "r279", "r285", "r646" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Impairment of goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [ "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r285", "r646" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r709" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Period Increase (Decrease)", "terseLabel": "Goodwill of period increase (decrease)" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r104", "r189", "r230", "r237", "r241", "r243", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r420", "r644", "r719" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r100", "r132", "r230", "r237", "r241", "r243", "r487", "r502", "r644" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Net income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r8", "r101", "r131", "r234", "r251", "r501" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Investment (income) loss from joint venture", "negatedTerseLabel": "Share of (income) loss from joint venture" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r290", "r292", "r594" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r292", "r594" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r7" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Change in accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r217", "r218", "r222" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities", "terseLabel": "Convertible notes, warrants and preferred stock into common shares" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r79", "r134", "r176", "r233", "r437", "r595", "r672", "r751" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense", "verboseLabel": "Interest and bank charges" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r108", "r330", "r337", "r650", "r651" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest amount" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of related party for interest expense.", "label": "Interest Expense, Related Party, Type [Extensible Enumeration]" } } }, "localname": "InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_InterestIncomeOperating": { "auth_ref": [ "r103", "r587", "r624", "r625", "r671", "r672", "r757" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.", "label": "Interest Income, Related Party", "terseLabel": "Interest income" } } }, "localname": "InterestIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r180", "r183", "r184" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivable": { "auth_ref": [ "r689", "r756" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.", "label": "Interest Receivable", "verboseLabel": "Interest receivable" } } }, "localname": "InterestReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureInventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r165", "r637", "r660" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "verboseLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureInventoryDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r8" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Shares and warrants issued/to be issued for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Right-Of-Use Assets and Lease Liability" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r106" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees", "verboseLabel": "Legal and professional fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "Lessee, Operating Lease, Discount Rate", "terseLabel": "Weighted average discount rate" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r732" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of maturities of lease liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r447" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r447" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r447" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r447" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r447" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r447" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r731" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Term of contract" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Operating Lease Right-Of-Use Assets and Lease Liability" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r26", "r189", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r387", "r390", "r391", "r420", "r561", "r643", "r674", "r719", "r735", "r736" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Current liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r98", "r130", "r497", "r660", "r699", "r708", "r728" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' deficiency" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "LIABILITIES AND STOCKHOLDERS' DEFICIENCY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r28", "r153", "r189", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r387", "r390", "r391", "r420", "r660", "r719", "r735", "r736" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r21", "r86", "r87", "r88", "r91", "r189", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r387", "r390", "r391", "r420", "r719", "r735", "r736" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total long term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Long term liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r21", "r129", "r744" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "verboseLabel": "Outstanding loan" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r23" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "verboseLabel": "Maximum loan" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityPeriodicPaymentInterest": { "auth_ref": [ "r23" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payment applied to interest.", "label": "Line of Credit Facility, Periodic Payment, Interest", "terseLabel": "Interest expense on loan" } } }, "localname": "LineOfCreditFacilityPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded to Other Party", "terseLabel": "Settlement amount" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r21", "r129", "r323", "r336", "r648", "r649", "r744" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetailsCalc2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r158" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetailsCalc2": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.", "label": "Long-Term Debt, Current Maturities", "negatedLabel": "Current portion" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r10", "r194", "r328" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r10", "r194", "r328" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r700" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r159" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetailsCalc2": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Non-current portion" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesRepaymentScheduleOfMinimumPrincipalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [ "r295", "r296", "r297", "r300", "r715", "r716" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r295", "r296", "r297", "r300", "r715", "r716" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r295", "r682" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "terseLabel": "Amount payable" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [ "r714", "r715", "r716" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.", "label": "Loss Contingency, Damages Sought, Value", "terseLabel": "Approximate lawsuit, amount" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureContingenciesAndCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery & equipment", "verboseLabel": "Machinery & Equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r81", "r589", "r672", "r750" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.", "label": "Management Fee Expense", "verboseLabel": "Management services fee" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ManagementFeePayable": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fee payable for management of fund or trust.", "label": "Management Fee Payable", "terseLabel": "Outstanding management service fee" } } }, "localname": "ManagementFeePayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input, Exercise Price [Member]", "verboseLabel": "Exercise price" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Expected dividend rate", "verboseLabel": "Dividend yield" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Liquidity term", "verboseLabel": "Expected life" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk free interest rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "verboseLabel": "Stock price" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Noncontrolling interest, ownership percentage by noncontrolling owners" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r182" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r182" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r109", "r110", "r111" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r102", "r111", "r133", "r151", "r169", "r171", "r175", "r189", "r199", "r203", "r204", "r205", "r206", "r209", "r210", "r219", "r230", "r237", "r241", "r243", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r414", "r420", "r504", "r585", "r609", "r610", "r644", "r672", "r719" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r198", "r199", "r200", "r201", "r202", "r205", "r211", "r226", "r249", "r250", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r291", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r382", "r383", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r418", "r419", "r421", "r422", "r423", "r424", "r435", "r436", "r440", "r441", "r442", "r443", "r448", "r449", "r450", "r451", "r452", "r467", "r468", "r469", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r528" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "Operating Lease Right-Of-Use Assets and Lease Liability" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r45", "r146", "r147", "r148", "r149", "r150", "r198", "r199", "r200", "r201", "r202", "r205", "r211", "r226", "r249", "r250", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r291", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r382", "r383", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r418", "r419", "r421", "r422", "r423", "r424", "r435", "r436", "r440", "r441", "r442", "r443", "r448", "r449", "r450", "r451", "r452", "r467", "r468", "r469", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r528" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1": { "auth_ref": [ "r42", "r43", "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Intangible Assets Acquired", "verboseLabel": "Shares issued as consideration for services" } } }, "localname": "NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r107" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Total other expense (income)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "terseLabel": "Operation expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "verboseLabel": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r730" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r446" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r446" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "negatedLabel": "Current portion", "verboseLabel": "Operating lease liability - Current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r446" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Non-current portion", "verboseLabel": "Operating lease liability - Non-current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityMaturitiesDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r445" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "verboseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Nature of Business, Going Concern and Management Plans" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r85", "r125", "r526", "r527" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Organization, Nature of Business, Going Concern and Management Plans" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r5", "r13", "r126" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustment", "verboseLabel": "Foreign currency translation" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r83", "r489", "r557", "r558", "r674", "r748" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Due to Related Parties", "terseLabel": "Amounts due to related parties" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r27", "r660" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Due to Officers or Stockholders, Current", "terseLabel": "Shareholder advances [Note 15]" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r179" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "negatedLabel": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "OTHER EXPENSES (INCOME)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of related party for receivable, after allowance for credit loss, classified as other and current.", "label": "Other Receivable, after Allowance for Credit Loss, Current, Related Party, Type [Extensible Enumeration]" } } }, "localname": "OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of related party for receivable, after allowance for credit loss, classified as other.", "label": "Other Receivable, after Allowance for Credit Loss, Related Party, Type [Extensible Enumeration]" } } }, "localname": "OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r163", "r572" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other Receivables", "terseLabel": "Other receivable", "verboseLabel": "Debt outstanding amount" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Due From Joint Ventures, Current", "verboseLabel": "Loans advanced amounts" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverTheCounterMember": { "auth_ref": [ "r641" ], "lang": { "en-us": { "role": { "documentation": "Transaction that does not take place on an organized exchange.", "label": "Over-the-Counter [Member]", "terseLabel": "Over the Counter" } } }, "localname": "OverTheCounterMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Parent" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r663", "r664", "r667", "r668", "r669", "r670", "r747", "r754" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r92", "r339" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r92", "r563" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r92", "r339" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r92", "r563", "r583", "r754", "r755" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r92", "r493", "r660" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r166", "r269", "r270", "r638" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "verboseLabel": "Prepaid asset" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private placements" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture": { "auth_ref": [ "r37" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.", "label": "Proceeds from Divestiture of Interest in Joint Venture", "terseLabel": "Recovery of investment", "verboseLabel": "Net proceeds from joint venture" } } }, "localname": "ProceedsFromDivestitureOfInterestInJointVenture", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r693" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "verboseLabel": "Debt issued" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r38" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from loans from related parties" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfBankOverdrafts": { "auth_ref": [ "r693", "r694", "r695" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow from the excess drawing from an existing cash balance, which will be honored by the bank but reflected as a loan to the drawer.", "label": "Proceeds from (Repayments of) Bank Overdrafts", "terseLabel": "Utilization of bank overdraft facility" } } }, "localname": "ProceedsFromRepaymentsOfBankOverdrafts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r672", "r752", "r753" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees", "verboseLabel": "Advisory and consultancy fee" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r151", "r169", "r171", "r181", "r189", "r199", "r209", "r210", "r230", "r237", "r241", "r243", "r256", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r385", "r388", "r389", "r414", "r420", "r487", "r503", "r538", "r585", "r609", "r610", "r644", "r657", "r658", "r673", "r692", "r719" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net (loss) for the period" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r114", "r138", "r141", "r142" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r115", "r154", "r500" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "FIXED ASSETS" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r9", "r488", "r500", "r660" ], "calculation": { "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Fixed assets", "totalLabel": "Fixed assets, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r9", "r138", "r141", "r498" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of fixed assets" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r367", "r456", "r457", "r556", "r557", "r558", "r559", "r560", "r582", "r584", "r618" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyMember": { "auth_ref": [ "r190", "r191", "r456", "r457", "r458", "r459", "r556", "r557", "r558", "r559", "r560", "r582", "r584", "r618" ], "lang": { "en-us": { "role": { "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family.", "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r456", "r457", "r734" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r590", "r591", "r594" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transactions and Balances" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Purchases from Related Party", "terseLabel": "Purchase goods, value" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.", "label": "Related Party Transaction, Rate", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "RelatedPartyTransactionRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions and Balances" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r367", "r456", "r457", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r556", "r557", "r558", "r559", "r560", "r582", "r584", "r618", "r734" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r453", "r454", "r455", "r457", "r460", "r535", "r536", "r537", "r592", "r593", "r594", "r615", "r617" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions and Balances" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalances" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r694" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.", "label": "Repayments of Debt", "terseLabel": "Payment of consideration in cash" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r39" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Settlement of related party loan" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r685", "r696", "r743", "r745" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r95", "r121", "r496", "r520", "r525", "r534", "r564", "r660" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "negatedLabel": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r148", "r195", "r196", "r197", "r200", "r208", "r210", "r261", "r267", "r373", "r374", "r375", "r378", "r379", "r395", "r398", "r399", "r402", "r412", "r516", "r518", "r539", "r754" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r231", "r232", "r236", "r239", "r240", "r244", "r245", "r246", "r364", "r365", "r465" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Sales", "verboseLabel": "REVENUE" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r144", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r635" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition, Policy [Policy Text Block]", "verboseLabel": "Revenue recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Consideration for the shares sold" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Number of shares sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock, price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Sales tax payable", "verboseLabel": "Gross sales tax payable" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]", "verboseLabel": "Gross Sales" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r62", "r64" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of business acquisitions" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r16", "r67", "r68", "r69", "r70", "r71", "r72", "r73", "r74" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "verboseLabel": "Schedule of fair value of the derivative liability" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [ "r189", "r252", "r253", "r255", "r256", "r420" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Joint Venture, JVCo" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r151", "r189", "r252", "r253", "r255", "r256", "r420" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureJointVentureAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureJointVentureSummarizesActivityOfPeriodOfJvcoDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r49", "r50", "r466" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r285", "r646" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Schedule of repayment of the minimum principal payments" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of recognized identified assets acquired and liabilities assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r81", "r82", "r590", "r591", "r594" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesShareholderLoanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r54", "r55", "r56", "r57", "r58", "r59", "r60", "r119", "r120", "r121", "r160", "r161", "r162", "r228", "r339", "r340", "r341", "r343", "r346", "r351", "r353", "r530", "r531", "r532", "r533", "r652", "r680", "r697" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of fair value of the warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r687", "r688", "r723" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A preferred stock" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price", "verboseLabel": "Exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "verboseLabel": "Expected dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "verboseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "verboseLabel": "Stock price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Remaining contractual life term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails", "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Shares, outstanding" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureConvertiblePromissoryNotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r112", "r186" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software and Software Development Costs [Member]", "terseLabel": "Software" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureFixedAssetsDetails", "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r145", "r160", "r161", "r162", "r189", "r215", "r216", "r220", "r222", "r228", "r229", "r256", "r301", "r303", "r304", "r305", "r308", "r309", "r339", "r340", "r343", "r346", "r353", "r420", "r530", "r531", "r532", "r533", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r551", "r563", "r586", "r611", "r626", "r627", "r628", "r629", "r630", "r680", "r697", "r705" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r15", "r33", "r148", "r173", "r174", "r175", "r195", "r196", "r197", "r200", "r208", "r210", "r227", "r261", "r267", "r355", "r373", "r374", "r375", "r378", "r379", "r395", "r397", "r398", "r399", "r400", "r402", "r412", "r429", "r430", "r431", "r432", "r433", "r434", "r452", "r516", "r517", "r518", "r539", "r611" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r195", "r196", "r197", "r227", "r465", "r529", "r551", "r554", "r556", "r557", "r558", "r559", "r560", "r563", "r566", "r567", "r568", "r569", "r570", "r573", "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r582", "r584", "r588", "r589", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r611", "r666" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line item]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r195", "r196", "r197", "r227", "r465", "r529", "r551", "r554", "r556", "r557", "r558", "r559", "r560", "r563", "r566", "r567", "r568", "r569", "r570", "r573", "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r582", "r584", "r588", "r589", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r611", "r666" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "verboseLabel": "Shares issued as consideration for advisory and other services (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r15", "r92", "r93", "r121", "r530", "r611", "r627" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Shares issued as consideration for private placement (in shares)", "verboseLabel": "Shares issued for prior private placements (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "verboseLabel": "Shares issued as consideration for advisory and other services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r93", "r96", "r97", "r113", "r565", "r583", "r612", "r613", "r660", "r674", "r699", "r708", "r728", "r754" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders' deficiency", "verboseLabel": "Value of shares, outstanding" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' deficiency" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r118", "r188", "r338", "r340", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r355", "r403", "r614", "r616", "r631" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "SUPPLEMENTARY CASH FLOW INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r641" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction [Domain]" } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r641" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r199", "r200", "r201", "r202", "r211", "r249", "r250", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r291", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r382", "r383", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r418", "r419", "r421", "r422", "r423", "r424", "r435", "r436", "r440", "r441", "r442", "r443", "r448", "r449", "r450", "r451", "r452", "r467", "r468", "r469", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOperatingLeaseRightOfUseAssetsAndLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureOrganizationNatureOfBusinessGoingConcernAndManagementPlansDetails", "http://www.targetgroupinc.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r46", "r47", "r48", "r136", "r137", "r139", "r140" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValueAddedTaxReceivableCurrent": { "auth_ref": [ "r689" ], "calculation": { "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Value Added Tax Receivable, Current", "terseLabel": "Sales tax recoverable, net of allowance", "verboseLabel": "Sales tax recoverable, gross" } } }, "localname": "ValueAddedTaxReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureSalesTaxRecoverableAndPayableDetails", "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r663", "r664", "r667", "r668", "r669", "r670" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillPurchaseConsiderationDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityDetails", "http://www.targetgroupinc.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "terseLabel": "Derivative liability, measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/DisclosureGoodwillAdditionalInformationDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r214", "r222" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares - diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r213", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.targetgroupinc.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org//323/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//350-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "50", "Subparagraph": "(a)", "Topic": "405", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483172/928-340-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "39", "Publisher": "FASB", "Section": "45", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-39", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r675": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r676": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r677": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r678": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r679": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(f)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r713": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 72 0001410578-23-001629-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-23-001629-xbrl.zip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�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�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�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end